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Abstract 
 
The term inflammation comprises the physiologic response of the organism to unchecked 
tissue damage from infection or injury. In spite of being a body’s natural defence, the 
inflammatory response may contribute to the development of pathologic processes when 
the anti-inflammatory defences of the organism are not enough to contain and antagonize 
the deleterious activities of the overproduced pro-inflammatory mediators. Chronic 
inflammatory diseases, like rheumatoid arthritis, Crohn’s disease, Alzheimer’s disease, 
diabetes, among others, are responsible for the permanent affliction, disability, and, many 
times, premature death of millions of patients. They constitute a heavy burden for modern 
society.  Unfortunately, the traditional steroidal or non-steroidal anti-inflammatory 
therapies are either not enough or associated with too many side effects. New therapeutic 
approaches are urgently required – more efficient and safer new drugs. 
In recent years, flavonoids have been associated with various health benefits, including its 
anti-inflammatory effects. These properties associated with their ubiquitous distribution in 
nature, and their presence in the great majority of foods, as part of our daily diet, made 
flavonoids great value-added molecules. Taking in account these potential anti-
inflammatory properties, flavonoids started to be considered a valuable alternative to 
modulate and prevent inflammatory processes; and moreover, to be the base to the 
synthesis of more potent and efficient anti-inflammatory drugs. The work developed in this 
PhD thesis intends to extend and rationalize the current knowledge on the alleged anti-
inflammatory properties of flavonoids by elucidating the mechanism of action related with 
their structure (structure-activity relationship). For this purpose, a group of 24 flavonoids 
were selected, belonging to three flavonoid classes, flavones, flavanones and flavonols. 
The first approach was based on the modulation of human neutrophils’ oxidative burst. All 
the flavonoids under study effectively inhibited the production of reactive oxygen species, 
in this in vitro model. The structural feature that determined the greater activity was the 
presence of a catechol group in B-ring. 
In a second approach, the ability of flavonoids to inhibit the leukotriene B4 production was 
evaluated. Flavonoids with a catechol group in B-ring were shown to be the most 
effective. In this same work, the type of inhibition of lipoxygenase and the interaction 
between the flavonoids and this enzyme were evaluated. It was clear that both the 
substituents in B-ring and A-ring influenced these parameters. 
The third work concerned the study of the inhibition of the production of prostaglandin 
(PG)E2, via cyclooxygenase (COX)-1 and -2. There were obvious differences between the 
flavonoids tested. Selective inhibitors of COX-1 and COX-2 were found. The best 
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inhibitors of PGE2 production – via COX-2 were also excellent inhibitors of the production 
of the studied cytokines. 
Finally the pro-apoptotic activity of the selected flavonoids was evaluated and all of them 
revealed to induce neutrophils’ apoptosis, via caspase pathways, although no 
mitochondrial involvement could be observed, suggesting a key role of the extrinsic 
apoptotic pathway. 
The experimental studies performed in the scope of this thesis allowed the conclusion that 
among the tested flavonoids, the ones with a catechol group in B-ring revealed overall 
best anti-inflammatory activities. Indeed, flavonoids 3’,4’- dihydroxyflavone, 5,3’,4’-
trihydroxyflavone, 7,3’,4’-trihydroxyflavone, and luteolin are undoubtedly good modulators 
of all the pro-inflammatory mediators evaluated. 
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Resumo 
 
O termo “inflamação” engloba uma resposta fisiológica do organismo a agressões 
tecidulares por infecção ou ferimento. Apesar de ser uma resposta natural de defesa, a 
resposta inflamatória pode contribuir para o desenvolvimento de processos patológicos 
quando as defesas anti-inflamatórias do organismo não são suficientes para conter e 
antagonizar os efeitos deletérios dos mediadores inflamatórios. As doenças crónicas 
inflamatórias, como a artrite reumatóide, a doença de Crohn, a doença de Alzheimer, a 
diabetes, entre outras são responsáveis pelo permanente sofrimento, incapacidade e, 
muitas vezes, pela morte prematura de milhões de doentes, constituindo assim um 
pesado fardo para a sociedade. Infelizmente, as terapias anti-inflamatórias tradicionais, 
com fármacos esteroides e não-esteroides, não são suficientes ou estão associadas a 
demasiados efeitos secundários. São assim necessárias novas abordagens terapêuticas 
urgentes – novos fármacos mais eficientes e seguros.  
Recentemente, os flavonoides têm vindo a ser associados a vários benefícios em saúde, 
incluindo os seus efeitos anti-inflamatórios. Estas propriedades, associadas à sua ampla 
distribuição na natureza, e presença na maioria dos produtos alimentares, como parte 
integral da dieta do dia-a-dia, têm feito dos flavonoides moléculas de excelente valor 
acrescentado. Tendo em conta estas potenciais propriedades anti-inflamatórias, os 
flavonoides começaram a ser considerados uma alternativa válida na modulação e 
prevenção do processo inflamatório; e ainda como base para a síntese de fármacos anti-
inflamatórios mais potentes e eficientes. O trabalho desenvolvido nesta tese de 
doutoramento pretende ampliar e tornar mais racional o conhecimento corrente acerca 
das propriedades anti-inflamatórias dos flavonoides, através da relação entre o seu 
mecanismo de ação e a sua estrutura (relação estrutura-atividade). Com esta finalidade, 
foi seleccionado um grupo de 24 flavonoides, pertencentes a três classes diferentes, 
flavonas, flavanonas e flavonois. 
A primeira abordagem baseou-se na modulação do burst oxidativo de neutrófilos pelos 
flavonoides. Todos os flavonoides em estudo inibiram de forma efectiva a produção de 
espécies reativas de oxigénio neste modelo in vitro. A característica estrutural que 
determinou uma melhor actividade foi o grupo catecol no anel B. 
No segundo trabalho foi estudada a capacidade dos flavonoides para inibirem a produção 
do leucotrieno B4. Mais uma vez, os melhores inibidores desta produção foram os 
flavonoides com o grupo catecol no anel B. Neste mesmo trabalho foi avaliada o tipo de 
inibição da lipoxigenase e a interacção entre esta e os flavonoides. Ficou claro que quer 
os substituintes no anel A, quer os do anel B influenciavam estes parâmetros. 
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O terceiro trabalho residiu no estudo da inibição da prostaglandina (PG)E2, via 
ciclooxigenase (COX)-1 e -2. Observaram-se diferenças óbvias entre os flavonoides 
testados. Foram encontrados inibidores selectivos das COX-1 e COX-2. Os melhores 
inibidores da PGE2-via COX-2 foram também excelentes inibidores da produção das 
citocinas estudadas. 
Finalmente, foi avaliada a actividade pro-apoptótica dos flavonoides selecionados e todos 
eles revelaram induzir a apoptose dos neutrófilos, pelas vias das caspases, embora não 
tenha sido observado o envolvimento mitocondrial, sugerindo um papel-chave da via 
extrínseca da apoptose. 
Os estudos experimentais realizados no âmbito desta tese permitem concluir que de 
entre os flavonoides estudados, aqueles que possuem um grupo catecol no anel B, foram 
os que revelaram uma melhor atividade anti-inflamatória global. De facto, os flavonoides 
3’,4’- dihidroxiflavone, 5,3’,4’-trihidroxiflavone, 7,3’,4’-trihidroxiflavone e a luteolin foram, 
indubitavelmente, bons moduladores de todos os mediadores inflamatórios avaliados. 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Flavonoides, Neutrófilos Humanos, Lipoxigenase, Ciclooxigenases, 
Apoptose. 
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 CHAPTER I. General Introduction 
 
I.1. Introduction 
 
Inflammation has become one of the hottest areas of biomedical research. An immense 
array and variety of inflammatory mechanisms are known to underlie serious chronic 
diseases and conditions. It is known that inflammation triggers and/or accelerates 
rheumatoid arthritis, osteoarthritis, inflammatory bowel diseases and is often involved in 
cardiovascular, neurodegenerative, and cancer diseases. With so many diseases at 
stake, affecting so many people, developing effective and safe anti-inflammatory drugs 
should be a top priority. It is true that a myriad of anti-inflammatory molecules are in the 
therapeutic market, but it is also true the traditional steroidal or non-steroidal anti-
inflammatory therapies are either not enough or associated with too many side effects. 
New therapeutic approaches are urgently required – more efficient and safer new drugs. 
Flavonoids, a large class of polyphenols, comprise a wide group of molecules, with a 
great structural variety, organized in subclasses. In recent years, the interest in those 
various classes of flavonoids has been growing due to their various beneficial healthy and 
pharmacological properties. These health promoting properties are probably due to their 
ability to interfere with pro-oxidant and pro-inflammatory systems, preventing their 
deleterious consequences. 
In this thesis a large group of selected flavonoids, belonging to three different flavonoid 
subclasses, flavones, flavanones, and flavonols, were evaluated concerning their ability to 
modulate pro-oxidant systems, key enzymes, and signalling pathways that are involved in 
inflammatory processes, to extend and rationalize the current knowledge on the alleged 
anti-inflammatory properties of flavonoids by elucidating the mechanism of action related 
with their structure (structure-activity relationship). 
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 I.2. General and specific objectives of the thesis 
 
The main objective of this thesis was to evaluate the modulating effect of a group of 
selected flavonoids, in in vitro models of inflammation, namely on the oxidative burst of 
human neutrophils, neutrophil’s apoptosis, as well as in pro-inflammatory enzymes, and 
pro-inflammatory signalling pathways in whole human blood. We expect to contribute for 
the definition of the best structure-activity relationship and consequently for the 
development of better and safer anti-inflammatory drugs. 
 
 
As specific objectives, we aimed to evaluate the effects of a series of flavonoids in: 
 
 The oxidative burst of human neutrophils. 
 The activity of LOX in human neutrophils. 
 The apoptotic effect in human neutrophils and respective pathways. 
 The activities of COX-1 and COX-2 enzymes in human whole blood. 
 The production of pro-inflammatory cytokines and chemokines, in human whole 
blood. 
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 I.3. Outline of the thesis 
 
This thesis is organized in four main chapters: 
 
Chapter I. General introduction 
This chapter is divided in three sections: the first section (I.1) includes a brief theoretical 
background of the thesis theme and the general motivation and objectives; the second 
section (I.2) comprises the main and the specifics objectives of this thesis; the last section 
(I.3) covers a general description of the other chapters, namely their organization and 
structure. 
 
 
Chapter II. Theoretical Background 
This chapter includes one section (II.1.), which comprises a review article, providing a 
comprehensive description of the inflammatory process and its mediators. This article also 
provides the state of the art concerning the main anti-inflammatory effects of flavonoids. 
 
 
Chapter III. Original Research 
This chapter is divided in four sections corresponding to published (III.1, III.2, III.3) and 
one submitted (II.4) original manuscripts, which resulted from the experimental studies 
designed to answer the questions that derived from the general and specific objectives of 
this thesis. 
 
 
Chapter IV. Discussion and Conclusions 
This chapter is divided in three sections: the first one (IV.1) consists in an integrated 
discussion of the performed original research; the second one (IV.2) comprises the 
general conclusions of the thesis and the third section (IVI.3) contains the references. 
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 CHAPTER II. Theoretical Background 
 
II.1. Pro-inflammatory pathways: the modulation by 
flavonoids 
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 Abstract 
Inflammation is a natural, carefully orchestrated response of the organism to tissue 
damage, involving various signalling systems and the recruitment of inflammatory cells. 
These cells are stimulated to release a myriad of mediators that amplify the inflammatory 
response and recruit additional cells. These mediators present numerous redundancies of 
functions, allowing a broad and effective inflammatory response, but simultaneously make 
the understanding of inflammation pathways much difficult. The extent of the inflammatory 
response is usually self-limited, although it depends on the balance between the pro- and 
anti-inflammatory signals. When that equilibrium is dislocated, a more widespread 
inflammatory response may take place. 
Flavonoids have been shown to be possible alternatives to the traditionally molecules 
used as anti-inflammatory agents. In fact, the biological activities of flavonoids include the 
modulation of the diverse phases of inflammatory processes, from the gene transcription 
and expression to the inhibition of the enzymatic activities and the scavenging of the 
reactive species. In the present manuscript, the inflammatory network and the flavonoids’ 
broad spectrum of action in many of the analysed inflammatory pathways are reviewed. 
 
 
 
 
 
 
 
 
 
 
Keywords: Flavonoids, Inflammatory pathways, Eicosanoids, Reactive species, 
Cytokines, Transcription factors. 
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 1. Introduction 
1.1. Inflammation 
 1.1.1. The Concept 
The word inflammation comprises the physiologic response of the organism to unchecked 
tissue damage from infection or injury; the inflammatory response is a body’s natural 
defence.1,2 Historically, there are Epyptian papyrus dated around 3000 BC already 
describing clinical features of inflammation. However, it was only in the first century AD 
that a Roman writer, Celsus, first listed the four cardinal signs of inflammation: rubor 
(redness), tumor (swelling), calor (heat) and dolor (pain).3 In the 19th century a fifth sign 
was added, loss of function (functio laesa). This addition is attributed to Rudolf Virchow, 
however some authors attribute it to Galen’s work during the 2nd century. Even though 
the latter has referred the disturbed function, he did not define the term loss of function as 
a specific symptom of inflammation, as Virchow did.2,4 Along the 19th century, other 
fundamental developments were made: the definition of inflammation not as a disease but 
as a nonspecific response in the host, the discovery of phagocytosis mechanism and the 
process of phagocytic cells’ recruitment to the injured area to engulf invading bacteria, 
and the discovery of molecules that mediate the vascular changes of inflammation. These 
events corresponded to the underlying basis for the important findings of chemical 
mediators of inflammation and the use of anti-inflammatory drugs in clinical medicine.3 
Inflammation is a carefully orchestrated response of the organism, involving endothelial 
cells, epithelial cells and the recruitment of inflammatory cells such as neutrophils, 
monocytes, macrophages, and, in some cases, lymphocytes.1 The local cells along with 
the recruited ones are stimulated to release a myriad of mediators that amplify the 
inflammatory response and recruit additional cells.5 Several functional redundancies have 
been noted for these mediators that allow a broad and effective response, but 
simultaneously hinder the understanding of the inflammation’s pathways.2 Regardless the 
self-limited physiology of the inflammatory response, it depends on the balance between 
the pro- and anti-inflammatory signals, and when that equilibrium is dislocated, a more 
widespread inflammatory response takes place.1 At this point, it is crucial to support the 
inflammation resolution with molecules that act as effective modulators of the various 
processes sheltered in the inflammation network. 
 
 1.1.2. Acute Inflammation vs Chronic Inflammation 
The inflammatory process may be classified as acute or chronic, according to the nature 
and the effectiveness of the initial response. The acute inflammation is defined as a 
transient and initial response to injury. It is rapid in onset and is of short duration, lasting 
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 for hours or a few days. It is characterized by the release of numerous chemical 
mediators, and leads to the exudation of fluid and plasma proteins (edema) and the 
migration of leukocytes, predominantly neutrophils.3,6 Acute inflammation may have 
different stimuli / causes: a) infections (bacterial, viral, fungal, parasitic) and microbial 
toxins; b) immune reactions, or hypersensitivity reactions, where the immune system 
damage the individual’s own tissues; c) tissue necrosis from various causes, ischemia, 
trauma, physical and chemical injury (e.g. thermal injury, irradiation, exposure to some 
environmental chemicals); d) hypoxia, which often underlies cell injury and it is mediated 
by a protein called hypoxia-induced factor-1α (HIF-1α), which is produced by cells 
deprived of oxygen and activates the transcription of many genes involved in 
inflammation; e) other stimuli: foreign bodies (e.g. splinters, dirt, sutures), because they 
cause traumatic tissue injury or carry microbes. The importance of this inflammatory 
process is related to the difficulty in the elimination of the stimuli, resulting in the 
persistence of the inflammation.3,7,8 When the acute inflammation is not enough to remove 
the invaders, it can progress to a chronic phase. The self-limiting response is turned into a 
loop, where the damage by itself attracts more pro-inflammatory mediators, in a resistant 
process to the normal feedback mechanisms.9 
Chronic inflammation is defined as a prolonged inflammation (weeks to months), where 
the tissue injury and the attempts to repair coexist.8 As described before, the chronic 
inflammation may follow the acute. However, it may also begin insidiously, as a low-grade 
response, without any manifestations of an acute reaction. This last form of chronic 
inflammation is associated with diseases such as rheumatoid arthritis, atherosclerosis, 
tuberculosis, and pulmonary fibrosis. It has also been implicated in the progression of 
cancer and in diseases such as Alzheimer disease.9 The chronic inflammation may have 
different stimuli / causes: a) infections by microorganisms that are difficult to eradicate is 
the most common cause; b) immune-mediated inflammatory diseases, as autoimmune 
diseases, which are caused by an excessive and inappropriate activation of the immune 
system; and c) prolonged exposure to potentially toxic agents, sterile, either exogenous 
(e.g. toxic plasma lipid components, that at least in part cause atherosclerosis) or 
endogenous (e.g. inhalation of particulate silica for prolonged periods).3,6,8 Chronic 
inflammatory diseases affect many people around the globe. The development of effective 
and safe anti-inflammatory drugs should be a top priority. However, the traditional 
steroidal or non-steroidal anti-inflammatory therapies are either not enough or associated 
with too many side effects. In recent years, flavonoids have attracted increasing interests 
due to their various beneficial pharmacological properties, probably due to their 
antioxidant and anti-inflammatory effects. 
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 1.2. Flavonoids 
 1.2.1. Definition, Classification and Nomenclature 
Flavonoids are part of the vast family of polyphenols, and were discovered by Albert 
Szent-Györgyi, while he was working on the isolation of vitamin C.10 They are bioactive 
molecules with important functions in plant cells. Flavonoids are the most widely 
distributed polyphenols in plants and fruits and an essential part of human diet. Flavonoids 
are structurally derived from benzo-ɣ-pyrone displaying a diphenylpropane (C6-C3-C6) 
basic structure, which consists of two benzene rings (A and B rings) linked by a pyran 
heterocyclic ring (C ring).11 There are various classes of flavonoids where they are 
grouped according to the oxidation and pattern of substitution of the C ring. What 
distinguishes the different flavonoids in the same class is the pattern of substitution of the 
A and B rings.12 Table 1 summarizes some dietary sources of flavonoids, according to 
their classes. 
 
Table 1 - Classification, structure and dietary sources of some flavonoids.  
Flavonoids 
Class 
Structure Flavonoid (examples) Dietary sources References 
Flavones 
 
Chrysin, apigenin, rutin, 
luteolin 
Fruit peel, red wine, red 
pepper, tomato skin, 
buckwheat 
12 
Flavonols 
 Quercetin, kaempferol, 
myricetin, fisetin, 
galangin 
Onion, red wine, olive 
oil, berries, grapes, 
broccoli, tea 
12 
Flavanones 
 
Naringin, naringenin, 
eriodictyol, hesperidin 
Lemons, oranges, 
grapes 
12 
Isoflavones 
 
Genistin, daidzin Soy 12 
Flavanonols 
 
Taxifolin, 
dihydrokaempferol 
Onion 13 
Flavans  
Flavan-3-ol (catechin), 
flavan-4-ol, flavan-3,4-
diol 
Tea 12 
Anthocyanidins 
 Apigenidin, cyanidin, 
malvidin, delphinidin 
Cherry, strawberry, 
easberry 
12 
O
O
OH
O
O
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 Flavonoids can also be found in commercially available products, namely as standardized 
phytotherapeutic extracts (ex. green tea extracts), part of dietary supplements (ex. 
quercetin and resveratrol capsules) or as isolated products.14 In the last few years the 
number of studies with flavonoids has been increasing considerably, not only due to their 
multiple biological properties, but also due to their promising use as alternative drugs in a 
myriad of diseases related to chronic inflammation (viral infections15, cancer, 
cardiovascular diseases16, rheumatoid arthritis, multiple sclerosis, inflammatory bowel 
disease, asthma, atherosclerosis, metabolic syndrome, and brain and skin inflammation17) 
and as food supplements. One of the known biological effects of flavonoids is their anti-
inflammatory activity. In this work the inflammatory network and the flavonoids’ broad 
spectrum of action in many of the analysed inflammatory pathways are reviewed. 
 
 
2. Cells mediating the inflammatory response 
The inflammatory process begins with the release of various mediators from the resident 
cells, including, mast cells, interstitial fibroblasts and vascular endothelial cells. This 
signalling changes the local adhesion molecules’ profile and creates a chemotactic 
gradient that recruits cells from the blood stream.5 The cells mediating the inflammatory 
response are represented in figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - Cells involved in the inflammatory response. 
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 2.1. Granulocytes 
Neutrophils, eosinophils and basophils compose the granulocytes, so called because of 
the presence of granules, actually highly developed vacuolar structures, in their 
cytoplasm. They are also known as polymorphonuclear leukocytes (PMNs) group, named 
for the nucleus' multilobulated shape. They play an important role in the inflammatory 
response. They are the first cells migrating from the circulation and arriving at the 
inflammatory site. The most relevant are neutrophils and eosinophils, even though 
basophils also participate in allergic reactions.4,6 
 
 2.1.1. Neutrophils 
Neutrophils are the major cell type in most acute inflammatory diseases, as they are the 
body’s first line defence, but they are also found in some chronic inflammatory diseases. 
Their primary function is to contain and kill invading pathogens.6 In general, the following 
sequential cellular events take place in acute inflammation, all involving neutrophils, being 
designated as neutrophil activation (Figure 2): 
1.  the peripheral blood neutrophils are subdivided in two pools, a circulating one and 
a marginating one, adhered to the endothelial cells. These pools are altered along 
the process due to the activation or inactivation of the neutrophils by a variety of 
mediators that are released; 
2.  chemotaxis: is the process of calling the neutrophils to the inflammation site, 
which is mediated by the chemotactic mediators, which bind to neutrophil 
receptors, causing the release of calcium, increasing neutrophil motility; 
3.  margination: the neutrophils are pushed to the periphery of the vessels by the 
action of fibrinogen and erythrocytes aggregated into rouleaux in the venules; 
4.  rolling: the neutrophils’ rolling occurs in the venules by the action of selectins 
adhesion molecules to which neutrophils establish a weak binding, causing them 
to “roll” (bind−detach, bind−detach) along the surface; 
5.  adhesion: the integrins adhesion molecules (ligands) are responsible for the 
adhesion of the neutrophils to the venular endothelial cells; 
6.  diapedesis: the neutrophils move, transmigrate, across the venular endothelium 
basement membrane to the interstitial tissue. This movement is possible due to 
the pores generated within the endothelial cells themselves; however, neutrophils 
may also pass between endothelial cells by disruption of cell-cell junctions. This is 
possible by the interactions between adhesion molecules found on neutrophils and 
endothelial cells known as platelet-endothelial cell adhesion molecules (PECAMs); 
7.  phagocytosis: consists in a multistep process that comprises the opsonization, 
ingestion, and killing of the pathogens. Phagocytosis may be triggered by two 
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 mechanisms: a) by direct neutrophil recognition of pathogen-associated molecular 
patterns (PAMPs) found in bacteria or viruses; these small molecule motifs are 
recognized by toll-like receptors (TLRs) and other pattern recognition receptors 
(PRRs); b) via opsonization, consisting in the modification of the surface of the 
pathogen by immunoglobulins (Igs) or complement components ,or both, that are 
later recognized by the receptors expressed by neutrophils, low-affinity FcγRIIa 
and high-affinity FcγRIIIb. After the recognition, neutrophils project pseudopodia in 
all directions around the particle. The pseudopodia meet one another on the 
opposite side and fuse, creating an enclosed compartment that contains the 
phagocytized particle. Then this compartment invaginates to the inside of the 
cytoplasm and breaks away from the outer cell membrane to form a free-floating 
phagocytic vesicle. A single neutrophil can typically phagocytize 3 to 20 bacteria 
before the neutrophil itself becomes inactivated and dies.3,8,18,19 
 
 
Figure 2 - The process of neutrophil activation.Adapted from 8 
 
Neutrophils are highly specialized cells that present cytoplasmic granules containing an 
impressive arsenal of microbicidal agents that are released upon cell activation.6 As soon 
as a neutrophil phagocytes a bacteria or extracellular material, the azurophilic granules 
fuse with the phagosome, creating a phagolisossome, directing the content to the 
ingested target. The lysosomes, azurophilic granules, contain a variety of proteases, 
including elastase, matrix metalloproteinase (MMP)-3,-8, and -9, cathepsins, and 
lysozyme. However, on one hand, the azurophilic granules differ from the true lysosomes 
because they lack lysosome-associated membrane proteins 1 and 2 (LAMP-1 and LAMP-
2) and the mannose- 6-phosphate receptor system; on the other hand, specific granules 
retain a variety of membrane-associated proteins (cytochromes, signalling molecules, and 
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 receptors), they are reservoirs of proteins destined for topologically external surfaces of 
phagocytic vacuoles and the plasma membrane.4,19 
Neutrophils contain a membrane-bound nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase that is assembled and activated during the inflammatory response 
leading to the formation of reactive oxygen species (ROS) and nitrogen (RNS) by the 
rapid consumption of oxygen, a process designated as oxidative burst, as will be 
described below. Furthermore, neutrophils also contain a key enzyme designated 
myeloperoxidase (MPO), which has microbicidal activity but has also an important role in 
tissue injury that occurs in the event of inflammatory diseases. As mentioned before, 
neutrophils are chemoattracted to the site of inflammation; this is done by 
chemoattractants, which include leukotriene B4 (LTB4), platelet-activating factor (PAF), 
interleukin (IL)-8, and the complement split product C5a. The concentrations of these 
chemoattractants and their gradient of distribution ascertain the migration of neutrophils. 
At low concentrations of the chemoattractants, the neutrophils migrate toward regions with 
higher concentrations. At high concentrations, they lead to the cease of the neutrophils’ 
migration and induce their activation; this happens for example at the bacterial source of 
the gradient. The neutrophils present another receptor, namely for growth factors, colony-
stimulating factors, and cytokines, which may also modulate neutrophils’ function. 4 More 
recently, another way of action of neutrophils have been described. It consists in the 
release of neutrophils extracellular traps (NETs), which are extracellular fribillar networks, 
produced by neutrophils, composed by nuclear chromatin associated with granule 
proteins. These NETs are produced in response to the infectious pathogens and 
inflammatory mediators. The bacteria become trapped in these NETs and are killed, 
avoiding the spread of bacteria. This function leads to cell death as the nuclei of the 
neutrophils are lost in the process.4,6,20 
 
 2.1.2. Eosinophils 
Eosinophils are found in great number in extravascular tissue, in contrast to neutrophils 
that are much more common in the bloodstream. The eosinophils need to be recruited by 
chemokines, and eotaxin is an especially important chemokine in this recruitment.3 
Eosinophils do not phagocyte the pathogens; they liberate their content alongside them, 
including four distinct granule cationic proteins: major basic protein, eosinophil 
peroxidase, eosinophil cationic protein and eosinophil-derived neurotoxin, and 
inflammatory mediators: lipid mediators, such as leukotriene C4(LTC4) and PAF, which 
may cause dysfunction to parasites but also destruction / lysis of other cells, contributing 
to tissue damage. These granulocytes are viewed as effector cells of allergic responses 
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 and parasite elimination. They are also present in the inflammatory response generated 
by allergic or immediate hypersensitivity reactions, as basophils and mast cells.1,4 
 
 2.1.3. Basophils 
Basophils represent less than 1 % of leukocytes and are the least abundant in the 
granulocyte population.21 During the inflammatory response, granulocytes migrate from 
the blood into tissues in response to chemoattractants, such as IL-8 produced by 
neutrophils, or eotaxin by eosinophils and by other basophils.22 Once in the periphery, 
these granulocytes can be activated by a variety of signals, including those mediated by 
cytokines [IL-3, IL-33, IL-18, IL-5 and granulocyte macrophage colony-stimulating factor 
(GM-CSF)], antibodies (IgE, IgD and IgG), allergens, proteases, TLR ligands and 
complement factors (C5a). When activated, granulocytes rapidly produce and secrete a 
myriad of mediators, namely: histamine, LTC4, PAF, all major mediators of acute 
bronchoconstriction, chemokines and cytokines [IL-4, IL-5, IL-13, and thymic stromal 
lymphopoietin (TSLP)]. As an example, the cytokine IL-3 enhances the production of IL-4 
and IL-13 by basophils, in response to the IgE-mediated activation. Basophils are also 
capable of activate B cell populations, by increasing the production of IL-4 and B cell 
activating factor (BAFF) and by the induction of IgM, IgG and IGA, mediated by IgD. Also 
IL-4 and IL-13 can be produced via TLR2 ligand by basophils’ recognition of PAMPs.21 
Overall, basophils play their main role in allergic reactions.4 
 
 
2.2. Monocytes / Macrophages 
Monocytes are a heterogeneous population, which begin to migrate in the extravascular 
tissues quite early in acute inflammation. This process of monocyte adhesion to, and 
diapedesis through, the vascular endothelial cells is similar to that of neutrophils, but 
monocytes respond to a different set of chemotactic factors, including the chemokines, 
chemokine (C-C motif ligand 5, also known as, regulated on activation, normal T cell 
expressed and secreted (CCL5 or RANTES), CCL2, CCL7, monocyte chemoattractant 
protein-1 (MCP-1), macrophage inflammatory protein 1 alpha and 1 beta (MIP-1α and -
1β), and the growth factors, transforming growth factor beta (TGF-β) and platelet-derived 
growth factor (PDGF). When a monocyte reaches the extravascular tissue, it undergoes a 
transformation into a larger phagocytic cell, the macrophage.1,3,23 
Macrophages constitute a bridge between the innate and adaptive immune system being 
their basic functions, the constant immune surveillance and the orchestration of the 
immune response. Macrophages recognize the pathogens trough the surface expressed 
receptors for PAMPs, including TLRs, formyl peptide receptors, and scavenger receptors, 
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 many of which are also found on neutrophils. Macrophages also have in their surface, 
receptors for multiple opsonins, including the mannose receptor (that directly recognizes 
glycoproteins on microbial surfaces), CR1, CR3, CR4, FcγRI, FcγRII, and FcγRIII. To 
exert their functions, macrophages are activated, and this may happen by the action of 
interferon gamma (IFN-γ), complement components, immune complexes, 
lipopolysaccharide (LPS), and cytokines, such as IL-1β, tumor necrosis factor alpha (TNF-
α), and IL-6. The mechanisms of destruction of the microbes are similar to the neutrophils: 
proteases (e.g. lysosomal enzymes, elastase and collagenase), ROS and RNS, oxidative 
stress products, and chloramines. Activated macrophages also produce a number of 
inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-12, and others), chemokines (including IL-
8, MCP-1, MCP-2, RANTES, and others), complement cascade proteins (C1, C2, C3, and 
C4), eicosanoids [e.g. prostaglandin (PG)E2 , thromboxane (TX)A2, prostacyclin (PGI2), 
LTB4, and PAF] that may contribute to the propagation of inflammation. In addition, 
activated macrophages produce pro-coagulant factors such as tissue factor (TF) and 
plasmin inhibitor (or alpha 2-antiplasmin), linking the inflammatory and clotting 
responses.3,4 These cells also have the ability to engulf pathogens and apoptotic cells, but 
they are capable of phagocyte much larger particles and also, after digesting particles, 
they can extrude the residual products and often survive and function for many more 
months.18 
 
 
2.3. Lymphocytes 
The term lymphocyte comprises three cellular types: natural killer (NK) cells, B cells and T 
cells. NK cells are effector lymphocytes of the innate immune system; they control several 
types of tumors and microbial infections by limiting their spread and subsequent tissue 
damage. NK cells have a cell-mediated function, based in reciprocal interactions with 
dendritic cells, macrophages, T cells and endothelial cells.24 B cells and T cells are the 
main type of lymphocytes and are part of the adaptive immune response; the first ones 
participate in the humoral immunity and the last ones in cell-mediated immunity.25 
As so, lymphocytes intervene both in antibody-mediated and cell-mediated immune 
responses. During inflammation, the cytokines produced by macrophages (TNF-α and IL-
1β) promote the recruitment of lymphocytes to the inflammatory site. For this migration, 
the antigen-stimulated lymphocytes of different types (T and B cells) use various adhesion 
molecules, namely selectins, integrins and their ligands. The interaction between 
lymphocytes and macrophages, in a bidirectional way, establishes a stage of persistent 
inflammatory response and, as such, the inflammatory reaction tends to be chronic and 
severe. Thus, macrophages display antigens to T cells and produce membrane molecules 
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 (co-stimulators) and cytokines (e.g., IL-12) that stimulate T-cells. When activated, these 
cells produce various cytokines that recruit monocytes and IFN-ɣ which is a powerful 
activator of macrophages.3 
 
 
2.4. Platelets 
Platelets are small and anucleate cellular fragments in circulation. Their primary function 
is to maintain homeostasis; they rapidly respond to vascular injury, become activated and 
induce platelet aggregation and thrombus formation. Platelets have the ability to modulate 
early inflammation, pointing out their vital role in this inflammatory phase, and 
straightening the link between inflammation and coagulation.4 Despite the platelet 
granules content in pro-coagulant factors, Willebrand factor, fibrinogen, and factor V, 
those granules also contain inflammatory mediators. When platelets are activated, in the 
presence of inflammatory mediators such as PAF, they liberate various inflammatory 
mediators: (i) the CD40 ligand (CD40L), a primarily platelet-based immunomodulator of 
the TNF family that has only recently been shown to be expressed by activated platelets; 
it is responsible for the stimulation of vascular endothelial cells to produce cytokines (e.g. 
IL-1 and IL-18) and for the increased thrombotic activity; (ii) lipid mediators, namely TXA2, 
hydroxyeicosatetrenoate (12-HETE) and PAF; (iii) the neutrophil activating peptide 2 
(NAP-2); (iv) sphigosine1-phosphate (S1P); (v) growth factors, namely PDGF and TGF-β; 
(vi) nitric oxide (NO); (vii) cytokines, including IL-1β and IL-7; (viii) chemokines, like the 
CXCL5, MCP-3, RANTES, MIP-1α, platelet factor 4 (PF4); (ix) histamine; (x) serotonin; 
(xi) growth-regulating oncogene-α (GRO-α); (xii) high mobility group box 1 (HMGB-1) and 
P-selectin. The P-selectin expressed in the surface of the platelets establishes a link to 
the selectin glycoprotein ligand-1 (PSGL-1) on leukocytes, creating a platelet-lymphocyte 
complex, which in turn leads to the activation of the lymphocytes. The P-selectin 
expression also results in the monocyte expression of TF and the release of inflammatory 
cytokines by monocytes. Platelets contribute to leukocyte-leukocyte and leukocyte-
endothelial cell interactions.4,26 Interestingly, it has been demonstrated that platelets are 
able to distinguish between their roles in immunity and hemostasis, being also able to 
respond differentially among various pathogen ligands.27 
 
 
2.5. Mast cells 
Mast cells are most commonly localized in perivascular locations within connective 
tissues. On their surface they expose the high affinity immunoglobulin E receptor (FcεRI) 
that binds the Fc portion of IgE antibody. In the presence of these stimuli, cells 
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 degranulate.3 The granular content of mast cells is similar to those of basophils, and, like 
basophils, mast cells may play a role in allergic reactions.4 Mast cells are also present in 
chronic inflammatory reactions, and due to its ability to secrete a plethora of cytokines, 
they have both the ability to promote and limit inflammatory reactions in different 
situations. Mast cells are able to produce various inflammatory mediators, namely: pre-
formed mediators that are granule associated (e.g. histamine), mediators synthesized de 
novo (e.g. LTC4, PAF, and PGD2), cytokines and chemokines [e.g. IL-1, IL-3, IL-4, IL-5, IL-
6, IL-8, IL-10, IL-13, IL-16, TNF-α, vascular endothelial growth factor (VEGF), TGF-β, 
MIP-1α, and MCP-1].1,3 
 
 
2.6. Epithelial cells 
Epithelial cells have an active role in the inflammation process. They are capable of 
escalate an immune response by the internalization of organisms and production and 
secretion of cytotoxic and microbicidal peptides. These cells may be induced by bacterial 
components, e.g. LPS, cytokines, TNF-α and IL-1β. This activation leads to the production 
of other inflammatory mediators, via nuclear factor kappa B (NF-ĸB) and IĸB signalling 
pathways: cytokines (e.g. TNF-α and IL-1β), chemokines (e.g. IL-8, MIP-2, CXC 
chemokines, MCP-1, IL-7 and IL-15), NO, adhesion molecules [e.g. β-integrins and 
intercellular adhesion molecule 1 (ICAM-1)] and a variety of receptors: TLRs (2 and 4), 
TNF-α receptors (TNFR1 and TNFR2), growth factor receptors and plasminogen activator 
receptors.1 
 
 
2.7. Endothelial cells 
Endothelial cells are crucial to the regulation and propagation of the inflammatory 
response. The activated endothelial cells produce a variety of proteins that contribute to 
inflammation in different pathways: ROS and RNS, inflammatory cytokines (TNF-α, IL-1β, 
and IL-6), chemokines (IL-8, RANTES and MIP-1), adhesion molecules [ICAM-1, ICAM-2, 
PECAM, vascular cell adhesion molecule 1 (VCAM-1), E-selectin, and P-selectin], 
proteases, leukotrienes (LTs) and prostaglandins (PGs) and growth factors (VEGF and 
TGF-β). Endothelial cells also express cytokine and chemokine receptors (TFNR1 and IL-
1R), TLRs and pro-coagulants and protease-activated receptors. These cells also carry 
out alterations of the cytoskeleton and of the intercellular proteins for the leukocytes' 
migration and to alter the vascular permeability.1,4 
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 2.8. Fibroblasts 
Fibroblasts are ubiquitously present in the human organism and are the main responsible 
for extracellular matrix production, and consequently by its effects, not only in tissue 
structural cells but also in hematopoietic cells. It is well demonstrated that fibroblasts are 
able to produce a myriad of inflammatory mediators, to which they can themselves 
respond, suggesting a central role in the regulation of the reparative response.28 They 
express matrix metalloproteinases (MMPs) and cytokines, such as TNF-α and IL-1β. They 
also synthesize collagen, required to tissue repair, but if it is laid down in an abnormal 
manner or excessive amount, it contributes to organ dysfunction. In this way, fibroblasts 
are intimately linked to the regulation and perpetuation of inflammation.1 
 
 
2.9. Dendritic cells 
Dendritic cells may be characterized as the conductors of the immune response, as they 
internalize and process antigens and then display them in the surface, in conjunction with 
human leukocyte antigen (HLA) molecules, allowing the “presentation” to the 
lymphocytes, resulting in the latter activation.1 
 
 
3. Effects of flavonoids on cells mediating the inflammatory 
response 
Flavonoids have the ability to interfere with the functions of cells mediating the 
inflammatory response and therefore interfere with the inflammatory process. Several 
studies with quercetin revealed its capacity to interfere with the inflammatory process, 
namely inhibition of the secretion of lysosomal enzyme from PMNs, induced by 
concanavalin A; inhibiton of neutrophil degranulation as well as the catalytic activity of 
elastase. Along with quercetin, luteolin, apigenin and kaempferol have been described as 
potent inhibitors of β-glucuronidase and lysozyme release from activated neutrophils.16 It 
is believed that, in general, flavonoids act as down-regulators of myeloid cell (mostly 
macrophage), meaning that they lower the expression of inducible nitric oxide synthase 
(iNOS), cyclooxygenase (COX)-2, pro-inflammatory cytokines IL-1β, TNF, IL-6, and other 
markers.17 Isoflavones proved to inhibit tyrosine protein kinase (PTK), which is involved in 
phosphorylation of particular T cell proteins, interfering in T cell proliferation. Genistein 
promoted the inhibition of p56lck in T cells stimulated with phytohaemagglutinin/ phorbol-
12-myristate-13-acetate (PHA/PMA), with subsequent reduction of IL-2 expression. It was 
also able to inhibit human peripheral mononuclear cell proliferation and IL-2 and LTB4 
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 production. Luteolin, apigenin, myricetin and quercetin proved to modulate lymphocytes 
and neutrophils.29 The detailed description of the flavonoids’ effects in the different cells 
involved in inflammation, namely granulocytes, macrophages, lymphocytes, mast cells, 
epithelial cells, endothelial cells, dendritic cells and fibroblasts was revised in 17. As this 
paragraph illustrates, all the phenomena involved in inflammation are linked. Therefore, it 
is a hard task to separate and categorize all the different inflammatory mediators and the 
flavonoids’ isolated effects in each one of them. Along this paper we will try to discuss 
these effects for each main inflammatory mediator, although, as we will see, a vast 
number of works study more than one mediator together, because they are all linked. 
 
 
4. Inflammatory mediators 
4.1. The complement cascade and effects of flavonoids 
The complement system was first discovered in 1899 by Bordet.4 It is an ancient defense 
mechanism of the body that links innate immunity and the humoral arm of adaptive 
immunity.5 This system is composed for more than thirty circulating and membrane-bound 
regulatory and constitutive glycoproteins that interact to recognize and kill pathogens. The 
tissue damage, when unregulated, leads to a deregulated activation of the complement 
cascade. An excessive activation of complement can be deleterious and has been 
implicated in the pathogenesis of multiple immune and inflammatory conditions. A wide 
variety of circulating glycoproteins and tissue membrane-bound proteins act to regulate 
the complement activity and down regulate its attack.30 
The complement cascade present three distinct pathways (figure 3): a) the classical, b) 
the alternative and c) the mannose-binding lectin (MBL). A) The classical pathway is 
triggered by the interaction of antigen:antibody complexes with C1. In humans, only IgM 
and IgG (except IgG4) are effective in the activation of the classical pathway. However, 
there are other molecules capable of activate the classical pathway, via direct interaction 
with C1q, namely C-reactive protein (CRP), serum amyloid P component (SAP), β-
amyloid, some gram-negative bacteria, some viruses, mycoplasmas, protozoa and 
intracellular components (e.g. DNA), mitochondrial membranes, cytoskeletal filaments and 
apoptotic cells. The overproduction of C3a and C5a during complement activation and the 
excessive formation of membrane attack complexes lead to the detrimental effect of 
complement. As such, a number of inhibitory molecules present in plasma or membrane-
bound guarantee the prevention of an uncontrolled activation of the complement system. 
The C1 inhibitor is present in plasma and prevents the activation of C1s and C1r, 
antagonizing the classical pathway. In addition, C1 inhibitor also inhibits the MBL 
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 pathway.4,30 B) The alternative pathway is triggered by bacterial products (e.g. LPS), 
which results in the sequential activation of C3a, C5a and the membrane attack complex. 
Although antibodies can activate this pathway, they are not necessary for the activation, 
neither is lectin. This alternative pathway initiates with the deposition of active C3 on a 
surface that has no regulators of the complement present. This leads to the formation of 
C3b fragments and the process continues as an unconstrained amplification loop. This 
pathway cannot distinguish ‘self from other’. Its specificity resides in the ability of host 
cells (but not bacteria) to defend themselves against indiscriminate complement 
activation.4,30 C) The MBL pathway is triggered by the binding of bacterial sugars, such as 
mannose, to MBL protein, activating C4a and C5a and then joins the common pathway for 
the activation of the membrane attack complex. However, MBL recognizes certain 
pathogenic carbohydrates expressed on the surface of microorganisms, but does not 
recognize carbohydrates such as galactose and sialic acid, which are the terminal sugars 
expressed on mammalian glycoproteins, allowing the discrimination between ‘self from 
other’. MBL is formed in the liver and are designated as complement-activating soluble 
pattern recognition molecules, i.e., it recognizes PAMPs in the microbes’ surfaces.4,30 The 
three pathways of the complement differ in their mechanisms of target recognition and 
initial activation but converge at the third component of complement, C3, with the 
proteolytic release of fragments and in the assembly of the membrane attack complex 
(MAC), formed by components C5b to C9, amplifying the inflammatory response and the 
mediated tissue injury.5 
Generally, the functions of the complement cascade can be divided in also three 
categories: a) inflammation, b) phagocytosis and c) cell lysis. a) Inflammation: the 
components C3a, C5a and C4a (in a lesser extent) generate an inflammatory response. 
They are the cleavage products of the corresponding complement components that 
stimulate histamine release from mast cells and they can rapidly increase vascular 
permeability and cause vasodilation, as well as, leukocyte chemotaxis and activation. 
They are called anaphylatoxins because they have effects similar to those of mast cell 
mediators that are involved in the reaction called anaphylaxis. C3a and C5a also induce 
TNF and IL-1β release by peripheral blood mononuclear cells (PBMCs). In addition, C5a 
activates the lipoxygenase (LOX) pathway of arachidonic acid (AA) metabolism, causing 
additional release of inflammatory mediators, it embed chemotaxis, enzyme release and 
generation of ROS in neutrophils and monocytes, which participate in the microorganisms 
killing.5 b) Phagocytosis: C3b and its cleavage product, inactive C3b, act as opsonins; 
they coat and opsonize cell membranes and soluble antigens for recognition and digestion 
by neutrophils and macrophages. c) Cell lysis: MAC (C5b-C9) deposits in cells and makes 
them permeable to water and ions and results in cells death (lysis).3,4,8 Moreover, the MAC 
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 formation has a stimulating effect on several nucleated cell types, namely induction of pro-
coagulant activity in platelets and endothelial cells, pro-inflammatory activity in endothelial 
cells and smooth muscle cells, and their proliferation, release of eicosanoids from 
phagocytic cells, and triggering of signal transduction pathways.30 Noteworthy, 
complement deficiencies cause susceptibility to bacterial infection, but also susceptibility 
to autoimmune diseases.4 
Studies of the effects of flavonoids in the complement cascade are scarce, however it is 
described they reduce the activation of the complement system, consequently reducing 
the adhesion of inflammatory cells to the endothelium.29 Very recently, a short 
communication stated the preliminary inhibitory mechanism of four flavonoids (quercitrin, 
afzelin, isoquercitrin and quercetin) in the complement activation cascade for the first time. 
All the three tested glycosides acted on all the tested components of the complement 
system, indicating that the glycoside moieties may be necessary to block C3 and C4 
components. The single studied flavonol probably interacted with C1q, C2, C5 and C9. 31 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 - Schematic representation of the different pathways of complement activation 
and their effects.Adapted from 32 
 
 
4.2. Lipid mediators of inflammation 
One of the most important roles of membrane lipids in inflammation signalling is their 
ability to serve as substrates for the generation of hydrophobic pro-inflammatory and anti-
inflammatory mediators. Phospholipase A2 (PLA2) is the key enzyme in the universe of 
lipids mediators. There are four types of PLA2: secretory PLA2 (sPLA2), which require 
Ca2+ in mM concentrations for optimal activity; cytoplasmic PLA2 (cPLA2), requiring Ca2+ 
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 in μM concentrations, which are AA-selective; Ca2+ - independent PLA2 (iPLA2), 
specificity for plasmalogen substrates; and PAF acetylhydrolase (PAF-PLA2), which has a 
series of isozymes specific for short chains. Under basal conditions, AA is released from 
the phospholipid membrane by iPLA2 and then is reacylated, i.e., reincorporated in the 
membrane, being unavailable for eicosanoids biosynthesis. When cells are stimulated by 
receptors activation, the intracellular levels of Ca2+ increase and the Ca2+ -dependent 
cPLA2 liberates arachidonate at a rate that exceeds the rate of reacylation. This leads to 
arachidonate metabolism by COX isoenzymes and by LOX.33 
 
 4.2.1. Eicosanoids 
Eicosanoids are lipid-derived molecules. They are not stored, but synthesized de novo 
from membrane lipids during cell activation by mechanical trauma, cytokines and growth 
factors, among others. Throughout this activation, the cPLA2 translocates to the nuclear 
envelope, endoplasmic reticulum and Golgi apparatus, where it releases the AA from the 
lipid bilayer. AA is a polyunsaturated fatty acid, normally covalently associated with cell 
membrane phospholipids.5 The schematic steps of eicosanoids’ production are explained 
in figure 4. 
 
 
 
 
 
 
 
 
 
 
Figure 4 - Schematic representation of eicosanoids’ formation through the arachidonic 
acid metabolic pathways. 
 
 4.2.1.1. Prostaglandins 
In the inflammation context there are two enzymes with primordial functions: COX-1 and 
COX-2. COXs are responsible for the incorporation of oxygen into the carbon-11 of AA, 
leading to the formation of the five-carbon ring common to all PGs, and the production of 
the unstable PGG2. The PGG2 is reduced to PGH2 by COXs, with a PGH synthases 
function. The PGH2 is then converted in different prostanoids by the action of specific 
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 terminal synthases, depending on the tissue; different cells produce different PGs in 
abundance.4,34 The PGs’ level is usually very low in normal tissues, but it rapidly increase 
in acute inflammation, well before leukocyte recruitment. In chronic inflammation the 
prostanoids levels are truly augmented due to COX-2 induction with inflammatory stimuli.5 
PGs are not stored in cells, but are produced on demand and seem to exert their effects 
on the cell of origin or nearby structures. They are rapidly degraded in vivo by 15-
hydroxyprostaglandin dehydrogenase (PGDH) during one passage through the lungs. 
COX-1 is expressed constitutively in a variety of tissues, including endothelium, 
monocytes, platelets, renal collecting tubules and seminal vesicles.33 Its mediators are 
relevant in various homeostatic processes, namely in the regulation of renal perfusion and 
salt and water handling, modulation of platelet aggregation and preservation of 
gastrointestinal mucosal integrity. Conversely, COX-2 is an inducible enzyme and it is 
expressed primarily in cells involved in inflammation, such as macrophages, fibroblasts 
and endothelial cells. COX-2’s expression is induced by various stimuli, including, growth 
factors [PDGF and epidermal growth factor (EGF)] and pro-inflammatory cytokines (IL-1β 
and TNF-α). During the inflammatory stimuli it is thought that activation of COX-2 is 
mediated by peroxynitrite anion (ONOO-).4,34,35 The bioactive prostanoids synthesized 
after the PGH2 include: PGD2, PGE2, PGF2, PGI2, and TXA2. The formation of PGJ2 
results from the dehydration of PGD2, a non-enzimatic process.4,34 To exert their effects, 
PGs need to bind to receptors. G protein-coupled receptors (GPCRs) and peroxisome 
proliferator-activated receptors (PPARs) are known to be activated in vitro, but it is not 
clear that PPARs mediate PGs effects in vivo. Generally the receptors where the COX 
products exert their effects are designated as P receptors, depending on the affinity to 
each prostanoid, namely PGD receptors (DP), four subtypes of the PGE receptor (EP1 
through EP4), PGF receptor (FP) and PGI2 receptor (IP). The receptors DP, EP2, EP4 
and IP induce the increase of cellular cAMP, while EP1 and FP induce Ca2+ mobilization. 
EP2, EP4 and IP regulate the macrophages’ cytokines production. Studies on the PGE2 
signalling propose the participation of phosphatidylinositol 3-kinase (PI3K), mitogen-
activated protein kinase (MAPK), and Wnt pathways in EP2R/EP4R regulation of cell 
growth, migration and apoptosis. Unlike conventional signalling via GPCRs, PGJ2 is 
actively transported into cells, where it acts on the intra-nuclear PPAR-γ. Consequently it 
inhibits the NF-κB activation, compromising the transcription of pro-inflammatory genes. In 
some cell types, PGJ2 may well directly inhibit NF-κB.5,33 The functions exerted by PGs 
are summarized in table 2, but they depend on the stimulus to inflammation, the 
predominant prostaglandin produced at a particular time and the profile of prostaglandin-
receptor expression. Recent studies have shown that PGs activity is linked with cytokines, 
PAMPs and damage-associated molecular pattern molecules (DAMPs). So, PGs are also 
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 able to convert short-lived inflammatory responses to long-term gene expression-
dependent processes. As such, PGs act as ‘cytokine amplifier’, explaining the importance 
of their roles in chronic inflammation.36 
 
 4.2.1.2. Prostacyclin 
PGI2 is one of the prostanoids products of the AA metabolism, through the action of COX-
2 and subsequently of the prostacyclin synthase (PGIS). The production of PGI2 can be 
stimulated by thrombin or it can be generated by transfer of PGH2 from platelets, contact 
with activated leukocytes or stretching of the arterial wall. Vascular endothelium lacks 
thromboxane synthase but possesses PGIS, which leads to the formation of PGI2. It has a 
short half-life, and is rapidly metabolized to the more stable and less biologically active, 6-
keto-PGF1α. The biological functions of prostacyclin are described in table 2.3,33,37 
 
 4.2.1.3. Leukotrienes 
The key enzyme for LTs production is 5-LOX. During the inflammatory process, i.e. cell 
activation, 5-LOX translocates from the cytosol to the nuclear membrane where it meets 
5-LOX-activating protein (FLAP). The AA, released from the lipid membrane by cPLA2, is 
also translocated to the nuclear membrane, where FLAP presents it to 5-LOX. 5-LOX 
oxygenates AA at the C-5, generating 5-hydroperoxyeicosatetraenoic acid (5-HPETE), 
which in turn is reduced to the more stable 5-hydroxyeicosatetraenoic acid (5-HETE), by a 
peroxidase, or is converted to LTA4, by LTA4 synthase. LTA4 can be converted in LTB4, by 
LTA4 hydrolase (in neutrophils and macrophages) or in LTC4, by conjugation with reduced 
glutathione (in eosinophils, mast cells, endothelial cells and macrophages). The LTC4, in 
turn, migrates from the nuclear envelope to out of the cell, using transporters such as the 
multidrug resistance–associated protein (MRP), and can be metabolized extracellularly to 
LTD4 by the action of transpeptidases, being the latter the precursor of LTE4. The 
designation cysteinyl LTs (Cys LTs) comprises LTC4, LTD4 and LTE4, which correspond to 
the “slow-reacting substance of anaphylaxis” for their slow and sustained smooth muscle 
contracting abilities. Each type of LTs has its specific activities, which are enumerated in 
table 2.4,5,33 LTs exert their effects via surface receptors. LTB4 has two identified 
receptors, BLT1 and BLT2; the first ones are over-expressed during inflammation. The 
high-affinity LTB4 receptors, BLT1, transduce chemotaxis and adhesion responses; 
whereas low-affinity receptors, BLT2, are responsible for secretion of granule contents 
and superoxide anion radical (O2-) generation. The Cys LTs also have two receptors, 
CysLT1 and CysLT2, promoting bronchial smooth muscle contraction through increased 
Ca2+ fluxes and kinase activation [(protein kinase (PK)C, MAPK].33,38 
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  4.2.1.4. Lipoxins  
Lipoxins (LXs), i.e. lipoxygenase interaction products, can be generated at mucosal 
surfaces via leukocyte-epithelial cell interactions and within the vascular lumen during 
platelet-leukocyte interactions.33 The human neutrophil predominantly produce 5-HPETE 
from the 5-LOX action; though, when high concentrations of AA are added, 15-LOX can 
be expressed and also actuate in AA. The AA generated by epithelial cells may be 
converted by 15-LOX into 15-HETE, which is subsequently converted into lipoxin (LX)A4 
A4and LXB4.19 In platelets, the LOX expressed is 12-LOX. It originates 12-HPETE, which 
yields 12-HETE by reduction of the hydroperoxy group; which in turn rends LXA4 and 
LXB4, from neutrophils’ LTA4.33 A third mechanism of LXs production is also described. It 
produces LXs of different stereochemistry epi-lipoxins, also named as the aspirin/triggered 
lipoxins (ATL); because the reaction is initiated by aspirin and requires COX2 in the first 
step.39 LXs act trough their own specific receptors for LXA4 and LXB4, but LXA4 can also 
interact with a subtype of LTD4 receptors. LXs are also able to act as intracellular targets, 
in their cells of origin or in other cells, after LXs uptake. Overall, LXs may play a role in the 
resolution of inflammation, as anti-inflammatory lipids.33 The specific effects of LXA4 and 
LXB4 are explained in table 2. However it is worth to notice that LXA4 activates PKC, 
being more potent than diacylglycerol (DAG) or AA. LXA4 appears to be specific for the γ 
subspecies of PKC and may be an important modulator of the intracellular signal 
transduction. 
 
 4.2.1.5. Thromboxanes 
TXA2 is synthesized in platelets and it is converted from PGH2 via the terminal enzyme 
thromboxane synthase and unlike PGs, it contains a six-member carbon ring. Even 
though TXA2 is known as a platelet product, it can be up-regulated in other cell types in 
response to cytokines. The TXA2’s production is COX-1 dependent. However, TXA2 is 
unstable and is rapidly converted to its inactive and stable form TXB2.33 Table 2 
summarizes the functions of TXA2. 
 
 4.2.1.6 Isoprostanes 
All the isoprostanes have in common the top (α) and the bottom (ω) side chains, which 
are always syn-, i. e. crowded together on the same face of the cyclopentane ring. This 
characteristic is also what distinguishes them from PGs. Isoprostanes are generated from 
three contiguous methylene-interrupted double bonds, which are present in various 
naturally occurring polyunsaturated fatty acids. Isoprostanes are released pre-formed, so 
their production is not blocked by non-steroidal anti-inflammatory drugs (NSAIDs). Thus, it 
is possible that inflammation unresponsive to NSAIDs may harvest to inhibition of 
II. Theoretical Background
25
 isoprostanes. Isoprostanes may exert their functions via PPARγ and NF-κB; those 
functions are summarized in table 2.33 
 
Table 2 - Biological functions of eicosanoids. 
 
 
 
Eicosanoid Functions References 
PGE2 
Vasodilation and vascular hyperpermeability at early inflammation (along with 
PGI2); pain; fever; induction of smooth muscle contraction. 
Inhibition of T-lymphocyte activation and proliferation; down-regulation antibody 
production; variable effects on secretion of MMPs; reduction of the production of 
several inflammatory cytokines (TNF, IFN-γ, and IL-12). 
4,33,34 
PGD2 
Vasodilation; mediation of histamine release from mast cells exposed to anti-IgE 
antibody; increase of the permeability of post-capillary venules; chemoattraction 
for neutrophils. 
4,34 
PGF2 
Contraction of uterine and bronchial smooth muscle and small arterioles; it is not 
known to participate in inflammatory events. 
4,34 
PGJ2 Reduction of macrophage activation; reduction of NO production. 4,34 
PGI2 
Vasodilation, via smooth muscle relaxation; inhibition of platelet aggregation; 
reduced cell proliferation; modulation of the function of dendritic cells, 
macrophages, monocytes, endothelial cells and eosinophils. 
33,37 
5-HPETE 
Increase of intracellular Ca2+ levels, facilitating PKC-dependent activation of a O2- 
generating system of neutrophils. 
33 
5-HETE 
Chemotaxis; leukocyte adhesion; increase of intracellular Ca2+ levels, facilitating 
PKC-dependent activation of a O2- generating system of neutrophils. 
33 
LTB4 
Chemotaxis; neutrophil and macrophages chemoattraction; stimulation of 
leukocyte adhesion to endothelial cells, by up-regulating leukocyte integrin 
expression; generation of ROS; release of lysosomal enzymes. 
3,5 
LTC4; LTD4; 
LTE4 
Vasoconstriction; increased vascular permeability; bronchoconstriction; LTs are 
much more potent than histamine in increasing vascular permeability and causing 
bronchospasm. 
8 
LXA4 
Antagonism of the LTD4-induced vasoconstriction; blockage of the binding of 
LTD4 to its receptors on mesangial cells; suppression of LTB4-induced plasma 
leakage and leukocyte migration; blockage of LTB4-induced neutrophil inositol 
triphosphate generation and Ca2+ mobilization, but not O2- generation; activation 
of monocytes and stimulation of macrophage phagocytosis of apoptotic 
neutrophils. 
33,39 
LXB4 
Stimulation of human peripheral blood monocytes; enhancing growth of myeloid 
progenitor cells; inhibition of human neutrophil transmigration and adherence. 
40 
TXA2 Vasoconstriction; platelet activation and aggregation; smooth muscle contraction. 3,4 
Isoprostane F2α 
III 
Vasoconstriction; suppression of the release of mediators of inflammation from 
macrophages; suppression of the IL-12 production by activated dendritic cells; 
reduction of cytokine production by Th1 and Th2 cells. 
33 
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  4.2.2. Effects of Flavonoids on Eicosanoids Production 
Flavonoids have proven to succeed in the inhibition of eicosanoids’ production through 
different pathways. They can inhibit the release of AA, interfering with cPLA2 and inhibit 
the eicosanoid biosynthesis pathway.11,15 However, the mechanisms involved in this 
enzymatic inhibition are not fully elucidated.29 Quercetin was the first flavonoid described 
as a PLA2 inhibitor from human neutrophils.16 7-O-Methylaromadendrin was shown to 
inhibit isolated sPLA2.41 It is believed that the co-planarity of the molecules helps the 
interaction between the flavonoid and the enzyme, highlighting the importance of the 
C2=C3 double bond in the C ring of flavonoids, which grants its co-planarity.29 The 
majority of studies about the flavonoids effects in the eicosanoids synthesis are done for 
PGs and LTs. 
 
 4.2.2.1. Effects of Flavonoids in the synthesis of Prostaglandins 
Flavonoids may inhibit the production of PGs, interfering with COX-2, by direct activity 
inhibition or by the reduction of COX-2 expression. Durga et al. reviewed the 
immunomodulatory effects of flavonoids. They reported that in LPS-induced 
macrophages, luteolin-induced lowering of mRNA and protein levels of COX-2 and 
increased iNOS activity; apigenin, kaempferol, catechin, myricetin, and genistein were 
found to inhibit COX-2.11 The overall anti-inflammatory effects of genistein were previously 
reviewed.42,43 Other studies using the gene-reporter assay to express COX-2 showed that 
some flavones and flavonols were active suppressors, but epigallocatechin-3-gallate 
(EGCG), catechin, and myricetin were not.16 Wang and co-workers demonstrated that 
apigenin decreased COX-2 expression and inhibited other inflammatory mediators in 
adenocarcinoma cells.44 Wogonin was found to inhibit COX-2 activity as well as COX-2 
expression in LPS-induced macrophages; and this may be a selective effect, since this 
flavonoid inhibited PGE2 production, but not LTB4 from IL-1β induced gingival fibroblasts.16 
Hämäläinen et al. studied the effect of 26 flavonoids from different classes in LPS-induced 
PGE2 production, COX-2 mRNA and protein expression on murine J774 macrophages. 
They concluded that flavone, luteolin‑7‑glucoside, kaempferol, isorhamnetin, morin, 
quercetin, naringenin, taxifolin, pelargonidin, daidzein, genistein, and genistin inhibited the 
production of PGE2. Flavone, isorhamnetin, daidzein, and genistein efficiently inhibited the 
expression of COX‑2. Two flavonols, kaempferol and isorhamnetin, significantly inhibited 
inducible microsomal prostaglandin E synthase‑1 (mPGES-1) accumulation; COX-2 and 
mPGES-1 are functionally coupled to result in increased PGE2 formation in macrophages 
and tissue cells. As so, the modulation of COX-2 pathway by these flavonoids seemed to 
be independent from the flavonoids’ structure, as no relation has been established 
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 between their activity and their flavonoid class.45 An interesting study about inflammation 
in human gestational tissues demonstrated the anti-inflammatory effects of the co-
administration of luteolin and kaempferol, in the foetal membrane. These flavonoids 
significantly inhibited the LPS-induced expression of COX-2 and PGE2 concentration. 
These two flavonoids only share one structural feature, the OH groups in positions 5 and 
7 in A ring, but no structure-activity relationship has been established, probably due to the 
reduced number of flavonoids studied.46 Hou and co-workers undertook a study with LPS-
activated RAW264 macrophage cells and investigated the effect of anthocyanidins in 
COX-2 expression. They concluded that an ortho-dihydroxyphenyl structure on the B ring 
suppressed this expression and that the number of OH groups on the B ring appeared to 
be related to a molecular conformation that influences the interactions between flavonoids 
and enzymes such as tyrosine kinase and protein kinase C, which are involved in the 
transcriptional activity of COX-2.47 Indeed, more recently, a docking study with luteolin, 
chrysin, apigenin and quercetin indicated that the catechol group of B ring of luteolin was 
orientated towards the hydrophobic pocket of COX-2. On the other hand, the A ring of 
quercetin was orientated towards the pocket, enabling the 3-OH group of C ring to 
interact; therefore, they concluded that quercetin may not be a classical COX inhibitor.48 In 
spite of the general results that have been obtained by these studies, in which COX-2 
expression is inhibited by flavonoids, López-Posadas and co-workers developed a study 
in an intestinal epithelial cell line (IEC18) with some controversial results. They studied 9 
flavonoids, among them flavonols, flavones, isoflavones and flavanones and they 
established the structure-activity relationship (SAR). They concluded that the effect of 
flavonoids on COX-2 expression was dependent on the experimental conditions tested, in 
non-stimulated or LPS-stimulated cells. They observed that flavonoids caused an increase 
in COX-2 expression under basal conditions. However, under LPS stimulation, they 
decreased or did not affect COX-2 levels, depending on the specific type. To explain 
these results, and because c-Jun N-terminal kinase (JNK), p38, extracellular signal-
regulated kinase (ERK)1/2 and NF-ĸB are described as involved in LPS activation, COX-2 
regulation and signal transduction, they further investigated these indicators. Once more, 
they verified that flavonoids show structure-dependent effects on ERK/p38/JNK 
phosphorylation, as several of them prevented IĸB phosphorylation completely, none of 
the flavonoids prevented p50/p65 nuclear translocation, and genistein actually increased 
it; flavonoids generally augmented NF-ĸB dependent gene transcription. They explained 
these results in the basis that IEC18 cells do not depend on the classical pathway for the 
regulation of NF-ĸB target genes and that alternative routes have been long known to 
exist in some cell types. They also showed that quercetin augment translocation of 
p50/p50 homodimers, which is commonly associated with repression of transcription, but 
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 it has also been reported to activate transcription. Adding to this, quercetin and possibly 
other flavonoids can exert these effects not only by affecting IĸBα phosphorylation but 
also Akt and perhaps other targets.49  
 
 4.2.2.3. Effects of Flavonoids in the synthesis of Leukotrienes 
Another way to modulate the production of eicosanoids is the interference in LTs 
production. The isoflavones ability to inhibit PMNs’ 5-LOX has been studied and it was 
stated that they act as redox inhibitors, by preventing 5-LOX activation from its resting 
form (ferrous state) to its reactive state (ferric). Genistein was more potent than daidzein; 
they only differ in one OH group in A ring.16 Flavonols (kaemferol, quercetin, morin and 
myricetin) were found to be better LOX inhibitors than flavones. Flavanones such as 
naringenin were ineffective.50 These findings may indicate a relation between flavonoids’ 
structure and their activity, evidencing the importance of the 3-OH in C ring and of the 
double bond in C2=C3, explaining the weaker performance of flavones and 
flavanones.51,52 A group of trihydroxyflavones demonstrated to inhibit the production of 
LTB4 by human 5-LOX. Moreover, they inhibited COX -1 and -2 activity, but not in a 
selective way. These flavonoids also presented a good antioxidant activity as we will see 
further ahead in this manuscript, corroborating the theory of the redox inhibitors.53 
Notwithstanding the redox inhibition of 5-LOX explanation, sakuranetin, a flavonoid from 
Inula viscosa, inhibited the LTB4 synthesis in leukocyte homogenates. The authors defend 
this result may indeed be obtained by the direct inhibition of 5-LOX, but also by interacting 
with other proteins, such FLAP, PKA, PKC, tyrosine kinases and by MAPK, that can 
modulate the 5-LOX activity.41 
Flavocoxid is a recent product composed by baicalin, extracted from Scutellaria 
baicalensis, and catechin, from Acacia catechu, concentrated to greater than 90% purity. 
It has demonstrated great efficacy in the simultaneous inhibition of PLA2, COX-2 and 5-
LOX. Flavocoxid demonstrated promising results when applied in osteoarthritis and in 
neuro-inflammatory diseases (e.g. ischaemic stroke, Parkinson's disease, Alzheimer's 
disease, muscular necrosis, etc.).54,55 
 
 
4.3. Production of Pro-Oxidant Reactive Species in Inflammatory Processes 
During inflammatory process various pro-oxidant reactive species (PORS) are 
overproduced and released by the activated immune cells. The term PORS may include 
radical or non-radical species. The immune cells involved in this production are mostly 
macrophages and neutrophils. The PORS produced are able to kill pathogens, but also 
function as determinant signal transduction molecules that regulate inflammatory genes’ 
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 expression. The problem resides in the association of the overproduction and release with 
the extraordinary reactivity of these species, which result in oxidative stress and non-
specific oxidative reactions between these species and the biological components, 
including nucleic acids, lipids, carbohydrates, proteins, and matrix components. This may 
lead to cell death and tissue damage. Therefore, this process, referred as respiratory or 
oxidative burst, is extremely potent and requires tight regulation to prevent phagocytes 
auto-destruction. The PORS can be subdivided in the ones derived from oxygen, ROS 
and the ones derived from nitrogen, RNS.4,5 The production of PORS in neutrophils is 
summarized in figure 5. 
 
 4.3.1. Reactive Oxygen Species 
The enzyme that triggers the PORS production is NADPH oxidase and it needs to be 
activated to exert its activity. There are several activation stimuli, namely: microbial 
products (e.g. LPS and lipoproteins), LTB4, PAF, cytokines (e.g. IFN-γ and IL-8) and 
engagement of Fc receptors by IgG. These leads to the translocation of various cytosolic 
proteins including Ras-related C3 botulinum toxin substrate 2 (Rac2) and Rho-family 
guanosine triphosphatase (GTPase) to the membrane-bound complex carrying 
cytochrome b558, with subsequent activation of reduced NADPH oxidase.5 
NADPH oxidase is formed by various components that are distributed in cytosol and in the 
membranes of various intracellular organelles, in resting macrophages and neutrophils. 
Upon stimulation those components assemble on a membrane-bound vesicle, which 
merges with cytoplasm.35 The central component of NADPH oxidase is cytochrome b558, 
composed by two polypeptides: p22phagocyte oxidase (phox) and gp91phox (thought to act as H+ 
channel), which is localized in the plasma membrane and in the membranes of specific 
granules. Three cytosolic proteins are also required: p47phox, p67phox, and p21rac. Upon 
neutrophil stimulation, the p47phox and p67phox components translocate to membranes to 
form an active complex with the cytochrome b558. The p21rac also translocates in 
response to stimuli, but its significance is controversial. The protein p40phox has also been 
reported to be associated with p47/p67 in the cytosol. It is reported that p40phox may 
regulate the oxidase system in a positive and a negative manner and may play an 
important role in phagocytosis-induced O2- production via a phox homology domain that 
binds to phosphatidylinositol (3,4,5)-trisphosphate (PIP3). 19 However, NADPH oxidases 
are of great importance in phagocytic cells, they are ubiquitous in other cells, where they 
are called non-phagocytic oxidases (NOXs). They are involved in a number of cellular 
events, namely cell proliferation and apoptosis. They also participate in the post-receptor 
signalling pathways (e.g. PDGF and angiotensin).4 
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 When assembled at the phagolisossome membrane, NADPH oxidase catalyzes a one-
electron reduction of O2 to form O2-. The enzyme superoxide dismutase (SOD), contained 
in phagocyted microorganisms, catalyzes the dismutation of O2-, originating O2 and 
hydrogen peroxide (H2O2), but this reaction can be also spontaneous, especially at low 
pH. H2O2 originates hydroxyl radical (OH) by the Haber–Weiss/Fenton reaction. So, in the 
presence of Fe2+ or Cu+ (free ionized and in a low oxidation state), the H2O2 reacts to form 
OH and hydroxyl anion (OH-). Endogenous reducing agents (e.g. ascorbic acid) 
regenerate a lower oxidation state of the transition metal cation, reinitiating the cycle. 
H2O2 can also originate hypohalous acids, by the action of MPO. MPO is present in the 
phagocytes ant it catalyzes the oxidation of the halide ions chloride (Cl−), bromide (Br−), 
and iodide (I−) by H2O2 to form hypoclorous acid (HOCl), hypobromous acid (HOBr) and 
hypoiodous acid (HOI), respectively. In neutrophils, most of the H2O2 produced is 
consumed by MPO to catalyze the formation of HOCl. Because MPO has the specialized 
capacity of oxidize Cl- and this last exists in high concentration in the body, it is generally 
accepted that the main function of MPO is to generate HOCl. This reaction, catalyzed by 
MPO, is important for the production of other bioreactive molecules, e.g. chloramines, 
which result from the reaction of HOCl with amines, and that are liposoluble and more 
toxic than HOCl itself.56 From the reaction of the oxidized halogen (OCl-), from HOCl, with 
H2O2 results singlet oxygen (1O2). 1O2 is an excited state of O2 with its two paired electrons 
and it is responsible of various deleterious effects, namely the initiation of lipid 
peroxidation by the interaction with the membrane lipids. From this reaction other radicals 
derived from the O2 can be formed, such as peroxyl radicals (ROO), the most common 
being the protonated form of O2-, which is usually termed hydroperoxyl radical or 
perhydroxyl radical (HOO). There are another sources of ROS, one of them being the 
oxidation of xanthine (or hypoxanthine) by xanthine oxidase, using O2 as co-substrate, to 
form uric acid and O2-.35 Another source of ROS is the mitochondrial respiratory chain, 
where they are produced as by-products. O2- results from the leakage of electrons from 
the mitochondrial electron transport chain, which is quantitatively the most important 
mechanism that leads to the production of other ROS in the cell.35 In terms of stability, O2- 
is relatively unreactive toward most of the biological substrates. From all the ROS formed, 
OH is the less stable of all, with high reactivity. Followed by H2O2, which, in turn, is rather 
unreactive. HOCl is the most bactericidal oxidant known to be produced by neutrophils.4,56 
ROS actively participate in the inflammation; activator protein 1 (AP-1) and NF-κB are 
activated by ROS, displaying the interference of ROS on the production of pro-
inflammatory mediators as collagenase, IL-1β and TNF-α. ROS have also demonstrated 
to up-regulate adhesion molecules and to increase cytokines and chemokines 
production.4 
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 More recently, some studies have defying the affirmation that HOCl is the most powerful 
tool on pathogens killing produced by neutrophils. This new thesis states that the O2- 
produced inside the phagolisossome causes a pH increase and a consequent influx of K+, 
liberating cationic proteases from the anionic proteoglycan matrix, freeing them to kill 
bacteria. Moreover, this model is supported by the fact that MPO deficiency is common 
(1:2000), yet surprisingly benign. As such, oxidants are not primarily destructive to 
microbes, but necessary to promote the proteolytic damage.19 
 
 4.3.2 Reactive Nitrogen Species 
The formation of NO is catalyzed by the enzyme NOS. There are three isoforms of NOS: 
a) neuronal NOS (nNOS or NOS1) and b) endothelial cell NOS (eNOS or NOS3) are both 
constitutively expressed, with their activity regulated by intracellular Ca2+ levels and the 
calcium-binding protein calmodulin, and are present in both the spinal cord and brain; and 
c) iNOS, macNOS, or NOS2, Ca2+ independent, which is normally expressed in 
macrophages, neutrophils, inflammatory cells and glia. The activity of iNOS is induced by 
a series of stimuli: IL-1β, TNF-α, IFN-α, products of viruses, bacteria (e.g. LPS), protozoa, 
and fungi and by low oxygen tension and low environmental pH. Thus, iNOS promotes the 
conversion of L-arginine and O2 to L-citrulline and NO.4,5 NO diffuses to its site of action 
and there it stimulates guanylate cyclase (GC) to produce cyclic guanosine 
monophosphate (cGMP). cGMP modifies the activation of protein kinases, ion channels 
and phosphodiesterases.34 NO is a really important RNS, displaying innumerous 
functions: through the activation of the enzyme soluble GC, it induces vascular 
hyperpermeability and inhibits platelet aggregation; 35 bactericidal; induces vasodilation, 
edema, cytotoxicity; mediates the cytokine-dependent processes that can lead to tissue 
destruction;4,8 activates the COXs enzymes and S-nitrosylates proteins;34 presents an 
anti-inflammatory function by preventing the adhesion and release of oxidants by 
activated neutrophils in the microvasculature. Overall, NO regulates physiologic 
processes, host defense, inflammation and immunity.4 Additionally, NO reacts with O2-, 
producing ONOO-, which is very cytotoxic and mutagenic, with a reactivity close to OH, 
rapidly damaging biomolecules. As NO diffuses really quickly through cytoplasm and 
membranes, the formation of ONOO- occurs close to the site of production of O2-. The 
half-life of ONOO- is short and it is rapidly converted in its protonated form, peroxynitrous 
acid (ONOOH). ONOOH becomes activated through a cis/trans isomerization, producing 
trans-ONOOH, which is a powerful oxidant, highly reactive and yields oxidizing and 
nitrating species. Therefore, it is thought to be responsible for many of the toxic effects of 
NO.35,56 Another fast reaction is the one between ONOO- and CO2, rendering the 
formation of nitrosoperoxycarbonate anion (ONOOCO2−). From the decomposition of 
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 ONOOCO2− results CO2 and NO3- (about 70 %) and also the free radicals NO2 and 
carbonate radical anion (CO3-) (about 30 %). Noteworthy, MPO are able to oxidize NO2− 
in the presence of H2O2 or H2O2-generating systems, leading to the production of nitrogen 
dioxide radical (NO2). The NO2 can also be formed by auto-oxidation of NO in the 
presence of O2. In turn, NO can also react with NO2, producing dinitrogen trioxide (N2O3), 
a potent nitrosating agent.56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 - Production of PORS in the activated neutrophil. 
 
 4.3.3. Antioxidants 
In vivo, several endogenous antioxidants are responsible for the task of inactivating pro-
oxidant intermediates, namely ROS and RNS, and protect normal tissues from their 
deleterious effects. Antioxidants can exert this effect by: a) sequestration of transition 
metal ions into complexes; b) scavenging or quenching of ROS and RNS; c) breaking 
chain reactions initiated by free radicals; and d) repairing damaged molecules.57 
Transition metal-binding proteins, namely ceruloplasmin, ferritin, transferrin and lactoferrin 
are responsible for sequestering cationic iron and copper, inhibiting this way the 
generation of OH. Chain-breaking antioxidants are small molecules that can receive or 
donate an electron and thereby form a stable by-product with a radical. They are usually 
classified as aqueous phase [ascorbic acid (vitamin C), albumin, reduced glutathione] or 
lipid phase [α-tocopherol (vitamin E), ubiquinol-10, and carotenoids]. SOD and catalase 
(CAT) enzymes are part of the group of molecules responsible to counter the activity of 
PORS. As said above, SOD catalyzes the dismutation of O2- to H2O2, which is then 
removed by CAT or glutathione peroxidase (GPx). CAT is a peroxisomal enzyme that 
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 catalyzes the conversion of H2O2 to water and O2. Enzymes such as GPx and glutathione 
reductase (GR) are additional mechanisms for maintaining redox balance and removal of 
toxic metabolites.5 This antioxidant system of defense is usually enough to maintain a 
reducing milieu in cells under physiological conditions. The problem appears when the 
production of PORS increase abruptly, overwhelming this antioxidant defenses, leading to 
oxidative stress.35 
 
 
4.4. Antioxidant Activity of Flavonoids 
As it was already described, the overproduction of ROS and RNS is deleterious for human 
tissues and it leads to the progression of the inflammatory response in an endless cycle. 
In this way molecules capable of arresting this cycle are of great value for the resolution of 
inflammation. The antioxidant activity of flavonoids is one for their best studied 
mechanisms of action, and therefore the processes affected by them and the best 
structure-activity relationship is well stablished. In general, the antioxidant activity of 
flavonoids may be undertaken by: a) direct scavenging of ROS or RNS by hydrogen atom 
donation; b) inhibition of oxidases responsible for O2- production, namely xanthine 
oxidase, COX, LOX, microsomal monooxygenase, glutathione S-transferase, 
mitochondrial succinoxidase and NADPH oxidase; c) activation of antioxidant enzymes 
involving the induction of phase II detoxifying enzymes, namely NAD(P)H-quinone 
oxidoreductase, glutathione S-transferase, and UDP-glucuronosyltransferase; d) chelating 
trace metals; and e) mitigation of oxidative stress caused by NO.12,58,59 Flavonoids can 
directly act upon ROS and RNS and stabilize them; this is the general equation (equation 
1) that summarizes this reaction: 
 
R + Flavonoid (OH) = RH + Flavonoid (O)  (Equation 1) 
 
In 2008, Gomes et al. reviewed the essential structural features for the scavenging of 
ROS and RNS: a) HOCl - a 5,7-OH group in A ring and a OH in C3 in C ring; b) 1O2 – a 
OH in C3 in C ring, a C2=C3 double bond, the existence of a 3’,4’-OH in B ring favours de 
activity; and c) ONOO- - the total number of OH, including a catechol group in B ring and a 
OH in C3 in C ring, a C2=C3 double bond.15 Thus, the search for the structural features 
that favour the most the antioxidant activity of flavonoids led to the following conclusions: 
the B ring 3’,4’ - OH configuration determine an excellent scavenging of ROS and RNS 
because it donates hydrogen and an electron to OH, ROO, and ONOO-, stabilizing them 
and yielding relatively stable flavonoid radicals. On the other hand, the occurrence of 
three OH groups in B ring does not increase the efficiency of an antioxidant molecule. 
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 Additionally, it is of general consensus the heterocycle contributes to antioxidant activity 
allowing the conjugation between the aromatic rings and the presence of a free 3-OH in C 
ring, contributing for the co-planarity of the rings. The existing OH groups in B ring are 
able to form hydrogen bounds with 3-OH, aligning the three rings. The absence of the 
C2=C3 double bond decreases the antioxidant activity (naringenin in contrast with 
apigenin). The combination of the 3- and 5-OH groups with the 4-oxo group in C ring 
allows electron delocalisation from the 4-oxo group to both substituents.12,15,29 Recently 
published articles revised flavones and their antioxidant, and anti-inflammatory properties, 
with important insights on SAR.60,61 More recently, a QSAR study using density functional 
theory (DFT) concluded that decreased electron-donating and electron-accepting 
capacities in rings A and B, respectively, should be achieved in order to design new 
flavonoids with antioxidant properties.14 
 
 4.4.1. Effects of Flavonoids on Reactive Oxygen Species 
In an in vitro study, the flavonoids quercetin, luteolin, apigenin, chrysin, 5- and 7- 
hydroxyflavones scavenged the ROS O2-, H2O2, HOCl, 1O2 and ROO; and the features 
designated above as essential for this activity were confirmed.62,63 Flavonoids already 
proved to inhibit NADPH oxidase and in this way they disable the progression of ROS and 
RNS production. Quercetin, in a human neutrophils study, inhibited the MPO activity, the 
O2- production, the phosphorylation of some proteins, and even diminished neutrophils 
degranulation. Kaempferol, even though not having the catechol group in B ring, but just a 
4’-OH, has also demonstrated good scavenging activity, maybe because of the 
combination of the other structural features (C2=C3 double bond, 3-OH group, or 4-oxo 
group on C ring). Catechins from Chinese green tea also scavenged H2O2 and O2- 
produced by the same system.14 5-Hydroxy-3,7,4’-trimethoxyflavone, the cat’s whiskers 
flavonoid, was able to effectively scavenge O2-, OH- and NO from lymphocytes of 
patients with rheumatoid arthritis.64 Eriodictyol, hesperetin, taxifolin and luteolin proved to 
inhibit MPO release, while eriodictyol and taxifolin also strongly inhibited MPO activity, 
interfering in HOCl production. In this study they also accept that these results are directly 
related to the inhibition of O2- production because of the OH groups in B ring. 
Interestingly, the two flavonoids described in this study as MPO inhibitors lack the C2=C3 
double bond that has being considered crucial for this activity, by in vitro and by docking 
studies.14 In fact, in 2008, Shiba and co-workers studied quercetin and their metabolites 
as MPO inhibitors and concluded that the OH groups in positions 3, 5, and 4′ and the 
C2=C3 double bond were determinant for the inhibitory effect. Through a computer 
docking stimulation they also suggested the binding of quercetin and the metabolites to a 
hydrophobic region at the entrance to the distal heme pocket of MPO.65 Quercetin, silibin 
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 and luteolin have been described as the most potent inhibitors of xanthine oxidase.29 As 
mentioned above, xanthine oxidative is one of the enzymes responsible for the O2- 
production, following the conversion of of xanthine dehydrogenase into xanthine oxidase, 
under stressful conditions. Durga et al. described silibin along with quercetin as inhibitors 
of the activity of xanthine oxidase, thereby preventing oxidative damage by the release of 
free radicals.11 Rutin and epicatechin have also been described as potential radical 
scavengers. They have a powerful OH scavenging effect and also inhibited the 
generation of O2- in a hypoxanthine - xanthine oxidase system.11,16 The assessment of the 
antioxidant properties of flavonoids may be undertaken in vitro in non-cellular or cellular 
systems. When studies are conducted in cellular systems it allows the prediction of the 
flavonoids activity in an environment that resembles more the physiological conditions, 
namely their effect in the modulation of the oxidative burst phenomenon. 
Trihydroxyflavones proved to be good scavengers of ROS in vitro, and these results were 
confirmed by in vitro cellular assays.53 Also in human neutrophils, Freitas et al. studied 
four chlorinated flavonoids and their non-chlorinated parent flavonoids and concluded the 
chlorinated ones were more efficient, the more active being 8-chloro-3’,4’,5,7-
tetrahydroxiflavone. These results are of major interest because it has been already 
described that flavonoids react with HOCl, becoming chlorinated, and these products that 
will act in the inflammatory site may present different properties from the initial flavonoids, 
as it was proven.66 
It is generally accepted that flavonoids are capable of chelating metals. The structural 
features for this property have already been established. The 3’-OH and the 4’-OH groups 
in B ring, known as catechol group, are very active in chelating metals. The 3-OH-4-
carbonyl and the 5-OH-4-carbonyl groups also contribute to metal chelation.67 Quercetin, 
which owns the described features, was found to chelate Fe and hence prevent lipid 
peroxidation.11,16 Moreover, a molecular modelling indicated that the preferred site of 
chelation is located on the 3-OH-4-carbonyl group, followed by the 5-OH-4-carbonyl and 
the 3’, 4′-OH groups. In this sense, Fe can produce complexes with one, two or three 
molecules of quercetin.68 Hydroxylated flavones, C-glycosyl flavones, methoxyflavones 
and flavonols show their inhibitory properties of lipid peroxidation induced by FeSO4 plus 
cysteine, in rat liver microsomes. This effect was also observed for hydroxyethyl rutosides 
and 7,3’,4’-trihydroxyethyl quercetin.14 Assini and co-workers revised the biological 
properties of citrus flavonoids in what refers to lipid metabolism.69 
 
 4.4.2. Effects of Flavonoids on Reactive Nitrogen Species 
Flavonoids already proved to inhibit LPS - induced iNOS gene expression and iNOS 
activity in cultured macrophages, reducing NO production.16,29 Also, quercetin, luteolin 
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 and apigenin inhibited NO production in LPS-induced macrophages and macrophages 
cell lines. Catechins and flavanones were active, but less potent. Further evidence proved 
that apigenin, as genistein and kaempferol, effectively lowered the NO production, by the 
iNOS down-regulation.50 Isoflavones (genistein, daidzein and glycitein) suppressed NO 
production in LPS-activated murine macrophages by three different mechanisms: 
scavenging of NO, inhibition of iNOS enzyme activity and inhibition of iNOS gene 
expression. Flavones, isorhamnetin, kaempferol, quercetin, naringenin and pelargonidin 
were already described as being able to inhibit LPS-induced iNOS expression. Prenilated 
flavonoids and bioflavonoids inhibited the production of NO in LPS - stimulated RAW 
264.7 cell line, by the suppression of iNOS induction, but not by the inhibition of its 
activity. Echinoisoflavone was the only one that simultaneously suppressed iNOS enzyme 
induction and its activity.16 Jaceosidin, a naturally occurring flavone, reduced LPS-induced 
NO production and iNOS expression in BV-2 mouse microglial cells, in a concentration-
dependent manner, and, similarly, in microglia, astroglia and macrophages.70 Silibinin 
inhibits NO activity, in a dose dependent manner.11  
A study employing 16 flavonoids and flavonoids glycosides confirmed that the total 
number of OH groups, the number of phenolic groups, the presence of vicinal OH groups 
and their position in the B ring are determinant for the flavonoid protection against ONOO- 
reactions.61 Genistein and daidzein demonstrated to scavenge the highly reactive ONOO-. 
In an in vitro assay these soybean isoflavones increased the LDL resistance to ONOO- - 
mediated oxidation, in a concentration – dependent manner.16  
 
 
4.5. Cytokines 
Cytokines are soluble, low-molecular–weight proteins that play an important role in the 
inflammatory response, in its regulation and propagation. Generally, cytokines can be 
produced and secreted by leukocyte, endothelial cells, epithelial cells, and fibroblasts. The 
production and secretion of cytokines are transcriptionally regulated. Cytokines exert a 
variety of functions in a variety of cells. They are characterized by their redundancy and 
pleiotropy, various cytokines can target the same receptor and a single cytokine can have 
multiple, even contradictory, effects.9 Their major role is the regulation of the intensity and 
duration of the inflammatory response.1,35 
Cytokine expression may be triggered by different factors: trauma, stress, ischemia, 
radiation, ultraviolet light, extracellular matrix components, microbial species and their 
soluble products (particularly via TLR and nucleotide oligomerization domain [NOD]-like 
receptors [NLRs]), DNA (mammalian or microbial), heat shock proteins, cell-cell contact, 
immune complexes/autoantibodies, local complement activation, ROS, RNS, electrolytes 
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 (e.g. K+ via P2X7 receptors) and cytokines themselves working in autocrine loops.71 In fact 
there are well documented examples of this latter regulation: IL-10, along with IL-4 and IL-
13, is considered an anti-inflammatory cytokine; they down-regulate pro-inflammatory 
signals.1 IL-4 and IL-10 inhibit IL-12 - induced IFN-γ secretion. Moreover, IL-10 
antagonizes many of the pro-inflammatory effects of TNF-α and IL-1β (table 3).71 
However, the production of IL-4 and IL-10 by monocytes can be down-regulated by IFN-ɣ, 
another cytokine.35 On the other hand, IL-6, IL-1 and TNF-α all considered pluripotent 
cytokines inter-regulate their production; in fact, the IL-6 production may be triggered by 
TNF-α and IL-1β; these last two cytokines work synergistically.72 The IL-11 secretion is 
enhanced by IL-1 and TGF-β.35  
Cytokines are synthesized in Golgi apparatus and then circulate through the 
endoplasmatic reticulum; they may remain bound to the membrane or released as soluble 
mediators or even be processed and migrate intracellularly, returning to the nucleus and 
act as transcriptional regulators. Cytokines can mediate autocrine or paracrine functions; 
autocrine, through release or membrane expression and immediate receptor binding on 
the source cell or intracellularly within the source cell; paracrine, allowing cellular 
communication beyond that assisted by local cell-cell contact.71 
The cells’ surface displays cytokine receptors to answer cytokine specific messages. So, 
through these receptors, cells process the information of substrate-bound cytokines, 
according to the density and state of activation of the surface receptors.30 Cytokine 
receptors comprise structurally related superfamilies and high-affinity molecular signalling 
complexes that mediate the cytokine’s communication. In the group of cytokine receptors 
we may find: heterodimeric or homodimeric receptors - a type I/II cytokine receptor; 
trimeric proteins usually associated with cell surface – a TNF receptor; receptor serine / 
threonine kinase – a TGF-β receptor; single-pass membrane receptors with Toll-IL-1 
receptor domains – a toll/IL-1 receptor; GPCRs family – a chemokine receptor and 
enzyme-linked receptors that phosphorylate tyrosine residues – a tyrosine kinase 
receptor.71 
After receptor coupling, there are several intracellular signal pathways through which 
cytokines mediate their effects. One of them is the Janus kinases (JAK) and their 
downstream transcriptional factors [e.g. signal transducers and activators of transcription 
(STATs)], mediating signals serving those cytokines that bind to common gamma chain, 
or to glycoprotein 130 (gp130) receptor. Similarly, the MAPK signalling cascade mediates 
signals in response to stress, cytokines, and proliferation factors. Another one is the 
spleen tyrosine kinase (Syk) that mediates the effector function of IgFc receptor and the B 
cell receptor and cooperates with other downstream cytokine-mediated signal pathways. 
PI3K signalling cascade is another signal pathway, which is involved in the formation and 
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 migration of second messengers. Finally, the NF-κB pathway is central to the pathways 
that mediate signals of TLRs, IL-1 superfamily members and to the function of TNF 
receptor. Once initiated the signalling cascade, several transcription factors can be 
recruited [e.g. NF-κB, AP-1, nuclear factor of activated T-cells (NFAT)] to the cytokine 
promoter region (figure 6).71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 - Cytokine signalling pathways and regulation.Adapted from 71 
 
There are a myriad of cytokines of diverse cellular sources that play decisive biological 
functions in inflammation. The most common and reported ones are summarized table 2. 
 
Table 3 - Principal cellular sources and actions in inflammation of selected cytokines. 
Cytokine Principal sources Actions in inflammation References 
IL-1β 
Macrophages (main source); 
monocytes; neutrophils; B 
lymphocytes; T lymphocytes; NK 
cells; keratinocytes; dendritic 
cells; endothelial cells. 
Induce transcriptional activation of various genes, encoding 
cytokines, chemokines, adhesion molecules, iNOS, proteases 
and COX-2; recruit inflammatory cells at the site of 
inflammation, by inducing the expression of adhesion 
molecules on endothelial cells and through the release of 
chemokines by stromal cells. 
1,3,8,35 
IL-2 Th1 cells. 
Promote proliferation of activated B lymphocytes and T 
lymphocytes; stimulate secretion of cytokines by T cells; 
increase cytotoxicity of NK cells (in combination with other 
stimuli). 
35 
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 Table 3 - Principal cellular sources and actions in inflammation of selected 
cytokines.(cont.) 
Cytokine Principal sources Actions in inflammation References 
IL-3 
T lymphocytes; NK 
cells. 
Stimulate pluripotent bone marrow stem cells to increase production of 
leukocytes, erythrocytes and platelets. 
35 
IL-4 Th2 cells. 
Induce the differentiation of CD4+ T cells into Th2 cells; down-regulate the 
differentiation of CD4+ T cells into Th1 cells; promote the growth and 
differentiation of B cells; inhibit the production of TNF, IL-1, IL-8 and PGE2 
by stimulated monocytes or macrophages; down-regulate endothelial cell 
activation induced by TNF; promote expression of the class II major 
histocompatibility complex (MHC), on B cells. 
35 
IL-5 
T lymphocytes; mast 
cells; monocytes; 
macrophages. 
Induce production of eosinophils from myeloid precursor cells. 35 
IL-6 
Monocytes; 
macrophages, 
lymphocytes; 
endothelial cells; 
intestinal epithelial 
cells. 
Stimulate the synthesis of CRP; induce pyrexia; increase the hepatic 
synthesis of acute phase reactants, such as ferritin, coagulation factors 
(e.g. fibrinogen) and CRP; cause the differentiation of T cells into Th17 
cells; activate the NF-ĸB and MAPK pathway, specifically, the ERK, 
1,3,8,72,73 
IL-8 
Monocytes; 
macrophages, 
endothelial cells, 
enterocytes. 
Stimulate chemotaxis oxidative burst by neutrophils. 35 
IL-9 Th2 cells. Promote proliferation of activated T cells and Igs secretion by B cells. 35 
IL-10 
Monocytes; B 
lymphocytes; T 
lymphocytes; 
dendritic cells; 
epithelial cells; 
keratinocytes. 
Inhibit the production of IL-1, TNF, IL-6, IL-8, IL-12, and GM-CSF, by 
monocytes and macrophages; inhibit lymphocytic and phagocytic function; 
increases synthesis IL-1RA, by activated monocytes; down-regulate the 
proliferation and secretion of IFN-γ and IL-2 by activated Th1 cells; 
potently activate B cell activation and immunoglobulin secretion; reduce 
adhesion molecule expression, MHC expression and MMP release. 
1,71 
IL-11 
Dendritic cells; 
fibroblasts; epithelial 
cells. 
Increase production of platelets; inhibit proliferation of fibroblast. 35 
IL-12 
Antigen-presenting 
cells. 
Promote Th1 responses by helper T lymphocytes; enhance IFN-γ 
secretion by Th1 cells. 
35 
IL-13 
Th2 cells; 
undifferentiated 
CD4+ T cells and 
CD8+ T cells. 
Promote the growth and differentiation of B cells; down-regulate the 
production of IL-1, TNF, IL-6, IL-8, IL-12, G-CSF, GM-CSF, MIP-1α and 
PGE2, by activated monocytes and macrophages; increase the production 
of anti-inflammatory proteins (e.g. IL-1RA and IL-1RII); inhibition of COX-2’ 
induction; induces 15-LOX. 
35 
IL-17 
Th17 cells; 
neutrophils. 
Amplify the neutrophil migration and recruitment; stimulate the production 
of pro-inflammatory cytokines; induce IL-6 and IL-8 production, from 
fibroblasts. 
19,35 
 
II. Theoretical Background
40
 Table 3 - Principal cellular sources and actions in inflammation of selected 
cytokines.(cont.) 
 
 
 
 
 
Cytokine Principal sources Actions in inflammation References 
IL-18 Mononuclear cells. 
Co-stimulation with IL-12 of the production of IFN-γ by T lymphocytes and 
NK cells; induce the production of CC and CXC from human mononuclear 
cells; activates neutrophils 
35 
IL-21 Th2 and Th17 cells. 
Modulate B cell survival; inhibit IgE synthesis and the production of pro-
inflammatory cytokine, monocytes and macrophages. 
35 
IL-23 
Dendritic cells; 
monocytes; 
macrophages. 
Promote differentiation of naïve T cells into Th17 cells, along with TGF-β. 35 
IL-27 
Dendritic cells; 
monocytes; 
macrophages. 
Suppresse effector functions of lymphocytes, monocytes and 
macrophages. 
35 
GM-CSF 
T lymphocytes; 
monocytes; 
macrophages; 
endothelial cells. 
Enhance the production of granulocytes and monocytes by bone marrow 
and of pro-inflammatory mediators, by monocytes and macrophages. 
35 
G-CSF 
Monocytes; 
macrophages; 
fibroblasts. 
Enhance the production of granulocytes by bone marrow. 35 
IFN-ɣ 
CD4+ Th1 cells; 
CD8+ Th1 cells; NK 
cells. 
Promote the differentiation of CD4+ T cells into the Th1 phenotype, along 
with IL-12; inhibits differentiation of CD4+ T cells into Th2 cells; stimulates 
the release of pro-inflammatory mediators (e.g. TNF, O2-, NO). 
35 
MIF 
Monocytes; 
macrophages. 
Up-regulate the expression of TLR4 on macrophages, amplifying the 
response of the innate immune system to LPS. 
35 
TGF-1β 
T lymphocytes; 
monocytes, 
macrophages; 
platelets. 
Promote the differentiation of naïve T helper cells into Treg cells; in 
conjugation with IL-6 or IL-23 promotes the differentiation of naïve helper T 
cells into Th17cells; stimulates chemotaxis by monocytes and induces 
synthesis of extracellular proteins by fibroblasts; inhibits Igs secretion by B 
lymphocytes; down-regulates the activation of NK cells. 
35 
TNF-α 
Macrophages (main 
source); monocytes; 
B lymphocytes; T 
lymphocytes dendritic 
cells; endothelial cell. 
Induce expression of cytokines, chemokines, growth factors and cell 
surface receptors that recruit hematopoietic cells, neutrophils, T 
lymphocytes, monocytes and macrophages; 
Induce the expression of angiogenic cytokines (e.g. VEGF and TGF-b) 
and plasminogen activator and its receptor; 
In later stage of inflammation: up-regulate the expression of MMP-9; 
suppresses the expression of the MMP-9 antagonist, tissue inhibitor of 
MMP-3. 
1,3,35 
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  4.5.1. Modulation of Cytokines Production by Flavonoids 
Various flavonoids were already described as good modulators of cytokines’ production. 
As it was shown for eicosanoids production, the different inflammatory mediators and their 
functions are all connected; and the same happens for cytokines. The molecular 
mechanisms involved in their modulation also include the inhibition of transcription factors, 
NF-ĸB and AP-1, and reduction of MAPK activity.50 
The structural features defined until now for a good inhibition of LPS-stimulated TNF-α 
release are: a double bond at position C2=C3 in C ring with an -oxo function at position 
C4 of C ring, along with the presence of OH groups at positions 3’ and 4’ in B ring.16 
Genistein, quercetin, luteolin, apigenin and rutin are capable of inhibiting pro-inflammatory 
cytokines such as TNF-α and IL-1.29 Quercetin also affected TNF-α expression in LPS-
induced RAW cells by inhibiting MAPK and AP-1 DNA binding.50 However, in another 
study, quercetin and luteolin showed a highest degree of inhibition of TNF-α than 
genistein, kaempferol, apigenin, diosmetin and hesperetin, which have only one hydroxyl 
group on the B ring, in LPS-stimulated macrophages.74 In this same study they observed 
for the first time that luteolin and quercetin stimulate LPS-induced IL-10 secretion. This 
may be due to post-transcriptional effects of the flavonoids, since it is well established that 
IL-10 can be regulated by post-transcriptional mechanisms in macrophages. Based on 
this evidence, they also propose that NF-ĸB is not the only signalling pathway affected by 
flavonoids; they may affect p38-MAPK, which is involved in the regulation of IL-10 
expression.74 A metabolite of rutin, 3,4-dihydroxytoluene, also reduced the TNF-α and in a 
minor extent IL-1β and IL-6, probably through the inhibition of NF-κB signalling in LPS-
activated murine macrophage cell line RAW 264.7.75 This indicates the study of 
flavonoids’ metabolites is also of preponderant interest. Jaceosidin reduced the levels of 
LPS-induced IL-1β, TNF-α in BV-2 microglial cells.70 Genistein was found to prevent IL-6, 
IL-1β and TNF-α formation in LPS induced human monocytes, as in macrophages, gastric 
epithelial cells and osteoblasts. Reports on LPS-induced macrophage RAW 264.7 cell line 
revealed that genistein, quercetin, luteolin and luteolin-7-glucoside are effective inhibitors 
of IL-6 and TNF-α production. In the same cell line, wogonin led to the decrease of TNF-α, 
IL-1β and IL-6 release. Eriodictyol and hesperetin only inhibited TNF-α release.11,16 All 
these works use different cell lineages and they show the same flavonoids having the 
same positive results in different inflammation related cells, making them even more 
interesting molecules. 
It is also believed that hydroxylation at positions C3, C5 and C7 are compulsory to 
observe the maximum inhibition of IL-4 production. Scutellarein, 3-hydroxyflavone, 
kaempferol, quercetin, eriodictyol, fustin and 7-hydroxyflavone share these structural 
features and demonstrated to be good inhibitors of IL-4 production. However, the detailed 
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 mechanisms by which flavonoids act in the modulation of cytokine synthesis remains 
unclear.29 Those are controversial results, because, as it was explained, IL-4, along with 
IL-10 and IL-13, is considered an anti-inflammatory cytokine. In this sense, the inhibition 
of its production might not be the best expected result. Luteolin, apigenin and fisetin 
demonstrated to inhibit the synthesis of IL-14 and IL-13 in an in vitro study.70  
 
 
4.6. Chemokines 
Chemokines are a group of small (8 to 12 KD) glycoproteins that, although structurally 
related to cytokines, are distinct from them as a result of their ability to bind and signal 
GPCRs. The main biological function of chemokines is the chemoattraction and activation 
of leukocytes in inflammation; they also control the normal migration of cells through 
various tissues. They are able to induce chemotaxis in a variety of other cells including 
eosinophils, fibroblasts and keratinocytes, being both chemotactic and cellular activating 
factors.1 Generally, the cellular sources of chemokines are leukocytes and endothelial 
cells.8 Numerous pro-inflammatory stimuli can lead to the production of chemokines, 
including cytokines, such as TNF and IL-1, and PAMPs, such as LPS.35 The produced 
chemokines can be stored in granules and are release upon stimulation. They are 
positively charged, so they can bind to the sulfated proteoglycans present on cell surfaces 
or they can stay in the extracellular matrix, remaining locally concentrated.76 
There are two types of chemokines: 1. CC (or β) chemokines, which include MCP-1, MIP-
1α, RANTES and eotaxin. They act primarily on monocytes, lymphocytes, basophils and 
eosinophils (eotaxin selectively recruits eosinophils), but not in neutrophils; 2. CXC (or α) 
chemokines, which include IL-8, GRO-a, and epithelial derived neutrophil-activating 
peptide (NEA-78). They differ from CC chemokines because of the presence of one amino 
acid between two amino-terminal cysteine (C) residues. CXC chemokines act primarily on 
neutrophils.1,5 It is also described the existence of two more families of chemokines: the C 
(or γ) chemokines, composed by lymphotactin, which are relatively specific for 
lymphocytes and the CX3C (or δ) chemokines, with only one member called fractalkine. It 
exists as a surface-bound protein and as a soluble form, derived by proteolysis of the 
membrane-bound protein, which has a great chemoattractant activity for monocytes and T 
cells.1,3,8,35 
IL-8 is one of the most studied chemokines. It is secreted by activated macrophages, 
endothelial cells, and other cell types. The IL8’s inducers are microbial products and other 
cytokines, mainly IL-1 and TNF. IL-8 causes chemotaxis and activation of neutrophils. IL-8 
leads to neutrophils’ degranulation, increased expression of surface adhesion molecules 
and production of ROS; however, it has limited activity on monocytes and eosinophils.35 
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 The chemokines effects are mediated by receptors, in which some receptors are highly 
specific, whereas others bind multiple chemokines of both CC and CXC families.1 These 
receptors are GPCRs and comprise CXC chemokine receptors (CXCR) and CC 
chemokine receptors (CCR). IL-8, for example, has two receptors, CXCR1 (IL-8R1), 
predominantly expressed in neutrophils, and CXCR2 (IL-8R2).35 During the inflammatory 
process, different leukocytes generally express more than one receptor type, so the type 
of inflammation will depend on the types of chemokines that are produced and the types 
of responding leukocytes. Chemokines are essential to determine which of these events 
will occur: leukocyte extravasation out of the bloodstream and into the tissue, and 
leukocyte navigation within tissue to the correct anatomic location, however, the exact 
mechanism of this directional sensing in mammalian cells is not clear.76 
 
 4.6.1 Modulation of Chemokines Production by Flavonoids 
Noteworthy, chemokines and cell adhesion molecules (CAMs) may not be the more 
directly studied inflammatory mediators, because their synthesis are intrinsically 
dependent on cytokines, for example; and once these last are modulated, those other 
molecules are consequently modulated too. Aromadendrine (dihydrokaempferol) 
presented anti-inflammatory activity in the keratinocyte cell line NCTC 2544, through the 
decrease of ICAM-1 expression of membrane and of the IL-8 release induced by IFN-ɣ 
and histamine.77 5,7-Dihydroxy-3,4,6-trimethoxyflavone down-regulated expression of 
adhesion molecules such as ICAM-1 and VCAM-1 in TNF-α – stimulated human bronchial 
epithelial cell line BEAS-2B. These effects were a consequence of the inhibition of both 
phosphorylation of Akt and IKK as well as the activation of NF-ĸB. Taken together, these 
led to the weakened adhesion of inflammatory cells such as monocytes and eosinophils to 
the bronchial epithelial cells.78 The involvement of the CAMs in inflammation will be 
discussed further ahead in this review; a well as the effects of flavonoids in chemokines 
and in CAMs will be further discussed in the in vivo section. 
 
 
4.7. Growth factors 
Growth factors are produced during the inflammation process, but, in general, they exert 
their effects in the late stages of inflammation, participating in the regulation of cell growth, 
tissue repair and angiogenesis.1 The growth factors and respective functions, are: EGF 
that stimulates keratinocyte migration and granulation tissue formation; fibroblast growth 
factor (FGF) is chemotactic for fibroblasts, stimulates keratinocyte migration and 
angiogenesis; insulin-like growth factor 1 (IGF-1) is pro-fibrotic; keratinocyte growth factor 
(KGF) and hepatocyte growth factor (HGF) are pro-inflammatory and fibrotic; platelet 
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 derived growth factor (PDGF) is chemotactic for neutrophils, macrophages, fibroblasts, 
endothelial cells (angiogenesis) and smooth muscle cells (angiogenesis); TGF-β is a 
mediator of tissue repair and fibrosis, regulates cell growth, death, and apoptosis, cell 
differentiation and extracellular matrix synthesis, induces vasculogenesis and enhances 
mesenchymal cell proliferation and VEGF regulates vascular permeability, induces 
vascular endothelial cell proliferation, upregulates tissue and urokinase plasminogen 
activator expression. They globally contribute to cellular proliferation and amplification of 
the inflammatory response.1,5,8 
 
 
4.8. Cell adhesion molecules 
Adhesion molecules are divided into five groups, based on structural homology: 
cadherins, mucins, integrins, selectins, and immunoglobulin superfamily molecules.  
Cadherins are expressed most often on epithelial cells and interact with each other in a 
Ca2+-dependent manner. Mucins are glycosylated proteins that interact mainly with 
selectins. The integrins family is subdivided in four subfamilies. Overall, they are 
responsible for a critical physical link between external cell medium components (other 
cells and the extracellular matrix) and those components within the cell (cytoskeleton, 
cytosolic molecules and nucleus).30 
The selectin family is constituted by three homologous proteins: L-selectin, E-selectin and 
P-selectin. The selectins roles are to mediate cell - cell interaction and to contribute to cell 
activation by intracytoplasmic signalling L-selectin. During inflammation, L-selectin is 
responsible for the binding of neutrophils to activated endothelial cells. Its ligands include 
glycan-bearing cell adhesion molecule-1 (GlyCAM-1), mucosal addressin cell adhesion 
molecule-1 (MadCAM-1) and CD34.30 Upon stimulation, L-selectin is constitutively 
expressed in neutrophils, eosinophils, monocytes, and naïve T and B lymphocytes, as 
well as on the surface of some activated T cells and memory T cells. E-selectin is not 
expressed in the surface of non-stimulated endothelium; it is produced after the 
stimulation with IL-1, TNF-α and bacterial endotoxin. E-selectin functions as a ligand of 
various myeloid cells and of T lymphocytes. P-selectin is expressed by activated 
endothelium, but also by platelets. When the endothelial cells are stimulated with agents 
such as complement C5a, histamine, thrombin, and LTC4, the P-selectin preformed stored 
in intracellular granules is rapidly translocated to the cell surface.79 The immunoglobulin 
gene superfamily (IgSF) of CAMs is composed by: ICAM-1, CD54, which is expressed 
constitutively in low amounts along the luminal, intercellular, and subluminal surface of 
endothelial cells, in leukocytes, epithelial cells and fibroblasts; its levels greatly increase 
after stimulation by IL-1, TNF-α, IFN-γ or bacterial endotoxin; ICAM-2, CD102, which is 
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 also constitutively expressed on endothelial, mononuclear cells, basophils, mast cells and 
platelets; its expression appears to be unaffected by cytokines; ICAM-3, CD50, which is 
constitutively expressed on all leukocytes and on mast cells; its cross-linking results in 
Ca2+ mobilization, tyrosine phosphorylation, enhanced adhesion, chemokine secretion and 
modulation of basophil mediators release; vascular cell adhesion molecule 1 (VCAM-1, 
CD106), which has been identified on cell types other than endothelium, namely 
macrophages, dendritic cells, astrocytes, bone marrow stromal cells and respiratory 
epithelial cell lines; IL-1, TNF-α and bacterial endotoxin induce increased expression of 
VCAM-1; finally, platelet–endothelial cell adhesion molecule 1 (PECAM-1, CD31), which is 
expressed on endothelial cells and circulating leukocytes, mediating neutrophil and 
monocyte transendothelial migration.79 
 
 
4.9. Transcription Factors 
 4.9.1. NF-ĸB 
As it has been becoming clear along this review, NF-ĸB is involved in almost all of the 
inflammatory phenomena. NF-ĸB is a crucial transcription factor in the orchestration of the 
inflammatory response, regulating the transcription of more than 150 genes. NF-ĸB exists 
in the form of homo- or heterodimer, the most common is the association of the portions 
p50 and p65. In resting cells these dimers exist in the cytosol, in an inactive form, 
because they are bonded to IκB, an inhibitory protein. Five IκB - like proteins have already 
been identified: IκBα, IκBβ, IκBγ, IκBε and Bcl-3. So, under the stimuli of pro-inflammatory 
trigger (e.g. TNF, IL-1, or LPS) the IκB is phosphorylated by an enzyme complex called 
IκB kinase (IKK). IKK contains two catalytic subunits, IKKα and IKKβ, and two copies of a 
regulatory scaffold protein called NF-κB essential modulator (NEMO or IKKγ). 35 This 
phosphorylation targets IκB for ubiquitination and subsequent proteosomal degradation. 
The degradation and removal of IκB allows the translocation of NF-κB active form to the 
nucleus where it binds to regulatory elements in the promoter regions of various NF-κB-
responsive genes. Noteworthy, this system exhibits a self-regulatory behavior, as the 
activation and migration of NF-κB to the nucleus are associated with the subsequent 
induction of IκB isoforms. NF-κB has been reported as one of the most remarkable pro-
inflammatory gene expression regulators and mediates several cytokines synthesis, such 
as TNF-α, IL-1β, IL-6 and IL-8, as well as COX-2.38  
 
 4.9.2. cAMP response element-binding protein 
Various receptor systems promote the activation of cAMP response element-binding 
protein (CREB). CREB is known for its role in cell proliferation, differentiation and survival. 
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 Nevertheless, it simultaneously has demonstrated specific functions in immune 
responses, including NF-ĸB inhibition, inducing macrophage survival and promoting the 
proliferation, survival and regulation of T and B lymphocytes. This signalling pathway is 
activated in response to various cytokines IL-2, IL-6, IL-10, and TNF-α.80 The ERK1/2 
signalling pathway, also known as the p42/p44 MAPK pathway, is usually associated with 
pro-survival signalling through mechanisms that may involve activation of the cAMP 
response CREB. 
Upon stimulation, CREB is phosphorylated by serine/ threonine kinases on serine 133 and 
this activates various signalling cascades, including PKA and PKC. Consequently, CREB 
seek out the co-factor CREB-binding protein (CBP) and/or p300. This will allow CREB to 
interact with DNA at cAMP-responsive elements (CREs), leading to the transcription of 
CREB-responsive genes (e.g., IL-2, COX-2). NF-κB has the ability to bind to CBP and 
when CREB and NF-κB are both present, CREB act as an NF-κB inhibitor by competing 
for a restricted pool of CBP.38 
Noteworthy, ERK belongs to the MAPK family, a distinct signalling cascade in the cell that 
responds to a variety of extracellular stimuli. MAPKs are implicated in the gene expression 
associated with the regulation of inflammation, cell survival, proliferation, iNOS and 
cytokine expression, and collagenase production. p38 is another element of MAPK family; 
it is associated with cellular responses, including inflammation, cell cycle, development, 
cell differentiation, senescence, tumorigenesis, and cell death (apoptosis). Finally, JNK is 
also part of MAPKs and regulates many cellular events, such as growth control, 
transformation, and programmed cell death (apoptosis). MAPKs also regulate the 
downstream phosphorylation of the transcription factors, NF-κB and AP-1.81 
 
 4.9.3. Janus kinase signal transducer and activator of transcription  
The Janus kinase signal transducer and activator of transcription (JAK/STAT) are 
activated in response to various cytokines, chemoattractants and growth factors. The 
activity of this transcription factor is mediated via cytokine / hematopoietic receptors that 
activate specific members of the Janus cytoplasmic tyrosine kinases (JAKs 1 to 3, and 
TYK2). JAK is consequently dimerized and phosphorylated, creating STATs binding sites. 
The substrates of the active JAKs are the receptor subunits and members of the STAT 
family of transcription factors (STATs 1 to 4, 5a/b and 6), which are phosphorylated by 
JAKs, undergo homo- or heterodimerization and translocate into the nucleus, where they 
bind to consensus STAT recognition sequences.38 
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  4.9.4. Mothers Against Decapentaplegic  
The mothers against decapentaplegic (SMADs) family of transcription factors is the 
primary signalling cascade initiated by the binding of TGF-β superfamily to their type II 
membrane receptor serine-threonine kinases and transphosphorylate the Gs domains of 
type I receptors. The receptor - associated SMADs (R-SMADs) are recruited and 
phosphorylated and they dissociate from the receptors. R-SMADs forms a complex with 
co-SMAD (e.g. SMAD4) translocate into the nucleus, and bind to SMAD-binding elements 
(SBEs) in the promoters of target genes, initiating transcription. The R-SMADs are 
eventually dephosphorylated; they dissociate and the inactive SMADs are exported to the 
cytoplasm.38 
 
 
4.10. Modulation of Transcription Factors – Gene Expression – by 
Flavonoids 
Transcription factors have become important subjects of study as they are involved in all 
the signalling cascades of inflammation, modulating the expression and release of almost 
all inflammatory mediators. Reversely, their expression is also modulated by these same 
mediators, creating a cycle, which is essential to interrupt to achieve a successful anti-
inflammatory activity. 
Flavonoids have been found to modulate PKCs and MAPKs, preventing the transcription 
of factors as AP-1 or NF-ĸB.11,82 The inhibition of kinases is due to the competitive binding 
of flavonoids with ATP at catalytic sites on these enzymes that are involved in signal 
transduction and cell activation processes involving cells of the immune system.12 p38-
MAPK positively regulates a number of cytokine genes in vitro including TNF-α, IL-6 and 
iNOS.16 Luteolin and quercetin already demonstrate their inhibition of LPS-induced 
promotion of p38 and ERK 1/2 pathways preventing the release and production of TNF-
α.11 Naringenin’s activity in the modulation of TLR2, TLR4, and CD86 receptors and 
downstream via the p38-MAPK pathway was confirmed in C. trachomatis infected J774 
macrophages.83 Rutin decreased PMA-stimulated phosphorylation of p38, ERK1/2, and c-
Jun.84 Flavone jaceosidin suppressed LPS-induced phosphorylation of p38-MAPK and 
ERK in primary microglial cells. These effects, along with the inhibition of COX-2 
expression, make this flavonoid a promising molecule for the resolution of neuro-
inflammation.70 
Luteolin also inhibited the gene expression and the cytokines production by blocking 
protein tyrosine phosphorylation and NF-ĸB activation in murine macrophages RAW 
264.7; this activity was also described in LPS-induced epithelial and dendritic cells 
through the inhibition of IKKs and in mouse alveolar macrophages by blocking the NF-ĸB 
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 and AP-1 activation pathways.16 However, in another study, luteolin suppressed NF-ĸB 
activation and TNF-α production in co-cultured intestinal epithelial Caco-2 and 
macrophage RAW 264.7 cells.85 These studies, with co-cultured cell lines, emphasize the 
importance of luteolin and its promising use in inflammation treatment as it is active in 
more than one type of cells possibly involved in this process. More recently, also in RAW 
264.7 cell line, luteolin inhibited TNF-α production, but did not suppress LPS-induced NF-
ĸB and MAPKs signalling. On the other hand, it markedly attenuated LPS-activated 
phosphorylation of the JNK downstream c-Jun and Jun-2 luciferase reporter activity.86 
Likewise, quercetin proved to modulate the transcription pathways via suppression of 
TLR4 signalling, through the up-regulation of Toll-interacting protein expression, once 
more in RAW 264.7 macrophages.87 Moreover, in the same LPS-induced cell line, 
quercetin arrested Src and Syk-mediated PI3K and Akt activations, and it disrupted LPS-
induced p85 association to TLR4/MyD88 complex and limited interleukin-1 receptor-
associated kinase 1 (IRAK1), TNF receptor associated factor 6 (TRAF6) and TGF-β 
activated kinase-1 (TAK1) with a subsequent suppression in IKKαβ-mediated IκB 
phosphorylation. In addition, it attenuated TAK1-mediated JNK1/2 and p38-MAPK 
phosphorylations but stimulated HO-1 induction, leading to NF-ĸB and AP-1 expression 
inhibition.88 Overall, quercetin and luteolin proved to affect various transcription signalling 
pathways, in their different levels, in different cell lines, and generally the results obtained 
are accordant. 
Genistein reduced the LPS-induced activation of NF-ĸB in monocytes, illustrating a 
potential flavonoid-gene interaction.16 Genistein also attenuated the inflammatory 
response via inhibition of NF-ĸB activation following adenosine monophosphate-activated 
protein kinase (AMPK) stimulation, which is connected to metabolic syndrome-related 
diseases, in LPS-stimulated RAW 264.7 macrophages.89 Galangin, another flavonol, 
decreased the degradation of IĸBα and nuclear translocation of p65 NF-ĸB, regulating the 
decrease in the elevated gene expression of TNF-α, IL-6, IL-1β and IL-8 in mast cells, and 
consequently in allergic inflammation.90 In a study with β-amyloid peptide 25-35-stimulated 
BV-2 cell line, used as a microglial model, genistein was able to inhibit the TLR4 and NF-
ĸB transcription and NF-ĸB activity. This means that genistein may be used not only to 
attenuate the common inflammatory processes, but also neuro-inflammation, a process 
involved in neurodegenerative diseases.91,92 
Flavones, daidzein, genistein, isorhamnetin, kaempferol, quercetin, naringenin and 
pelargonidin were already described as inhibitors of LPS-activation of NF-ĸB. However, 
only genistein, kaempferol, quercetin and daidzein inhibited simultaneously the STAT-1 
activation.16 Kaempferol, in turn, shortened the LPS-induced production of pro-
inflammatory mediators through the down-regulation of p38, JNK, TLR4 and NF-ĸB.81 
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 Moreover, kaempferol showed to inhibit the phosphorylation of ERK-1/2, p38 and JNK, as 
well as the activation of NF-ĸB by IL-1β, in rheumatoid arthritis fibroblasts. In this same 
study kaempferol also inhibited the production of COX-2, PGE2 and MMP-1 and 3.93 
Wogonin led to the reduction in phosphorylation and activation of STAT1 and STAT3 
through the blockade of the nonreceptor tyrosine kinase Jak-1 and Jak-3 in LPS/IFN-ɣ-
activated BV2 microglial cells; and the consequently decrease in IL-6 and TNF-α 
production, in a concentration-dependent manner.94 
In an inflammation-related colon cancer intervention, oroxylin A supressed NF-ĸB 
activation, through the inhibition of phosphorylation-dependent IKK activation in LPS 
stimulated HCT116 cells and THP-1 cells.95 It has already been reported that flavonoids 
not only directly inhibit NF-ĸB, but are also able to activate the nuclear factor E2-related 
factor 2 (Nrf2) systems, which in turn, increase the activity of antioxidant enzymes and 
inhibit NF-ĸB. Catechins, quercetin and isoflavones were described as exerting these 
activities.96 Quercetin was recently identified as preventing the oxidative damage by 
down-regulating p38, ERK1/2 and MAPK and modulating the redox cross talk between 
NF-ĸB and Nrf-2, in a HepG2 (human hepatoma) cell line exposed to ochratoxin A 
(mycotoxin).97 As so, it has been proved that quercetin modulates the NF-ĸB transcription 
by more than one signalling pathway. 
A study with trimethoxyflavones revealed that 4’-bromo-5,6,7-trimethoxyflavone was the 
best suppressor of NF-ĸB, iNOS and COX-2 expression, and consequently the best 
inhibitor of NO, PGE2, TNF-α, IL-6 and IL-1β production, in LPS-treated RAW 264.7 cells. 
This, taken together, shows the halogenation of flavonoids as a promising feature to 
enhance their anti-inflammatory activity.98 The potential of chlorinated flavonoids was also 
described by Freitas et al. as they efficiently modulated neutrophils' oxidative burst and 
lifespan, by driving neutrophil apoptosis in a caspase-dependent fashion.66 
Finally, in a recent study, a biflavonoid, kolaviron, tested in a RAW 264.7 macrophage cell 
line, showed no inhibition on LPS-induced production of IL-1α, IL-33, IL-1β, IFNβ1-1 and 
TNF-α. However, it inhibited the IL-6 production, and probably via inhibition of ERK1/2, 
p38, Akt, p-c-JUN and JNK signalling pathways.99,100 Also an epicatechin trimer, 
procyanidin C1, inhibited LPS - induced MAPK and NF-κB signalling through TLR4 in 
RAW 264.7 macrophages.101 Other associations of flavonoids have been studied.102 The 
review of the flavonoids’ effects on gene expression allowed the comprehension of the 
numerous studies that have been handled to understand the different action pathways. 
However, it was also clear that one flavonoid can affect more than one pathway at the 
same time, and sometimes the effects produced may be antagonistic. Nevertheless, the 
recent studies using flavonoids were undoubtedly focused in gene expression and 
transcription pathways. 
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 4.11. Other Inflammatory mediators 
 4.11.1. Platelet-activating factor 
The platelet-activating factor (PAF) precursor, lyso-PAF, is released from the cell 
membrane by the action of cPLA2 on phosphatidylcholin. PAF, a lipid-inflammation 
mediator, is synthesized by activated neutrophils, eosinophils, monocytes, platelets, 
endothelial cells, mast cells and fibroblasts. PAF acts via GPCRs and platelet-activating 
factor receptor (PAFR), in a paracrine and autocrine manner, on eosinophils, neutrophils, 
macrophages, platelets, endothelial cells and lymphocytes.3,4 Activation of PAFR results in 
inhibition of cAMP, mobilization of Ca2+, and activation of MAPKs; the long-term 
responses depend on intracellular, most likely on nuclear receptor activation. The PAF’s 
functions comprise: activation of platelets, chemoattraction and activation of neutrophils, 
macrophages and eosinophils, bronchoconstriction, and increase of vascular permeability 
and vasodilation.33 
 
 4.11.2. Kinins 
The kinin-generating system is responsible for the generation of peptides important to the 
inflammatory response. The major proteins of this system are Hageman factor, clotting 
factor XI, prekallikrein and high molecular weight kininogen. Bradykinin is the most 
important biologically active peptide generated by kinin-generating system. Bradykinin 
holds a variety of functions, namely: increasing vascular permeability, vasodilation, 
hypotension, induction of pain, contraction of many types of smooth muscle cells and 
activation of PLA2.30 Additionally, kinins can increase IL-1 production through initial 
stimulation of TNF. The kinins effects are associated with the production of other 
inflammatory mediators, such as NO, IL-6, IL-8 and mast cells-derived products.5 
 
 4.11.3. The inflammasome 
The inflammasome is an intracellular multi-protein complex, composed by 22-family-
member human Nod-like receptor (NLR) family of cytoplasmic proteins. The 
inflammasome is an important regulator of inflammation. The activated NLR proteins 
recruit additional proteins to form a complex with caspase-1 and with adaptor molecule 
apoptosis-associated speck like protein (ASC).5 The activation of caspase-1 is a critical 
step that leads to the cleavage and activation pro-IL-1β and pro-IL-18.103 
 
 4.11.4. C-reactive protein 
The exact function of CRP is unknown, but it has an important role in the recognition of 
phosphocholine, phospholipids, fibronectin, chromatin and histones, all exposed at sites of 
tissue damage and by apoptotic cells; so, CRP may target them for clearance. 
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 Additionally, CRP activates the classical complement pathway and interacts with cells of 
the immune system. It is also responsible for the induction of inflammatory cytokines, 
tissue factors, and shedding of the IL-6 receptor, all of which result in a complement-
dependent increase in tissue damage. Nevertheless, CRP presents also anti-inflammatory 
effects, namely the non-inflammatory clearance of apoptotic cells and preventing 
neutrophil adhesion to the endothelium. In chronic inflammation the levels of CRP are 
always raised.2 
 
 4.11.5. Serum amyloid A 
The precise function of serum amyloid A (SAA) is not known, but it is considered pro-
inflammatory. SAA acts via TLR2, activating the NF-κB pathway and binding to the G 
protein–coupled formyl peptide receptor like-1 (FPRL1). It consequently induces various 
cytokines, acts as chemotactic for leukocytes and stimulates angiogenesis, TF and matrix 
MMPs’ expression.2 
 
 4.11.6. Vasoactive amines 
These inflammatory mediators comprise two molecules: histamine and serotonin. 
Histamine is the decarboxylation product of the amino acid histidine and is stored in mast 
cells and basophils granules. Histamine is released when cells are subjected to certain 
stimuli, namely: physical injury, such as, trauma, cold or heat; binding of antibodies to 
mast cells, which underlies allergic reaction, IgE; fragments of complement, 
anaphylatoxins (C3a and C5a); histamine-releasing proteins derived from leukocytes; 
neuropeptides (e.g. substance P) and cytokines (IL-1, IL-8).3 The biological effects 
produced by histamine are performed via specific receptors, H1 and H4, which are 
GPCRs, widely distributed across tissues. Its vasoactive effects are mediated mainly by 
H1 receptors on microvascular endothelial cells, via stimulation of inositol 1,4,5-
trisphosphate (IP3) production and Ca2+ fluxes/PKC activation, increasing NO generation 
and LTs production. H1 receptors also promote NF-κB activation and inflammatory 
cytokine/chemokine production.38 Histamine’s main functions are: vasodilation, increase 
venular permeability, enhance leukocyte rolling and firm adhesion, induction of gaps in the 
endothelial cell lining, and enhance leukocyte extravasation.5,8 
Serotonin (5-hydroxytryptamine) is a preformed vasoactive mediator, stored in the dense 
body granules of platelets.4 Serotonin is released when platelets aggregate after the 
interaction with collagen, thrombin, adenosine diphosphate and antigen-antibody 
complexes.3 Serotonin actions are similar to those of histamine. Serotonin biological 
effects comprise: promotion of fibrosis, by enhancing the synthesis of collagen by 
fibroblasts, and also neurotransmission.4 
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  4.11.7. Proteases 
Proteases include cysteine proteases, serine proteases, as well as MMPs and related 
enzymes [A disintegrin and metalloproteinases (ADAMs) and A disintegrin and 
metalloproteinase with thrombospondin motifs (ADAMTSs)].4 They are vital for the 
degradation of the extracellular matrix, a key mechanism of tissue turnover in 
inflammation; preparing the tissue for the ingrowth of new blood vessels and adherence 
and retention of newly recruited cells.5 
Serine proteases, such as, trypsin, chymotrypsin, and elastase, are found in high levels 
and released by infiltrating neutrophils at the inflammation sites. They can directly digest 
the extracellular matrix or activate the pro-enzyme forms of secreted MMPs. Indeed, the 
large family of proteases is the MMPs family. They are a family of more than twenty 
extracellular endopeptidases, including, collagenases, entactin or nidogen-1, gelatinases, 
matrilysins and stromelysins. MMPs are produced as pro-enzymes and depend on metal 
ions (zinc/metzincin superfamily) to be active. The gene expression of MMPs is induced 
by multiple pro-inflammatory cytokines (TNF, IL-1, IL-17 and IL-18), through MAPK signal 
transduction pathways. They participate in the degradation of the extracellular matrix, in 
the cleavage of cell surface molecules and other pericellular non-matrix proteins, 
regulating cell behavior and in the digestion of matrix proteins associated with growth 
factors. The function of MMPs is endogenously regulated by tissue inhibitor of 
metalloproteinases (TIMPs). In the presence of cytokines inhibitors and growth factors, 
matrix protein production increases, and TIMPs inhibit MMPs activity.5 
The effects of flavonoids in these “Other Inflammatory Mediators” are less studied than in 
the other mediators referred; however, some of those effects will be described in the next 
points of this article. 
 
 
5. Flavonoids Conjugates / Complexes in Inflammation 
5.1. Glycosylated flavonoids 
Glycosides of flavonoids are commonly found in nature and their bioavailability is higher 
compared to their aglycones. Noteworthy, the colonic microflora is considered to be a key 
hydrolase source for hydrolysis of flavonoid glycosides. In the digestive tract, by the action 
of β-glucosidases, the flavonoid glycosides suffer hydrolysation and they are absorbed as 
aglycones. The flavonoid glycosides are too water-soluble to diffuse across the cellular 
membrane, but their aglycones are more hydrophobic and can be easily absorbed by the 
epithelial cells through passive diffusion.104 As so, it has been of interest to study if the 
biological effects of flavonoid glycosides differ from their aglycones. Generally, the 
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 aglycones are more potent antioxidants than their glycosides. This assumption was 
ascertained by a study where the antioxidant properties of flavonol glycosides from tea 
declined as the number of glycosidic moieties increased.12 When studying the 2,2-
diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging potential of O-glycosylated 
flavonoids, it was concluded that the glycosylation of flavonol on both OCH3 and OH 
reduced this potential. The inhibition of xanthine oxidase showed naringenin as having 
stronger chelating action with metallic ions than its glycoside. The glycosylation of 
flavonols, kaempferol and quercetin, obviously reduced the ONOO- scavenging potential. 
All these studies corroborate the loose of the antioxidant properties when flavonoids are 
glycosylated. However, flavonoids may be O-glycosilated and C-glycosilatied and several 
reports showed different results when comparing these two substitutions. The O-
glycosylation of flavanones at the C-7 position reduced the radical scavenging potential of 
flavanones, which may be caused by the steric effect and the ability to delocalize 
electrons. This behaviour of O-glycosylated flavonoids may be different in a cellular 
environment; and so far the related data is not sufficient to draw a conclusion on the 
influence of O-glycosylation of flavonoids on their cellular antioxidant potential. Studies 
undertaken to discover the antioxidant effects of C-glycosylated flavonoids have 
concluded that this glycosylation enhances this effect. In a trolox equivalent antioxidant 
capacity (TEAC) assay, the antioxidant activity of luteolin 6-C-glucopyranoside was 
lowered when more glycosides were added.104 Naturally occurring glycosylated flavonoids 
were not capable of inhibit the production of NO in LPS-activated RAW 264.7 cells, 
regardless the aglycones types. Quercetin showed to have more potential to inhibit NO 
production, iNOS expression and NF-ĸB activation than its glycosides and the same 
happened with cirsimaritin and its glycosides in LPS-induced RAW 264.7 macrophages. 
Similarly, apigenin showed inhibition of NO production and iNOS and COX-2 expression 
while vitexin and isovitexin (apigenin C-glycosides) were inactive, in LPS-stimulated RAW 
264.7 cells.105 Myricetin and its 3-O-glycosides significantly inhibited the LPS-stimulated 
production of NO and pro-inflammatory cytokines and the increasing of iNOS and COX-2 
levels in the same cell line as the apigenin study. Icariin and one of its metabolites also 
significantly inhibited LPS-induced inflammatory response, in vitro, in RAW 264.7 cells, 
and in vivo, in C57BL/6J mice.106,107 All in all, no clear structure-activity relationships, 
depending on the positions or types of sugar substitution, was found in the anti-
inflammatory activity for flavonoid glycosides. These differences between O- and C- 
glycosylated flavonoids may be simply explained by the mechanism of action of 
antioxidant flavonoids. As it was already explained, the free OH groups of flavonoids are 
determinant for the co-planarity of the rings, by the establishment of hydrogen bounds and 
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 the donation of hydrogen and an electron to the PORS and metal chelating, determining 
the potent antioxidant effects of these flavonoids.104 
Recently Kim and co-workers undertook a study in RAW 264.7 macrophages with 
myricetin, myricitrin, myricetin 3-O-(2’’-O-galloyl)-α-L-rhamnopyranoside, myricetin 3-O-
(2’’-O-galloyl)-b-D-galactopyranoside and quercetin 3-O-(2’’-O-galloyl)-β-D-
galactopyranoside. Where they found that galloyl flavonol glycosides, the last three, were 
clearly good inhibitors of TNF-α, IL-1β and IL-6 production, they inhibited the expression 
of iNOS and COX-2 proteins, indicating that the presence of a galloyl group in the sugar 
moiety played a key role in O2- radical-scavenging and anti-inflammatory activity. 108 
Kaempferol-3-O-rutinoside and kaempferol-3-O- glucoside were effective inhibitor of 
neuro-inflammation by the modulation of NF-ĸB and STAT3 activation.109 Another study 
with isoorientin (luteolin-6-C-glucoside), in the same neuro-inflammation model, but now 
induced by LPS, inhibited the translocation of NF-ĸB from cytosol to the nucleus, by IĸB 
degradation, and decreased the production of TNF-α, IL-1β and NO. It was also proved 
that scavenging of PORS and attenuation of ERK1/2, JNK and p38-MAPK 
phosphorylation may be involved on the inhibition of the production of pro-inflammatory 
mediators. In general, it was concluded that the anti-inflammatory effect of isoorientin was 
mediated through the inhibition of MAPK/NF-ĸB signalling pathways.110 Orientin and 
isoorientin also inhibited high glucose-induced vascular inflammation via the inhibition of 
NF-κB in primary human endothelial cells. Moreover, they attenuated H2O2 generation, 
up-regulation of adhesion molecules, monocyte endothelial cell adhesion and disruption of 
the endothelial barrier function. 111 Furthermore, orientin was able to suppress TNF-α, IL-6 
production and the activation of NF-κB or ERK1/2 by LPS and protect the vascular barrier 
integrity by inhibiting CAMs expression.112 
Xiao and co-workers revised the flavonoids glycosylation and their biological benefits and 
stated that, in vivo (oral treatment), flavonoid glycosides and their aglycones showed 
similar anti-inflammatory activity or even higher for the glycosides.104 However, in another 
in vivo study, carrageenan-induced oedema in the mouse paw (intravenous treatment), 
aglycones (quercetin and hesperetin) gave positive results, while the glycosylated 
flavonoids showed no significant activity (rutin and hesperidin) (table 4).29 These two 
different results may be attributed to the importance of the administration via of the 
flavonoids, because they imply different metabolism pathways. It should be noticed that 
after the intestinal modifications of flavonoids they suffer further metabolization and the 
non-conjugated aglycones are scarcely detected in the human plasma. Quercetin is an 
example of that: quercetin-3-O-glucuronide and quercetin-3'-O-sulfate are the major 
quercetin conjugates in rat and human plasma, while the aglycone could not be detected. 
However, when macrophage cell lines (RAW 264.7 and/or THP-1) in vitro were analysed, 
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 it was clear that quercetin-3-O-glucuronide could bind to the cell surface but not 
accumulate intracellularly, while the aglycones were incorporated into cells, presumably 
via simple diffusion. These evidences once more the effects of flavonoids are mostly 
attributable to their aglycones; and in this case, the β-glucuronidase - mediated 
conversion of quercetin-3-O-glucuronide into the aglycone is essential for the anti-
inflammatory effects. On the other hand, it is also known that the conjugation 
(glucuronidation and/or sulfation) of OH groups on polyphenols promotes their rapid 
excretion and attenuates their anti-inflammatory activities. It is why the health benefits of 
conjugated flavonoids in vivo still continue to be controversial. 113 The EGCG effects in 
inflammation were reviewed in 114. An increasing number of in vitro and in vivo studies that 
describe the anti-inflammatory effects of flavonoids glycosides has being published, 
showing the rising interest in these molecules.106,115-124  
Another flavonoid derivative, a flavoalkaloid, named lilaline (3,4′,5,7-tetrahydroxy-8-(4-
methyl-5-oxo-2-pyrrolidinyl)-flavone), isolated from the flowers of Lilium candidum L., was 
described as having anti-inflammatory properties through the inhibition of COX enzyme.125 
 
 
5.2. Flavonoid-metal ion complexes 
As stated above, flavonoids may chelate metals and in this way contribute to the 
antioxidant resolution of inflammation. Additionally, flavonoid-metal ion complexes have 
appeared as a novel class of therapeutic agents. Their anti-inflammatory activities have 
been studied using carrageenan paw oedema and xylene-induced ear oedema mice 
models. Complexes of luteolin and La(III), Ho(III), Yb(III), Lu(III) and Y(III) showed better 
anti-inflammatory effect compared to luteolin per si. This result was associated to their 
ability to resist telangiectasia, a condition characterized by development of small new 
dilated capillaries near the surface of the skin, which retard vascular permeability and 
prevent tissue oedema caused by the acute inflammation. Similarly, complexes of 
quercetin and Zn and Mn have also been found to exhibit higher anti-inflammatory activity 
than quercetin. It is believed that these complexes act in COX and LOX pathways, but 
more studies are needed to better understand the therapeutic properties of these 
complexes.126 
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 6. In vivo studies 
6.1. Non-human studies 
There have been an increasing number of in vivo studies where the anti-inflammatory 
properties of flavonoids are evaluated. Table 4 summarizes the in vivo – inflammation 
mediators related studies. The major problem found when we review this topic is the 
variety of models for the same disease, hindering the possibility of establishing a 
comparison between them, or even take a conclusion of different results for the same 
flavonoid obtained in different model diseases. Likewise, there are some diseases for 
which a model does not exist or is very rare to find a study about it (e.g. multiple 
sclerosis). Inflammatory bowel disease is one of the diseases for which there are several 
models. However, they differ in their immune and pathological characteristics. For 
instance, dietary rutin supplementation failed to ameliorate colitis in MDR1A knockout 
mice, but it was beneficial in acetic acid, trinitrobenzene sulfonic acid (TNBS) and 
dextrane sulfate sodium (DSS) induced colitis. As so, it is difficult to predict the 
implications of these discrepancies, if there are any.17 The administration form of the 
flavonoids is also crucial for its effects and it was been a goal to study how the 
bioavailability of flavonoids could be enhanced. Quercetin has been described as 
presenting several solubility problems in the administration media. Liposomal quercetin 
was viewed as an alternative. In fact, liposomal quercetin proved to attenuate bleomycin-
induced pulmonary fibrosis in Sprague-Dawley rats, by the suppression of TNF-α, IL-1β 
and IL-6 production.127 Recently, a study in male Sprague Dawley rats, LPS-induced 
inflammation model, showed gold-nanoparticules loaded with puerarin or curcumin or both 
were more potent inflammatory inhibitors than the isolated flavonoids. This demonstrated 
that the effectiveness of these flavonoids in vivo may be conditioned by their 
bioavailability. 128 It is also very common to find in vivo studies about the anti-neoplasic 
properties of flavonoids through the modulation of the immune response, 17 but in this 
article we just discuss the anti-inflammatory effects. 
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 Table 4 - Inflammation mediators related in vivo studies. 
Flavonoid/s Model Effect Reference 
Fisetin, flavone, 
tricetin 
Pulmonary inflammation 
model - LPS – induced, in 
male C57BL/6 mice 
Fisetin reduced MPO levels, and  gene expression of 
IL-6, TNF-α, MIP-1α, MIP-2, IL-1β, and IĸBα 
transcription; flavone significantly reduced TNF-α and 
MIP-2 gene transcription; tricetin reduced IL-1β and 
IĸBα transcription 
129 
Apigenin, fisetin, 
kaempferol, luteolin, 
patuletin, patulitrin, 
quercetin 
Asthma models (BALB/c 
mice, cats, guinea pigs) 
Reduced asthma signals, like IL-4, IL-5, IL-13, TNF- α 
production, eotaxin levels, IgE levels, NF-ĸB 
expression, EPO activity, etc. 
Revised in 
17 and 130 
Catechin, EGCG, 
flavopiridol, 
genistein, 
hesperidin, 
nobiletin, quercetin, 
resveratrol, rutin, α-
glucosylhesperidin  
Rheumatoid arthritis models 
(collagen- and adjuvant 
induced arthritis) 
Inhibition of osteoclast / macrophage differentiation 
and function, estrogen modulation; down-regulated 
NFAT (disintegrin-like and metalloprotease) 
expression in synovial fibroblasts and chondrocytes 
Revised in 
17 
Baicalin, genistein, 
resveratrol, silibinin 
Multiple sclerosis model - 
injection of Freund’s adjuvant 
and a myelin glycoprotein - 
induced allergic 
encephalomyelitis, in mice  
Resveratrol induced apoptosis of preferentially 
activated but also quiescent T cells; however, in 
various other cases, the mechanism was largely 
undetermined 
Revised in 
17 
Diosmin, EGCG, 
genistein, 
hesperidin, 
quercetin 
glycosides, morin, 
quercitrin, rutin  
Inflammatory bowel disease 
models 
Diverse intestinal anti-inflammatory activities, through 
immunomodulatory effects at the epithelial level 
Revised in 
17 
Quercitrin, rutin 
Inflammatory bowel disease 
models 
As quercetin pro-drugs, prevented premature 
absorption of the aglycone in the small intestine and 
releasing it in the colon; this is based on the inability of 
quercetin to ameliorate DSS colitis and suggests a 
local action of the flavonoid 
Revised in 
17 
Fisetin, morin, 
myricetin 
Atherosclerosis models 
Reduced foam cell formation, inhibited LDL oxidation 
by neutrophil MPO blockage 
Revised in 
17 
EGCG, tea 
catechins, 
theaflavin, 3-
methoxypuerarin 
Ischaemia-reperfusion 
models 
Protection against post-ischemic myocardial 
remodelling via anti-inflammatory actions; inhibition of 
PI3K - the structure-activity relationship has been 
defined 
Revised in 
17 
Chalcone, 
hesperetin, 
kaempferol, 
naringenin, 
quercetin 
Metabolic syndrome models 
Decrease of TNF and iNOS expression in visceral fat; 
partial PPAR-γ agonists in fat cells, but it has been 
argued that the antagonist component may be the 
predominant one in vivo; reduction of inflammatory 
cytokines’ production 
Revised in 
17 
Luteolin, quercetin 
Traumatic brain damage – 
brain inflammation models  
Various anti-inflammatory actions in myeloid cells; 
however quercetin might be toxic to neurons in 
micromolar concentrations in basal conditions 
Revised in 
17 
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 Table 4 - Inflammation mediators related in vivo studies. (cont.) 
 
 
Flavonoid/s Model Effect Reference 
ECGC, eupatilin, 
jaceosidin, 
myricitrin 
Skin inflammation models 
diminished the skin cells response to IgE-antigen 
complexes 
Revised in 
17 
Apigenin, flavone, 
flavonol, 
kaempferol, 
luteolin, quercetin, 
rutin 
Carrageenan – induced 
inflammation model, in male 
Wistar rats 
Luteolin, kaempferol, chrysin and hesperidin did not 
inhibit the total cell migration; quercetin, rutin, flavone, 
apigenin and flavonol reduced the number of rolling, 
adherent and migrated leukocytes, except apigenin; 
quercetin inhibited the cleavage of L-selectin and the 
expression of β2-integrin; rutin and flavonol only 
inhibited the expression of β2-integrin 
Revised in 
131 
Hesperidin, 
naringin 
Inflammation model - injection 
of sterile air followed by 
carrageenan – induced, in 
healthy colony-bred Wistar 
albino male rats 
Increased SOD and GSH, normalized the total count 
of leukocytes, neutrophils and lymphocyte and TNF-α 
concentration; hesperidin was more effective than 
naringin 
132 
Daidzein, 
genistein 
Cutaneous inflammatory 
response model – TPA – 
induced, in female Swiss albino 
Reduced NO production, increased GSH levels, 
restored SOD and CAT activities, inhibited TNF-α, IL-6 
and IL1-β production, reduced expression of NF-ĸB 
and COX-2 
133 
Curcumin and 
Quercetin 
Acute inflammation model - 
carrageenan - induced, in male 
albino rats 
Inhibited the NO levels, augmented GSH levels, HO-1 
mRNA expression, reduced TNF-α release. Both 
flavonoids moderately lowered inflammation, while 
their combination was more effective 
134 
Quercetin, rutin 
Hepatotoxic and inflammatory 
liver model -  high cholesterol 
diet – induced, in Swiss albino 
mice 
Scavenged DPPH radical, chelated Fe, restored the 
SOD, catalase and glutathione levels, lowered the 
expression of p65 NF-ĸB, iNOS and C- reactive protein 
and the production of TNF-α and IL-6 
135 
7, 3′-dimethoxy 
hesperetin 
Adjuvant-induced arthritis 
model, in male  male Sprague-
Dawley rats 
Supressed the levels and expression of IL-6; 
apparently decreased mRNA expression of JAK2 and 
STAT3 as well as protein expression of p-JAK2 and p-
STAT3 in the rats synovium 
136 
7, 3′-dimethoxy 
hesperetin 
Adjuvant-induced arthritis 
model, in male  male Sprague-
Dawley rats 
Decreased the serum concentrations of TNF-α and IL-
1β, in a dose-dependent manner 137 
Alpinetin 
Lung injury model – LPS - 
induced, in male BALB/c mice - 
Inhibited TNF-α, IL-6 and IL-1β production, reduced 
the total cohort of macrophages and neutrophils (also 
blocked IκBα and p65 NF-ĸB phosphorylation and 
activation of ERK and p38 in RAW 264.7 cells) 
138 
Baicalin (baicalein 
7-O-glucuronide) 
Renal ischemia-reperfusion 
injury model - clamping of the 
left renal artery plus a right 
nephrectomy - induced, in male 
Wistar rats 
Slightly down-regulated SOD activity, inhibited the 
increased expression of TLR2/4, MyD88, p-NF-κB and 
p- IκB, increase the expression of IκB protein, inhibited 
mitochondria - mediated cell apoptosis pathway 
139 
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 Table 4 - Inflammation mediators related in vivo studies. (cont.) 
 
Flavonoid/s Model Effect Reference 
Baicalin 
Chronic obstructive pulmonary 
disease model - cigarette 
smoke exposure - induced, in 
male Sprague-Dawley rats 
Inhibited IL8, IL6 and TNF-α release, supressed p65 
NF-ĸB expression 140 
Baicalin 
Age inflammation model, in 
young and old specific 
pathogen free male Fischer 
344 rats 
Old rats showed high levels of PPARɣ, but decreased 
levels of phospho-PPARɣ, down-regulated levels of 
VCAM-1, IL-1β and IL-6 genes 
141 
Baicalin 
Mastitis model - S. aureus – 
induced, in female BALB/c 
mice 
Inhibited TNF-α, IL-1β and IL-6 production, 
suppressed NF-κB expression and the phosphorylated 
IκB levels in the mammary gland, slightly reduced the 
phosphorylated JNK and ERK proteins 
142 
Baicalin 
Adjuvant-induced arthritis 
model, in male C57BL/6 (B6) 
mice 
Inhibited the up-regulated IL-17 mRNA expression 123 
Baicalein 
Parkinson’s disease model  -  
MPTP – induced, in male 
C57B/6 mice 
Inhibited of NF-ĸB nuclear translocation, attenuated 
ERK and JNK phosphorylation in astrocytes 
143 
Baicalein 
Asthma model - ovalbumin or 
IL-13 – induced, in male Balb/c 
mice 
Modulated the Th1/Th2 response by increasing IFN-ɣ 
and decreasing IL-4 and IL-13, reduced TLR2 levels 
without affecting TLR-4 levels, reduced the 15-LOX 
metabolites levels 
144 
Baicalein 
Acute lung injury model – LPS - 
induced, in male Sprague-
Dawley rats 
Diminished iNOS / NO cascade and O2- formation 
and nitrotyrosine expression, induced HO-1 due to 
Nrf2 activation, inhibited p65 NF-κB translocation in 
lung tissues 
145 
Butein 
Spinal cord injury model  - T12 
segment – induced, in female 
Sprague Dawley rats  
Attenuated the expression of p65 NF-ĸB, inhibited the 
production of phosphorylated IĸBα, reduced MPO 
activity 
146 
Catechin 
Cardiotoxicity model – 
Adriamycin - induced, in male 
Wistar rats  
Increased CAT, GSH-Px and SOD activities, 
significantly decreased the expression levels of TNF-α 
and NF-ĸB 
147 
Chrysin 
Colitis model – DSS - induced, 
in BALB/c mice 
Reduced NO and PGE2 production, reduced MPO 
activity, prevented the elevation of IL-1β and IL-6 
levels, had no effect on TNF-α, inhibited Ik-Bα 
degradation and NF-ĸB translocation 
148 
Chrysin 
Colitis model mice – DSS or 
TNBS – induced, in female 
C57BL/6 
Inhibited NF-ĸB, reduced the production of TNF-α and 
IL-6, the activity of MPO, down-regulated iNOS, Cox-2 
and ICAM-1, limited the inflammatory (histologic) 
response, probably through PXR-mediated NF-ĸB 
inhibition 
149 
Chrysin 
Obesity model - high-fat - 
induced, in male C57BL/6J 
mice 
Attenuated the increase of IL-1β, TNF-α and the 
reduction of IL-10( also studied murine RAW 264.7 
cells - mechanism of action involves activation of 
PPAR-ɣ functions) 
150 
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 Table 4 - Inflammation mediators related in vivo studies. (cont.) 
 
Flavonoid/s Model Effect Reference 
Chrysin 
Spinal cord injury model - 
modified weight-drop method - 
induced, in adult Wistar rats 
Dose-dependently suppressed the activities of p65 
NF-κB subunit, TNF-α, IL-1β and IL-6, suppressed 
iNOS activity and decreased NO bioavailability 
151 
Chrysin 
Lung fibrosis model - 
bleomycin – induced, in female 
Wistar Albino rats 
Increased the levels of SOD and CAT, reversed GSH 
depletion 
152 
Chrysin 
Autoimmune neuritis - P0 
peptide 180-199 and 
Mycobacterium (M) 
tuberculosis (strain H37RA) - 
induced, in male Lewis rats 
Down-regulated the expression of iNOS and COX-2, 
via inhibition of the NF-ĸB pathway, inhibited IL-1β, IL-
2, IL-6, IL-12, IFN-ɣ and TNF-α, the level of IL-4 was 
up-regulated; IL-1α, IL-10, IL-13, GM-CSF and 
RANTES showed no significant changes 
153 
Diosmetin 
(diosmin 
aglycone) 
Acute pancreatitis model - 
cerulean – induced, in male 
C57BL/6 mice 
Lowered the plasma levels of TNF-α, IL-1β, IL-6, 
reduced MPO activity, iNOS expression and p65 NF-
ĸB expression and nuclear translocations in pancreas 
tissue 
154 
Diosmin 
Hepatic toxicity model - ethanol 
– induced, in female Wistar rats 
Restored the XO level, reduced the TNF-α levels, 
supressed NF-ĸB, COX-2 and iNOS expression 155 
EGCG Atherosclerosis models 
LDL protection / down-regulation of CD36 mechanism 
and appears to exert it specifically in atherosclerotic 
lesions 
Revised in 
17 
Genistein 
Asthma model mice - 
ovalbumin – induced, in female 
specific-pathogen-free ICR 
Inhibited the up-regulation of eotaxin, IL-4, IL-5 and 
MMP-9 mRNA expression and the down-regulation of 
IFN-γ and TIMP-1 mRNA expression, induced MPO 
and SOD activities 
156 
Hesperidin 
Rheumatoid arthritis – collagen 
– induced, in male Wistar rats 
Decreased TBARS and NO levels, significantly 
replenished GSH and SOD level, probably by 
scavenging RS 
157 
Isorhamnetin 
Acute inflammation models - 
carrageenan – induce, in 
Sprague-Dawley rats 
Decreased TNF-α, IL-1β, IL-6 and iNOS (in 
macrophages RAW 264.7 cell line, attenuated JNK 
and AKT/IKKαβ, which resulted in decrease of nuclear 
translocation of the p65 subunit) 
158 
Kaempferol 
Air pouch inflammation model  
rats - carrageenan – induced, 
in male Wistar rats 
Decreased the NO and PGE2 levels of exudates in a 
dose-dependent manner 
159 
Kaempferol 
Colitis model - DSS – induced, 
in female C57BL/6J mice 
Decreased MPO activity and the plasma levels of 
LTB4, PGE2 and NO, down-regulated the expression 
of COX-2 and iNOS, supressed TNF-α, IL-1β, and IL-6 
expression 
160 
Kaempferol 
Atherosclerosis model - high 
cholesterol diet – induced, in 
male New Zealand white 
rabbits 
Decreased levels of TNF-α and IL-1β, increased 
serum SOD activity, decreased gene and protein 
expressions of E-selectin, ICAM-1, VCAM-1, and 
MCP-1 
161 
Luteolin 
Colitis model - DSS – induced, 
in mice 
Blocked epithelial protective NF-κB proteins, because 
DSS elicits colitis primarily by disruption of the 
epithelial layer 
Revised in 
17 
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 Table 4 - Inflammation mediators related in vivo studies. (cont.) 
Flavonoid/s Model Effect Reference 
Luteolin Colitis, in IL-10 KO mice 
Ameliorated colitis, because colonic inflammation 
develops in a more progressive and subtle fashion 
originating from immunological imbalance 
Revised in 
17 
Malvidin-3-O-β 
glucoside 
Arthritis model - 
Mycobacterium butyricum - 
induced, in young female Lewis 
rats 
Diminished inflammatory cachexia and arthritic paw 
scores, down-regulated NO generation and peritoneal 
macrophages 
162 
Morin 
Diabetes model - citrate buffer - 
induced, in male Wistar albino 
rats 
Reimbursed the levels of TBARS, GSH and SOD and 
CAT activities in the brain towards their control values, 
reduced TNF-α, IL-1β and IL-6 
163 
Myricetin 
Acute inflammation models - 
carrageenan - induced, in male 
Wistar rats  
Increased the serum levels of SOD 164 
Naringenin 
Asthma model - ovalbumin - 
induced, in female BALB/c 
mice 
Significantly reduced the level of Th2 cells, IL-4, IL-13, 
CCL5, CCL11 and iNOS, abolished IĸBα degradation, 
inhibited NF-ĸB activation 
165 
Naringenin 
Colitis model - DSS - induced, 
in male BALB/c mice 
Reduced expression of IFN-ɣ and IL-6, suppressed IL-
17A gene expression, so may directly suppress the 
differentiation of Th17 cells 
166 
Naringenin  
Colitis model - DSS - induced, 
in female C57BL/6 mice 
Suppressed TLR4 signalling, reduced phospho-p65 
NF-ĸB expression and the 
phosphorylation/degradation of IκBα, inhibited p65 NF-
ĸB nuclear translocation, and consequently the 
expression of iNOS, ICAM-1, MCP-1, Cox-2, TNF-α 
and IL-6 
167 
Naringin 
Chronic pulmonary neutrophilic 
inflammation - cigarette smoke 
– induced, in male and female 
Sprague-Dawley rats 
Decreased the release of IL-8 and TNF-α, elevated the 
release of IL-10, dose-dependently, inhibited MPO 
activity, inhibited the content of MMP-9, reduced the 
neutrophils percentage in the bronchoalveolar lavage 
fluid 
168 
Naringin 
Nephrotoxicity model - 
gentamicin – induced, in male 
Sprague–Dawley rats 
Restored the antioxidant levels (SOD, CAT, GPx, GR, 
GST, GSH and vitamin C), decreased the expression 
of NF-κB and NF-κB-DNA binding activities and TNF-α 
and IL-6 levels, supressed renal MPO activity 
169 
Puerarin 
Kidney inflammation Male ICR 
mice - carbon tetrachloride – 
induced 
Attenuated the decrease in GSH level and the 
increase in ROS and TBARS levels, the up-regulation 
of iNOS, COX-2, phospho-ERK1/2, NF-ĸB expression 
in the nuclear fraction and the inhibition of the nuclear 
translocation of Nrf2 
170 
Prunetin 
Endotoxemia model - LPS-
induced, in male C57BL/6 mice 
Inhibited NO and PGE2 production, through the 
suppression of iNOS and COX-2, by modulating IĸBα-
NF-ĸB signalling (those effects were also observed in 
macrophages RAW 264.7 cell line) 
171 
Quercetin 
Gastric mucosa inflammation 
model - H. pylori – induced, in 
female short-hair guinea pigs 
Decreased neutrophils and mononuclear cells 
infiltration, decreased lipid peroxidation 
172 
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 Table 4 - Inflammation mediators related in vivo studies. (cont.) 
 
 
 
 
Flavonoid/s Model Effect Reference 
Quercetin 
Chronic obstructive pulmonary 
disease model - elastase and 
LPS – induced, in C57BL/6 
mice 
Reduced TBARS, iNOS, the levels of KC/CXCL-1, 
MIP-2/CXCL-2 and MCP-1/CCL2, IL-1 β, IL-12p40 and 
MIP-1β, the mRNA and activity levels of both MMP9 
and MMP12 
173 
Quercetin 
Endotoxaemic condition - LPS 
– induced, in male ICR mice 
Enhanced eNOS expression and abolished iNOS 
expression, decreased NO3- / NOO- levels, reduced 
the rate of O2- production, partially prevented losses of 
GSH and regained the GSH redox ratio 
174 
Quercetin 
Renal dysfunction model lead – 
induced, in adult male Wistar 
rats 
Inhibited ERK, JNK and p38 phosphorylation and p65 
NF-κB translocation, down-regulated IL-1β, IL-6, TNF-
α and COX-2 expression 
175 
Quercetin 
Abdominal aortic aneurysms – 
CaCl2 - induced, in male 
C57/BL6 mice 
Reduced TNF-α, IL-1β and MCP-1 levels, Nf-ĸB 
activation, MMP-2 and MMP-9 
176 
Quercetin 
Atherosclerotic plaque model - 
diet induced, in C57BL LDLr−/− 
mouse 
Decreased MCP-1 and IL-17α levels 177 
Rutin 
Colitis models - TNBS – 
induced, in rats 
Inhibited the TNF-α – dependent NF-ĸB activation and 
supressed MPO activity 
Revised in 
178 
Rutin 
Colitis model - DSS - induced, 
in mice 
Attenuated the IL-1β, IL-6, GM-CSF production and 
iNOS activity 
Revised in 
178 
Rutin 
Gastric mucosal damage - 
gastric I/R model – induced, in 
rats 
Inhibited the iNOS and cNOS elevation, in the gastric 
mucosa 
Revised in 
178 
Rutin 
Cholestasis and consequent 
liver injury model - bile duct 
ligation and scission – induced, 
in male Sprague–Dawley rats –
-  
Decreased mitogenic IL-1β and fibrogenic TGF-β1 
expression, supressed inflammatory cell 
recruitment/accumulation and NF-ĸB activation, 
probably via interference with ERK activation and/or 
enhancement of Nrf2, HO-1 and AMPK activity 
179 
Silibinin 
Asthma model - ovalbumin - 
induced - pathogen-free inbred 
female BALB/c mice 
Attenuated eosinophils recruitment and inflammatory 
cells infiltration, reduced TNF-α, IL-1β, IL-4, IL-5 and 
IL-13 expression, phosphorylation and degradation of 
IkBα and prevented NF-ĸB translocation 
180 
Silibinin 
Nephrotoxicity model - arsenic 
– induced, in adult male albino 
rats of Wistar strain 
Decreased the TBARS, TNF-α, NO, iNOS, NF-ĸB and 
caspase-3 levels, increased the GSH, TSH, vitamins C 
and D, SOD, catalase and GPx levels 
181 
Wogonin 
Acute lung inflammation model 
- LPS - induced Female 
C57BL/6 mice 
Attenuated the release of TNF-α, IL-6 ,IL-1β, NO 
production and iNOS overexpression, induced PPARγ-
mediated attenuation of NF-ĸB activation 
182 
5-Hydroxy-3,7,4’-
trimethoxyflavone 
Acute inflammation models - 
carrageenan-induced, in rats 
Inhibited NO production and protected the oxidative 
DNA damage due to H2O2 scavenging 
64 
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 Table 4 - Inflammation mediators related in vivo studies. (cont.) 
 
MPTP - 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridin; EPO - eosinophil peroxidase; GSH - glutathione; GSH-Px 
- plasma glutathione peroxidase; TPA - 12-O-tetradecanoylphorbol-13-acetate; PXR - pregnane X receptor; 
TBARS - thiobarbituric acid reactive substances. 
 
 
6.2. Human studies 
Several studies have been performed to evaluate the modulation of the inflammatory 
mediators by flavonoids in healthy human volunteers or in patients with coronary artery 
disease, diabetes, postmenopausal women, etc. The question is that the majority of these 
studies were conducted in the basis of the administration of a limited number of foods of 
plant origin such as black and green teas, fruit juices, grape extract and red wine. The 
studies with isolated flavonoids are scarce, which makes it difficult to understand the true 
value of each flavonoid for the human pathophysiologic condition. Revised in 50  As an 
example, quercetin (1 mg/mL) was administered to 20 cyclists (other 20 placebo) for 24 
days period. Quercetin effectively attenuated the post-exercise increase in blood IL-8 and 
IL-10 mRNA and tended to lower plasma levels of IL-8 and TNF-α. However, quercetin did 
not alter the muscle NF-ĸB content or the exercise-induced increases in muscle COX-2 
mRNA, neither the IL-6, IL-8, IL-1β, and TNF-α expression.184 The same authors 
undertook another study with quercetin, this time with runners, where they observed once 
more the attenuation of IL-8 lowering after exercise; but, one more, the IL-6 levels 
remained unaffected.185 Moreover, a 2-month flavonoid quercetin-vitamin C 
supplementation in non-professional athletes with regular exercise, led to reducing 
oxidative stress and inflammatory biomarkers, including CRP and IL-6 with little effect on 
E-selectin.186 So, quercetin has been revealing promising effects in the modulation of 
inflammatory mediators, in vivo, regardless the particular studies conditions. 
Other studies in humans have been developed, and recently published. Landberg and co-
workers assessed the relationship between the intake of 6 flavonoid subclasses 
(flavonols, flavones, flavanones, flavan-3-ols, anthocyanidins, and polymeric flavonoids), 
and their main sources, and the biomarkers of inflammation, in a cross-sectional study of 
participants from the Nurses’ Health Study cohort. They concluded that, in general, higher 
intakes of selected flavonoid subclasses (flavanones, flavones, and flavonols) were 
Flavonoid/s Model Effect Reference 
5,7,3’,4’,5’-
pentamethoxyflav
anone 
Sepsis model - cecal ligation 
and puncture – induced, in 
female C57/BL6 mice 
Decreased expression of IL-1β, IL-6 and TNF-a, down-
regulated STAT1 (this results were simultaneously 
assessed in murine RAW 264.7 cells and bone 
marrow-derived macrophages) 
183 
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 associated with a modest decrease in the concentrations of inflammatory biomarkers; 
also, flavonoids typically found in citrus fruits were modestly associated with lower plasma 
IL-18 concentrations.187 Between 2005 and 2007, Filiberto and co-workers, developed a 
study in healthy regularly menstruating women, to understand whether habitual low 
isoflavone intake was associated with serum CRP concentration, a factor associated with 
beneficial effects on inflammation. They concluded that dietary isoflavone intake were 
associated with decreased serum CRP concentrations, and subsequently may have the 
potential to improve health status among young women.188 Another study with isoflavones 
administered during a year to elderly women concluded that they had produced no effect 
in the inflammatory mediators, namely IL-6. They also associated the isoflavones to soy 
protein, however no improvement was shown.189 Nicastro and co-worker also studied 
isoflavonoids, but to determine the relationship between excreted urinary isoflavonoids 
and high serum CRP level or white blood cells count in adults in the United States. 
However, this sectional analysis only suggested possible inverse associations between 
soy intake and inflammation; no clear patterns of associations with individual isoflavonoids 
emerged. The daidzein metabolite, O-desmethylangolensin was the only one whose 
excretion was inversely associated with circulating levels of both CRP and white blood 
cells count.190 Very recently, Jennings and co-workers published a work where they stated 
that anthocyanidins intake, concentrations readily achieved in the diet ,lowered the CRP 
levels, in a cross-sectional study of 1997 females aged between 18 and 76 years. In 
reality, they studied the effect of the intake of various flavonoids subclasses (flavanones, 
anthocyanins, flavan-3-ols, polymeric flavonoids, flavonols, flavones), through a food 
frequency questionnaire using an extended U. S. Department of Ariculture database; 
however, no significant associations were observed for total or other flavonoid 
subclasses.191 Overall, the results obtained in these studies are truly promising; however, 
much more needs to be done in this area, because many flaws can be detected, as the 
majority of the publications point in the studies discussion. 
 
 
7. Conclusions 
Inflammation is a complex process where all the routes are inter-related. The control or 
modulation of this process requires molecules capable of restrain more than one 
inflammation route / inflammatory mediator. Flavonoids appear as an alternative class of 
molecules who proved to be effective from the transcription level to the enzymatic level. 
Moreover, and besides all the in vivo studies already carried out, it is clear that is 
necessary to establish a disease reference model to compare the effects of different 
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 flavonoids and to enable the comparison of their effects in the all possible inflammatory 
mediators in the same model. All in all, flavonoids are a great promise in the resolution of 
the inflammatory processes and more studies should be done to completely characterize 
all their beneficial mechanisms of action. 
 
 
Acknowledgements 
Daniela Ribeiro and Marisa Freitas acknowledge Fundação para a Ciência e a Tecnologia 
(FCT) the financial support for the PhD grant (SFRH/BD/72966/2010) and Pos-doc grant 
(SFRH/BPD/76909/2011), respectively, in the ambit of “QREN - POPH - Tipologia 4.1 - 
Formação Avançada”, co-sponsored by FSE and by national funds of MCTES. 
 
 
References 
1. Chow CW, Downey GP. Basic Biology and Critical Care Medicine - Inflammation. 
In: Albert RK, Slutsky AS, Ranieri VM, Torres A, Takala J, editors. Clinical Critical Care 
Medicine. 1st edition. Volume 1. Michigan: Elsevier Inc.; 2006. pp 1-12. 
2. Saxena A, Cronstein BN. Acute Phase Reactants and the Concept of 
Inflammation. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR, editors. 
Kelley's Textbook of Rheumatology. Philadelphia: Elsevier Saunders; 2013. pp 818-829. 
3. Perkins JA. Acute and Chronic Inflammation. In: Perkins JA, editor. Robbins & 
Cotran Pathologic Basis of Disease. Philadelphia: Elsevier Saunders; 2010. pp 43-77. 
4. Abeles AM, Pillinger MH, Abramson SB. Inflammation. In: Hochberg MC, Silman 
AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. Volume 1. 
Philadelphia: Elsevier Mosby; 2011. pp 183-198. 
5. Firestein GS. Mechanisms of inflammation and tissue repair. In: Goldman L, 
Schafer A, editors. Goldman's Cecil Medicine. Volume 24th. Philadelphia: Elsevier 
Saunders; 2012. pp 230-235. 
6. Kumar V, Abbas AK, Aster JC. Inflammation and Repair. In: Kumar V, Abbas AK, 
Aster JC, editors. Robbins Basic Pathology. Philadelphia: Elsevier Saunders; 2013. pp 29-
73. 
7. Cross S. Inflammation. In: Cross S, editor. Underwood's Pathology: a Clinical 
Approach. 6th edition. Philadelphia: Elsevier Ltd.; 2013. pp 165-182. 
8. Goljan EF. Inflammation and Repair. In: Goljan EF, editor. Rapid Review 
Pathology. Volume 1. Philadelphia: Elsevier Saunders; 2014. pp 36-55. 
II. Theoretical Background
66
 9. Prakken BJ, Albani S. Inflammation. In: Cassidy JT, Petty RE, Laxer R, Lindsley C, 
editors. Textbook of Pediatric Rheumatology. 6th edition. Philadelphia: Elsevier Saunders; 
2011. pp 53-59. 
10. Murray MT. Flavonoids—Quercetin, Citrus Flavonoids, and Hydroxyethylrutosides. 
In: Pizzorno JE, Murray MT, editors. Textbook of Natural Medicine. 4th edition. St. Louis: 
Elsevier Churchill Livingstone; 2012. pp 772-777. 
11. Durga M, Nathiya S, Devasena T. Immunomodulatory and antioxidant actions of 
dietary flavonoids. Int J Pharm Pharm Sci 2014;6(2):50-56. 
12. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an 
overview. ScientificWorldJournal 2013:1-16. 
13. Weidmann AE. Dihydroquercetin: More than just an impurity? Eur J Pharmacol 
2012;684(1-3):19-26. 
14. Bubols GB, Vianna Dda R, Medina-Remon A, von Poser G, Lamuela-Raventos 
RM, Eifler-Lima VL, Garcia SC. The antioxidant activity of coumarins and flavonoids. Mini 
Rev Med Chem 2013;13(3):318-334. 
15. Gomes A, Fernandes E, Lima JLFC, Mira L, Corvo ML. Molecular mechanisms of 
anti-inflammatory activity mediated by flavonoids. Curr Med Chem 2008;15(16):1586-
1605. 
16. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA. 
Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular 
disease. Inflamm Res 2009;58(9):537-552. 
17. Gonzalez R, Ballester I, Lopez-Posadas R, Suarez MD, Zarzuelo A, Martinez-
Augustin O, Sanchez de Medina F. Effects of flavonoids and other polyphenols on 
inflammation. Crit Rev Biochem Mol Biol 2011;51(4):331-362. 
18. Hall JE. Resistance of the Body to Infection: I. Leukocytes, Granulocytes, the 
Monocyte-Macrophage System, and Inflammation. In: Hall JE, editor. Guyton and Hall 
Textbook of Medical Physiology. 12th edition. Philadelphia: Elsevier Saunders; 2011. pp 
423-432. 
19. Scher JU, Abramson SB, Pillinger MH. Neutrophils. In: Firestein GS, Budd RC, 
Gabriel SE, McInnes IB, O'Dell JR, editors. Kelley's Textbook of Rheumatology. 9th 
edition. Philadelphia: Elsevier Saunders; 2013. pp 152-169. 
20. Baines KJ, Simpson JI, Gibson PG. Biology of Neutrophils. In: Adkinson Jr. NF, 
Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske RF, O'Hehir RE, editors. 
Middleton's Allergy Principles and Practice. 8th edition. Volume 1. Philadelphia: Elsevier 
Saunders; 2014. pp 280-291. 
21. Siracusa MC, Comeau MR, Artis D. New insights into basophil biology: initiators, 
regulators, and effectors of type 2 inflammation. Ann N Y Acad Sci 2011;1217:166-177. 
II. Theoretical Background
67
 22. Geering B, Stoeckle C, Conus S, Simon HU. Living and dying for inflammation: 
neutrophils, eosinophils, basophils. Trends Immunol 2013;34(8):398-409. 
23. Xiong H, Pamer EG. Monocytes and infection: Modulator, messenger and effector. 
Immunobiology 2014;DOI: 10.1016/j.imbio.2014.08.007. 
24. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer 
cells. Nat Immunol 2008;9(5):503-510. 
25. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood 
2008;112(5):1570-1580. 
26. Steinhubl SR. Platelets as mediators of inflammation. Hematol Oncol Clin N 
2007;21(1):115-121. 
27. Herter JM, Rossaint J, Zarbock A. Platelets in inflammation and immunity. J 
Thromb Haemost 2014. 
28. Jordana M, Sarnstrand B, Sime PJ, Ramis I. Immune-inflammatory functions of 
fibroblasts. Eur Respir J 1994;7(12):2212-2222. 
29. Lago JH, Toledo-Arruda AC, Mernak M, Barrosa KH, Martins MA, Tiberio IF, Prado 
CM. Structure-activity association of flavonoids in lung diseases. Molecules 
2014;19(3):3570-3595. 
30. Massey HD, McPherson RA. Mediators of inflammation: Complement, cytokines, 
and adhesion molecules. In: McPherson RA, Pincus MR, editors. Henry's Clinical 
Diagnosis and Management by Laboratory Methods. 22nd edition. Philadelphia: Elsevier 
Saunders; 2011. pp 914-932. 
31. Jiang Y, Lu Y, Zhang YY, Chen DF. Anti-complementary constituents of 
Houttuynia cordata and their targets in complement activation cascade. Nat Prod Res 
2014;28(6):407-410. 
32. Janeway Jr CA, Travers P, Walport M, J Shlomchik MJ. Innate Immunity. 
Immunobiology: The Immune System in Health & Disease. 6th edition. New York: Garland 
Science; 2005. 
33. Zurier RB. Prostaglandins, Leukotrienes, and Related Compounds. In: Firestein 
GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR, editors. Kelley's Textbook of 
Rheumatology. 9th edition. Philadelphia: Elsevier Saunders; 2013. pp 340-357. 
34. Dawes JM, Andersson DA, Bennett DLH, Bevan S, McMahon SB. Inflammatory 
Mediators and Modulators of Pain. In: McMahon S, Koltzenburg M, Tracey I, Turk DC, 
editors. Wall & Melzack's Textbook of Pain. 6th edition. Philadelphia: Elsevier Saunders; 
2013. pp 48-67. 
35. Fink MP. The Inflammatory Response. In: Townsend Jr. CM, Beauchamp RD, 
Evers BM, Mattox KL, editors. Sabiston Textbook of Surgery. Philadelphia: Elsevier 
Saunders; 2012. pp 40-65. 
II. Theoretical Background
68
 36. Aoki T, Narumiya S. Prostaglandins and chronic inflammation. Trends Pharmacol 
Sci 2012;33(6):304-311. 
37. Dorris SL, Peebles RS, Jr. PGI2 as a regulator of inflammatory diseases. Mediat 
Inflamm 2012;2012:1-9. 
38. Bertics PJ, Koziol-White CJ, Gavala MI, Wiepz GJ. Signal Transduction. In: 
Adkinson Jr. NF, Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske RF, O'Hehir 
RE, editors. Middleton's Allergy: Principles ans Practice. 8th edition. Volume 1. 
Philadelphia: Elsevier Saunders; 2014. pp 184-202. 
39. Schwab JM, Serhan CN. Lipoxins and new lipid mediators in the resolution of 
inflammation. Curr Opin Pharmacol 2006;6(4):414-420. 
40. Maddox JF, Colgan SP, Clish CB, Petasis NA, Fokin VV, Serhan CN. Lipoxin B4 
regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 
analogs with increased biologic activity. FASEB J 1998;12(6):487-494. 
41. Hernandez V, Recio MC, Manez S, Giner RM, Rios JL. Effects of naturally 
occurring dihydroflavonols from Inula viscosa on inflammation and enzymes involved in 
the arachidonic acid metabolism. Life Sci 2007;81(6):480-488. 
42. Li J, Gang D, Yu X, Hu Y, Yue Y, Cheng W, Pan X, Zhang P. Genistein: the 
potential for efficacy in rheumatoid arthritis. Clin Rheumatol 2013;32(5):535-540. 
43. Nagaraju GP, Zafar SF, El-Rayes BF. Pleiotropic effects of genistein in metabolic, 
inflammatory, and malignant diseases. Nutr Rev 2013;71(8):562-572. 
44. Wang YC, Huang KM. In vitro anti-inflammatory effect of apigenin in the 
Helicobacter pylori-infected gastric adenocarcinoma cells. Food Chem Toxicol 
2013;53:376-383. 
45. Hamalainen M, Nieminen R, Asmawi MZ, Vuorela P, Vapaatalo H, Moilanen E. 
Effects of flavonoids on prostaglandin E2 production and on COX-2 and mPGES-1 
expressions in activated macrophages. Planta Med 2011;77(13):1504-1511. 
46. Wall C, Lim R, Poljak M, Lappas M. Dietary flavonoids as therapeutics for preterm 
birth: luteolin and kaempferol suppress inflammation in human gestational tissues in vitro. 
Oxid Med Cell Longev 2013;2013:485201. 
47. Hou DX, Yanagita T, Uto T, Masuzaki S, Fujii M. Anthocyanidins inhibit 
cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship 
and molecular mechanisms involved. Biochem Pharmacol 2005;70(3):417-425. 
48. D’Mello P, Gadhwal MK, Joshi U, Shetgiri P. Modeling of COX-2 inhibitory activity 
of flavonoids. Int J Pharm Pharm Sci 2011;3(4):33-40. 
49. Lopez-Posadas R, Ballester I, Mascaraque C, Suarez MD, Zarzuelo A, Martinez-
Augustin O, Sanchez de Medina F. Flavonoids exert distinct modulatory actions on 
II. Theoretical Background
69
 cyclooxygenase 2 and NF-kappaB in an intestinal epithelial cell line (IEC18). Brit J 
Pharmacol 2010;160(7):1714-1726. 
50. Serafini M, Peluso I, Raguzzini A. Session 1: Antioxidants and the immune system 
Flavonoids as anti-inflammatory agents. P Nutr Soc 2010;69(3):273-278. 
51. Redrejo-Rodriguez M, Tejeda-Cano A, Pinto MD, Macias P. Lipoxygenase 
inhibition by flavonoids: semiempirical study of the structure-activity relation. J Mol Struc-
Theochem 2004;674(1-3):121-124. 
52. Loke WM, Proudfoot JM, Stewart S, McKinley AJ, Needs PW, Kroon PA, Hodgson 
JM, Croft KD. Metabolic transformation has a profound effect on anti-inflammatory activity 
of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase 
inhibitory activity. Biochem Pharmacol 2008;75(5):1045-1053. 
53. Gomes A, Couto D, Alves A, Dias I, Freitas M, Porto G, Duarte JA, Fernandes E. 
Trihydroxyflavones with antioxidant and anti-inflammatory efficacy. Biofactors 
2012;38(5):378-386. 
54. Burnett BP, Bitto A, Altavilla D, Squadrito F, Levy RM, Pillai L. Flavocoxid inhibits 
phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-
lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant. Mediat 
Inflamm 2011;2011:385780. 
55. Singh DP, Chopra K. Flavocoxid, dual inhibitor of cyclooxygenase-2 and 5-
lipoxygenase, exhibits neuroprotection in rat model of ischaemic stroke. Pharmacol 
Biochem Behav 2014;120:33-42. 
56. Freitas M, Lima JL, Fernandes E. Optical probes for detection and quantification of 
neutrophils’ oxidative burst. A review. Anal Chim Acta 2009;649:8 -23. 
57. Rizzo AM, Berselli P, Zava S, Montorfano G, Negroni M, Corsetto P, Berra B. 
Endogenous antioxidants and radical scavengers. Adv Exp Med Biol 2010;698:52-67. 
58. Prochazkova D, Bousova I, Wilhelmova N. Antioxidant and prooxidant properties 
of flavonoids. Fitoterapia 2011;82(4):513-523. 
59. Ravishankar D, Rajora AK, Greco F, Osborn HM. Flavonoids as prospective 
compounds for anti-cancer therapy. Int J Biochem Cell Biol 2013;45(12):2821-2831. 
60. During A, Larondelle Y. The O-methylation of chrysin markedly improves its 
intestinal anti-inflammatory properties: Structure-activity relationships of flavones. 
Biochem Pharmacol 2013;86(12):1739-1746. 
61. Sadowska-Bartosz I, Adamczyk R, Bartosz G. Protection against peroxynitrite 
reactions by flavonoids. Food Chem 2014;164:228-233. 
62. Fernandes E, Gomes A, Silva AMS, Santos CMM, Pinto DCGA, Cavaleiro JAS, 
Lima JLFC. 2-Styrylchromones: Novel strong scavengers of reactive oxygen and nitrogen 
species. Bioorg Med Chem 2007;15(18):6027-6036. 
II. Theoretical Background
70
 63. Gomes A, Fernandes E, Garcia MBQ, Silva AMS, Pinto DCGA, Santos CMM, 
Cavaleiro JAS, Lima JLFC. Cyclic voltammetric analysis of 2-styrylchromones: 
Relationship with the antioxidant activity. Bioorg Med Chem 2008;16(17):7939-7943. 
64. Bala A, Chetia P, Dolai N, Khandelwal B, Haldar PK. Cat's whiskers flavonoid 
attenuated oxidative DNA damage and acute inflammation: its importance in lymphocytes 
of patients with rheumatoid arthritis. Immunopharmacology 2014;22(1):55-61. 
65. Shiba Y, Kinoshita T, Chuman H, Taketani Y, Takeda E, Kato Y, Naito M, 
Kawabata K, Ishisaka A, Terao J, Kawai Y. Flavonoids as substrates and inhibitors of 
myeloperoxidase: Molecular actions of aglycone and metabolites. Chem Res Toxicol 
2008;21(8):1600-1609. 
66. Freitas M, Ribeiro D, Tomé SM, Silva AMS, Fernandes E. Synthesis of chlorinated 
flavonoids with anti-inflammatory and proapoptotic activities in human neutrophils. Eur J 
Med Chem 2014;86:153-164. 
67. Tarahovsky YS, Kim YA, Yagolnik EA, Muzafarov EN. Flavonoid-membrane 
interactions: involvement of flavonoid-metal complexes in raft signaling. Biochim Biophys 
Acta 2014;1838(5):1235-1246. 
68. Ren J, Meng S, Lekka Ch E, Kaxiras E. Complexation of flavonoids with iron: 
structure and optical signatures. J Phys Chem B 2008;112(6):1845-1850. 
69. Assini JM, Mulvihill EE, Huff MW. Citrus flavonoids and lipid metabolism. Curr Opin 
Lipidol 2013;24(1):34-40. 
70. Nam Y, Choi M, Hwang H, Lee MG, Kwon BM, Lee WH, Suk K. Natural flavone 
jaceosidin is a neuroinflammation inhibitor. Phytother Res 2013;27(3):404-411. 
71. McInnes IB. Cytokines. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell 
JR, editors. Kelley's Textbook of Rheumatology. 9th edition. Philadelphia: Elsevier 
Saunders; 2013. pp 369-381. 
72. Naugler WE, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in 
immunity, inflammation and cancer. Trends Mol Med 2008;14(3):109-119. 
73. Scheller J, Garbers C, Rose-John S. Interleukin-6: from basic biology to selective 
blockade of pro-inflammatory activities. Semin Immunol 2014;26(1):2-12. 
74. Comalada M, Ballester I, Bailon E, Sierra S, Xaus J, Galvez J, de Medina FS, 
Zarzuelo A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse 
macrophages by naturally occurring flavonoids: analysis of the structure-activity 
relationship. Biochem Pharmacol 2006;72(8):1010-1021. 
75. Su KY, Yu CY, Chen YP, Hua KF, Chen YL. 3,4-Dihydroxytoluene, a metabolite of 
rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by 
reducing the activation of NF-kappaB signaling. BMC Complement Altern Med 
2014;14:21. 
II. Theoretical Background
71
 76. Mikhak Z, Luster AD. Chemokines. In: Adkinson Jr. NF, Bochner BS, Burks AW, 
Busse WW, Holgate ST, Lemanske RF, O'Hehir RE, editors. Middleton's Allergy 
Principles and Practice. 8th edition. Volume 1. Philadelphia: Elsevier Saunders; 2014. pp 
98-112. 
77. Venditti A, Serrilli AM, Rizza L, Frasca G, Cardile V, Bonina FP, Bianco A. 
Aromadendrine, a new component of the flavonoid pattern of Olea europaea L. and its 
anti-inflammatory activity. Nat Prod Res 2013;27(4-5):340-349. 
78. Jung J, Ko SH, Yoo do Y, Lee JY, Kim YJ, Choi SM, Kang KK, Yoon HJ, Kim H, 
Youn J, Kim JM. 5,7-Dihydroxy-3,4,6-trimethoxyflavone inhibits intercellular adhesion 
molecule 1 and vascular cell adhesion molecule 1 via the Akt and nuclear factor-kappaB-
dependent pathway, leading to suppression of adhesion of monocytes and eosinophils to 
bronchial epithelial cells. Immunology 2012;137(1):98-113. 
79. Broide DH, Sriramarao P. Cellular Adhesion in Inflammation. In: Adkinson Jr. NF, 
Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske RF, O'Hehir RE, editors. 
Middleton's Allergy Principles and Practice. 8th edition. Volume 1. Philadelphia: Elsevier 
Saunders; 2014. pp 83-97. 
80. Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in 
immune function. J Immunol Res 2010;185(11):6413-6419. 
81. Mansuri ML, Parihar P, Solanki I, Parihar MS. Flavonoids in modulation of cell 
survival signalling pathways. Genes Nutr 2014;9(3):400. 
82. Nam NH. Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 
2006;6(8):945-951. 
83. Yilma AN, Singh SR, Morici L, Dennis VA. Flavonoid naringenin: a potential 
immunomodulator for Chlamydia trachomatis inflammation. Mediat Inflamm 
2013;2013:102457. 
84. Ku SK, Lee IC, Han MS, Bae JS. Inhibitory Effects of Rutin on the Endothelial 
Protein C Receptor Shedding In Vitro and In Vivo. Inflammation 2014. 
85. Nishitani Y, Yamamoto K, Yoshida M, Azuma T, Kanazawa K, Hashimoto T, 
Mizuno M. Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-
kappaB inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors 
2013;39(5):522-533. 
86. Chen D, Bi A, Dong X, Jiang Y, Rui B, Liu J, Yin Z, Luo L. Luteolin exhibits anti-
inflammatory effects by blocking the activity of heat shock protein 90 in macrophages. 
Biochem Biophys Res Commun 2014;443(1):326-332. 
87. Byun EB, Yang MS, Choi HG, Sung NY, Song DS, Sin SJ, Byun EH. Quercetin 
negatively regulates TLR4 signaling induced by lipopolysaccharide through Tollip 
expression. Biochem Biophys Res Commun 2013;431(4):698-705. 
II. Theoretical Background
72
 88. Endale M, Park SC, Kim S, Kim SH, Yang Y, Cho JY, Rhee MH. Quercetin 
disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation 
factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-kappaB-induced inflammatory 
mediators production in RAW 264.7 cells. Immunobiology 2013;218(12):1452-1467. 
89. Ji G, Zhang Y, Yang Q, Cheng S, Hao J, Zhao X, Jiang Z. Genistein suppresses 
LPS-induced inflammatory response through inhibiting NF-kappaB following AMP kinase 
activation in RAW 264.7 macrophages. PloS One 2012;7(12):e53101. 
90. Kim HH, Bae Y, Kim SH. Galangin attenuates mast cell-mediated allergic 
inflammation. Food Chem Toxicol 2013;57:209-216. 
91. Jeong JW, Lee HH, Han MH, Kim GY, Kim WJ, Choi YH. Anti-inflammatory effects 
of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in 
lipopolysaccharide-stimulated BV2 microglia. Chem-Biol Interact 2014;212:30-39. 
92. Zhou X, Yuan L, Zhao X, Hou C, Ma W, Yu H, Xiao R. Genistein antagonizes 
inflammatory damage induced by beta-amyloid peptide in microglia through TLR4 and NF-
kappaB. Nutrition 2014;30(1):90-95. 
93. Yoon HY, Lee EG, Lee H, Cho IJ, Choi YJ, Sung MS, Yoo HG, Yoo WH. 
Kaempferol inhibits IL-1b-induced proliferation of rheumatoid arthritis synovial fibroblasts 
and the production of COX-2, PGE2 and MMPs. Int J Mol Med 2013;32(4):971-977. 
94. Yeh CH, Shih HC, Hong HM, Lee SS, Yang ML, Chen CJ, Kuan YH. Protective 
effect of wogonin on proinflammatory cytokine generation via Jak1/3-STAT1/3 pathway in 
lipopolysaccharide stimulated BV2 microglial cells. Toxicol Ind Health 2013. 
95. Yao J, Hu R, Sun J, Lin B, Zhao L, Sha Y, Zhu B, You QD, Yan T, Guo QL. 
Oroxylin A prevents inflammation-related tumor through down-regulation of inflammatory 
gene expression by inhibiting NF-kappaB signaling. Mol Carcinog 2014;53(2):145-158. 
96. Cardozo LF, Pedruzzi LM, Stenvinkel P, Stockler-Pinto MB, Daleprane JB, Leite 
M, Jr., Mafra D. Nutritional strategies to modulate inflammation and oxidative stress 
pathways via activation of the master antioxidant switch Nrf2. Biochimie 2013;95(8):1525-
1533. 
97. Ramyaa P, Krishnaswamy R, Padma VV. Quercetin modulates OTA-induced 
oxidative stress and redox signalling in HepG2 cells - up regulation of Nrf2 expression and 
down regulation of NF-kappaB and COX-2. Biochim Biophys Acta 2014;1840(1):681-692. 
98. Kim DH, Yun CH, Kim MH, Naveen Kumar C, Yun BH, Shin JS, An HJ, Lee YH, 
Yun YD, Rim HK, Yoo MS, Lee KT, Lee YS. 4'-bromo-5,6,7-trimethoxyflavone represses 
lipopolysaccharide-induced iNOS and COX-2 expressions by suppressing the NF-kappaB 
signaling pathway in RAW 264.7 macrophages. Bioorg Med Chem Lett 2012;22(1):700-
705. 
II. Theoretical Background
73
 99. Ayepola OR, Chegou NN, Brooks NL, Oguntibeju OO. Kolaviron, a Garcinia 
biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via 
suppression of inflammatory responses. BMC Complement Altern Med 2013;13:363. 
100. Abarikwu SO. Kolaviron, a natural flavonoid from the seeds of Garcinia kola, 
reduces LPS-induced inflammation in macrophages by combined inhibition of IL-6 
secretion, and inflammatory transcription factors, ERK1/2, NF-kappaB, p38, Akt, p-c-JUN 
and JNK. Biochim Biophys Acta 2014;1840(7):2373-2381. 
101. Byun EB, Sung NY, Byun EH, Song DS, Kim JK, Park JH, Song BS, Park SH, Lee 
JW, Byun MW, Kim JH. The procyanidin trimer C1 inhibits LPS-induced MAPK and NF-
kappaB signaling through TLR4 in macrophages. Int Immunopharmacol 2013;15(2):450-
456. 
102. Sung NY, Yang MS, Song DS, Kim JK, Park JH, Song BS, Park SH, Lee JW, Park 
HJ, Kim JH, Byun EB, Byun EH. Procyanidin dimer B2-mediated IRAK-M induction 
negatively regulates TLR4 signaling in macrophages. Biochem Biophys Res Commun 
2013;438(1):122-128. 
103. Ren K, Torres R. Role of interleukin-1b during pain and inflammation. Brain Res 
Rev 2009;60(1):57-64. 
104. Xiao J, Chen T, Cao H. Flavonoid glycosylation and biological benefits. Biotechnol 
Adv 2014;In Press. 
105. Choi JS, Islam MN, Ali MY, Kim EJ, Kim YM, Jung HA. Effects of C-glycosylation 
on anti-diabetic, anti-Alzheimer's disease and anti-inflammatory potential of apigenin. 
Food Chem Toxicol 2014;64:27-33. 
106. Xu CQ, Liu BJ, Wu JF, Xu YC, Duan XH, Cao YX, Dong JC. Icariin attenuates 
LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB 
signaling pathway. Eur J Pharmacol 2010;642(1-3):146-153. 
107. Wu J, Du J, Xu C, Le J, Liu B, Xu Y, Dong J. In vivo and in vitro anti-inflammatory 
effects of a novel derivative of icariin. Immunopharmacol Immunotoxicol 2011;33(1):49-54. 
108. Kim HH, Kim DH, Kim MH, Oh MH, Kim SR, Park KJ, Lee MW. Flavonoid 
constituents in the leaves of Myrica rubra sieb. et zucc. with anti-inflammatory activity. 
Arch Pharm Res 2013;36(12):1533-1540. 
109. Yu L, Chen C, Wang LF, Kuang X, Liu K, Zhang H, Du JR. Neuroprotective effect 
of kaempferol glycosides against brain injury and neuroinflammation by inhibiting the 
activation of NF-kappaB and STAT3 in transient focal stroke. PloS One 2013;8(2):e55839. 
110. Yuan L, Wu Y, Ren X, Liu Q, Wang J, Liu X. Isoorientin attenuates 
lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-
related MAPK/NF-kappaB signaling pathway in BV-2 microglia. Mol Cell Endocrinol 
2014;386(1-2):153-165. 
II. Theoretical Background
74
 111. Ku SK, Kwak S, Bae JS. Orientin inhibits high glucose-induced vascular 
inflammation in vitro and in vivo. Inflammation 2014. 
112. Lee W, Ku SK, Bae JS. Vascular barrier protective effects of orientin and 
isoorientin in LPS-induced inflammation in vitro and in vivo. Vascul Pharmacol 
2014;62(1):3-14. 
113. Kawai Y. b-Glucuronidase activity and mitochondrial dysfunction: the sites where 
flavonoid glucuronides act as anti-inflammatory agents. J Clin Biochem Nutr 
2014;54(3):145-150. 
114. Riegsecker S, Wiczynski D, Kaplan MJ, Ahmed S. Potential benefits of green tea 
polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid 
arthritis. Life Sci 2013;93(8):307-312. 
115. Kim MS, Kim SH. Inhibitory effect of astragalin on expression of 
lipopolysaccharide-induced inflammatory mediators through NF-kappaB in macrophages. 
Arch Pharm Res 2011;34(12):2101-2107. 
116. Kim TH, Ku SK, Bae JS. Inhibitory effects of kaempferol-3-O-sophoroside on 
HMGB1-mediated proinflammatory responses. Food Chem Toxicol 2012;50(3-4):1118-
1123. 
117. Soromou LW, Chen N, Jiang L, Huo M, Wei M, Chu X, Millimouno FM, Feng H, 
Sidime Y, Deng X. Astragalin attenuates lipopolysaccharide-induced inflammatory 
responses by down-regulating NF-kappaB signaling pathway. Biochem Biophys Res 
Commun 2012;419(2):256-261. 
118. Borghi SM, Carvalho TT, Staurengo-Ferrari L, Hohmann MS, Pinge-Filho P, 
Casagrande R, Verri WA, Jr. Vitexin inhibits inflammatory pain in mice by targeting 
TRPV1, oxidative stress, and cytokines. J Nat Prod 2013;76(6):1141-1149. 
119. Chanet A, Milenkovic D, Claude S, Maier JA, Kamran Khan M, Rakotomanomana 
N, Shinkaruk S, Berard AM, Bennetau-Pelissero C, Mazur A, Morand C. Flavanone 
metabolites decrease monocyte adhesion to TNF-alpha-activated endothelial cells by 
modulating expression of atherosclerosis-related genes. Br J Nutr 2013;110(4):587-598. 
120. Lee MJ, Song HJ, Jeong JY, Park SY, Sohn UD. Anti-oxidative and anti-
inflammatory effects of qgc in cultured feline esophageal epithelial cells. Korean J Physiol 
Pharmacol 2013;17(1):81-87. 
121. Park CM, Song YS. Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-
induced inflammatory responses through modulation of NF-kappaB/AP-1/PI3K-Akt 
signaling cascades in RAW 264.7 cells. Nutr Res Pract 2013;7(6):423-429. 
122. Stanca E, Serviddio G, Bellanti F, Vendemiale G, Siculella L, Giudetti AM. Down-
regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat 
II. Theoretical Background
75
 liver: potential antiinflammatory effect of silybin. Biochim Biophys Acta 
2013;1832(12):2019-2026. 
123. Yang X, Yang J, Zou H. Baicalin inhibits IL-17-mediated joint inflammation in 
murine adjuvant-induced arthritis. Clin Dev Immunol 2013;2013:268065. 
124. Zhang D, Gao X, Wang Q, Qin M, Liu K, Huang F, Liu B. Kakkalide ameliorates 
endothelial insulin resistance by suppressing reactive oxygen species-associated 
inflammation. J Diabetes 2013;5(1):13-24. 
125. Khadem S, Marles RJ. Chromone and flavonoid alkaloids: Occurrence and 
bioactivity. Molecules 2012;17(1):191-206. 
126. Selvaraj S, Krishnaswamy S, Devashya V, Sethuraman S, Krishnan UM. 
Flavonoid-metal ion complexes: a novel class of therapeutic agents. Med Res Rev 
2014;34(4):677-702. 
127. Baowen Q, Yulin Z, Xin W, Wenjing X, Hao Z, Zhizhi C, Xingmei D, Xia Z, Yuquan 
W, Lijuan C. A further investigation concerning correlation between anti-fibrotic effect of 
liposomal quercetin and inflammatory cytokines in pulmonary fibrosis. Eur J Pharmacol 
2010;642(1-3):134-139. 
128. Singh AK, Jiang Y, Gupta S, Younus M, Ramzan M. Anti-inflammatory potency of 
nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-
induced inflammation. J Med Food 2013;16(10):899-911. 
129. Geraets L, Haegens A, Brauers K, Haydock JA, Vernooy JH, Wouters EF, Bast A, 
Hageman GJ. Inhibition of LPS-induced pulmonary inflammation by specific flavonoids. 
Biochem Biophys Res Commun 2009;382(3):598-603. 
130. Tanaka T, Takahashi R. Flavonoids and asthma. Nutrients 2013;5(6):2128-2143. 
131. Suyenaga ES, Klein-Junior LC, Passos CD, Marin R, Santin JR, Machado ID, 
Farsky SH, Henriques AT. Beyond organoleptic characteristics: The pharmacological 
potential of flavonoids and their role in leukocyte migration and in l-selectin and beta2-
integrin expression during inflammation. Phytother Res 2014;In Press. 
132. Jain M, Parmar HS. Evaluation of antioxidative and anti-inflammatory potential of 
hesperidin and naringin on the rat air pouch model of inflammation. Inflamm Res 
2011;60(5):483-491. 
133. Khan AQ, Khan R, Rehman MU, Lateef A, Tahir M, Ali F, Sultana S. Soy 
isoflavones (daidzein & genistein) inhibit 12-O-tetradecanoylphorbol-13-acetate (TPA)-
induced cutaneous inflammation via modulation of COX-2 and NF-kB in Swiss albino 
mice. Toxicology 2012;302(2-3):266-274. 
134. Heeba GH, Mahmoud ME, Hanafy AA. Anti-inflammatory potential of curcumin and 
quercetin in rats: Role of oxidative stress, heme oxygenase-1 and TNF-alpha. Toxicol Ind 
Health 2012;30(6):551-560. 
II. Theoretical Background
76
 135. Sikder K, Kesh SB, Das N, Manna K, Dey S. The high antioxidative power of 
quercetin (aglycone flavonoid) and its glycone (rutin) avert high cholesterol diet induced 
hepatotoxicity and inflammation in Swiss albino mice. Food Funct 2014;5(6):1294-1303. 
136. Li R, Cai L, Ren DY, Xie XF, Hu CM, Li J. Therapeutic effect of 7, 3'-dimethoxy 
hesperetin on adjuvant arthritis in rats through inhibiting JAK2-STAT3 signal pathway. Int 
Immunopharmacol 2012;14(2):157-163. 
137. Li R, Cai L, Xie XF, Peng L, Wu TN, Li J. 7,3'-dimethoxy hesperetin inhibits 
inflammation by inducing synovial apoptosis in rats with adjuvant-induced arthritis. 
Immunopharmacol Immunotoxicol 2013;35(1):139-146. 
138. Huo M, Chen N, Chi G, Yuan X, Guan S, Li H, Zhong W, Guo W, Soromou LW, 
Gao R, Ouyang H, Deng X, Feng H. Traditional medicine alpinetin inhibits the 
inflammatory response in Raw 264.7 cells and mouse models. Int Immunopharmacol 
2012;12(1):241-248. 
139. Lin M, Li L, Li L, Pokhrel G, Qi G, Rong R, Zhu T. The protective effect of baicalin 
against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis. 
BMC Complement Altern Med 2014;14:19. 
140. Lixuan Z, Jingcheng D, Wenqin Y, Jianhua H, Baojun L, Xiaotao F. Baicalin 
attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced 
inflammatory models. Pulm Pharmacol Ther 2010;23(5):411-419. 
141. Lim HA, Lee EK, Kim JM, Park MH, Kim DH, Choi YJ, Ha YM, Yoon JH, Choi JS, 
Yu BP, Chung HY. PPARg activation by baicalin suppresses NF-kB-mediated 
inflammation in aged rat kidney. Biogerontology 2012;13(2):133-145. 
142. Guo M, Zhang N, Li D, Liang D, Liu Z, Li F, Fu Y, Cao Y, Deng X, Yang Z. Baicalin 
plays an anti-inflammatory role through reducing nuclear factor-kappaB and p38 
phosphorylation in S. aureus-induced mastitis. Int Immunopharmacol 2013;16(2):125-130. 
143. Lee E, Park HR, Ji ST, Lee Y, Lee J. Baicalein attenuates astroglial activation in 
the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model by 
downregulating the activations of nuclear factor-kappaB, ERK, and JNK. J Neurosci Res 
2014;92(1):130-139. 
144. Mabalirajan U, Ahmad T, Rehman R, Leishangthem GD, Dinda AK, Agrawal A, 
Ghosh B, Sharma SK. Baicalein reduces airway injury in allergen and IL-13 induced 
airway inflammation. PloS One 2013;8(4):e62916. 
145. Tsai CL, Lin YC, Wang HM, Chou TC. Baicalein, an active component of 
Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in 
rats. J Ethnopharmacol 2014;153(1):197-206. 
II. Theoretical Background
77
 146. Lu M, Wang S, Han X, Lv D. Butein inhibits NF-kappaB activation and reduces 
infiltration of inflammatory cells and apoptosis after spinal cord injury in rats. Neurosci Lett 
2013;542:87-91. 
147. Abd El-Aziz TA, Mohamed RH, Pasha HF, Abdel-Aziz HR. Catechin protects 
against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated 
rats. Clin Exp Med 2012;12(4):233-240. 
148. Shin EK, Kwon HS, Kim YH, Shin HK, Kim JK. Chrysin, a natural flavone, 
improves murine inflammatory bowel diseases. Biochem Biophys Res Commun 
2009;381(4):502-507. 
149. Dou W, Zhang J, Zhang E, Sun A, Ding L, Chou G, Wang Z, Mani S. Chrysin 
ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-
kappaB signaling pathway. J Pharmacol Exp Ther 2013;345(3):473-482. 
150. Feng X, Qin H, Shi Q, Zhang Y, Zhou F, Wu H, Ding S, Niu Z, Lu Y, Shen P. 
Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARgamma. 
Biochem Pharmacol 2014;89(4):503-514. 
151. Jiang Y, Gong FL, Zhao GB, Li J. Chrysin suppressed inflammatory responses and 
the inducible nitric oxide synthase pathway after spinal cord injury in rats. Int J Mol Sci 
2014;15(7):12270-12279. 
152. Kilic T, Ciftci O, Cetin A, Kahraman H. Preventive effect of chrysin on bleomycin-
induced lung fibrosis in rats. Inflammation 2014. 
153. Xiao J, Zhai H, Yao Y, Wang C, Jiang W, Zhang C, Simard AR, Zhang R, Hao J. 
Chrysin attenuates experimental autoimmune neuritis by suppressing immuno-
inflammatory responses. Neuroscience 2014;262:156-164. 
154. Yu G, Wan R, Yin G, Xiong J, Hu Y, Xing M, Cang X, Fan Y, Xiao W, Qiu L, Wang 
X, Hu G. Diosmetin ameliorates the severity of cerulein-induced acute pancreatitis in mice 
by inhibiting the activation of the nuclear factor-kappaB. Int J Clin Exp Pathol 
2014;7(5):2133-2142. 
155. Tahir M, Rehman MU, Lateef A, Khan R, Khan AQ, Qamar W, Ali F, O'Hamiza O, 
Sultana S. Diosmin protects against ethanol-induced hepatic injury via alleviation of 
inflammation and regulation of TNF-alpha and NF-kappaB activation. Alcohol 
2013;47(2):131-139. 
156. Bao ZS, Hong L, Guan Y, Dong XW, Zheng HS, Tan GL, Xie QM. Inhibition of 
airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine 
model of allergic asthma. Int Immunopharmacol 2011;11(8):899-906. 
157. Umar S, Kumar A, Sajad M, Zargan J, Ansari M, Ahmad S, Katiyar CK, Khan HA. 
Hesperidin inhibits collagen-induced arthritis possibly through suppression of free radical 
II. Theoretical Background
78
 load and reduction in neutrophil activation and infiltration. Rheumatol Int 2013;33(3):657-
663. 
158. Yang JH, Kim SC, Shin BY, Jin SH, Jo MJ, Jegal KH, Kim YW, Lee JR, Ku SK, 
Cho IJ, Ki SH. O-Methylated flavonol isorhamnetin prevents acute inflammation through 
blocking of NF-kappaB activation. Food Chem Toxicol 2013;59:362-372. 
159. Mahat MY, Kulkarni NM, Vishwakarma SL, Khan FR, Thippeswamy BS, Hebballi 
V, Adhyapak AA, Benade VS, Ashfaque SM, Tubachi S, Patil BM. Modulation of the 
cyclooxygenase pathway via inhibition of nitric oxide production contributes to the anti-
inflammatory activity of kaempferol. Eur J Pharmacol 2010;642(1-3):169-176. 
160. Park MY, Ji GE, Sung MK. Dietary kaempferol suppresses inflammation of dextran 
sulfate sodium-induced colitis in mice. Dig Dis Sci 2012;57(2):355-363. 
161. Kong L, Luo C, Li X, Zhou Y, He H. The anti-inflammatory effect of kaempferol on 
early atherosclerosis in high cholesterol fed rabbits. Lipids Health Dis 2013;12:115. 
162. Decendit A, Mamani-Matsuda M, Aumont V, Waffo-Teguo P, Moynet D, Boniface 
K, Richard E, Krisa S, Rambert J, Merillon JM, Mossalayi MD. Malvidin-3-O-beta 
glucoside, major grape anthocyanin, inhibits human macrophage-derived inflammatory 
mediators and decreases clinical scores in arthritic rats. Biochem Pharmacol 
2013;86(10):1461-1467. 
163. Ola MS, Aleisa AM, Al-Rejaie SS, Abuohashish HM, Parmar MY, Alhomida AS, 
Ahmed MM. Flavonoid, morin inhibits oxidative stress, inflammation and enhances 
neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol Sci 
2014;35(7):1003-1008. 
164. Wang SJ, Tong Y, Lu S, Yang R, Liao X, Xu YF, Li X. Anti-inflammatory activity of 
myricetin isolated from Myrica rubra Sieb. et Zucc. leaves. Planta Med 2010;76(14):1492-
1496. 
165. Shi Y, Dai J, Liu H, Li RR, Sun PL, Du Q, Pang LL, Chen Z, Yin KS. Naringenin 
inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-
kB activity in a murine model of asthma. Can J Physiol Pharmacol 2009;87(9):729-735. 
166. Azuma T, Shigeshiro M, Kodama M, Tanabe S, Suzuki T. Supplemental 
naringenin prevents intestinal barrier defects and inflammation in colitic mice. J Nutr 
2013;143(6):827-834. 
167. Dou W, Zhang J, Sun A, Zhang E, Ding L, Mukherjee S, Wei X, Chou G, Wang ZT, 
Mani S. Protective effect of naringenin against experimental colitis via suppression of Toll-
like receptor 4/NF-kappaB signalling. Br J Nutr 2013;110(4):599-608. 
168. Nie YC, Wu H, Li PB, Luo YL, Long K, Xie LM, Shen JG, Su WW. Anti-
inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette 
smoke-exposed rats. J Med Food 2012;15(10):894-900. 
II. Theoretical Background
79
 169. Sahu BD, Tatireddy S, Koneru M, Borkar RM, Kumar JM, Kuncha M, Srinivas R, 
Shyam Sunder R, Sistla R. Naringin ameliorates gentamicin-induced nephrotoxicity and 
associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible 
mechanism of nephroprotection. Toxicol Appl Pharmacol 2014;277(1):8-20. 
170. Ma JQ, Ding J, Xiao ZH, Liu CM. Puerarin ameliorates carbon tetrachloride-
induced oxidative DNA damage and inflammation in mouse kidney through ERK/Nrf2/ARE 
pathway. Food Chem Toxicol 2014;71:264-271. 
171. Yang G, Ham I, Choi HY. Anti-inflammatory effect of prunetin via the suppression 
of NF-kappaB pathway. Food Chem Toxicol 2013;58:124-132. 
172. Gonzalez-Segovia R, Quintanar JL, Salinas E, Ceballos-Salazar R, Aviles-Jimenez 
F, Torres-Lopez J. Effect of the flavonoid quercetin on inflammation and lipid peroxidation 
induced by Helicobacter pylori in gastric mucosa of guinea pig. J Gastroenterol 
2008;43(6):441-447. 
173. Ganesan S, Faris AN, Comstock AT, Chattoraj SS, Chattoraj A, Burgess JR, Curtis 
JL, Martinez FJ, Zick S, Hershenson MB, Sajjan US. Quercetin prevents progression of 
disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir 
Res 2010;11:131. 
174. Kukongviriyapan U, Sompamit K, Pannangpetch P, Kukongviriyapan V, Donpunha 
W. Preventive and therapeutic effects of quercetin on lipopolysaccharide-induced 
oxidative stress and vascular dysfunction in mice. Can J Physiol Pharmacol 
2012;90(10):1345-1353. 
175. Liu CM, Sun YZ, Sun JM, Ma JQ, Cheng C. Protective role of quercetin against 
lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and 
NF-kappaB pathway. Biochim Biophys Acta 2012;1820(10):1693-1703. 
176. Wang L, Wang B, Li H, Lu H, Qiu F, Xiong L, Xu Y, Wang G, Liu X, Wu H, Jing H. 
Quercetin, a flavonoid with anti-inflammatory activity, suppresses the development of 
abdominal aortic aneurysms in mice. Eur J Pharmacol 2012;690(1-3):133-141. 
177. Garelnabi M, Mahini H, Wilson T. Quercetin intake with exercise modulates 
lipoprotein metabolism and reduces atherosclerosis plaque formation. J Int Soc Sports 
Nutr 2014;11:22. 
178. Hosseinzadeh H, Nassiri-Asl M. Review of the protective effects of rutin on the 
metabolic function as an important dietary flavonoid. J Endocrinol Invest 2014. 
179. Pan PH, Lin SY, Wang YY, Chen WY, Chuang YH, Wu CC, Chen CJ. Protective 
effects of rutin on liver injury induced by biliary obstruction in rats. Free Radical Bio Med 
2014;73:106-116. 
II. Theoretical Background
80
 180. Choi YH, Jin GY, Guo HS, Piao HM, Li L, Li GZ, Lin ZH, Yan GH. Silibinin 
attenuates allergic airway inflammation in mice. Biochem Biophys Res Commun 
2012;427(3):450-455. 
181. Prabu SM, Muthumani M. Silibinin ameliorates arsenic induced nephrotoxicity by 
abrogation of oxidative stress, inflammation and apoptosis in rats. Mol Biol Rep 
2012;39(12):11201-11216. 
182. Yao J, Pan D, Zhao Y, Zhao L, Sun J, Wang Y, You QD, Xi T, Guo QL, Lu N. 
Wogonin prevents LPS-induced acute lung injury and inflammation in mice via PPAR-
gamma-mediated attenuation of the nuclear factor-kappaB pathway. Immunology 2014. 
183. Feng L, Song P, Zhou H, Li A, Ma Y, Zhang X, Liu H, Xu G, Zhou Y, Wu X, Shen 
Y, Sun Y, Wu X, Xu Q. Pentamethoxyflavanone regulates macrophage polarization and 
ameliorates sepsis in mice. Biochem Pharmacol 2014;89(1):109-118. 
184. Nieman DC, Henson DA, Davis JM, Angela Murphy E, Jenkins DP, Gross SJ, 
Carmichael MD, Quindry JC, Dumke CL, Utter AC, McAnulty SR, McAnulty LS, Triplett 
NT, Mayer EP. Quercetin's influence on exercise-induced changes in plasma cytokines 
and muscle and leukocyte cytokine mRNA. J Appl Physiol 2007;103(5):1728-1735. 
185. Nieman DC, Henson DA, Davis JM, Dumke CL, Gross SJ, Jenkins DP, Murphy 
EA, Carmichael MD, Quindry JC, McAnulty SR, McAnulty LS, Utter AC, Mayer EP. 
Quercetin ingestion does not alter cytokine changes in athletes competing in the Western 
States Endurance Run. J Interferon Cytokine Res 2007;27(12):1003-1011. 
186. Askari G, Ghiasvand R, Feizi A, Ghanadian SM, Karimian J. The effect of 
quercetin supplementation on selected markers of inflammation and oxidative stress. J 
Res Med Sci 2012;17(7):637-641. 
187. Landberg R, Sun Q, Rimm EB, Cassidy A, Scalbert A, Mantzoros CS, Hu FB, van 
Dam RM. Selected dietary flavonoids are associated with markers of inflammation and 
endothelial dysfunction in U.S. women. J Nutr 2011;141(4):618-625. 
188. Filiberto AC, Mumford SL, Pollack AZ, Zhang C, Yeung EH, Perkins NJ, 
Wactawski-Wende J, Schisterman EF. Habitual dietary isoflavone intake is associated 
with decreased C-reactive protein concentrations among healthy premenopausal women. 
J Nutr 2013;143(6):900-906. 
189. Mangano KM, Hutchins-Wiese HL, Kenny AM, Walsh SJ, Abourizk RH, Bruno RS, 
Lipcius R, Fall P, Kleppinger A, Kenyon-Pesce L, Prestwood KM, Kerstetter JE. Soy 
proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a 
randomized controlled trial. Nutr Res 2013;33(12):1026-1033. 
190. Nicastro HL, Mondul AM, Rohrmann S, Platz EA. Associations between urinary 
soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-
2008. Cancer Causes Control 2013;24(6):1185-1196. 
II. Theoretical Background
81
 191. Jennings A, Welch AA, Spector T, Macgregor A, Cassidy A. Intakes of 
anthocyanins and flavones are associated with biomarkers of insulin resistance and 
inflammation in women. J Nutr 2014;144(2):202-208. 
 
 
II. Theoretical Background
82
 CHAPTER III. Original Research 
 
III.1. Modulation of human neutrophils’ oxidative burst 
by flavonoids 
 
 
 
Reprinted from European Journal of Medicinal Chemistry 
 
Copyright © (2013) with kind permission from Elsevier 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
My contribution for this work comprised all the performed studies, except the flavones 
synthesis. 
 
 
 
III.1. Original Research
83
at SciVerse ScienceDirect
European Journal of Medicinal Chemistry 67 (2013) 280e292
III.1. Original ResearchContents lists availableEuropean Journal of Medicinal Chemistry
journal homepage: http: / /www.elsevier .com/locate/ejmechOriginal articleModulation of human neutrophils’ oxidative burst by ﬂavonoids
Daniela Ribeiro a, Marisa Freitas a,*, Sara M. Tomé b, Artur M.S. Silva b, Graça Porto c,
Eduarda Fernandes a,*
aREQUIMTE, Laboratório de Química Aplicada, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto,
Portugal
bDepartamento de Química & QOPNA, Universidade de Aveiro, 3810-193 Aveiro, Portugal
cHematologia Clínica, Hospital Geral de Santo António, 4050-011 Porto, Portugala r t i c l e i n f o
Article history:
Received 10 December 2012
Received in revised form
2 June 2013
Accepted 3 June 2013
Available online 21 June 2013
Keywords:
Flavonoids
Inﬂammation
Neutrophils
Oxidative burst
Reactive oxygen species* Corresponding authors. REQUIMTE, Laboratório
tamento de Ciências Químicas, Faculdade de Farmácia
Jorge Viterbo Ferreira n 228, 4050-313 Porto, Portu
fax: þ00351226093483.
E-mail addresses: egracas@ff.up.pt, marisafreitas@
0223-5234/$ e see front matter  2013 Elsevier Mas
http://dx.doi.org/10.1016/j.ejmech.2013.06.019a b s t r a c t
Inﬂammation is a normal response towards tissue injury, but may become deleterious to the organism if
uncontrolled. The overproduction of reactive species during the inﬂammatory process may cause or
magnify the damage at inﬂammatory sites. Flavonoids have been suggested as therapeutic agents to avoid
such damage, as these compounds exhibit anti-inﬂammatory activity, through themodulation of oxidative
stress and signalling pathways. Both effects may attenuate neutrophils’ activities at inﬂammatory sites. In
this study,we investigated the structure/activity relationship of a series ofﬂavonoids on the oxidative burst
of human neutrophils in vitro, as ameasure of its anti-inﬂammatory potential. Neutrophilswere stimulated
with phorbol-12-myristate-13-acetate, and ﬂuorescence and chemiluminescence techniqueswere used to
evaluate the generation of reactive oxygen species. All the tested ﬂavonoids revealed the ability to
modulate the neutrophil’s oxidative burst. From the obtained results, the pivotal role of the catechol group
in the B-ringwas evidenced as well as theminor importance of the hydroxylations in the A-ring, which did
not appear to be determinant for the activity, although clearly inﬂuencing the lipophilicity of the tested
ﬂavonoids. It is also clariﬁed the importance of the methylation in the OH group at the B-ring catechol
moiety. In conclusion, the obtained results uncover new possible strategies for the resolution of inﬂam-
matory processes, using ﬂavonoids to modulate neutrophil’s oxidative burst.
 2013 Elsevier Masson SAS. All rights reserved.1. Introduction
The term ‘ﬂavonoid’ is generally used to describe a broad group
of natural products that possess a C6eC3eC6 carbon framework, or
more speciﬁcally an arylbenzopyran skeleton (the benzopyran ring
system is also called chroman) [1]. Fig. 1 shows the generic struc-
ture of ﬂavonoids and the carbon numbering system. Flavonoids
are a group of more than 4000 naturally occurring polyphenolic
compounds that are nearly ubiquitous in plants [2]. Apart from
their physiological role in plants, ﬂavonoids have been reported to
exhibit multiple biological effects, e.g. antioxidant [3e5], antiviral
[6], antibacterial [7], anti-inﬂammatory [5,8,9], vasodilatory [10],
anticancer [11], and anti-ischaemic [12] properties. Moreover, these
compounds are able to control platelet aggregation and improvede Química Aplicada, Depar-
, Universidade do Porto, Rua
gal. Tel.: þ00351220428675;
ff.up.pt (E. Fernandes).
son SAS. All rights reserved.capillary function [13,14]. It has become clear that the mechanisms
of action of ﬂavonoids comprise the modulation of oxidative stress
and the intracellular signalling pathways, resulting from their in-
teractions with several key enzymes, signalling cascades involving
cytokines and regulatory transcription factors, and antioxidant
systems, which are vital for the cellular function [15]. These activ-
ities of ﬂavonoids may vary signiﬁcantly, depending on slight var-
iations in their chemical structure or other characteristics such as
the spatial conformation or the lipophilicity of themolecule [15,16].
Evaluation of the structureeactivity relationship of ﬂavonoids may
thus help to choose selected ﬂavonoids or combinations of ﬂavo-
noids for clinical development.
Inﬂammation is the ﬁrst response of the body to infection,
irritation or other injuries, and is considered as a non-speciﬁc im-
mune response aiming to neutralize the aggressor agents and to
repair damaged tissues, assuring this way the survival of the or-
ganism. While inﬂammation is a normal response towards tissue
injury, it is often uncontrolled in chronic autoimmune diseases,
namely rheumatoid arthritis and Crohn’s disease, and when it is
linked to an allergic response, like asthma and anaphylactic shock
[17]. Due to the permanent afﬂiction, disability, and, many times,84
Fig. 1. Generic structure of ﬂavonoids and carbon numbering system.
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eases, chronic inﬂammation is a heavy burden for modern society.
Unfortunately, the available treatments, albeit successful in some
cases, have numerous and severe side effects. Therefore, there has
been a constant pursuit for alternative therapeutic approaches.
Flavonoids, in particular, have been considered to possess anti-
inﬂammatory properties, both in vitro and in vivo [15].
Also known as polymorphonuclear leukocytes, neutrophils are
the most common type of white blood cells and constitute the ﬁrst
line of defence of the innate immune system [18]. In the event of an
inﬂammatory response, it occurs an increase in neutrophils’ attri-
butes namely in its number, life span, mobility, tissue inﬂux ability,
and phagocytic capacity [19]. Neutrophils use an extraordinary
array of oxygen-dependent and oxygen-independent microbicidal
weapons to destroy and remove infectious agents [18]. The oxygen-
dependent mechanisms involve the production of reactive oxygen
species (ROS) and oxygen-independent mechanisms include most
of the other neutrophil functions, such as chemotaxis, phagocy-
tosis, degranulation, and the release of lytic enzymes and bacteri-
cidal peptides [18]. While these factors have important roles in host
defence and inﬂammation, their overproduction, especially when
high levels of ROS are attained and sustained, may cause or magnify
damage in the inﬂammatory sites [15,20e22].Fig. 2. Chemical structures oThe antioxidant and anti-inﬂammatory effects of ﬂavonoids
may contribute to modulate the neutrophils’ oxidative burst and
therefore be useful for preventing the deleterious effects of sus-
tained or uncontrolled inﬂammatory processes. For that purpose,
much still needs to be investigated to ﬁnd the most effective
compounds. Hence, in this study, we investigated the structure/
activity relationship of a series of ﬂavonoids on the oxidative burst
of human neutrophils in vitro, as a measure of its anti-inﬂammatory
potential. Fig. 2 shows the chemical structures of the studied ﬂa-
vonoids. To study the putative modulatory effect of ﬂavonoids on
the stimulation of neutrophils by phorbol-12-myristate-13-acetate
(PMA), ﬂuorescence and chemiluminescence techniques were
used.
2. Materials and methods
2.1. Materials
The following reagents were purchased from SigmaeAldrich Co.
LLC (St. Louis, USA): phorbol-12-myristate-13-acetate (PMA), N-
acetyl-3,7-dihydroxyphenoxazine (amplex red), peroxidase from
horseradish (HRP), N,N0-dimethyl-9,90-biacridinium dinitrate
(lucigenin), histopaque 1077, histopaque 1119, Dulbecco’s Phos-
phate Buffer saline, without calcium chloride and magnesium
chloride (PBS), trypan blue solution 0.4%, dimethylsulfoxide
(DMSO), trizma, D-(þ)-glucose, superoxide dismutase (SOD),
catalase, apigenin, chrysin, luteolin, ()-naringenin, ()-erio-
dictyol, and quercetin. 4-Aminobenzoyl hydrazide (ABAH) was
purchased from Calbiochem (San Diego, CA, USA). 2-[6-(40-Amino)
phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (APF) was purchased
from Invitrogen, Life Technologies Ltd (Paisley, UK). Acacetin,f the studied ﬂavonoids.
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(Steinheim, Germany). Calcium chloride dihydrate and magnesium
sulphate were purchased from Merck (Darmstadt, Germany). Po-
tassium chloride was purchased from Pronalab (Abrunheira,
Portugal) and sodium chloride from Honeywell Riedel-de Haën
(Hanover, Germany). The other tested ﬂavonoids were purchased
from Indoﬁne Chemical Company, Inc. (Stryker Lane Hillsborough,
USA). 3-Methoxybenzaldehyde 7a, 4-methoxybenzaldehyde 7b
and 3,4-dimethoxybenzaldehyde 7c were purchased from Sigmae
Aldrich (Madrid, Spain). All chemicals and solvents used in the
synthesis procedures were obtained from commercial sources and
used as received or dried by standard procedures.
2.2. General methods
Melting points were measured in a Reichert Thermovar appa-
ratus ﬁtted with a microscope and are uncorrected. Nuclear mag-
netic resonance (NMR) spectra were recorded on a Bruker Avance
300 spectrometer (300.13 MHz for 1H and 75.47 MHz for 13C), in
CDCl3 as solvent if not stated otherwise. Chemical shifts (d) are
reported in ppm and coupling constants (J) in Hz; the internal
standard was TMS. Unequivocal 13C assignments were made with
the aid of 2D gHSQC and gHMBC (delays for one-bond and long-
range J C/H couplings were optimised for 145 and 7 Hz, respec-
tively) experiments. Positive-ion ESI mass spectra were acquired
with a Q-TOF 2 instrument [dilution of 1 mL of the sample in a
chloroform solution (ca. 10e5M) in 200 mL of 0.1% triﬂuoroacetic
acid/methanol solution]. Nitrogen was used as the nebuliser gas
and argon as the collision gas. The needle voltagewas set at 3000 V,
with the ion source at 80 C and the desolvation temperature at
150 C. The cone voltage was 30 V. High-resolution mass spectra
analyses were performed on a Bruker MicrOTOF spectrometer
(University of Vigo). Elemental analyses were obtained with a LECO
630-200-200 CHNS analyser (University of Aveiro). Preparative
thin-layer chromatography was performed with Merck silica gel
(60 DGF254). Column chromatography was performed with Merck
silica gel (60, 70e230 mesh).
A microplate reader (Synergy HT, BIO-TEK), for ﬂuorescence and
chemiluminescence measurements, plus temperature control ca-
pacity, was used for all the assays.
2.3. Synthesis of 20-hydroxyacetophenones 6a, b
20-Hydroxy-40,60-dimethoxyacetophenone (95% yield) (6a) [23]
and 20-hydroxy-40,60-bis[(2-methoxyethoxy)methoxy]acetophe-
none (39% yield) (6b) [24] were prepared according to procedures
previously described in the literature.
2.4. Synthesis of 3-methoxy-4-[(2-methoxyethoxy)methoxy]
benzaldehyde (7c)
2-Methoxyethoxymethyl chloride (MEMCl) (0.58 mL, 5.10 mmol)
was slowly added to a stirring solution of 4-hydroxy-3-
methoxybenzaldehyde (0.74 g, 4.85 mmol) and anhydrous K2CO3
(1.34 g, 9.71 mmol) in acetone (25 mL). The solution was reﬂuxed,
under nitrogen atmosphere, for 1 h. The reaction mixture was
ﬁltered, evaporated to dryness and puriﬁed by silica gel column
chromatography using dichloromethane as eluent. 3-Methoxy-4-
[(2-methoxyethoxy)methoxy]benzaldehyde (7c), a light orange oil,
was obtained in good yield (87%, 1.02 g). 1H NMR: d 3.37 (s, 3H, 40-
CH3), 3.55e3.58 (m, 2H, H-30), 3.86e3.90 (m, 2H, H-20), 3.95 (s, 3H, 3-
OCH3), 5.43 (s, 2H, H-10), 7.33 (d, J 8.7 Hz,1H, H-5), 7.42e7.45 (m, 2H,
H-6 and H-2), 9.88 (s, 1H, CHO) ppm. 13C NMR: d 55.7 (3-OCH3), 59.0
(C-40), 68.2 (C-20), 71.4 (C-30), 94.0 (C-10), 109.4 (C-2), 114.7 (C-5),
126.4 (C-6), 131.0 (C-1), 150.0 (C-3), 151.9 (C-4), 191.0 (CHO) ppm.MS(ESIþ) m/z (rel. int.): 263 ([M þ Na]þ, 100). HRMS (ESIþ) m/z:
C12H17O5, calcd 241.1071 [M þ H]þ, found: 241.1097; C12H16NaO5,
calcd 263.0890 [M þ Na]þ, found: 263.0884.
2.5. Synthesis of 20-hydroxychalcones 8aed
An aqueous solution of sodium hydroxide was slowly added
(60%, 2.5 mL) to a methanolic solution (2.5 mL) of the appropriate
20-hydroxycetophenones 6a, b (0.5 mmol). After cooling the reac-
tion mixture to room temperature, the appropriate benzaldehydes
7aed (1.0 mmol) were added and the mixture stirred at room
temperature for 3 h (for 8a) to 4 h (for 8bed). After this period, the
reaction mixture was poured into ice (100 g), water (50 mL) and
concentrated hydrochloric acid to adjust pH to 2. The obtained
precipitate was ﬁltered and taken in chloroform (100 mL). The
organic layer was successively washed with a saturated solution of
potassium hydrogen carbonate (2  100 mL), water (100 mL) and
then dried through anhydrous sodium sulphate. The solvent was
evaporated to dryness and the obtained 20-hydroxychalcones 8ae
d were recrystallized from ethanol (for 8a) or puriﬁed by silica gel
column chromatography using dichloromethane as eluent (for 8be
d). The synthesized compounds were obtained as canary yellow
crystals (for 8a) or bright yellow oils (for 8bed) in good yields: 8a
68%, 0.11 g; 8b 75%, 0.18 g; 8c 83%, 0.24 g; 8d 86%, 0.21 g.
2.5.1. 20-Hydroxy-3,40,60-trimethoxychalcone (8a)
Mp 112e113 C (lit [25,26]. 94 C). 1H NMR: d 3.84 (s, 3H, 40-
OCH3), 3.85 (s, 3H, 3-OCH3), 3.92 (s, 3H, 60-OCH3), 5.96 (d, J 2.4 Hz,
1H, H-50), 6.11 (d, J 2.4 Hz, 1H, H-30), 6.94 (ddd, J 8.0, 2.3 and 0.9 Hz,
1H, H-4), 7.12 (t, J 2.3 Hz, 1H, H-2), 7.21 (brd, J 8.0 Hz, 1H, H-6), 7.33
(t, J 8.0 Hz,1H, H-5), 7.74 (d, J 15.6 Hz,1H, H-b), 7.88 (d, J 15.6 Hz,1H,
H-a), 14.28 (s, 1H, 20-OH) ppm. 13C NMR: d 55.3 (3-OCH3), 55.6 (40-
OCH3), 55.8 (60-OCH3), 91.3 (C-50), 93.8 (C-30), 106.3 (C-10), 113.6 (C-
2), 115.6 (C-4), 120.9 (C-6), 127.9 (C-a), 129.8 (C-5), 137.0 (C-1), 142.1
(C-b), 159.8 (C-3), 162.5 (C-60), 166.2 (C-40), 168.4 (C-20), 192.6 (C¼O)
ppm. MS (ESIþ) m/z (rel. int.): 315 ([M þ H]þ, 100), 337 ([M þ Na]þ,
11). Anal. Calcd for C18H18O5 (314.33): C 68.78, H 5.77; found: C
68.74, H 5.87%.
2.5.2. 3,20-Dihydroxy-4-Methoxy-40,60-di[(2-methoxyethoxy)
methoxy]chalcone (8b)
1H NMR: d 3.37 and 3.38 (2s, 2  3H, H-400 and H-4000), 3.55e3.58
(m, 2H, H-300), 3.58e3.61 (m, 2H, H-3000), 3.80e3.83 (m, 2H, H-2000),
3.87e3.90 (m, 2H, H-200), 3.91 (s, 3H, 4-OCH3), 5.27 (s, 2H, H-1000),
5.37 (s, 2H, H-100), 6.24 (d, J 2.3 Hz, 1H, H-50), 6.27 (brs, 1H, 3-OH),
6.31 (d, J 2.3 Hz, 1H, H-30), 6.84 (d, J 8.3 Hz, 1H, H-5), 7.07 (dd, J 8.3
and 1.9 Hz, 1H, H-6), 7.21 (d, J 1.9 Hz, 1H, H-2), 7.70 (d, J 15.5 Hz, 1H,
H-b), 7.80 (d, J 15.5 Hz, 1H, H-a), 14.03 (s, 1H, 20-OH) ppm. 13C NMR:
d 55.8 (4-OCH3), 58.8 (C-400 and 4000), 68.0 (C-2000), 68.5 (C-200), 71.3
(C-300 and C-3000), 92.8 (C-100), 94.0 (C-1000), 94.6 (C-50), 97.3 (C-30),
107.2 (C-10), 110.5 (C-5), 112.8 (C-2), 122.6 (C-6), 125.1 (C-a), 128.7
(C-1), 142.8 (C-b), 145.8 (C-3), 148.8 (C-4), 159.5 (C-60), 163.1 (C-40),
167.2 (C-20), 192.6 (C¼O) ppm. MS (ESIþ) m/z (rel. int.): 501
([M þ Na]þ, 100). HRMS (ESIþ), m/z: C24H31O10, calcd 479.1912
[Mþ H]þ, found: 479.1903; C24H30NaO10, calcd 501.1731 [Mþ Na]þ,
found: 501.1733.
2.5.3. 20-Hydroxy-3-methoxy-4,40,60-tri[(2-methoxyethoxy)
methoxy]chalcone (8c)
1H NMR: d 3.35, 3.38 and 3.39 (3s, 3  3H, H-400, H-4000 and H-
40000), 3.53e3.58 (m, 6H, H-300, H-30’’ and H-30000), 3.80e3.83 (m, 2H,
H-200), 3.83e3.87 (m, 2H, H-2000), 3.87e3.90 (m, 2H, H-20000), 3.92 (s,
3H, 3-OCH3), 5.28 (s, 2H, H-100), 5.37 (s, 2H, H-10000), 5.38 (s, 2H, H-
1000), 6.27 (d, J 2.3 Hz, 1H, H-50), 6.33 (d, J 2.3 Hz, 1H, H-30), 7.14 (d, J
1.7 Hz, 1H, H-2), 7.19 (dd, J 8.4 and 1.7 Hz, 1H, H-6), 7.23 (d, J 8.4 Hz,86
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(s, 1H, 20-OH) ppm. 13C NMR: d 55.8 (3-OCH3), 59.0 (C-400, C-4000 and
C-40000), 68.0 (C-20000), 68.1 (C-200), 68.6 (C-2000), 71.4 (C-300, C-3000 and C-
30000), 92.9 (C-100), 94.1 and 94.2 (C-1000 and 10000), 94.8 (C-50), 97.5 (C-
30), 107.4 (C-10), 111.0 (C-2), 115.8 (C-5), 122.1 (C-6), 125.7 (C-a),
129.7 (C-1), 142.5 (C- b), 148.4 (C-4), 149.6 (C-3), 159.7 (C-60), 163.3
(C-40), 167.2 (C-20), 192.6 (C¼O) ppm. MS (ESIþ) m/z (rel. int.): 589
([M þ Na]þ, 100). HRMS (ESIþ), m/z: C28H39O12, calcd 567.2436
[M þ H]þ, found: 567.2457; C28H38NaO12, calcd 589.2256
[M þ Na]þ, found: 589.2265.
2.5.4. 20-Hydroxy-3,4-dimethoxy-40,60-di[(2-methoxyethoxy)
methoxy]chalcone (8d)
1H NMR: d 3.34 (s, 3H, H-4000), 3.39 (s, 3H, H-400), 3.52-3.55 (m,
2H, H-3000), 3.55-3.58 (m, 2H, H-300), 3.80-3.83 (m, 2H, H-200), 3.83-
3.86 (m, 2H, H-2000), 3.93 (s, 6H, 3,4-OCH3), 5.28 (s, 2H, H-100), 5.38 (s,
2H, H-1000), 6.26 (d, J 2.4 Hz,1H, H-50), 6.34 (d, J 2.4 Hz,1H, H-30), 6.90
(d, J 8.3 Hz, 1H, H-5), 7.14 (d, J 1.9 Hz, 1H, H-2), 7.22 (dd, J 8.3 and
1.9 Hz, 1H, H-6), 7.75 (d, J 15.5 Hz, 1H, H-b), 7.83 (d, J 15.5 Hz, 1H, H-
a), 13.09 (s, 1H, 20-OH) ppm. 13C NMR: d 55.8 and 56.0 (3-OCH3 and
4-OCH3), 59.0 (C-4000), 59.1 (C-400), 68.2 (C-200), 68.7 (C-2000), 71.5 (C-
300 and C-3000), 93.0 (C-100), 94.3 (C-1000), 94.8 (C-50), 97.6 (C-30), 107.6
(C-10), 110.2 (C-2), 111.1 (C-5), 122.8 (C-6), 125.2 (C-a), 128.4 (C-1),
142.8 (C- b), 149.2 (C-3), 151.1 (C-4), 159.7 (C-60), 163.3 (C-40), 167.2
(C-20), 192.7 (C¼O) ppm. MS (ESIþ) m/z (rel. int.): 515 ([M þ Na]þ,
100). HRMS (ESIþ), m/z: C25H33O10, calcd 493.2068 [M þ H]þ,
found: 493.2084; C25H32NaO10, calcd 515.1888 [M þ Na]þ, found:
515.1880.
2.6. Synthesis of 30,5,7-trimethoxyﬂavone (10a)
A catalytic amount of iodine (6 mg, 5.70 mmol) was added to a
solution of 20-hydroxy-3,40,60-trimethoxychalcone 8a (0.30 g,
0.95 mmol) in DMSO (10 mL). The solution was stirred at reﬂux,
under nitrogen atmosphere, for 30 min. After this period the reac-
tion was poured into ice (100 g), water (50 mL) and sodium thio-
sulfate (w0.5 g). The obtained solid was ﬁltered and taken in
chloroform (100 mL). The organic layer was successively washed
with a sodium thiosulfate solution (20%, 2  100 mL) and water
(100 mL) and then dried through anhydrous sodium sulphate. The
solvent was evaporated to dryness and the residue was recrystal-
lized in ethanol to give 30,5,7-trimethoxyﬂavone (10a), a white solid,
in good yield (71%, 0.21 g). Mp 147e148 C. 1H NMR: d 3.89 (s, 3H, 30-
OCH3), 3.92 (s, 3H, 7-OCH3), 3.96 (s, 3H, 5-OCH3), 5.38 (d, J 2.3 Hz,1H,
H-6), 6.57 (d, J 2.3 Hz, 1H, H-8), 6.68 (s, 1H, H-3), 7.05 (ddd, J 7.9, 2.6
and 1.4 Hz, 1H, H-40), 7.40e7.38 (m, 1H, H-20), 7.40 (t, J 7.9 Hz, 1H, H-
50), 7.46 (dt, J 7.9 and 1.4 Hz, 1H, H-60) ppm. 13C NMR: d 55.4 (5-
OCH3), 55.7 (7-OCH3), 56.4 (30-OCH3), 92.8 (C-8), 96.2 (C-6), 109.2
(C-3 and C-10), 111.3 (C-20), 116.9 (C-40), 118.3 (C-60), 130.0 (C-50),
132.8 (C-10), 159.9 (C-30), 159.9 (C-9), 160.4 (C-2), 160.9 (C-5), 164.0
(C-7), 177.6 (C-4) ppm. MS (ESIþ) m/z (rel. int.): 313 ([M þ H]þ, 100),
647 ([2M þ Na]þ, 77). MS (ESIþ) m/z (rel. int.): 301 ([M þ H]þ, 34).
HRMS (EI),m/z for C18H16O5: calcd 312.0998 [M]þ$, found: 312.0998.
2.7. Synthesis of polyalkoxyﬂavones 10bed
Sodium periodate (2.97 mmol) was added to a suspension of the
appropriated 20-hydroxychalcones 8bed (0.59 mmol) in DMSO
(10 mL). The reaction mixture was stirred under nitrogen at 100 C
for 8 h (for 8b), 48 h (for 8c) or 72 h (for 8d). Then, it was poured
into ice (100 g) and a sodium thiosulfate solution (10%, 50 mL).
The obtained precipitate was ﬁltered, taken in ethyl acetate
(100 mL), washed with water (2  100 mL) and then dried over
anhydrous sodium sulphate. The solvent was evaporated to dryness
and the obtained oils were puriﬁed by preparative thin-layerchromatography using ethyl acetate as eluent affording poly-
alkoxyﬂavones 10bed as yellowish oils in moderated yields: 10b,
36%, 0.10 g; 10c, 44%, 0.15 g; 10d, 44%, 0.13 g.
2.7.1. 30-Hydroxy-40-methoxy-5,7-di[(2-methoxyethoxy)methoxy]
ﬂavone (10b)
1H NMR: d 3.38 and 3.40 (2s, 2  3H, H-400 and H-4000), 3.56e3.61
(m, 4H, H-300 and H-3000), 3.84e3.87 (m, 2H, H-2000), 3.93e3.96 (m,
2H, H-200), 3.97 (s, 3H, 40-OCH3), 5.35 (s, 2H, H-1000), 5.42 (s, 2H, H-
100), 5.92 (brs, 1H, 30-OH), 6.56 (s, 1H, H-3), 6.77 (d, J 2.3 Hz,1H, H-6),
6.89 (d, J 2.3 Hz, 1H, H-8), 6.94 (d, J 8.5 Hz, 1H, H-50), 7.42 (dd, J 8.5
and 2.2 Hz, 1H, H-60), 7.46 (d, J 2.2 Hz, 1H, H-20) ppm. 13C NMR:
d 56.1 (40-OCH3), 58.9 and 59.1 (C-400 and C-4000), 68.1 (C-200), 68.2 (C-
2000), 71.5 (C-300 and C-3000), 93.3 (C-1000), 94.4 (C-100), 97.2 (C-8), 102.0
(C-6), 107.7 (C-3), 110.6 (C-10), 110.6 (C-50), 112.2 (C-20), 118.7 (C-60),
124.6 (C-10), 146.0 (C-30), 149.2 (C-40), 158.0 (C-7), 159.3 (C-9), 160.8
(C-2), 161.2 (C-5), 177.4 (C-4) ppm. MS (ESIþ) m/z (rel. int.): 477
([M þ H]þ, 34), 499 ([M þ Na]þ, 100), 975 ([2M þ Na]þ, 15). HRMS
(ESIþ), m/z: C24H29O10, calcd 477.1755 [M þ H]þ, found: 477.1753;
C24H28NaO10, calcd 499.1575 [M þ Na]þ, found: 499.1573.
2.7.2. 30,5-Dihydroxy-40-methoxy-7-[(2-methoxyethoxy)methoxy]
ﬂavone (9a)
Mp 142e143 C (light yellow powder recrystallized from
ethanol). 1H NMR: d 3.40 (s, 3H, H-400), 3.57e3.60 (m, 2H, H-300),
3.83-3.87 (m, 2H, H-200), 4.00 (s, 3H, 40-OCH3), 5.34 (s, 2H, H-100),
5.75 (s, 1H, 30-OH), 6.48 (d, J 2.2 Hz, 1H, H-6), 6.58 (s, 1H, H-3), 6.69
(d, J 2.2 Hz, 1H, H-8), 6.97 (d, J 8.0 Hz, 1H, H-50), 7.44 (d, J 2.2 Hz, 1H,
H-20), 7.45 (dd, J 8.0 and 2.2 Hz, 1H, H-60), 12.75 (s, 1H, 5-OH) ppm.
13C NMR: d 56.1 (40-OCH3), 59.1 (C-400), 68.2 (C-200), 71.5 (C-300), 93.3
(C-100), 94.3 (C-8), 100.1 (C-6), 104.7 (C-3), 106.3 (C-10), 110.7 (C-50),
112.3 (C-20), 119.2 (C-60), 124.4 (C-10), 146.0 (C-30), 149.6 (C-40), 157.6
(C-9), 162.0 (C-5), 162.9 (C-7), 163.9 (C-2), 182.5 (C-4) ppm. MS
(ESIþ) m/z (rel. int.): 489 ([M þ H]þ, 100). HRMS (ESIþ), m/z for
C20H21O8: calcd 389.1231 [M þ H]þ, found: 389.1229.
2.7.3. 30-Methoxy-40,5,7-tri[(2-methoxyethoxy)methoxy]ﬂavone
(10c)
1H NMR: d 3.38, 3.39 and 3.40 (3s, 3  3H, H-400, H-4000 and H-
40000), 3.56e3.61 (m, 6H, H-300, H-3000 and H-30000), 3.85e3.88 (m, 2H,
H-2000), 3.89-3.91 (m, 2H, H-20000), 3.93e3.97 (m, 2H, H-200), 4.00 (s,
3H, 30-OCH3), 5.37 (s, 2H, H-1000), 5.41 (s, 2H, H-10000), 5.43 (s, 2H, H-
100), 6.59 (s, 1H, H-3), 6.79 (d, J 2.3 Hz, 1H, H-6), 6.92 (d, J 2.3 Hz, 1H,
H-8), 7.31 (d, J 8.5 Hz,1H, H-50), 7.36 (d, J 2.1 Hz,1H, H-20), 7.48 (dd, J
8.5 and 2.1 Hz, 1H, H-60) ppm. 13C NMR: d 56.1 (30-OCH3), 58.9 and
59.0 (C-400, C-4000 and C-40000), 68.0 and 68.1 (C-200, C-2000 and C-20000),
71.4 (C-300, C-3000 and C-30000), 93.2 (C-1000), 94.1 (C-10000), 94.4 (C-100),
97.1 (C-8),102.1 (C-6),108.0 (C-3),109.0 (C-20), 111.6 (C-10),115.7 (C-
50), 119.5 (C-60), 125.3 (C-10), 149.2 (C-40), 149.7 (C-30), 158.0 (C-7),
159.2 (C-9), 160.7 (C-2), 161.1 (C-5), 177.3 (C-4) ppm. MS (ESIþ) m/z
(rel. int.): 565 ([MþH]þ, 100), 587 ([MþNa]þ, 94). HRMS (ESIþ),m/
z: C28H37O12, calcd 565.2280 [M þ H]þ, found: 565.2264;
C28H36NaO12, calcd 587.2099 [M þ Na]þ, found: 587.2077.
2.7.4. 5-Hydroxy-30-methoxy-40,7-di[(2-methoxyethoxy)methoxy]
ﬂavone (9b)
Mp 124e125 C (white powder recrystallized from ethanol). 1H
NMR: d 3.38 and 3.39 (2 s, 6H, H-400 and H-4000), 3.56e3.60 (m, 4H,
H-300 and H-3000), 3.84e3.91 (m, 4H, H-200 and H-2000), 4.00 (s, 3H, 30-
OCH3), 5.36 (s, 2H, H-100), 5.42 (s, 2H, H-1000), 6.48 (d, J 2.2 Hz, 1H, H-
6), 6.61 (s,1H, H-3), 6.73 (d, J 2.2 Hz,1H, H-8), 7.32 (d, J 8.6 Hz,1H, H-
50), 7.38 (d, J 2.1 Hz, 1H, H-20), 7.49 (dd, J 8.6 and 2.1 Hz, 1H, H-60),
12.73 (s, 1H, 5-OH) ppm. 13C NMR: d 56.2 (30-OCH3), 59.0 and 59.1
(C-400 and C-4000), 68.1 (C-200), 68.2 (C-2000), 71.4 (C-300 and C-3000), 93.1
(C-100), 94.1 (C-1000), 94.2 (C-8), 100.3 (C-6), 105.0 (C-3 and C-10),87
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40), 157.6 (C-9), 162.0 (C-5),163.0 (C-7),164.0 (C-2 and C-4) ppm.MS
(ESIþ) m/z (rel. int.): 477 ([M þ H]þ, 100). HRMS (ESIþ), m/z:
C24H29O10 for calcd 477.1755 [M þ H]þ, found: 477.1748.
2.7.5. 30,40-Dimethoxy-5,7-di[(2-methoxyethoxy)methoxy]ﬂavone
(10d)
1H NMR: d 3.38 and 3.40 (2  s, 6H, H-400 and H-4000), 3.57e3.61
(m, 4H, H-300 and H-3000), 3.85-3.88 (m, 2H, H-2000), 3.94-3.96 (m, 2H,
H-200), 3.97 (s, 3H, 40-OCH3), 4.00 (s, 3H, 30-OCH3), 5.37 (s, 2H, H-1000),
5.43 (s, 2H, H-100), 6.59 (s, 1H, H-3), 6.79 (d, J 2.4 Hz, 1H, H-6), 6.92
(d, J 2.4 Hz, 1H, H-8), 6.97 (d, J 8.5 Hz, 1H, H-50), 7.35 (d, J 2.1 Hz, 1H,
H-20), 7.52 (dd, J 8.5 and 2.1 Hz, 1H, H-60), 12.73 (s, 1H, 5-OH) ppm.
13C NMR: d 56.0 (40-OCH3), 56.1 (30-OCH3), 58.9 and 59.0 (C-400 and
C-4000), 68.2 (C-200 and C-2000), 71.4 and 71.5 (C-300 and C-3000), 93.2 (C-
1000), 94.5 (C-100), 97.1 (C-8), 102.1 (C-6), 107.7 (C-3), 108.5 (C-20),
110.6 (C-10), 111.1 (C-50), 119.6 (C-60), 124.0 (C-10), 149.2 (C-30), 151.7
(C-40), 158.0 (C-7), 159.3 (C-9), 160.9 (C-2), 161.1 (C-5), 177.4 (C-4)
ppm. MS (ESIþ) m/z (rel. int.): 491 ([M þ H]þ, 54), 513 ([M þ Na]þ,
100). HRMS (ESIþ), m/z for C25H30NaO10: calcd 513.1731 [M þ Na]þ,
found: 513.1728.
2.7.6. 5-Hydroxy-30,40-dimethoxy-7-[(2-methoxyethoxy)methoxy]
ﬂavone (9c)
Mp 136e137 C (light yellow powder recrystallized from
ethanol). 1H NMR: d 3.39 (s, 3H, H-400), 3.57e3.60 (m, 2H, H-300),
3.84e3.87 (m, 2H, H-200), 3.98 (s, 3H, 40-OCH3), 4.00 (s, 3H, 30-OCH3),
5.36 (s, 2H, H-100), 6.48 (d, J 2.2 Hz, 1H, H-6), 6.61 (s, 1H, H-3), 6.73
(d, J 2.2 Hz, 1H, H-8), 6.99 (d, J 8.5 Hz, 1H, H-50), 7.36 (d, J 2.1 Hz, 1H,
H-20), 7.53 (dd, J 8.5 and 2.1 Hz, 1H, H-60), 12.75 (s, 1H, 5-OH) ppm.
13C NMR: d 56.1 (30-OCH3 and 40-OCH3), 59.1 (C-400), 68.2 (C-200), 71.4
(C-300), 93.1 (C-100), 94.1 (C-8), 100.2 (C-6), 104.7 (C-3 and C-10),
108.7 (C-20), 111.1 (C-50), 120.1 (C-60), 123.7 (C-10), 149.3 (C-30), 152.3
(C-40), 157.6 (C-9), 161.9 (C-5), 162.9 (C-7), 164.1 (C-2 and C-4) ppm.
MS (ESIþ) m/z (rel. int.): 403 ([M þ H]þ, 100). HRMS (ESIþ), m/z for
C21H23O8: calcd 403.1387 [M þ H]þ, found: 403.1383.
2.8. Synthesis of 30,5,7-trihydroxyﬂavone (4b)
A solution of 30,5,7-trimethoxyﬂavone (10a) (81 mg, 0.36 mmol)
in freshly distilled dichloromethane (5 mL) was cooled to 78 C in
a propan-2-ol bath. A solution of 1 M boron tribromide in
dichloromethane (1.95 mL, 1.95 mmol) was added dropwise (2.5
equiv. for eachmethyl group to be cleaved). The solutionwas stirred
under nitrogen for 10 days at room temperature. After this period,
water (40 mL) was slowly added to the reaction mixture with
vigorously stirring until the formation of a yellow precipitate. The
solid was removed by ﬁltration and then abundantly washed with
water (150 mL) and diethyl ether (50 mL) affording 30,5,7-
trihydroxyﬂavone (4b) as a light yellow solid (78.6%, 55 mg).
Mpdec 290-201 C. 1H NMR (CD3OD): d 6.23 (d, J 2.0 Hz, 1H, H-6),
6.46 (d, J 2.0 Hz, 1H, H-8), 6.66 (s, 1H, H-3), 7.00 (brdd, J 7.6 and
1.5 Hz, 1H, H-40), 7.33-7.39 (m, 1H, H-20), 7.36 (t, J 7.8 Hz, 1H, H-50),
7.43 (brd, J 7.8 Hz, 1H, H-60) ppm. 13C NMR (CD3OD): d 95.1 (C-8),
100.3 (C-6), 105.5 (C-10), 105.9 (C-3), 113.8 (C-20), 118.5 (C-60), 120.1
(C-40), 131.3 (C-50), 133.7 (C-10), 159.4 (C-30), 159.5 (C-9), 163.3 (C-5),
165.7 (C-2), 166.3 (C-7), 183.9 (C-4) ppm. MS (ESIþ) m/z (rel. int.):
271 ([M þ H]þ, 100). MS (ESIþ) m/z (rel. int.): 301 ([M þ H]þ, 34).
HRMS (EI), m/z for C15H10O5: calcd 270.0528 [M]þ$, found:
270.0529.
2.9. Synthesis of 5,7-dihydroxyﬂavones 4feh
A diluted solution of hydrochloric acid (20%, 10 mL) was added
to a suspension of the appropriated polyalkoxyﬂavones 10bed (0.27 mmol) in tetrahydrofuran (5 mL). The reaction was stirred
under nitrogen at room temperature for 3 h. After this period the
reactionwas poured into ice (100 g) and water (50mL). The solid so
obtained was ﬁltered, washed abundantly with water (150 mL) and
diethyl ether (50 mL) affording the expected 5,7-dihydroxyﬂavones
4feh as light yellow solids in good yields: 4f, 90%, 73 mg; 4g, 89%,
70 mg; 4h, 86%, 73 mg.
2.9.1. 40,5,7-Trihydroxy-30-methoxyﬂavone (4f)
Mpdec. 322e323 C (lit [27]. 330e331 C). 1H NMR (DMSO-d6):
d 3.90 (s, 3H, 30-OCH3), 6.21 (d, J 2.0 Hz, 1H, H-6), 6.52 (d, J 2.0 Hz,
1H, H-8), 6.90 (s, 1H, H-3), 6.94 (d, J 8.9 Hz, 1H, H-50), 7.56 (s, 1H, H-
20), 7.56e7.59 (m, 1H, H-60), 10.02 (brs, 1H, 30-OH), 10.89 (brs, 1H, 7-
OH), 12.98 (s,1H, 5-OH) ppm. 13C NMR (DMSO-d6): d 56.0 (30-OCH3),
94.1 (C-8), 98.9 (C-6), 103.3 (C-3), 103.8 (C-10), 110.2 (C-20), 115.8 (C-
50), 120.4 (C-60), 121.6 (C-10), 148.1 (C-30), 150.8 (C-40), 157.4 (C-9),
161.5 (C-5), 163.7 (C-2), 164.2 (C-7), 181.9 (C-4) ppm. MS (ESIþ) m/z
(rel. int.): 301 ([M þ H]þ, 100), 323 ([M þ Na]þ, 4). HRMS (EI), m/z
for C16H12O6: calcd 300.0634 [M]þ$, found: 300.0634.
2.9.2. 30,5,7-Trihydroxy-40-methoxyﬂavone (4g)
Mpdec. 252e253 C (lit [27]. 253e254 C). 1H NMR (DMSO-d6):
d 3.87 (s, 3H, 40-OCH3), 6.20 (d, J 2.1 Hz,1H, H-6), 6.47 (d, J 2.1 Hz,1H,
H-8), 6.76 (s,1H, H-3), 7.09 (d, J 8.6 Hz,1H, H-50), 7.43 (d, J 2.3 Hz,1H,
H-20), 7.55 (dd, J 8.6 and 2.3 Hz, 1H, H-60), 9.52 (bs, 1H, 7-OH), 12.94
(s,1H, 5-OH) ppm. 13C NMR (DMSO-d6): d 55.8 (40-OCH3), 94.0 (C-8),
98.9 (C-6), 103.6 (C-3), 103.8 (C-10), 112.2 (C-50), 113.0 (C-20), 118.8
(C-60), 123.0 (C-10), 146.8 (C-30), 151.2 (C-40), 157.4 (C-9), 161.5 (C-5),
163.6 (C-2), 164.3 (C-7), 181.8 (C-4) ppm. MS (ESIþ) m/z (rel. int.):
301 ([M þ H]þ, 34). HRMS (EI), m/z for C16H12O6: calcd 300.0634
[M]þ$, found: 300.0632.
2.9.3. 5,7-Dihydroxy-30,40-dimethoxyﬂavone (4h)
Mp 283e284 C. 1H NMR (DMSO-d6): d 3.86 (s, 3H, 30-OCH3),
3.89 (s, 3H, 40-OCH3), 6.21 (d, J 2.0 Hz, 1H, H-6), 6.54 (d, J 2.0 Hz, 1H,
H-8), 6.98 (s, 1H, H-3), 7.13 (d, J 8.5 Hz,1H, H-50), 7.57 (d, J 1.9 Hz,1H,
H-20), 7.69 (dd, J 8.5 and 1.9 Hz, 1H, H-60), 10.87 (brs, 1H, 7-OH),
12.93 (s,1H, 5-OH) ppm. 13C NMR (DMSO-d6): d 55.7 (30-OCH3), 55.8
(40-OCH3), 94.1 (C-8), 98.9 (C-6), 103.8 (C-10), 103.8 (C-3), 109.4 (C-
20), 111.7 (C-50), 120.0 (C-60), 122.9 (C-10), 149.0 (C-30), 152.1 (C-40),
157.4 (C-9), 161.4 (C-5), 163.3 (C-2), 164.2 (C-7), 181.8 (C-4) ppm. MS
(ESIþ)m/z (rel. int.): 315 ([M þ H]þ, 100). HRMS (EI),m/z: C17H14O6:
calcd 314.0790 [M]þ$, found: 314.0799.
2.10. Cell viability
Cell viability was determined by the trypan blue exclusion assay.
Neutrophils were incubated with all the tested ﬂavonoids (at the
maximum concentration tested,100 mM) for 1 h at 37 C. Twenty mL
of neutrophil suspension were added to an equal volume of trypan
blue solution 0.4% in a microtube and gently mixed. After 2 min on
ice, neutrophil number and viability (viable cells excluding trypan
blue) were counted. Assays were performed in triplicate.
2.11. Measurement of oxidative burst in human neutrophils
Neutrophils were isolated from blood donated by healthy hu-
man volunteers to whom the design and execution of the experi-
ment were thoroughly explained, and informed consent was
obtained. Essentially, the study was based on the stimulation of
human neutrophils with PMA and subsequent measurement of the
neutrophil-ROS-generating-capacity. For this purpose, chem-
iluminescencemethods, using luminol and lucigenin as probes, and
ﬂuorescence methods, using amplex red and APF as probes, were
adapted to a microplate reader (Synergy HT, BIO-TEK), as detailed88
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ments, performed in triplicate in each experiment.
2.12. Isolation of neutrophils
Following informed consent, venous blood was collected from
healthy human volunteers by antecubital venipuncture, into
K3EDTA vacuum tubes. The isolation of human neutrophils was
performed by the gradient density, as previously reported [28].
Brieﬂy, 3 mL of histopaque 1077 was carefully layered on top of
3 mL of histopaque 1119 in a 15 mL polypropylene tube. Then
4.5 mL of the collected blood was decanted on top of this discon-
tinuous density gradient. The tube was centrifuged at 890 g for
30 min at 20 C. After centrifugation the neutrophil pellet was
removed using a Pasteur pipette and doubled in volume using PBS
(this reduces the viscosity of the histopaque-neutrophil suspension
so that cells can be centrifuged without the need of high g forces);
the neutrophils were then centrifuged at 870 g for 5 min at 4 C.
The supernatant was decanted and a mixture of 1.25 mL of
PBSþ 5.25 mL of sterile distilled water was added to the neutrophil
pellet to lyse any remaining red blood cells. The tube was gently
inverted for 2 min, after which isotonicity was re-established by
adding 2.2 mL of 3% NaCl. This suspension was then submitted to a
new centrifugation at 870 g for 5 min at 4 C after which the su-
pernatant was decanted and the neutrophil pellet resuspended in
Triseglucose. The obtained cell suspensions contained more than
99% of neutrophils and the control of their viability showed more
than 95% of the cells excluding trypan blue solution 0.4%. Isolated
neutrophils were kept in ice until use. Tris-glucose (25 mM Tris,
1.26 mM CaCl2$2H2O, 5.37 mM KCl, 0.81 mMMgSO4, 140 mM NaCl,
and 5.55 mM D-Glucose) was the incubation media used, as pre-
viously recommended [29].
2.13. Evaluation of neutrophils’ oxidative burst
2.13.1. Oxidation of luminol
The chemiluminescent probe luminol has been thoroughly
studied and used for monitoring the production of reactive species
by neutrophils, namely the superoxide anion radical (O2),
hydrogen peroxide (H2O2), hydroxyl radical (HO), hypochlorous
acid (HOCl), nitric oxide (NO) and peroxynitrite anion (ONOO)
[22]. The measurement of neutrophils’ oxidative burst was under-
taken by chemiluminescence, by monitoring ROS-induced oxida-
tion of luminol, according to a previously described procedure [30].
The reaction mixtures contained neutrophils (1 106 cells/mL) and
the following reagents at the indicated ﬁnal concentrations (in a
ﬁnal volume of 250 mL): tested compounds at various concentra-
tions (0e100 mM), luminol (500 mM) and PMA (160 nM). Cells were
pre-incubated with luminol and the tested compounds for 5 min
before the addition of PMA and themeasurements were carried out
at 37 C, under continuous soft shaking. Kinetic readings were
initiated immediately after cell stimulation. Measurements were
taken at the peak of the curve. This peak was observed at around
10 min. Effects are expressed as the percent inhibition of luminol
oxidation. ABAH, SOD and catalase were used as positive controls.
2.13.2. Oxidation of lucigenin
The measurement of neutrophils’ oxidative burst was under-
taken by chemiluminescence, bymonitoring O2-induced lucigenin
oxidation, according to a previously described procedure [30]. The
reaction mixtures contained neutrophils (5  106 cells/mL) and the
following reagents at the indicated ﬁnal concentrations (in a ﬁnal
volume of 250 mL): tested compounds at various concentrations
(0e100 mM), lucigenin (50 mM) and PMA (160 nM). Cells were pre-
incubated with lucigenin and the tested compounds for 5 minbefore the addition of PMA and themeasurements were carried out
at 37 C, under continuous soft shaking. Kinetic readings were
initiated immediately after cell stimulation. Obtained values
correspond to the slope measured between 10 and 30 min. Effects
are expressed as the percent inhibition of lucigenin oxidation. SOD
was used as positive control.
2.13.3. Oxidation of amplex red
Amplex red is a highly sensitive and chemically stable ﬂuo-
rescent probe for the extracellular detection of H2O2 [22]. The
measurement of neutrophil burst was undertaken by ﬂuores-
cence, by monitoring H2O2-induced oxidation of amplex red, ac-
cording to a previously described procedure [31], with
modiﬁcations. The reaction mixtures contained neutrophils
(1 106 cells/mL) and the following reagents at the indicated ﬁnal
concentrations (in a ﬁnal volume of 250 mL): tested compounds at
various concentrations (0e100 mM), amplex red (25 mM), HRP
(0.25 U/mL) and PMA (160 nM). Cells were pre-incubated with
amplex red, HRP and the tested compounds for 5 min before the
addition of PMA and the measurements were carried out at 37 C,
under continuous soft shaking. Kinetic readings were initiated
immediately after cell stimulation. The excitation and emission
wavelengths used were 563 and 587 nm, respectively. Obtained
values correspond to the slope measured between 5 and 10 min.
Effects are expressed as the percent inhibition of amplex red
oxidation. Catalase was used as positive control.
2.13.4. Oxidation of APF
APF is a non-ﬂuorescent derivative of ﬂuorescein that is
oxidized by HOCl, ONOO and HO, in a concentration-dependent
manner. Its selectivity was tested using themyeloperoxidase (MPO)
inhibitor, ABAH. The addition of ABAH to human neutrophils,
stimulated with PMA, decreased the APF-dependent ﬂuorescence
signal to the level of the control assay, ruling out the involvement of
HO and ONOO [22]. The measurement of neutrophils’ oxidative
burst was undertaken by ﬂuorescence, by monitoring HOCl-
induced oxidation of APF, according to a previously described
procedure [31], with modiﬁcations. The reaction mixtures con-
tained neutrophils (2  106 cells/mL) and the following reagents at
the indicated ﬁnal concentrations (in a ﬁnal volume of 250 mL):
tested compounds at various concentrations (0e100 mM), PMA
(160 nM) and APF (1 mM). Cells were pre-incubated with PMA and
the tested compounds for 6 min before the addition of APF and the
measurements were carried out at 37 C, under continuous soft
shaking. Kinetic readings were initiated immediately after the
addition of APF. The excitation and emission wavelengths used
were 500 and 520 nm, respectively. Obtained values correspond to
the slope measured between 5 and 15 min. Effects are expressed as
the percent inhibition of APF oxidation. ABAH was used as positive
control.
3. Results
3.1. Synthesis of ﬂavones
Flavones 10aed were obtained by a conventional synthetic
route involving the base-catalysed aldol condensation of conve-
niently protected 20-hydroxyacetophenones 6a,b with the appro-
priate benzaldehydes 7aed leading to 20-hydroxychalcones 8ae
d which, by oxidative cyclization, can be converted to ﬂavones
10aed in good yields (Scheme 1). The cyclodehydrogenation of 20-
hydroxychalcone 8a with a catalytic amount of iodine in reﬂuxing
DMSO yielded ﬂavone 10a in good yield (71%). However, the
cyclization step of chalcones 8bed, by this method, was inefﬁ-
cient. The cleavage of the protecting methoxyethoxymethyl89
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complex mixture of degradation products (yields of less than 10%).
Aiming for better yields milder reaction conditions were used
[32], thus 20-hydroxychalcones 8bedwere heated at 100 C for 8e
72 h with sodium periodate in DMSO promoting a smooth con-
version to the corresponding ﬂavones 10bed. Under these con-
ditions, it was obtained approximately 15% of 5-OMEM
deprotected ﬂavones 9aec, as by-products, due to the markedly
leaving character of MEM group that consequently decreased the
obtained main ﬂavones 10bed yields. The ﬁnal synthetic step
involved the selective cleavage of the protecting groups of ﬂa-
vones 10aed affording the expected 5,7-dihydroxyﬂavones 4b
and 4feh in good yields. The cleavage of the methyl groups of
ﬂavone 10awas achieved by treatment with boron tribromide (2.5
equiv per methyl group) in dichloromethane and the cleavage of
MEM groups of ﬂavones 10bed was performed by stirring in a
diluted hydrochloric acid solution.
3.2. Cell viability
Neutrophils’ viability was assessed by the trypan blue assay
after exposure to the tested ﬂavonoids. Cell viability was main-
tained over 98%, after 1 h of exposure to the different ﬂavonoids, at
the maximum concentration tested, 100 mM.Scheme3.3. Oxidation of luminol by neutrophils e generated ROS
All the tested ﬂavonoids 1aed, 2aed, 3aed, 4aei and 5aecwere
effective inhibitors of the neutrophils’ oxidative burst, compound
2d being the most active (IC50 ¼ 1.6  0.2 mM). As shown in Table 1,
from all ﬂavones of group 1, ﬂavone 1d was noticeably more
effective than the others, presenting an IC50 of 3.0  0.4 mM, which
is around 8 times lower than the second most active ﬂavone of this
group 1b, with an IC50 of 24.0 4.0 mM. From group 2, it is clear that
ﬂavone 2dwas much more active than the other ﬂavones from this
group. On the other hand, ﬂavone 2a reached only a 30.1  4.1%
effect for the concentration of 25 mM. In what concerns group 3, 3d
and 3bwere the most active, the ﬁrst one being considerably more
potent than the second one, with IC50s of 13.5  3.3 mM and
37.4  3.0 mM, respectively. The 3a and 3c did not even reach an
activity of 50%. For ﬂavonoids 4aei, chrysoeriol 4f was the most
potent (IC50 ¼ 2.8  0.5 mM), the obtained IC50 for diosmetin 4g
being slightly higher than 4f (IC50 ¼ 3.6  0.4 mM). Luteolin 4e
presented an IC50 of 9.3  1.2 mM, close to the one obtained for 4b
(IC50 ¼ 10.0  2.0 mM). The order of potencies found for the other
derivatives was: apigenin 4c (IC50 ¼ 24.0  3.0 mM) > quercetin
4i > chrysin 4a > 4h > acacetin 4d (26.7  4.3%, inhibition for
25 mM). Flavanones 5aec appeared to be less effective modulators
of neutrophils’ oxidative burst than the corresponding ﬂavones 4c,1.
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Table 1
Chemical structures and inhibition of PMA-induced neutrophils’ oxidative burst by the studied ﬂavonoids, assessed by the chemiluminescent probes, luminol and lucigenin
(IC50 mM, mean  SEM).
Compound R1 R2 R3 Luminol Lucigenin
IC50 (mM) IC50 (mM)
1a Flavone
O
O
R1
R2 H H e LA 57.0  7.5
1b OH H e 24.0  4.0 47.0  5.0
1c H OH e 40.3  2.4 LA
1d OH OH e 3.0  0.4 8.1  0.6
2a
O
O
R1
R2
OH
H H e LA 96.0  4.0
2b OH H e 14.5  2.6 32.0  3.0
2c H OH e 18.0  3.0 67.8  7.3
2d OH OH
e
1.6  0.2 4.9  0.4
3a
O
O
R1
R2
OH
H H e LA 33.0  7.0
3b OH H e 37.4  3.0 34.8  5.3
3c H OH e LA 26.9  5.2
3d OH OH e 13.5  3.3 14.7  2.5
4a Chrysin
O
O
R1
R2
OH
OH
R3
H H H 53.0  4.6 9.59  0.05
4b OH H H 10.0  2.0 15.8  0.8
4c Apigenin H OH H 24.0  3.0 7.7  2.8
4d Acacetin H OMe H LA 7.0  1.5
4e Luteolin OH OH H 9.3  1.2 9.5  2.2
4f Chrysoeriol
OMe OH H 2.8  0.5 7.1  0.3
4g Diosmetin OH OMe H 3.6  0.4 15.0  4.9
4h OMe OMe H 57.6  4.02 16.0  1.0
4i Quercetin OH OH OH 26.0  4.2 11.3  2.3
5a ()-Naringenin
O
O
R1
OH
OH
R2
OH
H H e 51.4  4.6 31.0  5.0
5b ()-Eriodictyol OH H e 18.0  3.0 15.5  2.6
5c Taxifolin OH OH e 53.5  2.4 15.5  4.6
Positive controls
ABAH e e e 43.6  8.8 e
Catalase e e e 2597  684 U/mL e
SOD e e e e 48.5  8.4 U/mL
LA - Less than 40% of inhibition neutrophils’ oxidative burst, up to the highest tested concentration (100 mM).
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group (IC50 ¼ 18.0  3.0 mM). ABAH and catalase, which were used
as positive controls, presented an IC50 of 43.6  8.8 mM and
2597  684 U/mL, respectively. SOD, which was also used as a
positive control, presented a 49.3  5.1% effect for the concentra-
tion of 1000 U/mL.
3.4. Oxidation of lucigenin by neutrophils e generated O2

All the studied ﬂavonoids 1aed, 2aed, 3aed, 4aei and 5aec
revealed good activity inmodulating the production of the O2 or in
its scavenging, compound 1c being the less active of all the testedﬂavonoids, as shown in Table 1. Flavone 2dwas themost effective of
all (IC50 ¼ 4.9  0.4 mM), as it was for the probe luminol. For
compounds 1aed, 1d showed once more the lowest IC50,
8.1  0.6 mM. Flavones 2aec were considerably less active than
ﬂavone 2d. In what concerns compounds 3aed, 3d was the most
effective (IC50 ¼ 14.7  2.5 mM), the other ﬂavones from this group
being signiﬁcantly less potent. Regarding the results of 4aei, it is
obvious that acacetin 4d, chrysoeriol 4f and apigenin 4c were the
most potent, presenting IC50 of 7.0  1.5 mM, 7.1  0.3 mM and
7.7  2.8 mM, respectively. Once again, ﬂavanones 5aec revealed to
be less effective than the corresponding ﬂavones 4c, e and ﬂavonol
4i, but this difference is not as obvious as seen before for luminol.91
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potent of this group, with IC50s of 15.5  2.6 mM and 15.5  4.6 mM,
respectively. SOD, which was used as a positive control, presented
an IC50 of 48.5  8.4 U/mL.
3.5. Oxidation of amplex red by neutrophils e generated H2O2
Table 2 shows the results of the amplex red oxidation. It is clear
that in group 1aed the most potent was compound 1d
(IC50 ¼ 3.2  0.9 mM). Compound 1b, for the concentration of
40 mM, inhibited the oxidation of amplex red just in 17.0 3.4%. TheTable 2
Chemical structures and inhibition of PMA-induced neutrophils’ oxidative burst by the s
mean  SEM).
Compound R1
1a Flavone
O
O
R1
R2
H
1b OH
1c H
1d OH
2a
O
O
R1
R2
OH
H
2b OH
2c H
2d OH
3a
O
O
R1
R2
OH
H
3b OH
3c H
3d OH
4a Chrysin
O
O
R1
R2
OH
OH
R3
H
4b OH
4c Apigenin H
4d Acacetin H
4e Luteolin OH
4f Chrysoeriol OMe
4g Diosmetin OH
4h OMe
4i Quercetin OH
5a ()-Naringenin
O
O
R1
OH
OH
R2
OH H
5b ()-Eriodictyol OH
5c Taxifolin OH
Positive controls
ABAH e
Catalase e
NA e No activity was found up to the highest tested concentration (100 mM).
LA e Less than 40% of inhibition neutrophils’ oxidative burst, up to the highest tested co
a Interference with the methodology.other two ﬂavonoids showed no activity at concentrations up to
100 mM. From ﬂavonoids 2aed, 2d was the one that had the best
activity (IC50 ¼ 3.2  0.7 mM), followed by 2b and 2c that presented
an activity under 20% for 40 mM. 5-Hydroxyﬂavone 2a had no ac-
tivity for the tested concentrations. In group 3aed, ﬂavones 3d and
3b proved to be the most active, although the ﬁrst one was
considerably more potent than the second one, with IC50s of
3.7  0.5 mM and 79.6  5.5 mM, respectively. In group 4aei, only
chrysin 4a and acacetin 4d showed no activity at concentrations up
to 100 mM. The most effective was luteolin 4e (IC50 ¼ 4.0  1.0 mM).
From the ﬂavanones 5aec it is noteworthy that ()-eriodictyol 5btudied ﬂavonoids, assessed by the ﬂuorescent probes, amplex red and APF (IC50 mM,
R2 R3 Amplex red APF
IC50 (mM) IC50 (mM)
H e NA 64.9  6.2
H e LA a
OH e NA a
OH e 3.2  0.9 0.9  0.2
H e NA a
H e LA a
OH e LA a
OH e 3.2  0.7 0.39  0.08
H e LA a
H e 79.6  5.5 a
OH e LA a
OH e 3.7  0.5 5.2  1.4
H H NA NA
H H LA 65.4  4.6
OH H 16.2  3.3 12.3  2.2
OMe H NA NA
OH H 4.0  1.0 0.9  0.1
OH H 8.6  1.8 0.4  0.2
OMe H 10.3  1.2 0.7  0.3
OMe H LA 3.33  0.09
OH OH 8.0  3.0 0.7  0.1
H e LA a
H e 4.0  1.0 1.4  0.2
OH e 41.3  11.9 15.3  2.7
e e e 30.6  6.1
e e 386.9  6.9 U/mL e
ncentration (100 mM).
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IC50 ¼ 4.0  1.0 mM. Catalase, which was used as a positive control,
presented an IC50 of 386.9  6.9 U/mL.
3.6. Oxidation of APF by neutrophils-generated HOCl
In what concerns APF assays, all the ﬂavonoids that could be
tested presented a great capacity of scavenge or preventing the
production of HOCl during the oxidative burst (Table 2). From ﬂa-
vonoids 1aed it is clear that the most potent was 1d (IC50 ¼
0.9 0.2 mM), followed by 1a (IC50¼ 64.9 6.2 mM). In group 2aed,
ﬂavonoid 2d was the only one that could be tested, showing a
potent activity, IC50 ¼ 0.39  0.08 mM. In group 3aed, 3d was the
only one that did not interfere with the methodology and pre-
sented a IC50 of 5.2 1.4 mM. Regarding the results of the ﬂavonoids
4aei, the order of potencies found was: chrysoeriol 4f (IC50 ¼
0.4  0.2 mM) > quercetin 4i ¼ diosmetin 4g > luteolin 4e > 4h >
apigenin 4c > 4b (IC50 ¼ 65.4  4.6 mM). The ﬂavones chrysin 4a
and acacetin 4d had no activity at concentrations up to 100 mM.
Analysing the IC50 of the ﬂavanones 5aec, ()-eriodictyol 5b
appeared to be the best neutrophils’ oxidative burst modulator,
with an IC50 of 1.4  0.2 mM, followed by taxifolin 5c. It was not
possible to evaluate the other tested ﬂavonoids using this screening
test because those compounds interfered with the methodology,
causing an increase in the ﬂuorescence signal in a concentration -
dependent manner, in the presence of the stimulated neutrophils.
ABAH, which was used as a positive control, presented an IC50 of
30.6  6.1 mM.
4. Discussion
The group of ﬂavonoids evaluated in the present study, 1aed,
2aed, 3aed, 4aei and 5aec, enabled the establishment of impor-
tant structure/activity relationships, and presented potent com-
pounds, concerning the modulation of the human neutrophils’
oxidative burst. The observed modulation of the oxidative burst
may arise from the ﬂavonoids’ effects on different processes,
namely ROS-scavenging or inhibition of their production, by
interfering with the release or the activity of different enzymes, like
NADPH-oxidase or MPO, although one should also consider that
these activities could be conditioned by the spatial conformation or
the lipophilicity of the compounds studied and their possible
interaction with cellular macromolecules.
Luminol is a highly sensitive chemiluminescent probe widely
used to detect O2, HO, H2O2, HOCl, NO and ONOO. Due to its
chemical structure, small size and lipophilicity, luminol is able to
diffuse across biological membranes and consequently allow the
detection of both extra and intracellular production of reactive
species. Among all the studied ﬂavonoids, 2d was the one that
demonstrated the best inhibition of the chemiluminescence
(IC50 ¼ 1.6  0.2 mM), followed by chrysoeriol 4f, 1d and diosmetin
4g, with IC50s of 2.8  0.5, 3.0  0.4 and 3.6  0.4 mM, respectively.
All of these compounds are substituted in the B-ring, 2d and 1d
have in common a catechol group in the B-ring, and the ones from
group 4, 4f and 4g, have a methoxyl group and a hydroxyl group in
the same ring. The results obtained indicate that the modulating
activity of ﬂavonoids may be determined by the B-ring substitution,
the presence of a catechol group being the most important factor
for a high activity. Interestingly, methylation of the 30-hydroxyl
group might lead to similarly efﬁcient compounds, though the
absence of this hydroxyl group decreased the activity, as ascer-
tained by comparison of chrysoeriol 4fwith apigenin 4c, with IC50s
of 2.8  0.5 and 24.0  3.0 mM, respectively. These observations are
in agreement with the ﬁndings of Mladenka and coworkers [12].
The substitution pattern in A-ring did not seem determinant for agood activity. When a catechol group was present in the B-ring, the
5-OH seemed to be more important than the 7-OH, which appar-
ently contributed to diminish the activity, 2d vs 3d, with IC50s of
1.6 0.2 and 13.5 3.3 mM, respectively. Moreover, the existence of
more than one hydroxyl in the A-ring also did not favour the ac-
tivity, 2d vs luteolin 4e, with IC50s of 1.6  0.2 and 9.3  1.2 mM,
respectively. The diffusion of chemical compounds into the cell is a
function of their lipophilicity, i.e. their ability to incorporate in the
lipids of the cell membrane. Replacement of a hydroxyl by a
methoxyl group increases the lipophilicity [33], thus enhancing the
inhibitory activity of chrysoeriol 4f (IC50¼ 2.8 0.5) and diosmetin
4g (IC50 ¼ 3.6  0.4) comparing with luteolin 4e (IC50 ¼ 9.3 
1.2 mM). Landi-Librandi and coworkers [34] undertook a study with
liposomal ﬂavonoids and concluded that the ability to inhibit the
chemiluminescence of luminol was a function of the lipophilicity of
the compounds. In spite of this, ﬂavone 4h, which has two
methoxyl groups in the B-ring presented a low activity
(IC50 ¼ 57.6  4.02 mM), which may indicate that the lipophilicity is
not by itself determinant for the activity observed. In fact, the more
hydrophobic ﬂavonoids can partitionate in the hydrophobic core of
the membranes and the more hydrophilic ﬂavonoids interact by
hydrogen bonding with the polar head groups at the lipidewater
interface of membranes. This type of interaction may provide a
level of protection for the bilayer from external and internal ag-
gressors (i.e. oxidants) contributing to preserve the structure and
function of biological membranes, in part by inhibiting the lipid
oxidation chain reaction. A possible consequence of this interaction
is a direct modulation of membrane physical properties on the
capacity of ﬂavonoids to efﬁciently scavenge free radicals [35,36]. It
was already stated that luminol detects unspeciﬁcally a series of
reactive species and the effect observed may be caused by the in-
hibition of a number of different processes. Thus, to assess the
ﬂavonoids activity in more detail it was necessary to use different
and more speciﬁc probes.
In this sense, lucigeninwas used to speciﬁcally detect O2. It has
been suggested that O2 production might be artiﬁcially over-
estimated because lucigenin may undergo redox cycling.
Notwithstanding this possibility, Afanas’ev and coworkers [37]
attested that the redox cycling of lucigenin is negligible, particu-
larly in cellular systems that produce signiﬁcant amounts of O2,
and for that reason lucigenin-ampliﬁed chemiluminescence re-
mains the most sensitive and highly speciﬁc test for O2 in bio-
logical systems [22]. O2 is the ﬁrst reactive specie produced during
the oxidative burst, from which starts the reactive species cascade
formation. Therefore its scavenging, or production inhibition, is
crucial for the modulation of the oxidative burst. The results ob-
tained revealed that ﬂavonoid 2d was the most effective in inhib-
iting the oxidation of lucigenin, with an IC50 of 4.9  0.4 mM.
Flavones acacetin 4d, chrysoeriol 4f and apigenin 4c presented
almost the same capacity of inhibiting the oxidative burst, with an
IC50 of 7.0 1.5, 7.10.3 and 7.7 2.8 mM, respectively, followed by
ﬂavone 1d, with an IC50 of 8.10.6 mM. In a more general approach
of the results, when the ﬂavonoids presented none or just one
hydroxyl group in the A-ring, it is clear that the hydroxyl groups in
the B-ring are essential for a higher activity, 1a vs 1d, with IC50s of
57.0  7.5 and 8.1  0.6 mM, and 2a vs 2d, with IC50s of 96.0  4.0
and 4.9  0.4 mM, respectively. When the ﬂavonoid presented two
hydroxyl groups in the A-ring, and a meta-methylation of the
catechol in the B-ring, a greater activity was registered, luteolin
4e vs chrysoeriol 4f, with IC50s of 9.5  2.2 and 7.1  0.3 mM,
respectively. Thus, in this case, the unsubstituted catechol in the B-
ring does not seem to be so determinant for a higher activity. In
addition, in group 4aei, the presence of just one 40-OH in the B-ring
rendered apigenin 4c, one of the most potent in this group of ﬂa-
vonoids, with an IC50 of 7.7  2.8 mM. Actually, Hu and coworkers93
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contributes to a higher O2 scavenging activity. On the other hand,
the free radical scavenging activity may not be the main mecha-
nism governing the inhibitory effect of ﬂavonoids [34]. Actually,
bibliography indicates that (i) ﬂavonoids containing an unsub-
stituted catechol in the B-ring (quercetin 4i, luteolin 4e) do not
inhibit NADPH-oxidase; (ii) methylation of the catechol arrange-
ment in the B-ring (chrysoeriol 4f vs luteolin 4e) or the omission of
one OH group converts the ﬂavonoid into an NADPH-oxidase in-
hibitor; (iii) among ﬂavonoids of non-catechol type, those pos-
sessing a 40-OH group in the B-ring are NADPH-oxidase inhibitors
(apigenin 4c vs chrysin 4a) and (iv) the presence of a vicinal (ortho)
hydroxy-methoxy arrangement at an aromatic ring generally en-
hances the inhibitory potency, but is not essential for the inhibitory
capacity [12,16]. The results obtained in the present work are in
agreementwith these statements, so probably the tested ﬂavonoids
act as O2- scavengers as well as inhibitors of its production, by
interfering with NADPH-oxidase. It should also be clear that here
the ﬂavanones 5aec were not more active than the corresponding
ﬂavones 4c, 4e or ﬂavonol 4i. In fact, the IC50 of quercetin 4i and
taxifolin 5c are not so different, with IC50s of 11.3  2.3 and
15.5  4.6 mM, respectively, though the same cannot be said about
the other four ﬂavonoids (Table 1). Therefore it was not clear if the
C2eC3 double bond in the C-ring is or not determinant for the in-
hibition of the lucigenin reduction.
To detect the extracellular H2O2 released by human neutrophils,
we used a highly speciﬁc and sensitive ﬂuorescent probe, amplex
red. Among all the tested ﬂavonoids the most potent inhibitors of
the oxidation of amplex red were those that present a catechol
moiety in the B-ring, with this order of effect: 2d (IC50 ¼ 3.2 
0.7 mM) > 1d > 3d > luteolin 4e ¼ ()-eriodictyol 5b (IC50 ¼ 4.0 
1.0 mM) (Table 2). Hence, this moiety clearly displays a crucial
importance for the inhibition in study. Noteworthy, a 7-OH group in
the A-ring appeared to be as important as the existence of a 5-OH or
even none hydroxyl groups, 3d, 2d and 1d, with IC50s of 3.7  0.5,
3.2  0.7 and 3.2  0.9 mM, respectively. As well, the existence of
two hydroxyl groups in position 5 and 7 in the A-ring simulta-
neously did not contribute for a higher activity, 3d, 2d or 1d vs
luteolin 4e, with an IC50 of 4.0  1.0 mM. However, the methoxy-
hydroxylated ﬂavonoids, chrysoeriol 4f and diosmetin 4g, and the
one with a 3-OH group in the C-ring, quercetin 4i, presented good
activities, with IC50s of 8.6  1.8, 10.3  1.2 and 8.0  3.0 mM,
respectively, demonstrating that these features have somemeaning
in the inhibition of amplex red oxidation. Flavonoids that did not
possess a catechol moiety in the B-ring displayed very low activities
or no activity at all, as for example 1b or chrysin 4a. Nevertheless, it
should be stated that amplex red only detects the extracellular
H2O2, giving information about the ability of the ﬂavonoids to
scavenge or inhibit the formation of this reactive specie, but not the
total effect because the intracellular H2O2 is not taken in account. In
what concerns the ﬂavanones 5aec tested, ()-eriodictyol 5b stood
out among all being muchmore active, with an IC50 of 4.0 1.0 mM,
demonstrating that even in the absence of a C2eC3 double bond, the
30,40-(OH)2 in the B-ring remained with the pivotal role and the 3-
OH did not contribute for a good activity. Moreover, ()-eriodictyol
5b and luteolin 4e showed the same activity, whichmade clear that
with this OH’s substitution pattern, the C2eC3 is not important for
the studied effect. On the other hand, this is not true for quercetin
4i and taxifolin 5c (Table 2). For example, the ﬁrst one is muchmore
active than the second, with IC50s of 8.0  3.0 and 41.3  11.9 mM,
respectively. Taxifolin 5c has been already described as having a
low capacity to scavenge H2O2 and organic peroxides and a low
antioxidant capacity in comparison with quercetin 4i, in studies
undertaken in retinal cells after ascorbate/Fe2þ-induced oxidative
stress, and it has been suggested that differencesmay arise from theless planar structure of taxifolin which results in a higher ability to
undergo inactivation through the formation of strong hydrogen
bonds with macromolecules [39,40].
APF is a non-ﬂuorescent derivative of ﬂuorescein that originates
ﬂuorescein intracellularly, allowing the selective detection of HOCl,
in a concentration-dependent manner, as it was demonstrated by
using ABAH. Because of the high concentration of Cl in body ﬂuids,
MPO has the specialized ability to oxidize chloride and it is
generally considered that its function is to generate HOCl, which
represents a critical step in the production of many other bio-
reactive molecules, namely chloramines, which are more toxic than
HOCl itself [22]. Therefore the capacity of scavenging HOCl or
modulating its production is very important for the modulation of
neutrophils’ oxidative burst. Flavone 2d kept being the most active
(IC50 ¼ 0.39  0.08 mM), followed by other ﬂavonoids, in
descending order of potencies: chrysoeriol 4f (IC50 ¼ 0.4  0.2 mM)
> quercetin 4i > diosmetin 4g > luteolin 4e > 1d > ()-eriodictyol
5b (IC50 ¼ 1.4  0.2 mM). Analysing these results, and the chemical
structures of the tested compounds, we can infer that the most
active ﬂavonoid 2d has a 5-OH group in the A-ring and a catechol
group in the B-ring, though all the others hold a 5,7-OH or a 7-OH in
the A-ring. Thus, probably, the presence of two hydroxyl groups in
the A-ring is not really important for the activity. Moreover,
chrysoeriol 4f and diosmetin 4g present a methoxylation in the B-
ring which appeared to contribute for the activity, with IC50s of
0.4  0.2 and 0.7  0.3 mM, respectively, as well as the 3-OH in the
C-ring, because quercetin 4i proved to be a little more active than
luteolin 4e, with IC50s of 0.7  0.1 and 0.9  0.1 mM, respectively.
The 3-OH substitution has already been described as an important
feature for the HOCl scavenging activity, considering that quercetin
4i showed the strongest effect in a cyclic voltammetric analysis
[41]. In this same study, luteolin 4e and apigenin 4c also showed a
good scavenging activity. In general, excluding those ﬂavonoids not
tested due to the interference with the methodology, it became
clear that the presence of two substitution groups in positions 30-
and 40- in the B-ring is essential for a good activity (1b vs 1d and 4a
vs luteolin 4e). In 1988, Pincemail and coworkers [42] have already
stated that quercetin 4iwas an inhibitor of MPO activity, indicating
that it behaved as a competitive inhibitor. More recently, a docking
study suggested that quercetin 4i binds to the hydrophobic region
at the entrance to the distal haeme pocket of MPO, with the B-ring
of quercetin being oriented to the haeme center. The results also
indicated that the B-ring’s hydroxyl group(s) of ﬂavonoids may be
important for entering the pocket, reaching the active site of MPO.
Moreover, quantitative structureeactivity relationship analysis
suggested that the existence of the 3-, 40-, and 5-OHs, and C2eC3
double bond were required for the inhibitory effect [43]. These
results suggested that quercetin 4i and related ﬂavonoids are
effective substrates for the MPO enzyme. Regarding ﬂavanones,
they showed to be less active than the corresponding ﬂavone,
()-eriodictyol 5b vs luteolin 4e, with IC50s of 1.4  0.2 and
0.9  0.1 mM, respectively or ﬂavonol, taxifolin 5c vs quercetin 4i,
with IC50s of 15.3  2.7 and 0.7  0.1 mM, respectively, enlightening
the importance of the C2eC3 double bond for the inhibition of the
amplex red oxidation. It was also clearly demonstrated that among
the ﬂavanones tested 5a-c, the 3-OH group in the C-ring did not
play a pivotal role for a good activity. Hart and coworkers [44]
conducted a study on human neutrophils stimulated with serum
treated zymosan and concluded that taxifolin 5c and eriodictyol 5b
inhibited the release of MPO by 50e60% and from those, 40% of the
activity were also inhibited. In turn, luteolin 4e inhibited almost in
100% the release of MPO, though it barely inhibited the MPO ac-
tivity. Using a combination of biological assays and theoretical
calculation studies, Shiba and coworkers [43] suggested this order
of inhibitory effect on MPO: quercetin 4i > luteolin 4e > taxifolin94
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potencies, they concluded that, the activity of the ﬂavonoids lacking
the 3-OH in the C-ring, compared to quercetin 4i, was relatively
weak, showing the signiﬁcance of the number and position of the
hydroxyl group on the inhibitory effect. In addition, taxifolin 5c,
which contains the same number and positions of hydroxyl groups
as quercetin 4i, exhibited weak activity, showing the requirement
of a C2eC3 double bond for the activity. These main conclusions are
identical to the ones reached in this work for the modulation of the
oxidative burst, related to HOCl scavenging or production. It should
be noted thatMPO enzyme is localized inside of the phagolysosome
and that APF detects the intracellular HOCl, thus, the activity of the
ﬂavonoid is not just a function of its real activity but also a function
of its lipophilicity, i.e., of its capacity to interact with the cell
membranes. This may explain why ﬂavone 2d is the most active,
even with less hydroxyl groups, because it is less hydrophobic and
therefore can penetrate easily into membranes and reach the active
site in higher concentrations. This could also explain why the ﬂa-
vones with a methoxylation in the B-ring 4feh had become such
good inhibitors of APF oxidation, almost as good as quercetin 4i or
even better.
To the best of our knowledge, some of the ﬂavonoids tested in
this work were never studied for this kind of modulation activity,
allowing us to do a better integration of the obtained results.
Thus, the present study evidences the catechol group in the B-ring
as the pivotal characteristic that renders ﬂavonoids good modu-
lators of the neutrophils’ oxidative burst. It was also clearly shown
that the number of hydroxyl groups really inﬂuences the activity,
as the ﬂavone 1a did not present good activity for any of the
assays, when compared with the other tested ﬂavonoids. In
addition, the current study extends knowledge on the importance
of the hydroxylations in the A-ring, which did not appear to be
determinant for the activity, although clearly inﬂuence the lip-
ophilicity of the tested ﬂavonoids and consequently the capacity
to pass through the cell membranes. Another main feature that
contributed for higher activity was the presence of a 30-methoxyl
group in the B-ring. On the other hand, the presence of the 3-OH
in the C-ring and the C2eC3 double bond just became important
features when the H2O2 and HOCl reactive species were studied.
Overall, these observations indicate that the studied ﬂavonoids
are undoubtedly good modulators of the human neutrophils’
oxidative burst, at very low concentrations, which may represent
an excellent new strategy for the resolution of inﬂammatory
processes.
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The lipoxygenase (LOX) products have been identiﬁed as mediators of a series of inﬂammatory diseases,
namely rheumatoid arthritis, inﬂammatory bowel disease, psoriasis, allergic rhinitis, atherosclerosis and
certain types of cancer. Hence, LOX inhibitors are of interest for the modulation of these phenomena and
resolution of the inﬂammatory processes. During LOX activity, peroxyl radical complexes are part of the
reaction and may function as sources of free radicals. Thus antioxidants, such as ﬂavonoids, capable of
inhibiting lipid peroxidation and scavenging free radicals, may act as LOX inhibitors. The aim of this work
was to assess the structureeactivity relationship among a series of ﬂavonoids concerning 5-LOX inhi-
bition, through a systematic study of the inhibition of the formation of LTB4 in human neutrophils. The
type of inhibition of the ﬂavonoids was further studied using soybean LOX, type I, and Saturation Transfer
Difference 1H NMR (STD-1H NMR) was used to characterize the binding epitopes of the compounds to
LOX-1. The obtained results reinforce ﬂavonoids as effective inhibitors of LTB4 production in human
neutrophils. It was also possible to establish a structure/activity relationship for the inhibitory activity
and the type of inhibition.
 2013 Elsevier Masson SAS. All rights reserved.1. Introduction
Lipoxygenases (LOXs) constitute a family of nonheme iron-
containing dioxygenases ubiquitously distributed in plants, fungi
and animals. In humans there are six functional LOXs: 5-
lipoxygenase (5-LOX), 12/15-LOX (15-LOX-1), platelet-type 12-
LOX, epidermis-type 12R-LOX), epidermis-type 15-LOX (15-LOX-
2) and epidermis-Alox3 [1]. These enzymes catalyze four distinct
reactions (5S, 12R, 12S, or 15S oxygenation), using arachidonic acid
(AA) as substrate, and producing fatty acid hydroperoxides. [2]
5-LOX is expressed in leukocytes, neutrophils, eosinophils, ba-
sophils and monocytes/macrophages [3]. In resting cells, 5-LOX is
located either in the cytosol, e.g. in neutrophils, or in a nuclear
soluble compartment associated with chromatin. Upon stimula-
tion, in neutrophils, 5-LOX translocates from the cytosol to the
nuclear envelope and contiguous perinuclear endoplasmic: þ35 1226093483.
ff.up.pt (E. Fernandes).
son SAS. All rights reserved.reticulum. Simultaneously, cytosolic phospholipase A2 (cPLA2)
migrates and liberates AA from phospholipids. Membrane-bound
5-LOX activating protein (FLAP) acts as an AA transfer protein
that “presents” the substrate, AA, to 5-LOX on the nuclear mem-
brane [4,5]. The leukotrienes (LTs) biosynthesis begins with the
dioxygenation of AA, which originates 5(S)-hydroperoxy-6-trans-
8,11,14-cis-eicosatetraenoic acid (5-HPETE) and leukotriene A4
(LTA4). The latter is converted in LTB4 by LTA4-hydrolase. 5-HPETE
can also be reduced by glutathione peroxidases to form the corre-
sponding 5(S)-hydroxy-6-trans-8,11,14-cis-eicosatetraenoic acid
(5-HETE) [3]. The biosynthesis of these LOX products play an
important role in a variety of disorders related with inﬂammatory
processes, through the interaction with the LTB4 receptors, BLT1
and BLT2, the ﬁrst one expression is upregulated in inﬂammation
[6]. LTs have been identiﬁed as mediators of a series of inﬂamma-
tory diseases, namely rheumatoid arthritis, inﬂammatory bowel
disease, psoriasis, allergic rhinitis, bronchial asthma, atheroscle-
rosis and certain types of cancer [7,8]. LTB4 participates in a range of
pathophysiological events and exerts its activity by the recruitment
of leukocytes to the inﬂammation sites. It has been demonstrated to98
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Additionally, LTB4 induces neutrophil adhesion, resulting in
neutrophil aggregation and stimulates neutrophil generation of
reactive oxygen species, release of granular enzymes and phago-
cytosis of bacteria. LTB4 also extends neutrophil survival by pre-
venting apoptosis. These effects contribute to the accumulation of
effector leukocytes at the invasion sites of pathogen as part of host
immune response [6]. It is worth to notice that in other cells, like
eosinophils, basophils, mast cells and monocytes, other leukotri-
enes are produced, LTC4, LTD4 and LTE4. They are also involved in
the inﬂammatory processes being important mediators in bron-
choconstriction and in hypersensitivity reactions [7]. Hence, LOX
inhibitors might be of interest for the modulation of these phe-
nomena and for the resolution of the inﬂammatory processes.
Presently available LTs inhibitors may be divided in redox-active
compounds, iron-ligand inhibitors with weak redox-active prop-
erties and non-redox-type inhibitors. Nordihydroguaiaretic acid
(NDGA) and coumarins are examples of redox-active compounds.
However they are nonselective, occasioning severe side effects like
methemoglobin formation or are rapidly metabolized [8]. Iron
chelating hydroxamic acid derivatives also proved to inhibit
chronic LTB4 production, though they presented extensive meta-
bolism and catabolite accumulation in vivo along with unfavorable
pharmacokinetic properties [11]. The classiﬁcation of non-redox-
type inhibitors relates to the lack of redox activity of the drugs
themselves but does not exclude that the inhibitory potency of the
drugs is affected by the redox state of their target, the 5-LOX. Some
of these drugs were already tested by oral administration, though
despite their strong potency in several ex vivo and in vitro models,
they failed to toughly inhibit LTs synthesis at sites of chronicFig. 1. Chemical structures oinﬂammation [8]. During the LOX-mediated metabolism of AA,
peroxyl radical complexes are part of the reaction, and may also
function as sources of free radicals. Thus antioxidants, such as ﬂa-
vonoids, capable of inhibiting lipid peroxidation and scavenging
free radicals, may be potential LOX inhibitors [12e16]. Thus, the
plethora of beneﬁcial pharmacological effects mediated by ﬂavo-
noids [17e19] and their anti-inﬂammatory effects may constitute a
solid alternative to the traditional anti-inﬂammatory molecules, in
the search for molecules presenting less side effects and higher
efﬁcacy [20]. Still, the precise mechanisms of anti-inﬂammatory
action have not been fully disclosed so far. Nonetheless, this ac-
tion may comprise the inhibition of inﬂammatory enzymes of the
AA’s cascade, including 5-LOX [21,22]. Accordingly, the aim of this
work was to assess the structureeactivity relationship among a
series of ﬂavonoids (Fig. 1) concerning 5-LOX inhibition, through a
systematic study of the inhibition of the formation of LTB4 in hu-
man neutrophils. The type of inhibition of the ﬂavonoids was
further studied using soybean LOX, type I (LOX-1) and Saturation
Transfer Difference 1H NMR (STD-1H NMR) was applied to inves-
tigate the interactions between the studied ﬂavonoids and LOX-1
and to determine the binding epitope in the several ligands.
2. Materials and methods
2.1. Reagents
The following reagents were obtained from SigmaeAldrich Co.
LLC (St. Louis, USA): trypan blue solution 0.4%, dimethylsulfoxide
(DMSO), Hank’s balanced salt solution (HBSS), nordihydroguaia-
retic acid (NDGA), calcium ionophore (A23187), arachidonic acidf the studied ﬂavonoids.
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magnesium chloride (MgCl2), apigenin, chrysin, luteolin, ()-nar-
ingenin, ()-eriodictyol, and quercetin. Boric acid and borax were
obtained from Merck (Darmstadt, Germany). Tris base and DL-
dithiothreitol (DTT) were obtained fromNzytech (Lisbon, Portugal).
Ammonium sulfate [(NH4)2SO4] was obtained from Scharlau (Bar-
celona, Spain). Deuterium oxide (D2O) was obtained from Euriso-
top (Gif-sur-Yvette, France). Dimethylsulfoxide-d6 (DMSO-d6) was
obtained from Cambridge Isotope Laboratories, Inc. (Andover, USA).
Acacetin and taxifolin were obtained from Fluka Chemie GmbH
(Steinheim, Germany). The ﬂavonoids 4b, f, g and h were synthe-
sized by co-authors of this manuscript, from the Departamento de
Química & QOPNA, Universidade de Aveiro [23]. The other tested
ﬂavonoids were obtained from Indoﬁne Chemical Company, Inc.
(Stryker Lane Hillsborough, USA). The ‘‘Leukotriene B4 Enzyme
Immunoassay (EIA) Kit’’ was obtained from Cayman Chemical (Ann
Arbor, MI).
2.2. Equipment
A multimode microplate reader (Synergy HT, BIO-TEK), with
temperature control capacity, was used in the spectrophotometric
readings in all the assays. All STD-NMR experiments were acquired
at 37 C in a Bruker Avance III spectrometer operating at 600 MHz,
with a 5 mm triple resonance cryogenic probe head.
2.3. Isolation and treatment of human neutrophils
Neutrophils were isolated from blood collected from healthy
human volunteers following informed consent. Venous blood was
collected by antecubital venipuncture, into K3EDTA vacuum tubes.
The isolation of the human neutrophils was performed by the
density gradient centrifugationmethod as previously reported [24].
Cell viability and cell yield were evaluated by the trypan blue
exclusion method, using a Neubauer chamber and an optic micro-
scope with the 40 magniﬁcation. HBSS was used as incubation
medium and the isolated neutrophils’ suspensions were kept on ice
until use. Neutrophil suspensions (3.5106 cells/mL) in HBSS were
placed in 96-well microplates (140 mL/well) at 37 C for 10 min to
equilibrate. The tested ﬂavonoids (0.15e40 mM) were then added,
and pre-incubated for 10 min. The cells were subsequently incu-
bated with A23187 (5 mM) and AA (10 mg/mL) for 8 min. The re-
actionwas stopped by the addition of cold methanol. Samples were
subsequently centrifuged at 13,000 g for 1 min, at 4 C [25].
2.4. Determination of LTB4 production in human neutrophils
The amount of LTB4 in the samples was measured using the
above mentioned commercial EIA kit, according to the manufac-
turer’s instructions. The 5-LOX inhibitor, NDGA (1 mM), was used as
positive control. The results are expressed as the percent inhibition
of control LTB4 production. Each study corresponds to at least three
experiments.
2.5. Soybean LOX-1 inhibition assay
This kinetic study was performed to determine the type of inhi-
bition of the tested compounds. The assay was carried out by
monitoring the LOX-1-mediated transformation of linoleic acid into
linoleic acid cis,trans-hydroperoxide derivative, at 234 nm, as pre-
viously described [26], with modiﬁcations. The reaction mixtures
contained the following reagents at the indicated ﬁnal concentra-
tions (in a ﬁnal volume of 300 mL): soybean LOX-1 (2000 U/mL), in
borate buffer 0.2 M, pH 9.0, tested compounds at various concen-
trations (0e100 mM), in DMSO, and linoleic acid at variousconcentrations (0e200 mM). LOX-1 was pre-incubated with the
tested compounds for 5 min before the addition of the substrate,
linoleic acid, and the measurements were carried out at 30 C, sub-
jected to continuous soft shaking. The increase in absorbance was
monitored for 10 min, with readings at each 30 s, and the obtained
values correspond to the slope measured between 0 and 3 min. The
type of inhibition (competitive, uncompetitive, noncompetitive) of
the tested compoundswas studied by using the nonlinear regression
MichaeliseMenten enzyme kinetics and the corresponding Line-
weavereBurk plots for each concentration of the inhibitor (three
different concentrations in each case) for three different concen-
trations of substrate. Each study corresponds to, at least, four indi-
vidual experiments, performed in triplicate in each experiment.
2.6. STD-1H NMR studies
2.6.1. Samples for STD-NMR
The soybean LOX-1 was supplied lyophilized. Thus a Tris buffer
solutionwas used (20mMTris, 7 mM (NH4)2SO4, 3.5 mMMgCl2 and
0.3 mM DTT in D2O) [27]. For the STD-NMR experiments, the tested
compounds stock solutions (16.6 mM) were prepared in DMSO-d6.
From these, an amount of 15 mL was added to the LOX solution
directly in the NMR tube. Then the Tris buffer solution previously
prepared at pH 9.0 was used to adjust the volume to 200 mL. Final
concentrations of LOX and ligands were 4 mM and 1248 mM,
respectively, and the ratio inhibitors/protein was kept to 300:1.
2.6.2. NMR Spectroscopy
The STD-NMR spectra were acquired with 384 transients in a
matrix with 64 K data points in t2 in a spectral window of 12335 Hz
centered at 2825 Hz. Excitation sculpting with gradients was
employed to suppress the water proton signals. nA spin lock ﬁlter
(T1p) with a 2 kHz ﬁeld and a length of 20 ms was applied to sup-
press protein background. Selective saturation of protein reso-
nances (on resonance spectrum) was performed by irradiating
at 600 Hz using a series of 40 Eburp2.1000 shaped 900 pulses
(50 ms, 1 ms delay between pulses) for a total saturation time of
2.0 s. For the reference spectrum (off resonance) the samples were
irradiated at 20000 Hz. Proper control experiments were per-
formed with the reference samples in order to optimize the fre-
quency for protein saturation (1.0 ppm) and off-resonance
irradiation, to ensure that the ligand signals were not affected.
The STD effect was calculated using (I0 ISTD)/I0, inwhich (I0 ISTD)
is the peak intensity in the STD spectrum and I0 is the peak intensity
in the off-resonance spectrum. The STD intensity of the largest STD
effect was set to 100% as a reference, and the relative intensities
were determined [28e30].
2.7. Statistical analysis
Statistics were calculated using GraphPad Prism (version 6.0;
GraphPad Software). Results are expressed as mean  standard
error of the mean (SEM). Statistical comparison between groups
was estimated using the one-way analysis of variance (ANOVA),
followed by the Bonferroni’s post-hoc test. In all cases, p-values
lower than 0.05 were considered as statistically signiﬁcant. The
type of inhibition parameters were all calculated with GraphPad
Software.
3. Results
3.1. Determination of LTB4 production by human neutrophils
It is possible to establish three distinct groups among all the
studied ﬂavonoids. The ﬁrst group comprises the most active100
Table 1
Inhibitory effects (IC50 mM, mean  SEM) of ﬂavonoids 1d, 2d, 3d, luteolin 4e and
quercetin 4i on the production of LTB4 by human neutrophils. NDGA was used as
positive control. Each study corresponds to at least three experiments.
Compounds R1 R2 R3 IC50 (mM)  SEM
1d OH OH e 1.7  0.1
2d OH OH e 2.9  0.8
3d OH OH e 2.0  0.7
4e Luteolin OH OH H 1.6  0.3
4i Quercetin OH OH OH 4.0  1.2
NDGA e e e e 56.6  2.5%1mM
-0.010 -0.005 0.000 0.005 0.010 0.015 0.020
100
200
300
400
500
1 /[S ] ( µ M - 1 )
1 / v
(s/Abs)
Luteolin (4e) 10 µM
Luteolin (4e) 50 µM
Control
Graphic 2. LineweavereBurk plot of soybean LOX-1 inhibition by luteolin 4e.
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III.2. Original Researchﬂavonoids, which presented IC50 values below 5 mM. The most
active ones were luteolin 4e and 30,40-dihydroxyﬂavone 1d (IC50 of
1.6  0.3 mM and 1.7  0.1 mM, respectively). Other 30,40-dihy-
droxyﬂavone derivatives 2d and 3d showed also a really good in-
hibition of LTB4 production (IC50 of 2.9  0.8 mM and 2.0  0.7 mM,
respectively). From this group quercetin 4i was the less active
(IC50¼ 4.0 1.2 mM) (Table 1). The second group corresponds to the
ﬂavonoids that expressed lower activities. Some of them did not
even reach an IC50. When analyzing Graphic 1, ﬂavonoids 5b, 4b, 3b
and 3a appeared as the most actives, yet they only achieved in-
hibitions of 53.4  4.8%, 52.0  3.6%, 51.40  0.5% and 53.1  8.3%,
respectively, for 40 mM. The other ﬂavonoids in this group had ac-
tivities lower than 50% of LTB4 production inhibition for 40 mM.
Finally, in the last group are placed the ﬂavones 2a and 4g which
did not inhibit the production of LTB4, although 4d barely inhibited
it too.
3.2. Soybean LOX-1 inhibition assay
The most active ﬂavonoids on the inhibition of LTB4 production
assay were selected to study their type of inhibition. Additionally,
four ﬂavonoids with lower activity were also studied, in order to4d 2b 5c 1b 4h 4a 1a 2c 1c 4f 3c 4c 5a 5b 4b 3b 3a
0
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Graphic 1. Inhibition of LTB4 production in human neutrophils by the indicated
studied ﬂavonoids determined by EIA. Each value represents mean  SEM of at least
three experiments. ***P < 0.001, **P < 0.01, compared to control.ﬁnd a relationship between the ﬂavonoid’s structure and the type
of LOX-1 inhibition. The studied ﬂavonoids were: 1d, 2c, 2d, 3d,
chrysin 4a, 4b, apigenin 4c, luteolin 4e and quercetin 4i. The type of
inhibition was deducted from the calculation of Km (Michaelise
Menten constant) and Vmax (maximum enzyme velocity) param-
eters obtained by the nonlinear regression MichaeliseMenten
enzyme kinetics, and complemented with the construction of the
LineweavereBurk double reciprocal plots. Parallel lines were ob-
tained for ﬂavones 2d and 4b, luteolin 4e (Graphic 2) and quercetin
4i (Graphic 3), attesting an uncompetitive inhibition type. In the
absence of inhibitors, a Km value of 200.4 mM and a Vmax value of
0.013 Abs/s were observed. For the increasing concentrations of
these ﬂavonoids, the Km and Vmax values decreased.
The other tested ﬂavonoids shared a mixed noncompetitive
type of inhibition, though with different variation patterns of Km
and Vmax.. Flavonoid 1d showed Km and Vmax values almost
invariable, when increasing its concentrations. For increasing-0.010 -0.005 0.000 0.005 0.010 0.015 0.020
100
200
300
400
1 /[S ] (µ M -1)
(s/Abs)
Control
Quercetin (4i) 100µM
Quercetin (4i) 25µM
Graphic 3. LineweavereBurk plot of soybean LOX-1 inhibition by quercetin 4i.
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Graphic 4. LineweavereBurk plot of soybean LOX-1 inhibition by apigenin 4c.
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Km and Vmax values of ﬂavonoid 3d suffered an increment when
its concentration was increased. Km and Vmax values of chrysin
4a decreased with increasing concentrations. The Km of apigenin
4c (Graphic 4) remained constant with increasing concentrations
of the ﬂavonoid, however the Vmax values were lowered. To
calculate the values of inhibition constant (Ki) the reciprocal of
maximal velocity (1/Vmax) was plotted against the inhibitor
concentrations, where the intercept on the inhibitor axis gave the
value of Ki [14]. The obtained Km, Vmax and Ki values are shown in
Table 2.Table 2
Inhibitor constant (Ki) values (mM) for the inhibition of soybean LOX-1 by the tested ﬂav
Compounds R1 R2 R3 Concentration (mM)
10
Km Vmax
1d OH OH e 136.6 0.009
2c H OH e 104.7 0.007
2d OH OH e e e
3d OH OH e 97.36 0.007
4a Chrysin H H H 70.96 0.006
4b OH H H e e
4c Apigenin H OH H e e
4e Luteolin OH OH e 189.6 0.012
4i Quercetin OH OH OH e e3.3. STD-1H NMR spectroscopy
STD-NMR spectroscopy experiments have become a robust
method to detect the binding of ligands to a given receptor [31e33].
We have applied STD to analyze the interaction of the different
ﬂavonoids with LOX-1. The ﬂavonoids assayed in the inhibition
studies were selected for the STD experiments and all showed STD
response. The STD-NMR spectrum is obtained by subtracting a
spectrum in which the protein is saturated (on-resonance) from
one without protein saturation (off-resonance), the difference
spectra contain only signals of the protons that received saturation
from the protein. Fig. 2 shows the STD result of luteolin 4e and of
5,30,40-trihydroxyﬂavone 2d, these ligands have a strong and a
weak STD response, respectively.
The ﬁrst step consisted on the analysis of the 1H NMR spectra of
LOX-1 using the prepared solution of the enzyme in a Tris buffer at
37 C. The spectra is dominated by a strong signal at 3.8 ppm from
the methylene protons of the Tris buffer. However these signals do
not overlap with the ligands resonance peaks which appear
exclusively in the aromatic region, and thus these conditions are
ideal of NMR.
Proper control experiments were performed to optimize the
frequency for protein saturation (1 ppm) and off-resonance irra-
diation, to ensure that the ligand signals were not affected.
Overall, in the STD-NMR spectra obtained for all the compounds
it was possible to integrate the resonances of the resolved proton
signals and determine relative STD effects on the A, B and C rings of
the studied ﬂavonoids.
The structural assignment of the ﬂavonoids was performed ac-
cording to the reported data, for ﬂavones 1d, 2d and 2c [34], for
ﬂavone 3d [35], for ﬂavonoids 4a, 4c, 4e and 4i and [36] for ﬂavone
4b.
The strongest STD results were obtained for apigenin 4c, luteolin
4e, 4b, 1d, and quercetin 4i. The weakest STD response was ob-
tained for ﬂavones 2c, 2d, chrysin 4a and 3d. The analysis of the STDonoids.
Ki (mM)
25 50 100
Vm Vmax Km Vmax Km Vmax
191.1 0.009 e e e e 84.5
e e 61.28 0.005 e e 102.6
103.8 0.006 46.39 0.003 e e 18.0
190.5 0.01 e e e e ND
55.02 0.005 e e e e 19.4
e e 144.7 0.009 111.4 0.006 95.4
191.4 0.01 e e 191 0.008 178.3
e e 148.5 0.009 e e 121.7
129.2 0.008 e e 100.4 0.006 106.7
102
Fig. 2. Expansion of the aromatic region on the STD-1H NMR spectra of compound 2d: a) and b); and of luteolin 4e: c) and d); in the presence of LOX-1 at 600 MHz and 37 C.
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be determined.
4. Discussion
This paper reinforces ﬂavonoids as effective inhibitors of LTB4
production in human neutrophils. It was also possible to establish a
structure/activity relationship for the inhibitory activity.
Concerning the inhibition of LTB4 production in human neu-
trophils by ﬂavonoids, luteolin 4e (IC50 ¼ 1.6  0.3), 1d, 3d, 2d and
quercetin 4i (IC50 ¼ 4.0  1.2) proved to be the most actives, in
descending order of potencies. All of them share the same substi-
tution pattern in the B-ring, a catechol group. The number of hy-
droxyl groups in the A-ring did not seem to be a determinant
feature for the inhibitory activity. However the presence of a 3-OH
on the C-ring clearly diminished the studied activity, as quercetin 4i
was 2.5 times less active than luteolin 4e. Considering the least
active studied ﬂavonoids, derivatives from group 1 (Fig. 1) pre-
sented low activities. The most active of them, 40-hydroxyﬂavone
1c, inhibited the production of LTB4 just 38.4  9.7% for the con-
centration of 40 mM. In group 2 (Fig. 1) it is possible to recognize
precisely the same pattern of activity, in which 5,40-dihydroxy-
ﬂavone 2c had an effect of 29.8  6.5% for 40 mM. Flavonoids in
group 3 (Fig. 1) seemed to be much better inhibitors than the
previous, so the 7-OH in the A-ring may favor the activity. It should
also be noted that, in group 5 (Fig. 1), it was once more clearly
shown that the 3-OH group contributes to lowering the ﬂavonoid
activity, because comparing ()-eriodictyol 5bwith taxifolin 5c, the
last one is considerable less potent than the ﬁrst one, 53.4  4.8%
and 19.9  2.2% of inhibition for 40 mM, respectively. Sadik et al.[37] studied the inhibition of 15-LOX by a group of ﬂavonoids,
namely ﬂavone, chrysin, apigenin, quercetin, luteolin, taxifolin, and
naringenin, and concluded that the vital features for the inhibition
of the pro-oxidants enzymes, like LOX, are the presence of ortho-
dihydroxyl groups (a catechol moiety) in the A-ring and in the B-
ring and the presence of the 2,3-double bond and a 4-oxo group in
the C-ring, although the presence of the 3-OH group diminishes the
inhibitory effect. Here, these assumptions are, in part, corroborated
and further extended with new data. The ﬂavanones from group 5
are clearly less active than the correspondent ﬂavones and the
ﬂavonol quercetin, displaying the importance of the 2,3-double
bond. In addition, in the same study it was concluded that luteo-
lin 4e was more effective than quercetin 4i, and one of the reasons
may be because the latter has an excessive number of OH groups,
which lowers the hydrophobicity, restraining the ﬂavonoid inter-
calation in the hydrophobic cavity that constitutes the access
channel to the active site of the enzyme. In other studies, it was
suggested that the planarity of the molecules may inﬂuence their
capacity to interact with LOX [38,39]. Actually it was settled, as in
the present study, that quercetin 4i and luteolin 4e were more
potent than taxifolin 5c, which reﬂects the marked non-planar
character of this molecule. Also it was previously proposed that
ﬂavonoids act as electron acceptors from chemical groups near the
LOX active center, the interaction being between the electron
acceptor, ﬂavonoid, and a nucleophilic group present in the LOX
molecule. The antioxidant activity of ﬂavonoids is based on two
possible reducing pathways: electron-transfer from themolecule to
the radical, leading to indirect H-abstraction and H-transfer from
the molecule to the radical. It has been clearly proved that the
B-ring is the most important site for the antioxidant capacity,103
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[16,40,41]. This may explain the good performance of quercetin 4i
in the inhibition of LOX and of the other ﬂavonoids with higher
activity, they all share this feature. Notwithstanding, there have
been some studies arguing that the hydrogen donation, or the
antioxidant activity, is not the only explanation for the inhibitory
capacity of the production of LTs [42,43]. Loke et al. [44] tested the
ﬂavonoids quercetin 4i, luteolin 4e and taxifolin 5c, and stated that
the essential feature for a good inhibitory activity of LTB4 produc-
tion was the 2,3-double bond and that the 3-OH group had a
minimal effect in this activity, as attested in our study. Moreover,
they observed a dissociation between this inhibitory effect and the
antioxidant properties of ﬂavonoids as the 2,3-double bond and the
absence of the 3-OH group have little effect in the antioxidant ac-
tivity also determined in their study, by the formation of lipid hy-
droperoxides and F2-isoprostanes in AAPH-induced LDL oxidation.
In reality there are various studies, as well as reviews, that ascertain
the 2,3-double bond in conjugation with a 4-oxo function in the C-
ring, providing electron delocalization from the B ring, and hy-
droxyl groups at positions 3 and 5, providing hydrogen bonding to
the oxo group, as two of the main structural features for the anti-
oxidant activity [15]. In another study Mahesha et al. [45] consid-
ered the isoﬂavones inhibition of LOX and reported that an electron
donated by isoﬂavones was accepted by the ferric form (Fe3þ) of
LOX, which is reduced to resting ferrous form (Fe2þ), thus inhibiting
LOX, whichmay be an additional mechanism of action applicable to
5-LOX.
Once deﬁned the effectiveness of the tested ﬂavonoids, it was
our aim to evaluate their type of LOX inhibition and simultaneously
determine the corresponding structureeactivity relationship. It is
almost certain that there is a common mechanism of reaction be-
tween the different LOXs, because their catalyzed oxygenation in-
volves a similar pair of double bonds on the fatty acid substrate and
its coupling with O2 [2]. In this sense, and because of the lack of
sufﬁciently puriﬁed human enzymes (human 5-LOX), most of the
structural research has been done on soybean LOX, as it was in this
study [46]. In 1989, Belman et al. [47] had already done this kind of
study, with soybean LOX, and at the time they reported that the use
of AA as substrate rapidly inactivated the enzyme. The kinetics
were linear for a very short period of time for accurate rates to be
obtained. So the alternative for this kind of studies was the use of
linoleic acid as substrate. The kinetic with linoleic acid were linear
for a sufﬁciently long time before inactivation and rates could easily
be obtained [2]. To completely characterize the LOX activity, qual-
itative kinetics proﬁle and quantitative parameters should be
considered. Quantitative parameters include estimation of Vmax,
Km as well as Ki [48]. Compounds 2d, 4b, luteolin 4e and quercetin
4i were found to be uncompetitive LOX inhibitors, since Vmax in
the presence of increasing concentrations of drug was invariably
lower than the Vmax observed in their absence, and the value of
Km also decreased, thus parallel lines were obtained in their
Lineweaver e Burk plot. They only bind to the enzymeesubstrate
complex [49]. Additionally comparing the Ki of these three ﬂavo-
noids, 2d presents a Ki of 18.0 mM, much lower than the ones of 4b,
luteolin 4e and quercetin 4i, 95.4 mM, 121.7 mM and 106.7 mM,
respectively, which denote ﬂavone 2d as having a stronger afﬁnity
for the enzyme, than the other three ﬂavonoids. From these ﬂa-
vonoids quercetin 4i and luteolin 4e have in common a catechol
group in B-ring and a 5,7-dihydroxyl in the A-ring, so these features
may determine this type of inhibition. On the contrary, the other
studied ﬂavonoids owned a mixed noncompetitive type of inhibi-
tion. This means that they are able to bind to both the free enzyme
and the enzymeesubstrate complex [49]. Flavonoids 1d, 2d, and
3d, luteolin 4e and quercetin 4i have a catechol group in B-ring,
however 1d and 3d have a different type of inhibition from theothers, possessing none OH group in A-ring or a 7-OH, respectively.
On the other hand, when ﬂavonoids present a 5-OH and a 7-OH in
the A-ring the number and location of the OH groups in B-ring
seem to deﬁne the type of inhibition. Flavone 4b has a 30-OH at the
B-ring and an uncompetitive type of inhibition, but chrysin 4a and
apigenin 4c which have none or a 40-OH, respectively, present a
mixed noncompetitive type. Flavonoid 2c possess just two OH
groups and have a mixed noncompetitive type of inhibition,
interestingly ﬂavones 1d and chrysin 4a have the same number of
OH and the same type of inhibition. In this sense, the type of in-
hibition is not just deﬁned by the number of OH groups present but
more by the relative position occupied by these groups. Note-
worthy, when studying the inhibition of 5-LOX the structure/ac-
tivity relationship clearly denotes the catechol group in B-ring as
the vital feature for a good activity. In the type of inhibition, this
relationship seems to be dependent not just on the OH of the B-ring
but also on those in the A-ring.
STD-NMR studies have also been performed in order to obtain
an epitope mapping of the studied ﬂavonoids that would indicate a
distinct contact with the enzyme and thus understand which re-
gions of the structure are in closer contact with LOX-1. NMR is a
very useful tool to study the molecular interactions in solution and
an essential technique to characterize events of molecular recog-
nition and to obtain information about the interactions of small
ligands with biologically relevant macromolecules (proteins or
nucleic acids). The STD-NMR technic has been used for some years
to characterize the ligandereceptor complexes [28]. The intensity
of the saturation transfer is quantiﬁed and is an indicator of the
afﬁnity. When a molecule binds to the receptor, only the regions
that are in close contact to the protein will receive magnetization
transfer and appear in the difference spectrum owing to a more
efﬁcient saturation transfer.
Fig. 3 summarizes the results obtained for the inhibition con-
stant and STD- NMR data for the studied compounds. For all
compounds the higher percentages of STD response were obtained
for the A-ring as can be seen in Fig. 3, in particular H6 and H8. This
clearly indicates a higher magnetization transfer and thus a closer
contact of this ring with LOX-1 and clearly evidences the pivotal
role of this ring in the interaction with the enzyme. However the
substitution pattern of B-ring seems to affect the interaction with
LOX-1, sincewhen there is no substituent, such as in chrysin 4a, this
ring receives less saturation indicating a weaker interaction (per-
centages of relative STD from H20 to H60 z 50%). This interaction
with LOX-1 does not seem to depend on the hydrophobicity of the
molecule, since for compounds 1d and chrysin 4a, the A-ring is the
one with a higher STD response.
From the epitopemapping analysis it is clear that the A-ring is in
more intimate contact with LOX-1, whereas B-ring region is more
solvent-exposed. However, no conclusion can be drawn regarding
the site of binding.
Moreover, the features that made the ﬂavonoids more active in
the inhibition of LTB4 production were not precisely the same that
interacted more with LOX-1. This ﬁnding indicates that we should
be cautious when comparing the two LOXs.
In conclusion, this complete systematic study of a series of ﬂa-
vonoids on the inhibition of LTB4 production results in the
achievement of solid structureeactivity relationships. In addition, it
was possible to deﬁne the features that contribute to the different
types of LOX inhibition, with a clear cooperation between A and B-
rings, indicating the existence of a substitution pattern in both of
them which favor the activity. Finally the obtained results in the
STD-NMR studies conﬁrmed the importance of the substitution
pattern of both rings for a higher interaction with LOX-1. The data
collected allowed the establishment of the epitope mapping of
these ﬂavonoids with this enzyme. These results open the104
Fig. 3. Epitope mapping obtained for all the tested ﬂavonoids with LOX-1.
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entities, especially by increasing their anti-inﬂammatory effects,
while maintaining of decreasing putative side effects, for a suc-
cessful prospective pharmaceutical application.Acknowledgments
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Flavonoids Inhibit COX-1 and COX-2 Enzymes and Cytokine/
Chemokine Production in Human Whole Blood
Daniela Ribeiro,1 Marisa Freitas,1 Sara M. Tomé,2 Artur M. S. Silva,2 Stefan Laufer,3
José L. F. C. Lima,1 and Eduarda Fernandes1,4
Abstract—Cyclooxygenase 2 (COX-2) and the production of cytokines/chemokines are important
targets for the modulation of the inflammatory response. Although a large variety of inhibitors of these
pathways have been commercialized, some of those inhibitors present severe side effects, governing the
search for new molecules, as alternative anti-inflammatory agents. This study was undertaken to study
an hitherto not evaluated group of flavonoids, concerning its capacity to inhibit COX-1 and COX-2
enzymes, as well as to inhibit the production of the cytokines and a chemokine, in a complex matrix
involved in the systemic inflammatory process, the blood, aiming the establishment of a structure–
activity relationship. The results obtained reveal promising flavonoids for the modulation of the
inflammatory process, namely the ones presenting a catechol group in B ring, as some flavonoids were
able to simultaneously inhibit the production of inflammatory prostaglandin E2 and pro-inflammatory
cytokines.
KEYWORDS: flavonoids; COX; human whole blood assay; cytokines; chemokine.
INTRODUCTION
The inflammatory response involves a broad series of
processes, where a variety of soluble mediators are in-
volved in the activation of resident cells (such as fibro-
blasts, endothelial cells, tissue macrophages, and mast
cells) and in the recruitment and activation of inflammatory
cells (such as monocytes, lymphocytes, neutrophils, and
eosinophils). Those soluble mediators may be organized
into four main groups: (a) inflammatory lipid metabolites
such as platelet-activating factor (PAF) and the derivatives
of arachidonic acid (prostaglandins (PGs), leukotrienes
(LTs), lipoxins); (b) three cascades of soluble proteases/
substrates (clotting, complement, and kinins), which gen-
erate numerous pro-inflammatory peptides; (c) nitric oxide,
a potent endogenous vasodilator; and (d) cytokines, which
are major determinants for the cellular infiltrate, the state of
cellular activation, and the systemic responses to inflam-
mation [1].
Cyclooxygenases (COXs) are determinant enzymes
in the production of PGs with a varied chemistry, with
different receptors and diverse mechanisms of modulation
of their function. All these features determine a variety of
physiological functions of PGs, namely, blood clotting,
ovulation, initiation of labor, bone metabolism, nerve
growth and development, wound healing, kidney function,
blood vessel tone, and immune responses. PGs are synthe-
sized in a broad range of tissue types and serve as autocrine
or paracrine mediators to signal changes within the imme-
diate environment [2].
There are three types of COX isoenzymes: 1, 2, and 3.
Under physiological conditions, COX-1 is constitutively
expressed at low levels, in virtually all tissues. COX-2
expression is more restricted, to the kidney, brain, testicles,
and tracheal epithelial cells. COX-3 is expressed in specific
sites, including the brain and the spinal cord, but its exact
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functions still needs to be disclosed. COX-1 is responsible
for the constant production of PGs critical to the autocrine/
paracrine responses to circulating hormones and mainte-
nance of gastric mucosal integrity and platelet function,
i.e., for the regulation of the homeostatic functions. On the
other hand, COX-2 is one of the key enzymes implicated in
the modulation of inflammation, and can be upregulated
20-fold in macrophages, monocytes, fibroblasts and endo-
thelial cells by various stimuli during the inflammatory
process. In contrast, COX-1 activity is unaffected or in-
creased only marginally (two- to fourfold). If so, COX-2
expression is high and transient, leading to a burst of
inflammatory PGs production in a tightly regulated time-
limited manner [3, 4]. This hyperexpression of COX-2
results from the integrated function of several inflammato-
ry mediators, including interleukins (ILs) and cytokines
[i.e., IL-1, IL-6, and tumor necrosis factor-alpha (TNF-
α)], via transcriptional activation [5].
During the inflammatory process, various cytokines are
produced. They are pleiotropic molecules that exert their
effects locally or systemically in an autocrine or paracrine
manner. Cytokines are part of a large and complex signaling
network and their effects depend on the context in which they
are working. These networks involve synergistic as well as
antagonistic interactions and exhibit both negative and posi-
tive regulatory effects on various target cells [1, 6]. The
cytokines may be divided in the ones participating in acute
or in chronic inflammation; however, there are some that
significantly contribute to both. Some of the cytokines
playing a part in acute inflammation are IL-1, TNF-α, IL-6,
and IL-11. The cytokines that participate in chronic inflam-
mation can be subdivided into the ones mediating humoral
responses, such as IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, and IL-
13 and transforming growth factor-beta (TGF-β), and those
mediating cellular responses, such as IL-1, IL-2, IL-3, IL-4,
IL-7, IL-9, IL-10, IL-12, interferons (IFNs), interferon–gam-
ma inducing factor (IGIF), TGF-β, and TNF-α and -β. Some
cytokines, such as IL-1, significantly contribute to both acute
and chronic inflammation [1].
There are also chemotactic cytokines, designated
chemokines. They are responsible for the migration of
circulating leukocytes to the sites of inflammation or injury
[7]. The secretion of these chemokines is usually induced
by pro-inflammatory cytokines such as IL-1, IL-2, TNF-α,
interferon-gamma (IFN- ), and the bacterial product, lipo-
polysaccharide. Likewise, the regulation of their produc-
tion is mediated by other cytokines such as TGF-β, IL-4,
and IL-10, although the effects vary according with the
chemokine and cell type [8]. The following chemokines
IL-8, granulocyte colony-stimulating factor (G-CSF) and
granulocyte–macrophage colony-stimulating factor (GM-
CSF) also participate in the acute inflammation [1].
The primary aim of these phenomena is the resolution
of the inflammatory process. However, it becomes a prob-
lem when they surpass normal physiological control
conducting to an exaggerated response, contributing to
the pathogenesis of a variety of diseases. It is also why
the overexpression of COX-2 and the overproduction of
cytokines/chemokines are usually related to autoimmune
diseases, such as rheumatoid arthritis, systemic lupus ery-
thematosus, or some forms of diabetes [3–5, 7].
In this sense, COX-2 and the cytokines/chemokines’
production are ideal targets for the modulation of the
inflammatory response. A large variety of non-selective
and selective inhibitors of COX-2 have been commercial-
ized. Notwithstanding some of those inhibitors revealed
that inhibition of COX-2 enzymatic activity is not amena-
ble to long-term treatment procedures, presenting severe
side effects as gastrointestinal bleeding, thrombosis, and
stroke [9–11]. Likewise, the anti-inflammatory therapies
based on the inhibition of the production of cytokines and
chemokines have also been pursued, glucocorticoids being
one of the options; however, they also are potent immuno-
suppressive agents, which limit their effectiveness in ther-
apy [12]. These limitations have been governing the search
for other therapies, namely, the ones based on gene and
antibodies therapies, as well as new molecules which may
constitute an alternative to the clinically available inhibi-
tors [13, 14]. One of these group of molecules may be
polyphenols, more precisely, flavonoids. Flavonoids rep-
resent a wide variety of molecules that share a basic skel-
eton, an arylbenzopyran ring system, and the different
rearrangements of this ring system originate different clas-
ses of flavonoids. All these classes are present ubiquitously
in nature; which makes flavonoids an even interesting
group of study molecules [15]. It has been proven that
flavonoids are able to behave as developmental
regulators/signaling molecules as well, by interacting with
specific proteins central to intracellular signaling cascades
[16]. Flavonoids have been already implicated as promis-
ing molecules in the resolution of the inflammatory pro-
cess, by means of their antioxidant activity and by interfer-
ing with a variety range of enzymes and signaling cascades
activated during this process [17–20].
Therefore, this study was undertaken to study the
flavonoids’ inhibition capacity of COX-1 and COX-2 en-
zymes, as well as to inhibit the production of the cytokines,
IL-6, IL-1β, TNF-α, and IFN- , and the chemokine, IL-8,
in a complex matrix involved in the systemic inflammatory
process, the blood, aiming the establishment of a structure–
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activity relationship. The chemical structures of the studied
flavonoids are represented in Fig. 1.
MATERIALS AND METHODS
Reagents
The following reagents were purchased from Sigma-
Aldrich Co. LLC (St. Louis, USA): dimethylsulfoxide
(DMSO), acetylsalicylic acid, gentamicin sulfate,
cremophor® EL, lipopolysaccharides from Escherichia
coli 026:B6 (LPS), calcium ionophore (A23187), arachi-
donic acid (AA), RPMI 1640 medium, fetal bovine serum,
L-glutamine, penicillin, streptomycin, 5Z-7-oxozeaenol,
apigenin 4c, chrysin 4a, luteolin 4e, (±)-naringenin 5a,
(±)-eriodictyol 5b, and quercetin 4i. Ethanol absolute was
purchased from Fisher Chemical (Loughborough, Leic,
UK). Acacetin 4d and taxifolin 5c were purchased from
Fluka Chemie GmbH (Steinheim, Germany). The
flavonoids 4b, chrysoeriol 4f, diosmetin 4g and 4h were
synthesized by co-authors of this manuscript, from the
Departamento de Química and QOPNA, Universidade de
Aveiro [19]. The other tested flavonoids were obtained
from INDOFINE Chemical Company, Inc. (Stryker Lane
Hillsborough, USA). The thromboxane synthase inhibitor
(TXBSI) was synthesized by co-authors of this manuscript,
from the Eberhard Karls University of Tübingen. The
“PGE2 Enzyme Immunoassay (EIA) Kit” was obtained
from Enzo Life Sciences (Lausen, Switzerland). The
“Multi-Analyte ELISArray Human Kit – Human Mix-N-
Match”, for the cytokines/chemokine determination, was
obtained from QIAGEN® (Boston, USA).
Human Whole Blood Assay
The blood was collected from healthy human volun-
teers, following informed consent. Venous blood was col-
lected by antecubital venipuncture, into heparin-Li+
vacuum tubes.
Fig. 1. Chemical structures of the studied flavonoids.
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COX-1 Assay
The human whole blood assay to assess the COX-1
inhibition was performed as previously reported, with
modifications [21]. Collected blood (500 μL) was placed
in microtubes and incubated in a water bath at 37 °C with
TXBSI (1 μM) and the tested flavonoids (1.25–100 μM) in
DMSO for 15 min. The use of thromboxane synthase
inhibitor, TXBSI, reduces the amount of A23187 needed
and results in higher prostaglandin production. During this
incubation period, the TXBSI and the tested flavonoids
interact with all the cells and the other components of the
blood. Then, the A23187 (12.2 μg/mL) was added and the
mixture was incubated for 15 min, allowing the triggering
of COX-1 activity. The reaction was stopped by placing the
samples on ice for 5 min. The samples were subsequently
centrifuged at 1,000 g for 20 min, at 4 °C, to separate the
blood cells from the supernatant, maintaining the low
temperature. The supernatant was then collected and stored
at −20 °C until use. The quantity of solvents used did not
have inhibitory effects and neither affected the cellular
viability (data not shown).
COX-2 Assay
The human whole blood assay to assess the COX-2
inhibition was performed as previously reported, with modi-
fications [21, 22]. Collected blood (800 μL) was placed in a
six-wells plate and incubated in a humidified incubator at 37
°C with TXBSI (1 μM), the acetylsalicylic acid (10 μg/mL),
and the t e s t ed f l avono id s (25–100 μM) in
DMSO/chremophor/ethanol 1 % (1:10) for 15 min. The use
of TXBSI reduces the amount of LPS needed and its incuba-
tion period. Then, LPS (10 μg/mL) was added and the
mixture was incubated for 5 h, allowing the activation of
COX-2. The reaction was stopped by adding DPBS–genta-
micin buffer (1 mL) to the samples and placing them on ice
for 10 min. The samples were subsequently centrifuged at
1,000g for 15min, at 4 °C, to separate the blood cells from the
supernatant, maintaining the low temperature. The superna-
tant was then collected and stored at −20 °C until use. The
quantity of solvents used did not have inhibitory effects and
neither affected the cellular viability (data not shown).
Determination of PGE2 Production
The amount of PGE2 in the samples (thawed plasma
supernatants) was measured using the above mentioned com-
mercial EIA kit, according to the manufacturer’s instructions,
as an indicator of COX-1 and −2 activities. COX inhibitors,
indomethacin (0.125–1 μM) and celecoxib (0.5–50 μM),
were used as positive controls. Results are expressed as the
percent inhibition of control PGE2 production. Each study
corresponds to at least four experiments.
Cytokines/Chemokine Assay
The human whole blood assay to assess the inhibition
of production of the cytokines (IL-1β, IL-6, TNF-α, and
IFN- ) and chemokine (IL-8) was performed as previously
reported, with modifications [23]. The collected blood (50
μL) was placed in a 24-wells plate with 950 μL of RPMI
1640 medium [(pH = 7.4) supplemented with 10 % fetal
bovine serum, 2 mM L-glutamine, 100 U/mL penicillin and
0.1 mg/mL streptomycin] and incubated in a humidified
incubator at 37 °C with the tested flavonoids (10 and 25
μM) inDMSO/RPMI 1640 (1:1) for 30min. Then, LPS (0.5
ng/mL) was added and the mixture was incubated for 16 h.
For the determination of the produced IFN- , 100 μL of
human whole blood with 900 μL of RPMI 1640 medium
and 10 μg/mL of LPS were used. After this incubation
period, the samples were subsequently centrifuged at 600
g for 5 min, at room temperature. The supernatant was then
collected and stored at −20 °C until use. The quantity of
solvents used did not have inhibitory effects and neither
affected the cellular viability (data not shown).
Determination of Cytokines/Chemokines Production
The amount of IL-1β, IL-6, TNF-α, IFN- , and IL-8
in the samples (thawed plasma supernatants) was measured
using the above mentioned commercial ELISA kit, accord-
ing to the manufacturer’s instructions. The 5Z-7-
oxozeaenol (a transforming growth factor-β-activated ki-
nase 1 (TAK-1) inhibitor) [24], 1 μM, was used as positive
control, leading to a complete inhibition of the production
of all the studied cytokines and chemokine. Due to the
naturally occurring differences in human cytokine release,
the value obtained for each volunteer was normalized to its
LPS control. The results are expressed as the percent
inhibition of control cytokines/chemokine production.
Each study corresponds to at least three experiments.
RESULTS
Human Whole Blood Assay
COX-1 Assay
Among all the tested flavonoids, it was clear that half
of them were good inhibitors of COX-1–PGE2 production
and the other half did not exhibit any activity up to the
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highest tested concentration, 100 μM. The most active
flavonoids were flavone 1a, 2a, 1d, 1c, and 3a, with
inhibitions of 89.3±2.5, 80.4±3.9, 80.4±4.2, 78.3±6.3,
and 72.6±4.2 %, respectively, for 100 μM (Table 1). In
Fig. 2, it is possible to identity flavone 2d and chrysin 4a as
having good activities, but with inhibition’s percentages
lower than 70 %. Moreover, among the less active flavo-
noids 4h, 3c, 1b, 3b, and luteolin 4e presented activities
lower than 50 %, up to 100 μM. The other tested flavo-
noids did not inhibit the COX-1–PGE2 production. Taking
in account the different substitution patterns of the studied
flavonoids from group 1, the most active was flavone 1a.
From group 2, the most active were 2a and 2d and the other
two flavonoids were not active. Flavone 3awas the best of
its group, followed by 3c and 3b, whereas 3d was not
active. Flavonoids of group 4 were less active, chrysin 4a
being the most active. Flavanones from group 5 were not
active. Indomethacin was used as positive control and
presented an activity of 91.8±3.2 %, for 1 μM.
COX-2 Assay
The best activity of COX-2–PGE2 production inhibition
was obtained for flavonoids 1d and 2d with the following
percentages of inhibition 74.6±2.4 and 67.2±2.9 %, respec-
tively, for 100 μM. Flavonoids 3d, diosmetin 4 g, 1c and
luteolin 4e were also quite active with percentages of inhibi-
tion of 59.2±2.9, 56.9±6.1, 56.4±4.3, and 56.4±6.9, respec-
tively, for 100 μM (Table 1). The other flavonoids in Fig. 3
showed activities lower than 50 % up to the highest tested
concentration, 100 μM, chrysin 4a and (±)-eriodictyol 5b
being the less active ones. The other tested flavonoids did
not inhibit the COX-2–PGE2 production, up to 100 μM.
Overall, from group 1, flavonoid 1d was the most active,
74.6±2.4 %, followed by 1c and flavone 1a, 38.6±1.8 %,
whereas 1b was not active. In group 2, flavone 2d was the
only one which proved to be capable of inhibiting COX-2–
PGE2 production. Flavone 3dwas the most active of group 3,
59.2±2.9 %, followed by 3c, 41.7±2.8 %. Flavones 3a and
3b were not active. In group 4, diosmetin 4 g (56.9±6.1 %),
luteolin 4e, apigenin 4c, chrysoeriol 4f and chrysin 4a (34.0±
4.0 %), were the only active flavonoids, in descending order
of potencies. Flavanone (±)-eriodictyol 5b was the only one
that presented any activity in group 5. Celecoxib was used as
positive control and presented an activity of 72.8±2.9 %,
for 5 μM.
Cytokines/Chemokines Assay
The flavonoids demonstrating the best inhibition pat-
terns on COX-2’s inhibition, 1d, 2d, 3d, and luteolin 4e, and
quercetin 4i, shared a catechol group in B ring, and were
selected to assess their ability to modulate the production of
cytokines/chemokine. Flavonoid 3d appeared as the most
active in what concerns the inhibition of IL-1β’s production,
with an inhibition activity of 85.0±4.1 %, for 25 μM, the
highest tested concentration. Flavonoids 1d and luteolin 4e
were also good inhibitors of IL-1β’s production with activi-
ties of 72.8±7.5 and 61.8±13.8 %, respectively, for 25 μM.
The other tested flavonoids presented activities lower than 50
%.All the tested flavonoids appeared as great inhibitors of the
production of IL-6, with percentages of inhibition always
higher than 50 %, for 25 μM, in the following order of
potencies, luteolin 4e (95.6±1.2 %) > 1d > 3d > 2d >
quercetin 4i (57.9±9.9 %). The production of IL-8 was the
less affected by the tested flavonoids. Nevertheless, flavo-
noids 3d and 2d had inhibition activities greater than 50 %,
for 25 μM, 61.9±12.5 and 60.3±3.3 %, respectively. In what
concerns the inhibition of IFN- ’s production, the flavonoids
under study displayed a great performance, with high per-
centages of activity, in the following order of potencies,
luteolin 4e (95.3±2.4 %) > 3d > 2d > quercetin 4i > 1d
(70.4±0.9 %). Once more, the flavonoids under study proved
to be good modulators of cytokines’ production, inhibiting in
a great extent the production of TNF-α. The best activity
belonged to luteolin 4e, followed by 1d, 2d, 3d, and quercetin
4i, with inhibitions of 76.2±9.0, 72.8±3.5, 71.2±1.6, 67.5±
1.5 and 59.1±3.3, respectively. All the tested flavonoids
demonstrated a concentration-dependent activity, data shown
in Fig. 4.
DISCUSSION
Flavonoids are promising molecules for the resolution
of the chronic inflammatory processes. In this sense, thiswork
aimed to study the structure–activity relationship between a
hitherto not studied series of flavonoids and COXs-1 and -2
enzymes, using a humanwhole blood technique.Moreover, it
was studied, in the same matrix, their ability to modulate the
production of a series of cytokines and chemokine, which are
important mediators of the inflammatory process.
The assays for the evaluation of the inhibition of the
isolated enzymes are important as they give the exact
information about the actual and sole impact of the drug
on the enzyme, avoiding other endogenous influences.
This kind of studies could also be performed in freshly
isolated cells, with minimized protein content. However,
these two kinds of assays present some pitfalls: they ne-
glect the plasma binding of the drug, the other blood
components, and the other interactions besides the drug–
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cell interaction. The whole blood assay minimizes the
introduction of artifacts that would occur during cell sepa-
ration steps, all cell–cell interactions persist and it assures
the maintenance of the plasma protein levels, which
resembles closely the in vivo pathophysiological con-
ditions [21].
Table 1. Inhibition and ratio of COX-1 and COX-2
Compounds R1 R2 R3 Inhibion (%) ± SEM COX-1 / COX-2Rao
COX-1 COX-2
1a Flavone H H - 89.3 ± 2.5 38.6 ± 1.8 2.3
1b OH H - 49.5 ± 7.1 NA -
1c H OH - 78.3 ± 6.3 56.4 ± 4.3 1.4
1d OH OH - 80.4 ± 4.2 74.6 ± 2.4 1.1
2a H H - 80.4 ± 3.9 NA -
2d OH OH - 67.8 ± 3.1 67.2 ± 2.9 1.0
3a H H - 72.6 ± 4.2 NA -
3b OH H - 37.1 ± 4.5 NA -
3c H OH - 43.1 ± 5.2 41.7 ± 2.8 1.0
3d OH OH - NA 59.2 ± 2.9 -
4a Chrysin H H H 67.4 ± 5.5 34.0 ± 4.0 2.0
4c Apigenin H OH H NA 45.2 ± 4.8 -
4e Luteolin OH OH H 33.5 ± 7.9 56.4 ± 6.9 0.6
4f Chrysoeriol OMe OH H NA 35.6 ± 2.5 -
4g Diosmen OH OMe H NA 56.9 ± 6.1 -
4h OMe OMe H 44.6 ± 7.2 NA -
5b (±)-Eriodictyol OH H - NA 25.5 ± 5.0 -
Production of PGE2 in humanwhole blood by the indicated studied flavonoids determined by EIA (%, mean±SEM), for the highest tested concentration, 100
μM. Each study corresponds to at least three experiments
NA no activity was found up to 100 μM
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Fig. 3. Inhibition of COX-2—production of PGE2 in human whole blood by the indicated studied flavonoids determined by EIA. Each value represents
mean±SEM of at least three experiments. ***P<0.001, **P<0.01, *P<0.1 compared to the stimulated control (TXBSI/LPS).
Fig. 2. Inhibition of COX-1—production of PGE2 in human whole blood by the indicated studied flavonoids determined by EIA. Each value represents
mean±SEM of at least three experiments. ***P<0.001, **P<0.01, *P<0.1 compared to the stimulated control (TXBSI/A23187).
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The studied flavonoids revealed clear patterns of ac-
tivity and some of them happened to be good inhibitors of
COX-1–PGE2 production. Flavonoids 1a, 2a, and 3awere
three of the most active (Table 1). All of them hold none or
Fig. 4. Inhibition of cytokines/chemokine—production in humanwhole blood by the indicated studied flavonoids determined by EIA. Each value represents
mean±SEM of at least three experiments. ***P<0.001, **P<0.01, *P<0.1 compared to the stimulated control (LPS).
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just one hydroxyl (OH) group, being the less substituted
flavonoids among them all. Flavonoids 4h, 3c, 1b, 3b and
luteolin 4e were active, but in a minor rate, with activities
of inhibition lower than 50 %, up to 100 μM. Overall, the
less substituted flavonoid of each group, from 1 to 4, were
the ones that showed the best activity. Adding to this,
flavones from group 1, flavone 1a, 1c, and 1d (Table 1)
were the most active between the studied flavonoids. Their
substitutions only occur in B ring, with none or two OH
groups, which highlight once more that less substituted
flavonoids may present a higher inhibition of COX-1. This
may happen because the inhibitor-binding site within the
active site in COX-1 is smaller and the interaction of less
substituted molecules may be easier than a more substitut-
ed and big molecule. Besides, it was the reason why it was
possible to selectively inhibit COX-2 and at the same time,
avoid interfering with the homeostatic functions related to
COX-1 [25, 26].
Moreover, the flavonoids of group 5 did not show any
activity, which might mean that the lack of a double bound
C2=C3 affects dramatically the studied activity.Wang and co-
workers, who studied the effect of the flavonoids luteolin 4e,
quercetin 4i, and (±)-naringenin 5a in the inhibition of COX-
1, have already reported that the C2=C3 double bound in C
ring, which determines the co-planarity of the molecule, was
essential for a higher COX-1 inhibitory activity. They also
concluded that the presence of a 3-OH group in the C ring
diminished slightly the COX-1 inhibitory activity. These
findings are, in part, in agreement with the ones of the present
study. However, in this study, quercetin 4i, which has a 3-OH,
did not present activity up to the highest tested concentration,
100 μM. This discrepancy may be due to the different work
material, the referred study used the microsomal isolated
enzyme and in the present study it was used human whole
blood, which is a most reliable matrix, more approximate to
the real physiological conditions [27].
The studied flavonoids also demonstrated a promising
inhibitory activity of COX-2–PGE2 production. The most
active were 1d, 2d, and 3d, which have in common a
catechol group in B ring. Luteolin 4e was also a good
inhibitor, sharing the same substitution pattern, but it was
as good as flavonoids 4g and 1c. In group 5, (±)-eriodictyol
5b was the only one that showed activity. Once more, the
importance of the catechol group in B ring was exposed.
So far, it was clear that the structure that defines a good
inhibitor of COX-1 is not the same for COX-2. The im-
portance of the presence of a catechol group to the inhibi-
tion of COX-2, as already been reported in non-cellular
in vitro studies and in isolated cells and it is now corrob-
orated in a whole blood assay. The active site of COX-2 is
divided into three important regions: a hydrophobic pocket
defined by Tyr385, Trp387, Phe518, Ala201, Tyr248, and
Leu352; the entrance of the active site lined with the
hydrophilic residues Arg120, Glu524, Tyr355 and a side
pocket lined by His90, Arg513, Val523, and Ser530 [28].
Priscilla D’Mello and co-workers undertook a docking
study where they found that the catechol group of B ring
of luteolin was orientated towards the hydrophobic pocket,
with 3′,4′-dihydroxy groups forming H-bonds with Tyr385
and Ser530. They also studied the interaction between
chrysin and apigenin with COX-2, concluding that the 5-
OH interacted with Tyr355 forming an H-bond and the 4′-
OH on the B ring of apigenin formed an additional H-bond
with Tyr385; but, Ser530 remained inaccessible, thereby
underlining the importance of the catechol moiety.
Moreover, they tested quercetin and found that although
quercetin contains a catechol-like function on the B ring, it
was not orientated towards the hydrophobic pocket. In-
stead, the A ring was orientated towards the pocket,
forming H-bond with Ser530 and the orientation enabled
the 3-OH group to interact with Tyr355. Thus, they
concluded that quercetin may not be a classical COX
inhibitor but may be involved in the inhibition of
transcription of COX-2 [29]. In a study with LPS-
activated RAW264 macrophage cells, anthocyanidins with
an ortho-dihydroxyphenyl structure on the B ring sup-
pressed the COX-2 expression. The number of OH groups
on the B ring appeared to be related to a molecular confor-
mation that influences the interactions between flavonoids
and enzymes such as tyrosine kinase and protein kinase C,
which are involved in the transcriptional activity of COX-2
[30].
Feng and co-workers found that COX-2 is an oxidant
stress-inducible gene, explaining the enhanced expression
of COX-2 during inflammation. So, the radicals species
produced by inflammatory cells could lead not only to the
deleterious over-expression of COX-2, but also to the
amplification of PGs during inflammation. The radical
scavengers may inhibit the formation of PGs by the sup-
pression of COX-2 expression [31]. Another study in
RAW264.7 cells stated that COX was activated by
peroxynitrite which may mean that this activation is par-
ticularly significant in cells with great amounts of nitric
oxide and superoxide anion radical [32]. This may also
explain why the flavonoids with a catechol group in B ring
were good inhibitors of the production of PGE2 via COX-
2, because they have already proven to be great modulators
of the oxidative burst during in the circumstances of an
inflammation process, namely by the scavenge of reactive
oxygen species [19].
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The COX’s inhibitory potential of flavonoids was
found, for the first time, in 1980 [33]. Further ahead,
several studies were developed and several flavones were
found to be COX inhibitors, while some flavonols were
LOX lipoxygenase (LOX) inhibitors. Moreover, it was
found that reduction of the C2=C3 double bond and gly-
cosylation reduced the inhibitory activity of COXs [34,
35]. Noteworthy is the interest in COX’s inhibitory activity
which has been growing since the discovery of the three
isoforms of the enzyme, especially COX-2 because of its
role both in the development and in the recovery of the
inflammatory process. Thus, COX-2 is a very interesting
drug target. Although the effect in vivo is difficult to
predict, Lopez-Posadas and co-workers have already stated
that some flavonoids probably downregulate the COX-2
expression and PG generation in conditions of intense
oxidative stress, as in profound inflammatory reactions
[36]. Furthermore, the series of flavonoids in this study
have already proven to be very good modulators of the
human neutrophil’s oxidative burst, the first cells implicat-
ed the inflammatory response. As so, these flavonoids
appear by now as promising anti-inflammatory agents [19].
Table 1 exposes the selective inhibition of COX-2 by
flavonoids 3d, apigenin 4c, chrysoeriol 4f, diosmetin 4g
and (±)-eriodictyol 5b; the first one is the most potent,
followed by diosmetin 4 g, and (±)-eriodictyol 5b was
the less active of them. All of these flavonoids are substitut-
ed in B ring, presenting a catechol group or a methoxyl and
an OH group and, in general, they are substituted in A ring
with a OH group in positions 5 and 7. The exception is 3d,
which has only a 7-OH in A ring. Apigenin 4c has already
been described as a potent transcriptional inhibitor of
COX-2 in mouse macrophages RAW 264.7, stimulated
with LPS or IFN- , via perturbation of NF-kB pathway
[37]. Later on, Raso and co-workers studied the inhibitory
effect of flavonoids in the PGE2 production in a macro-
phage cell line J774A.1 stimulated with LPS and showed
that the strongest active flavonoids examined possess a
C2=C3 double bond and 5,7-dihydroxyl groups in the A
ring, apigenin; highlighting once more the effect of flavo-
noids on macrophages [38]. As the ratio COX-1/COX-2
indicate the affinity for each study enzymes, if the ratio is
lower than 1, it means that the flavonoid under study has
more affinity for COX-2, which is the case of luteolin 4e,
the only one that showed to be more selective for COX-2,
but the ratio value is not very low, 0.6.
Flavonoids 1b, 2a, 3a, 3b, and 4h are COX-1 selec-
tive, but the most selective ones were 2a and 3a. The less
potent was 3b (Table 1). Yet again, these findings prove
that the less substituted flavonoids are better inhibitors of
COX-1 and even selective for this enzyme. Analyzing the
COX-1/COX-2 ratios, the studied flavonoids that revealed
ratios higher than 1, i.e., have more affinity for COX-1,
were flavone 1a, 1c, 1d and chrysin 4a. However, flavone
1a was the one with a higher ratio value, 2.3, followed by
chrysin 4a, 2.0, so they have more affinity for COX-1. The
activities of the flavonoids selective for COX-1 and with
higher affinities for this enzyme may be explored in other
directions, namely, in platelet studies, maybe revealing
other interesting and promising biological effects.
Inasmuch as the ideal inhibitor of COX-1, with antiplatelet
effect, is the one that act by affecting platelet COX-1
activity, but only cause a marginal and transitory inhibitory
effect on COX-2 [39].
Concerning the inflammatory diseases and the reso-
lution of chronic inflammatory processes, the major prob-
lem of the existent anti-inflammatory drugs is the adverse
reactions associated. The development of drugs that inhibit
both COX-2 and 5-LOX may lead to compounds with
enhanced efficacy, fewer side effects and with a wider
spectrum of activity, when compared with selective COX
inhibitors [40, 41]. In fact, flavonoids with a catechol
group in B ring, namely, 3d and luteolin 4e, which in this
study revealed to have a higher affinity for COX-2, have
already proven to be very good inhibitors of human 5-
LOX, so they are dual inhibitors, demonstrating a very
auspicious pattern of activity for the resolution of the
inflammatory processes [20].
Following this sense, the best inhibitors of COX-2,
sharing a catechol group in B ring, 1d, 2d, 3d, and luteolin
4e, and quercetin 4i were selected to assess their ability to
modulate the production of IL-1β, IL-6, IL-8, IFN- , and
TNF-α in the same matrix used to study the COX activity,
the human whole blood. Overall, the selected flavonoids
proved to be exceptional inhibitors of cytokines’ produc-
tion for the highest tested concentration, 25 μM. The lower
activities were observed for the inhibition of IL-8.
It is well documented that cytokines and chemokines
are essential keys of the inflammatory process. Actually,
neutrophils, which are the first cells reaching the site of
inflammation, may be primed by agents that include bac-
terial products and cytokines or chemokines, e.g., TNF-α,
GM-CSF, IL-8 and IFN- . Those neutrophils are then mo-
bilized to the site of infection or inflammation, where they
encounter activating signals to trigger bacterial killing and
synthesize other factors, which can subsequently activate
both neutrophils and other cells of the immune system. In
particular, neutrophils have been shown to synthesize and
secrete IL-8 in response to a number of stimuli, including
TNF-α and GM-CSF [42]. Thus, a “balance” between the
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effects of pro-inflammatory (i.e., IL-1β, TNFα, Il-6, IL-8,
and IFN-γ) and anti-inflammatory cytokines (i.e., IL-10,
IL-4, TGFβ) is believed to determine the outcome of
diseases [43].
The studied flavonoids were able to effectively
inhibit the production of IL-1β, in both tested con-
centrations of 10 and 25 μM. Flavonoid 3d, which
has a 7-OH in the A ring presented the best activity
(Fig. 4). However, the substitution did not seem
determinant for the activity as flavonoid 1d, which
has none OH groups in A ring, presented almost the
same activity. On the other hand, flavonoid 2d,
which has a 5-OH in the A ring was the less active,
indicating that this feature may not favor the activity
under study. Comparing the results obtained for
luteolin 4e and quercetin 4i, it is possible to con-
clude that the 3-OH in the C ring did not influence
in a positive way the activity, more on the contrary.
In healthy subjects, IL-1β is barely detectable in the
blood stream and during disease are in the
femtomolar range, and this is explained by the tre-
mendous potency of IL-1β to induce inflammatory
responses, and it is why this cytokine is essential to
be restrained in an inflammation process [44]. Also,
it is already proven that IL-1β play a critical role in
rheumatoid arthritis, as TNF-α which up-regulate
each other in a positive feedback loop to cause most
of the pathologic symptoms [45].
IL-6 can be induced by other pro-inflammatory cyto-
kines, like IL-1β and TNF-α, and depending on the con-
text, IL-6 is itself commonly regarded as pro-inflammatory,
or as an anti-inflammatory cytokine [6]. Luteolin 4e was
the best inhibitor of IL-6 production (Fig. 4). Luteolin has a
catechol group in B ring, as all the selected flavonoids, and
two OH groups in the C5 and C7 of A ring. Quercetin 4i
was the less active, and its substitution pattern is equal to
luteolin, but with an additional 3-OH in the C ring, so this
OH did not favor the inhibition of IL-6 production, as what
happened for IL-1β. The existence or not of an OH group
in the A ring did not seem to be determinant for the activity
as the other studied flavonoids presented almost the same
activities.
IL-8 was the only chemokine studied, and it is the
most potent chemokine in terms of neutrophils chemotaxis
and enzyme release [46]. IL-8 can be induced on virtually
all cells (leukocytes, fibroblasts, endothelial and epithelial
cells and tumor cells) upon stimulation with a variety of
products, including cytokines (IL-1β, TNF-α), other
chemoattractants (leukotriene B4) and bacterial material
[LPS, N-Formyl-Met-Leu-Phe (fMLP)] . In an
experimental collagen-induced arthritis, administration of
anti-IL-8 antibodies to the inflammatory joint reduced the
inflammation, which may indicate IL-8 as a potential target
for the resolution of this kind of inflammatory diseases
[47]. In this study, the tested flavonoids were able to inhibit
IL-8 production but in a less extent than the studied cyto-
kines. Nevertheless, the presence of just one OH group in
the A ring, independently of its position may be important
for a higher activity as flavonoids 3d and 2dwere the most
active (Fig. 4). The presence of a 3-OH in C ring did not
seem important for the activity as quercetin 4i and luteolin
4e presented almost the same activity. Finally, the number
of OH seems important for the activity, as flavonoid 1d, the
less substituted, was the less active. It is important to note
that IL-8 may be induced by cytokines such as IL-1β and
TNF-α, so flavonoids which modulate the production of
these cytokines, indirectly modulate de production of IL-8
[48].
IFN- is an important cytokine that has been implicat-
ed in the pathogenesis of a variety of autoimmune and
chronic inflammatory conditions systemic lupus erythema-
tosus, type I diabetes mellitus, adjuvant-induced arthritis
[1]. All the selected flavonoids were effective inhibitors of
the IFN- production, percentages higher than 60 %, for
25 μM. Luteolin 4e was the best one inhibiting the produc-
tion almost completely (Fig. 4). Once more, the presence of
OH groups in A ring appeared as an important feature to the
activity as flavonoid 1d was once more the less active.
The production of TNF-α was surely inhibited
by the selected flavonoids, in a concentration-
dependent manner. Analyzing the results, it may be
concluded that the presence and the position of the
OH groups in A ring is not a determinant for the
activity, as luteolin 4e, 1d, 2d, and 3d were equally
potent. On the other hand, the 3-OH in C ring did
not contribute for the activity improvement, because
quercetin 4i was the less active. There are other
reports of studies undertaken in isolated macrophages
that did not support the relevance of the 3-OH.
Although in different matrixes, these findings are in
agreement with the ones found in the present study
[43, 49]. TNF-α share several pro-inflammatory
properties with IL-1β, like fever induction and stim-
ulation of the production of collagenase and PGE2 by
synovial cells, contributing to the damage in inflam-
matory conditions such as rheumatoid arthritis. They
further exert secondary inflammatory effects by stim-
ulating IL-6 synthesis in several cell types. IL-6,
along with TNF-α and IL-1, induce fever and the
acute phase response, maintaining the inflammatory
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response through a cascade of cytokines with over-
lapping properties [1]. Luteolin and quercetin have
already proven to be effective inhibitors of the pro-
duction of TNF-α and IL-6, although the majority of
the studies were carried out in different matrices,
which did not allow concrete conclusions about the
effect in the human body [50, 51]. Xagorari and co-
workers have reported that luteolin and quercetin
inhibited LPS-stimulated TNF-α and IL-6 release in
RAW 264.7 macrophages [52]. Luteolin also
inhibited the production of TNF-α in vivo, in male
ICR mice [53]. Another study was undertaken in
mice, to which luteolin was administrated intraperito-
neally and it attenuated the increase in serum TNF-α
levels elicited by LPS [54]. In accordance with the
literature, in this work, luteolin 4e was the most
active flavonoid in the inhibition of almost all cyto-
kines, IL-6, IFN- , and TNF-α, which makes this
flavonoid a promise in the modulation of the inflam-
matory process.
All in all, the results of this work reveal promising
flavonoids for the modulation of the inflammatory process,
namely the ones presenting a catechol group in B ring.
Better still, these flavonoids are able to simultaneously
inhibit the production of inflammatory PGE2 and pro-
inflammatory cytokines.
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 Abstract 
Human neutrophils are key players in the inflammatory process, which is no less than a 
natural physiological response of the organism to tissue damage by injury or infection. 
Following its physiological activity at inflammatory sites, neutrophils are eliminated by 
apoptosis, as a natural and crucial phenomenon that should happen during the resolution 
of inflammation. During an uncontrolled inflammatory response neutrophils start the over-
production of reactive oxygen species and cytokines, and the gene expression of 
transcription factors, which modulate the apoptotic process and may delay it, causing an 
imbalance in the neutrophils’ homeostasis. Thus, the regulation of neutrophils’ apoptosis 
may constitute a new therapeutic target and another key to understand and to contain the 
uncontrolled deleterious effects of chronic inflammation. The aim of this work was to 
clarify the effects of a group of selected flavones and a flavonol in human neutrophil’s 
apoptosis process, and study the mechanisms by which this effect was produced, 
providing an insight on the structure/activity relationship. The studied flavonoids were 
effective pro-apoptotic molecules; this effect is potentially undertaken via caspases 3, 8 
and 9, mainly through the extrinsic apoptotic pathway. All the flavonoids sharing a 
catechol group in B ring showed good pro-apoptotic activities. However, the 3-OH in C 
ring or a 5-OH in A ring do not accredit for apoptosis, more on the contrary. Moreover, the 
presence of just one OH group in B ring clearly lowered the pro-apoptotic effect. These 
flavonoids revealed a great potential to be used in chronic inflammation where the normal 
apoptotic function of neutrophils is altered 
 
 
 
 
 
 
 
 
 
 
Key words: Flavonoids, Apoptosis, Caspase activation, Extrinsic pathway, Mitochondrial 
potential, p53 
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 1. Introduction 
Inflammation is a natural physiological response of the organism to tissue damage by 
injury or infection. Neutrophils are the first cells arriving at the site, where their lifetime can 
increase several fold. [1] They constitute the first line of host defence against invading 
pathogens (bacteria, fungi, etc.). Under physiologic conditions, the turnover of neutrophils, 
with a lifetime of around 2-3 days, is a natural homeostatic event. During inflammatory 
response, the turnover of neutrophils is referred to increase to around 5.4 days, but also in 
this case, death is an essential cellular event to maintain neutrophil number, avoiding the 
evolution to chronic inflammation. [2-4] Moreover, apoptosis is crucial for the efficient 
disposal of the engulfed pathogens, for the generation and release of neutrophil 
extracellular traps (NETs), and for the production of cytokines through the clearance of 
apoptotic neutrophils by macrophages. Constitutive neutrophil death is indeed an 
essential mechanism for the modulation of neutrophil’s homeostasis. [5] The delayed 
apoptosis of neutrophils has been related with numerous acute and chronic inflammatory 
diseases, namely in Kawasaki disease, [6] inflammatory bowel disease, [7], and 
rheumatoid arthritis [8] among others. In fact, in the event of inflammatory processes, 
neutrophils produce a myriad of inflammatory mediators, namely, reactive species, and 
pro-inflammatory cytokines; however, in a chronic state these mediators are over-
produced and lead to the damage of the adjacent healthy tissues, propagating the 
inflammation. As so, this delayed apoptosis and clearance of neutrophils may contribute 
to unwanted and exaggerated inflammation. The precise regulation of neutrophils’ 
apoptosis prevents the release of toxic intracellular components that can damage healthy 
tissue. [2, 9]  
Various molecules are involved in the survival of neutrophils; they are designated as pro-
survival stimuli, and comprise cytokines, granulocyte colony stimulating factor (GCSF), 
granulocyte macrophage colony-stimulating factor (GM-CSF), and interferon gamma (IFN-
ɣ), adenosine triphosphate (ATP), and leukotriene B4 (LTB4), among others. [5] It is also 
well stablished that the apoptotic process is regulated by a cascade of signalling 
pathways, involving anti-apoptotic and pro-apoptotic transcription factors. For example, 
the up-regulation of p53 triggers the extrinsic apoptotic cascade, [10] while some 
transcription factors may display anti-apoptotic effects, like nuclear factor kappa B (NF-ĸB) 
and signal transducer and activator of transcription 3 (STAT-3), or pro-apoptotic effects, 
like c-Jun N-terminal kinase (JNK), p38 (mitogen-activated protein kinases) and apoptosis 
inducing factor (AIF). [5] 
It is therefore of utmost importance to discover and study molecules capable of 
modulating and control neutrophils’ apoptosis to provide a fine balance between their 
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 immune functions and their safe clearance, and consequently modulate the inflammatory 
process. Flavonoids are natural polyphenols that can be widely found in nature. They are 
well-known as having a myriad of biologic activities, including positive modulating effects 
in inflammation. [11] These compounds exhibit antioxidant activity; modulate eicosanoids, 
cytokines, chemokines’ production and gene expression of transcription factors. [12, 13] 
Therefore, flavonoids, as molecules capable of modulating these inflammatory mediators 
may have also an important modulating activity of the apoptosis process of neutrophils, 
and this way to contribute to the resolution of inflammatory processes. 
The aim of this work was to clarify the effects of a group of selected flavones and flavonol 
(figure 1) in human neutrophil’s apoptosis process, and to study the mechanisms by which 
this effect was produced, and provide an insight on the structure/activity relationship.  
 
 
 
Figure 1 - Chemical structures of the studied flavonoids. 
 
 
2. Materials and Methods 
2.1. Materials 
The following reagents were purchased from Sigma-Aldrich Co. LLC (St. Louis, USA): 
dimethylsulfoxide (DMSO), RPMI 1640 medium, fetal bovine serum, L-glutamine, 
penicillin, streptomycin, nutlin-3, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), 
chrysin, apigenin, luteolin, and quercetin. The other tested flavonoids were obtained from 
Indofine Chemical Company, Inc. (Stryker Lane Hillsborough, USA). Annexin-V-FLUOS 
Staining Kit was obtained from Roche Diagnostics GmbH (Mannheim, Germany). 
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 Hemacolor® was obtained from Merck (Darmstadt, Germany). Z-DEVD-FMK, Z-IETD-
FMK, Z-LEHD-FMK, and BD™ MitoScreen Flow Cytometry Mitochondrial Membrane 
Potential Detection Kit were purchased from BD Biosciences (San Diego, USA). DC 
Protein Assay was purchased from Bio-Rad (California, USA).Nuclear Extract Kit and 
TransAM® p53 Transcription Factor Assay Kit were purchased from Active Motif (La 
Hulpe, Belgium). 
 
 
2.2. Methods 
 2.2.1. Isolation of Human Neutrophils 
Following informed consent, venous blood was collected by antecubital venepuncture 
from healthy human volunteer, into vacuum tubes with K3EDTA. The isolation of human 
neutrophils was performed by the density gradient centrifugation method as previously 
reported. [14] RPMI 1640 medium [(pH = 7.4) supplemented with 10 % fetal bovine 
serum, 2 mM L-glutamine, 100 U/mL penicillin and 0.1 mg/mL streptomycin] was used as 
incubation media in all experiments, in which isolated neutrophils were exposed to the 
tested flavonoids. 
 
 2.2.2. Assessment of neutrophils’ apoptosis 
 2.2.2.1. Cytomorphological alterations 
Following incubation of isolated neutrophils (1 x 106 / mL) with the tested flavonoids (50 
µM), in DMSO:RPMI (1:1), for 4 h, at 37 °C, in a humidified incubator, samples were 
cytocentrifuged, stained with Hemacolor®, and counted under light microscopy (100 x) to 
determine the proportion of cells displaying characteristic apoptotic morphology. At least 
400 cells were counted per slide. [15] 
 
 2.2.2.2. Annexin-V binding assay 
Following incubation of the isolated neutrophils (1 x 106 / mL) with the tested flavonoids (0 
- 50 µM), in DMSO:RPMI (1:1), for 4 h, at 37 °C, in a humidified incubator, neutrophils 
were analysed by flow cytometry, using the commercial Annexin-V-FLUOS Staining Kit 
according to the manufacturer's instructions, allowing the simultaneous staining with 
annexin-V labelled with fluorescein and propidium iodide. The fluorescence signals were 
collected using a BD Accuri™ C6 flow cytometer. A polygon gate was set according to the 
neutrophils’ light scattering properties (in a forward vs. side scatter plot) excluding cell 
debris and other blood cells, restricting the analysis to neutrophils only. At least 10,000 
cells were collected and their fluorescence signal detected, in logarithmic mode and the 
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 data were analysed using the BD Accuri™ C6 software. The green fluorescence due to 
Annexin-V conjugated with FITC was followed in channel 1 (FL1) and plotted as a 
histogram of FL1 staining. Fluorescence due to the propidium iodide incorporation was 
followed in channel 3 (FL3). [15] 
 
 2.2.2.3. Caspases-3, -8 and -9 activities 
The involvement of caspases -3, -8 and -9 in flavonoid – induced apoptosis were studied 
using three irreversible inhibitors of these caspases: Z-DEVD-FMK, Z-IETD-FMK, Z-
LEHD-FMK, respectively, which are able to block apoptosis. The isolated neutrophils (1 x 
106 / mL) were treated with the caspase inhibitor under study, Z-DEVD-FMK (10 µM), Z-
IETD-FMK (5 µM), or Z-LEHD-FMK (10 µM), in RPMI medium, for 30 min, at 37 °C, in a 
humidified incubator. Flavonoids (50 µM), in DMSO:RPMI (1:1), were then added and 
incubated for 4 h, in the same conditions. Apoptotic neutrophils were analysed by flow 
cytometry, using the commercial Annexin-V-FLUOS Staining Kit, as described above in 
2.2.2.2. [15] 
 
 2.2.3. Assessment of neutrophils’ mitochondrial potential 
To evaluate the flavonoids’ effect on mitochondrial membrane’s potential (∆Ѱm), isolated 
neutrophils (1 x 106 / mL) were incubated with the tested flavonoids (50 µM), in DMSO : 
RPMI (1:1), for 4 h, at 37 °C, in a humidified incubator. Afterwards, alterations of the 
mitochondrial potential were analysed by flow cytometry, using the commercial BD™ 
MitoScreen Flow Cytometry Mitochondrial Membrane Potential Detection Kit, according to 
manufacturers’ instructions. Briefly, samples were collected and centrifuged at 400 g, 5 
min, at room temperature. The supernatants were discarded and 500 µL of JC-1 (5,5’,6,6’-
tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide) work solution were added 
and the pellet resuspended. This mixture was incubated for 15min, in a humidified 
incubator. After the end of the incubation time, 2 mL of Assay Buffer 1x were added, 
followed by a centrifugation, 400 g, 5 min, at room temperature. The supernatant was 
discarded and the pellet resuspended in 500 µL of Assay Buffer 1x. The fluorescence 
signals were collected using a BD Accuri™ C6 flow cytometer, as described above. JC-1 
is a lipophilic fluorochrome that is used to evaluate the status of the ∆Ѱm. In live cells JC-
1 penetrates the plasma membrane of cells as monomers. Healthy mitochondrial 
membrane is polarized and JC-1 is rapidly taken up. This uptake increases the 
concentration gradient of JC-1 leading to the formation of JC-1 aggregates (known as J-
aggregates) within the mitochondria. JC-1 aggregates show a red spectral shift resulting 
in higher levels of red fluorescence emission which is measured in the FL-2 channel. On 
the other hand, in apoptotic cells with depolarized ∆Ѱm, JC-1 persist as monomers, and 
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 do not aggregate; this leads to reduced fluorescence in the FL-2 channel and to the 
appearance of a green spectral shift resulting in higher levels of green fluorescence 
emission which is measured in the FL-1 channel. [16] 
 
 2.2.4. Assessment of p53 activation in neutrophils 
Isolated neutrophils (8 x 106 / mL) were exposed to the tested flavonoids (50 µM), in 
DMSO : RPMI (1:1), for 4 h, 6h, 8h and 24h, at 37 °C, in a humidified incubator. After 
each incubation time, the nuclear extract was isolated, using the Nuclear Extract Kit, 
according to the manufacturers’ instructions, with the suggested sonication (2 cycles of 12 
s pulses) before the last centrifugation. The protein was quantified by the Lowry method 
(DC Protein Assay), and the cells’ lysates were diluted in complete lysis buffer to 3.5 
µg/mL. The p53 activation was evaluated by TransAM® p53 Transcription Factor Assay 
Kit, according to the manufacturers’ instructions. 
 
 2.2.5. Statistical analysis 
Statistics were calculated using GraphPad Prism™ (version 6.0; GraphPad Software). 
Results are expressed as mean ± standard error of the mean (SEM). Statistical 
comparison between groups was estimated using the one-way analysis of variance 
(ANOVA), followed by the Bonferroni's post-hoc test. In all cases, p-values lower than 
0.05 were considered as statistically significant. Inhibitory patterns were calculated with 
GraphPad Software. 
 
 
3. Results 
3.1. Effect of flavonoids on neutrophils’ apoptosis 
All the tested flavonoids were able to induce neutrophil’s apoptosis in the present 
experimental conditions. Despite the fact that these flavonoids have only slight structural 
differences, they present different activities. The flavones luteolin 4c, 3c, chrysin 4a and 
1c were clearly the most active, increasing apoptosis in 82 ± 6 %, 74 ± 11 %, 74 ± 10 % 
and 66 ± 7 %, respectively , for 50 µM (figure 2). The other tested flavonoids, quercetin 
4d, 2c and apigenin 4b resulted in a lower pro-apoptotic effect (less than 50 %): 36 ± 6%, 
41 ± 7 % and 10 ± 4%, respectively (figure 2). Figure 3 displays the representative images 
obtained for luteolin 4c, 3c, chrysin 4a and 1c through the cellular morphological study. It 
is possible to observe the cytomorphological alterations of apoptotic neutrophils, which 
appear with nuclear condensation and cellular shrinkage, when compared to healthy 
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 ones. In this figure is also displayed the representative flow cytometry plots of annexin-V 
[(annexin-V; x axis)/PI (y axis)] binding. 
 
 
Figure 2 - Effect of flavonoids (3.1 - 50 µM) on human neutrophils' apoptosis, assessed 
by flow cytometric analysis of annexin-V binding assay. ****p ≤ 0.001, ***p ≤ 0.001, **p ≤ 
0.01, and *p ≤ 0.05, compared with the control assay (without flavonoid). Values are given 
as the mean ± SEM (n≥3). 
 
 
3.2. Effect of caspases-3, -8 and -9 inhibitors on flavonoid-induced apoptosis 
The flavonoids under study were treated with specific and irreversible caspases inhibitors 
to verify its influence on the flavonoids-induced apoptosis. Figure 4 reveals that in the 
presence of Z-DEVD-FMK, a caspase-3 inhibitor, the induction of apoptosis decreased for 
all the flavonoids, to percentages lower than 20 %; the only exception was for flavone 1c, 
for which the induction of apoptosis decreased, but just to 39 ± 1 %. This significant 
decrease of apoptosis percentage indicates that flavonoids induce apoptosis via capase-
3. In what concerns caspase-8, the activity of all flavonoids was affected once more. 
Figure 4 clearly shows a diminished percentage of apoptosis for all the flavonoids in the 
presence of this inhibitor, almost all to values below 20 %, for 50 µM. This means that 
when caspase-8 is inhibited the flavonoids are not capable of inducing apoptosis in a 
large extent, which indicates that caspase-8 is also involved in the observed pro-apoptotic 
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Figure 3 - Representative flow cytometry plots of annexin-V [(annexin-V; x axis)/PI (y 
axis)] binding and representative images of cytocentrifuge preparations after staining with 
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 Hemacolor® for control (without flavonoid) (A), 50 µM of luteolin 4c (B), 50 µM of flavone 
3c (C), 50 µM of chrysin 4a (D), 50 µM of flavone 1c (E), after 4h of incubation. 
Arrowheads indicate an example of apoptotic neutrophil. 
 
 
effect. For apigenin 4b, this effect was not so pronounced since its capacity to induce 
apoptosis was already low, when compared to the other tested flavonoids. In the presence 
of , Z-LEHD-FMK, caspase-9 inhibitor, the pronounced decrease of apoptosis percentage 
is also plain; however, it is possible to distinguish two groups: one formed by luteolin 4c, 
flavone 1c, and chrysin 4a, flavone 3c, quercetin 4d, in which apoptosis percentages were 
near 20 %, for 50 µM; and the other integrating flavone 2c, and apigenin 4b, in which 
apoptosis percentages almost equalled the control (without flavonoid), for 50 µM (figure 
4). 
 
 
 
Figure 4 - The effect of caspases inhibitors in flavonoids’ pro-apoptotic activity. 
Neutrophils were cultured with or without the caspase 3, caspase 8 or caspase 9 
inhibitors, in the presence of the studied flavonoids (50 µM), before assessment of 
neutrophil apoptosis by flow cytometry analysis. ****p ≤ 0.001, ***p ≤ 0.001, **p ≤ 0.01, 
and *p ≤ 0.05, compared with the control assay (without flavonoid). The values are given 
as the mean ± SEM (n ≥ 3). 
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 3.3. Influence of flavonoids on neutrophils’ mitochondrial potential 
Figure 5 represents the percentage of cells expressing ∆Ѱm after 4h of incubation with 
the tested flavonoids. The values obtained under influence of the tested flavonoids were 
close to the control (without flavonoid). As so, none of the tested flavonoids affected the 
mitochondrial potential, at the present experimental conditions. CCCP was used as 
positive control (50 - 150 µM). 
 
Figure 5 - Effect of flavonoids in the ∆Ѱm, assessed by flow cytometric analysis, and 
expressed as the percentage of cells expressing ∆Ѱm, after the incubation period. ****p ≤ 
0.001, compared with the control assay (without flavonoid). The values are given as the 
mean ± SEM (n ≥ 3). 
 
 
 3.4. Activation of neutrophils’ p53 by the studied flavonoids 
Under the studied experimental conditions, none of the studied flavonoids was capable of 
activating p53, for all the incubation periods tested, 4, 6, 8 and 24h (data not shown). 
Nutlin-3a (40 µM) was used as positive control for which an effective activation was 
observed (data not shown). [17] 
 
 
4. Discussion 
Neutrophils are key players in the regulation of the inflammatory response; they are 
considered both inflammatory effectors and immunoregulatory cells. [18] It is now evident 
that neutrophils’ demise is mediated by a complex network of intracellular death / survival 
signaling pathways and variety of extracellular stimuli, namely by pro-inflammatory 
cytokines. [2] The flavonoids selected for this study were previously shown to be effective 
inhibitor of these pro-inflammatory cytokines [19], which make them potential modulators 
of apoptosis. The regulation of neutrophils’ apoptosis may constitute a new therapeutic 
target and another key to understand and to contain the uncontrolled deleterious effects of 
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 chronic inflammation, a condition that affects millions of people, characterized by 
permanent affliction and disability. [20] In this work, several assays were undertaken 
pursuing the idea that these flavonoids would be able to modulate neutrophil’s apoptosis. 
Moreover, it was bidden to understand in which apoptotic pathway this flavonoids were 
acting and finally their putative activating effect on p53.  
Five of the flavonoids selected for these study share a functional substitution pattern, a 
catechol group in B-ring, that has already demonstrated to be determinant for various of 
the anti-inflammatory effects of flavonoids [19, 21, 22]; those are flavones 1c, 2c, 3c, 
luteolin 4c and quercetin 4d, although they differ in the number of OH groups in A and C 
rings. Even though, chrysin 4a and apigenin 4b, which has none or just one OH group in 
B ring were tested to ascertain if the catechol group is indeed essential for the activities 
under study. 
All the tested flavonoids induced neutrophil’s apoptosis. Apigenin 4b, which has only one 
OH group in B-ring, was the less potent, with an apoptosis induction of only 10.4 ± 3.6 % 
for the highest tested concentration, 50 µM (figure 2). Luteolin 4c, flavonoids 3c and 2c, 
and chrysin 4a were the ones that led to a greater increase of apoptosis, compared to the 
control (without flavonoid) (figure 2). The first three flavonoids have in common the 
catechol group in B ring which may explain their proximity of potencies; however, chrysin 
4a has no OH group in B ring, and therefore this result does not corroborate the 
determinant role of the catechol group for the activity under study. On the other hand, it is 
possible to conclude that just one OH group in B-ring is not good enough to induce 
apoptosis, as confirmed in apigenin 4b , which only displayed a weak effect, 10 ± 4 %, for 
50 µM; quercetin 4d and flavone 2c, in their turn, had similar effects, by inducing 
apoptosis in 36 ± 6 %, 41 ± 7 %, respectively, for 50 µM; revealing that a 3-OH in C ring, 
for quercetin, and a 5-OH in A ring, for 2c, do not accredit for apoptosis, more on the 
contrary. Lucas and co-workers have already demonstrated that luteolin and apigenin 
induced neutrophils’ apoptosis, as did other plant flavone, wogonin, in a time- and 
concentration- dependent manner; however, they did not establish a structure/activity 
relationship. [23] Liu and co-workers showed that quercetin was able to prevent delayed 
apoptosis in neutrophils exposed to lipopolysaccharide (LPS), probably by quercetin 
ability to induce apoptosis, reversing the LPS effect; [24] this result corroborates the 
observations made in the present study. More recently, a study of the pro-apoptotic 
effects of chlorinated flavonoid in human neutrophils attested once more their involvement 
on the caspase-3 mediated apoptosis. [15] All in all, these results prove that the studied 
flavonoids are promising molecules to solve the inflammatory process by means of 
neutrophils’ apoptosis induction; avoiding the neutrophilia phenomenon, found in various 
III.4. Original Research
133
 infectious and chronic diseases, and consequently, the overproduction and release of 
toxic metabolites that always lead to tissue injury and subsequent organ dysfunctions. [5] 
Generally, the apoptosis process occurs through two different pathways: intrinsic and 
extrinsic. The intrinsic pathway is usually characterized by the loss of mitochondrial 
membrane’s integrity and release of cytochrome c, apoptotic protease activating factor 1 
(Apaf-1) and other pro-apoptotic factors into the cytoplasm. The mitochondrial 
membrane’s potential is highly dependent on the ratio between pro-apoptotic (Bax) and 
anti-apoptotic (Bcl-2) factors. The cytochrome c, Apaf-1, dATP and procaspase-9 
associate to form a complex designated as apoptosome that activates caspase-9 through 
autocatalysis. The extrinsic pathway is characterized by the triggering of the members of 
the death receptor super-family, such as tumor necrosis factor receptors (TNFR), Fas, etc. 
The ligands bind to the receptor, leading to the recruitment of specific adaptor proteins 
Fas-associated protein with Death Domain (FADD) / tumor necrosis factor receptor type 
1-associated death domain (TRADD) and recruitment and processing of procaspase-8 
molecules. The latter can in turn activate Bid, which represents a crosstalk between 
extrinsic and intrinsic death pathways, which may explain why this pathway may also 
activate caspase 9. Caspase-9 and caspase-8 activate caspases-3 through the cleavage 
of procaspase-3 that, in turn, activate other executor caspases and cleave cellular targets 
[2, 10] As so, it is essential to understand by which pathways these flavonoids exert their 
pro-apoptotic effects. For this purpose, three selective and irreversible caspase inhibitors 
were tested: Z-DEVD-FMK, for caspase-3, Z-IETD-FMK, for caspase-8, and Z-LEHD-FMK 
for caspase-9. In general, the obtained results indicate that flavonoids exert their effects 
via activation of caspases, as all the inhibitors used affected the apoptosis percentages of 
flavonoids. This is not new for apigenin and luteolin, as Lucas and co-workers, in the 
same work referred above, stated that their effect in apoptosis was achieved through 
direct effect in caspases, although they used a broad spectrum caspase inhibitor. [23] In 
this work we aimed to investigate the deeper effect in each caspase. The caspase-3 
inhibitor significantly decreased the apoptosis percentage of all flavonoids, down to values 
almost equal to the control (without flavonoid), for flavone 1c in a slighter extent, indicating 
that they exert their effect via caspase-3. Zielinska-Przyjemska and co-workers studied 
naringenin, naringin and hesperidin and concluded that they induce caspase-3 activity 
through their antioxidant effects. They observed that production of ROS inhibited the 
caspase-3 activation, and consequently the apoptosis process. The tested flavonoids 
reversed this process. [25] Interestingly, the flavonoids studied in the present work have 
also proved to modulate the production of several ROS [21]; so they may be able to 
modulate apoptosis, through direct or indirect inhibition of caspase-3 activity. However, as 
caspase-3 is common to the intrinsic and extrinsic apoptotic pathways, this result needed 
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 to be further investigated. For caspase-8, as for caspase-3, the pro-apoptotic effect of all 
flavonoids was reduced in the presence of the selective inhibitor, nearly to the control 
levels. Flavone 1c was the one that was less affected by the caspase inhibitor, similar to 
what happened for caspase-3. Generally, it is possible to conclude that caspase-8, 
associated with the extrinsic apoptotic pathway, is also involved in the pro-apoptotic effect 
of flavonoids. For caspase-9 two kinds of behaviour were observed, luteolin 4c, flavone 
1c, and chrysin 4a, flavone 3c, quercetin 4d, presented apoptosis percentages higher or 
near 20 %; and flavone 2c, and apigenin 4b lowered their activities to values below 20 %. 
The pro-apoptotic effects of the first group leave some doubts in what extent they are 
dependent on caspase-9, as the apoptotic induction is affected, but in a smaller extent.  
The ability of flavonoids to induce apoptosis has been described by several authors. 
However, this kind of activity is more explored for flavonoids as anti-cancer drugs, so the 
studies are mainly done in cancer cell lines. [26, 27] Luteolin, for example, is described as 
an inductor of caspases-3, -8 and -9 in human malignant cells. [28] Chrysin is also 
reported as able to induce apoptosis by the degradation of caspases-3 and-8, but once 
more in human cancer cell lines. [29] The studies of caspases inhibition in inflammatory 
cells, namely in neutrophils, are scarce; and, as it is well proved, the apoptosis modulation 
effect vary among cell types; this being one of the reasons why this kind of study is 
important for a better understanding of the mechanisms by which flavonoids act in each 
cell type. [30, 31] To our knowledge, it is the first time the effect of flavonoids 1c to 4d on 
caspases -8 and -9 activity is evaluated, in neutrophils. 
A study of the alteration of the mitochondrial membrane potential was undertaken, as it is 
involved in the intrinsic pathway. It was observed that none of the flavonoids altered the 
mitochondrial potential (figure 5), which does not corroborate the intrinsic pathway. We 
can speculate that one of the hallmarks of neutrophil physiology is a reduced number of 
mitochondria, and for this reason no effect was detected, however we obtained positive 
results when we used the positive control CCCP, discarding this hypothesis. Moreover, 
through the quantification of cytochrome c we would be able to corroborate these results, 
but because of the low number of mitochondria that kind of study is not possible. [5] The 
lower effects on the apoptosis induction observed for some flavonoids in the presence of 
caspase-9 inhibitor may be related to the fact that caspase-9 is involved in the intrinsic 
pathway of apoptosis or that caspase 8 may trigger caspase 9 activation through the 
crosstalk between extrinsic and intrinsic death pathways, as mentioned above. This last 
hypothesis is supported by the fact that the studies undertaken do not corroborate a key 
role of the intrinsic pathway.  
Finally, as the transcription signalling cascade is also implicated in apoptosis regulation, 
this work aim to understand the effect of the flavonoids on p53 activation. The p53 
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 transcription pathway is intimately related with inflammation and can act at least in to 
stages: as a common inhibitor of NF-ĸB-dependent transcription and as a positive 
regulator of neutrophils clearance by macrophages. [32] The up-regulation of p53 triggers 
the extrinsic pathway of apoptosis, and as the studied flavonoids seem to act through this 
pathway, they may also be related to the p53 activation. [10] However, under the studied 
experimental conditions no effect of the studied flavonoids was observed in p53 activation. 
In this work the spontaneous apoptosis was studied, but it is known that under 
inflammation conditions neutrophils overproduce ROS, as already mentioned. These ROS 
cause apoptosis by DNA damage but also by p53 activation; it is possible that the studied 
flavonoids as inhibitors of ROS production and activity may indirectly interfere with the p53 
activation. [2, 21] Several cytokines, tumor necrosis factor alpha (TNF-α), interferon 
gamma (IFN-ɣ), and chemokine interleukin 8 (IL-8) have also been reported to delay 
neutrophils’ apoptosis, contributing to extended inflammatory states. [1] The flavonoids 
studied in this work, particularly, luteolin 4c, and flavones 1c and 3c, have already 
demonstrated to be effective inhibitors of these pro-inflammatory mediators in human 
whole blood [19], which may contribute to boost their efficiency in human neutrophils’ 
apoptosis induction.  
In conclusion, the studied flavonoids were effective pro-apoptotic molecules; this effect is 
potentially undertaken via caspases 3, 8 and 9, but no mitochondrial involvement could be 
observed, indicating a key role of the extrinsic pathway. Thus, the majority of the studied 
flavonoids revealed a great potential to be used in chronic inflammation where the normal 
apoptotic function of neutrophils is altered. 
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 CHAPTER IV. Discussion and Conclusions 
 
IV.1. Integrated Discussion 
 
As mentioned before, chronic inflammatory diseases are responsible for the permanent 
affliction, disability, and, many times,  premature death of millions of patients. They 
constitute a heavy burden for modern society. Those diseases include rheumatoid arthritis 
Crohn’s disease, Alzheimer’s disease, diabetes, among others.(1, 2) 
Although inflammation is defined as a natural response of the body to infection, irritation 
or other injuries, it may trigger or aggravate several pathologic processes when the anti-
inflammatory defences of the organism are not enough to contain and antagonize the 
deleterious activities of the overproduced pro-inflammatory mediators. The mechanisms 
involved in inflammatory processes are well known; however, it is also clear that they are 
governed by a series of mediators that favour the inflammation and others that counteract 
those actions, resulting in complex networks that difficult the development of the ideal 
anti-inflammatory drugs.(3) Additionally, the available treatments, albeit successful in 
some cases, have numerous and severe side effects. These facts justify the constant 
pursuit for alternative therapeutic approaches for chronic inflammation diseases. 
In recent years, flavonoids have been associated with various health benefits, namely 
antioxidant (4), antiviral (5), antibacterial (6), anti-inflammatory (7), vasodilatory (8), 
anticancer (9), and anti-ischaemic (10) properties. These properties, associated with their 
ubiquitous distribution in nature, and their presence in the great majority of foods, as part 
of our daily diet,(11) confer flavonoids great value-added molecules. Taking in account 
these potential anti-inflammatory properties, flavonoids started to be considered a 
valuable alternative to modulate and prevent the inflammatory process; and moreover, to 
be the base for the synthesis of more potent and efficient anti-inflammatory drugs. Thus, a 
large number of studies have been performed, and it has become clear that the activities 
of flavonoids may vary significantly, depending on slight variations in their chemical 
structure or other characteristics such as the spatial conformation or the lipophilicity of the 
molecules.(2) In general, the studies available in the literature lack a coherent and rational 
approach of the flavonoids activity, since, frequently, only a small number of flavonoids 
are studied using the same techniques; there are a variety of assays for studying the 
same properties, most of them in non-cellular systems, not allowing a reliable comparison 
among them; most of the time the studies are done with the same flavonoids, not 
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 exploring new synthesized, and never tested flavonoids, or with plant extracts, which 
difficults the conclusions taken for each one of the flavonoids included in the extract. 
The work developed in this thesis intended to extend and rationalize the current 
knowledge on the alleged anti-inflammatory properties of flavonoids by elucidating the 
mechanisms of action related with their structure (structure-activity relationships). For this 
purpose, a group of 24 flavonoids were selected. They belong to three flavonoid classes, 
flavones, flavanones and flavonols, which have different patterns of substitution in A-, B- 
and C-rings (figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - Chemical structures of the studied flavonoids. 
 
Neutrophils are the first cells arriving at the inflammation loci and are part of the first line 
of defence of the innate immune system. During the inflammatory response, neutrophils 
greatly increase its number, life span, mobility, tissue influx ability, and phagocytic 
capacity.(12) Their role in inflammation is even more relevant because they are 
responsible for the production of an extraordinary array of oxygen-dependent and oxygen-
independent microbicidal weapons to destroy and remove infectious agents. The oxygen- 
dependent mechanisms involve the production of reactive oxygen species (ROS) and 
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 oxygen-independent mechanisms include most of the other neutrophil functions, such as 
chemotaxis, phagocytosis, degranulation, and the release of lytic enzymes and 
bactericidal peptides. These factors are essential for host defence and inflammation, but 
their overproduction, especially when high levels of ROS are overproduced in a sustained 
form, a process designated as oxidative burst, may cause or magnify damage in the 
inflammatory sites.(13, 14)  
The first work of this thesis (section III.1) aimed the study of the effect of the selected 
flavonoids in the human neutrophil’s oxidative burst, and to establish a relation between 
the activity found and their structure. Pursuing this idea, a series of studies were 
undertaken in phorbol-12-myristate-13-acetate (PMA)-activated human neutrophils and 
four luminescent and fluorescent probes were used to assess ROS production. The 
studied flavonoids were undoubtedly good modulators of the human neutrophils’ oxidative 
burst. Concerning the structure-activity relationship, the overall obtained results stress out 
the determinant importance of the catechol group in B-ring. Another main feature that 
contributed for higher activity was the presence of a 3’-methoxyl group in the B-ring. Of 
note, the current study extended knowledge on the importance of the hydroxylations in the 
A-ring. It became clear that the substitution pattern in A-ring, i.e. the number and position 
of OH groups, only implicated slight differences in the activity. The presence of the 3-OH 
in the C-ring and the C2=C3 double bond just became important features when the H2O2 
and HOCl reactive species were studied. Noteworthy the accepted general idea is that a 
flavonoid is a good antioxidant when it gathers a combination of essential features: OH 
groups in B-ring that are able to form hydrogen bounds with 3-OH, aligning the three 
rings; the combination of the 3- and 5-OH groups with the 4-oxo group in C ring allows 
electron delocalisation from the 4-oxo group to both substituents.(2) Actually, in this work 
it was attested the importance of these features, but just for some specific reactive 
species, proving that flavonoids do not act just by scavenging ROS, but also probably by 
enzymes inactivation; and finally their overall substitution pattern also affects its 
lipophilicity, which may explain some of the different results obtained here in this in vitro, 
cellular assay. To the best of our knowledge, some of the flavonoids tested in this work 
were never studied for this kind of modulation activity, allowing us to do a better 
integration of the obtained results. All in all, the studied flavonoids that showed the most 
promising activities in this study were flavones 2d and 1d, chrysoeriol 4f and luteolin 4e. 
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Figure 2 - Studied flavonoids that presented the best modulation of human neutrophils’ 
oxidative burst activity. 
 
Three of the most active flavonoids (figure 2) share the catechol group in B-ring. As it was 
mentioned, it is well documented that this feature determines an excellent scavenging of 
ROS, because it donates hydrogen and an electron, stabilizing them and yielding 
relatively stable flavonoid radicals. However, this does not explain the reason why a 
methoxylated flavonoid is among the most active ones. In fact, the replacement of an OH 
by a methoxyl group increases the lipophilicity of the molecules,(15) enabling the access 
of the flavonoid to the cell. Landi-Librandi and co-workers undertook a study with 
liposomal flavonoids and concluded that the ability to inhibit the chemiluminescence of 
luminol was a function of the lipophilicity of the compounds.(16) Moreover, the methylation 
of the catechol arrangement in the B-ring is described as having the capacity to convert 
the flavonoid into an nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase 
inhibitor, which may be one more reason for the observed activity of chrysoeriol 4f. (17, 
18) Another important enzyme in the oxidative burst process is myeloperoxidase (MPO), 
which is implicated in the HOCl formation, and a docking study indicated that the B-ring’s 
hydroxyl group(s) of flavonoids may be important for entering the pocket, reaching the 
active site of MPO.(19) 
 
Once revealed the great capacity of the tested flavonoids to modulate oxidative burst of 
neutrophils, as an important deleterious process of inflammation, it became of great 
interest to evaluate if these molecules may comprise activities in other pathways related to 
inflammation. As so, the second work of this thesis (III.2) was focused in the modulation of 
the production of leukotriene (LT)B4 and the type of inhibition and interaction between 
flavonoids and lipoxygenase (LOX), the enzyme involved in the production of this LT. 
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 Leukotrienes (LTs) are identified as mediators of a series of inflammatory diseases, 
namely rheumatoid arthritis, inflammatory bowel disease, psoriasis, allergic rhinitis, 
bronchial asthma, atherosclerosis and certain types of cancer. (20) LTB4, in particular, 
participates in a range of pathophysiological events and exerts its activity by the 
recruitment of leukocytes to the inflammation sites. It has been demonstrated to  be a 
potent neutrophil chemoattractant in humans in vivo. (21, 22) Studying the inhibition of 
LTB4 production in human neutrophils, three groups of flavonoids were established, with 
different potencies. The most active ones, comprised luteolin 4e, flavones 1d, 2d and 3d, 
and quercetin 4i, which share the same substitution pattern in the B-ring, a catechol group 
(figure 3). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 - Studied flavonoids that presented the best inhibition of LTB4 production. 
 
As it can be seen in figure 3, the number of OH groups in the A-ring did not seem to be a 
determinant feature for the inhibitory activity. The 3-OH in C-ring, although being 
important was not essential for a better activity, as quercetin 4i was 2.5 times less active 
than luteolin 4e. This is in agreement with the study of Sadik and co-workers.(23) 
Interestingly, some of the flavonoids with more activity in this study were equally active in 
the modulation of the oxidative burst. This may be because these compounds may act as 
electron acceptors from chemical groups near the LOX active centre, the interaction being 
between the electron acceptor, flavonoid, and a nucleophilic group present in the LOX 
molecule.(24) This explanation is not widely accepted. Hernandez and co-workers studied 
a group of flavonoids that did not match these structural features and they inhibited the 
production of LTB4 by LOX, proving that flavonoids do not have just this mode of action; 
they actually proposed that the studied flavonols indeed directly inhibit 5-LOX, but also 
interact with other proteins, such perhaps the cofactor 5-lipoxygenase activating protein 
(FLAP), or different protein kinases [such as protein kinase A, protein kinase C, protein 
Flavone 2d Flavone 1d Luteolin 4e 
Quercetin 4i Flavone 3d 
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 tyrosine kinases and by mitogen-activated protein kinase (MAPK) kinase] that can 
modulate the 5-LOX activity.(25)  
The most active flavonoids on the inhibition of LTB4 production assay and other four 
flavonoids with lower activity were selected for the study of their type of inhibition and to 
disclose a relationship between the flavonoid’s structure and the type of LOX inhibition. 
Noteworthy, the type of inhibition seemed to be dependent not just on the OH of the B-ring 
but also on those in the A-ring. Flavonoids 2d, 4b, luteolin 4e and quercetin 4i were found 
to be uncompetitive LOX inhibitors complex. Luteolin 4e and Quercetin 4i have in 
common a catechol group in B-ring and a 5,7-dihydroxyl in the A-ring, so these features 
may be related to this type of inhibition. On the contrary, the other studied flavonoids 
owned a mixed non-competitive type of inhibition. In this sense, the type of inhibition is not 
just defined by the number of OH groups present but more by the relative position 
occupied by these groups. The interaction between these same flavonoids and LOX were 
after evaluated by saturation transfer difference nuclear magnetic resonance (STD-NMR) 
spectroscopy and the results obtained corroborated the ones obtained for the type of 
inhibition assays. 
 
Revealed the activity of the selected solid group of flavonoids on the production of LTB4, 
other major groups of inflammatory mediators had to be studied: prostaglandins (PGs), 
cytokines and chemokines. The third work of this thesis (III.3) comprised the study of the 
flavonoids effects in prostaglandin (PG)E2, cytokines [interleukin (IL)-6, IL-1β, tumour 
necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-ɣ)] and chemokine (IL-8) 
production, in human whole blood, and the establishment of the respective structure-
activity relationship. PGE2 is a PG formed via cyclooxygenase (COX)-1 and COX-2, in the 
arachidonic acid cascade. COX-1 is constitutively expressed and responsible for the 
regulation of the homeostatic functions. COX-2 is implicated in the modulation of 
inflammation, and can be up-regulated 20-fold the inflammatory process. This hyper-
expression of COX-2 results from the integrated function of several inflammatory 
mediators, including ILs and cytokines (i.e. IL-1, IL-6, and TNF- α), via transcriptional 
activation.(26)  
The studied flavonoids revealed clear patterns of activity and some of them happened to 
be good inhibitors of COX-1 - PGE2 production. Flavonoids 1a, 2a, and 3a were three of 
the most active; they have in common none or just one OH group, being the less 
substituted flavonoids among them all (figure 4). Less substituted flavonoids have easier 
access to the small inhibitor binding active site of COX-1, than the more substituted ones. 
It was the reason why it was possible to selectively inhibit COX-2 and, at the same time, 
avoid interfering with the homeostatic functions related to COX-1. (27, 28) It was also 
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 clear that the lack of a C2=C3 double bond in C-ring, which determines the co-planarity of 
the molecule, affected dramatically the studied activity. This corroborates the results 
obtained by Wang and co-workers. (29)  
In what respects COX-2 assay, the most active flavonoids were 1d, 2d, and 3d, which 
have in common a catechol group in B ring (figure 4). Luteolin 4e was also a good 
inhibitor, sharing the same substitution pattern. So far, it was clear that the structure that 
defines a good inhibitor of COX-1 is not the same for COX-2 (figure 4), allowing the idea 
of the ultimate selective activity. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 - Studied flavonoids that presented the best inhibition of PGE2 production - via 
COX-1 (A) and - via COX-2 (B). 
 
The importance of the presence of a catechol group to the inhibition of COX-2, has 
already been reported in non-cellular in vitro studies and in isolated cells and it was now 
corroborated in a whole blood assay. (30) The OH groups on the B-ring appear to be 
related to a molecular conformation that influences the interactions between flavonoids 
and COX-2, being this group oriented to the hydorphobic pocket of the enzyme, (31) but 
also to the interactions between flavonoids and enzymes such as tyrosine kinase and 
protein kinase C, which are involved in the transcriptional activity of COX-2.(32) The ratio 
between COX-1 and COX-2 inhibitions revealed flavonoids 1b, 2a, 3a, 3b, and 4h as 
COX-1 selective, and 3d, apigenin 4c, chrysoeriol 4f, diosmetin 4g and (±)-eriodictyol 5b 
as COX-2 selective The activities of the flavonoids selective for COX-1 and with higher 
affinities for this enzyme may be explored in other directions, namely, in platelet studies, 
maybe revealing other interesting and promising biological effects.(33) The COX-2 
selective flavonoids, namely 3d that was one of the most active, are promising candidates 
to modulate the COX-2 activity.  
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 The best flavonoid inhibitors of COX-2, sharing a catechol group in B ring, 1d, 2d, 3d, and 
luteolin 4e, and quercetin 4i were selected to assess their ability to modulate the 
production of IL-1β, IL-6, IL-8, IFN-ɣ, and TNF-α in the same matrix used to study the 
COX activity, the human whole blood. Overall, the selected flavonoids proved to be 
exceptional inhibitors of cytokines’ production. The lower activities were observed for the 
inhibition of IL-8. Luteolin 4e was the most active flavonoid in the inhibition of almost all 
cytokines, IL-6, IFN-ɣ, and TNF-α, which makes this flavonoid a promise in the modulation 
of the inflammatory process. Various studies can be found in the literature, mainly for 
luteolin and quercetin, which corroborate some of the results obtained in this study; 
however, they were performed in different models, invalidating a reasonable 
comparison.(34, 35)  
 
The final work of this thesis (III.4) was devoted to an essential process to the healthy 
organism in the case of a chronic disease. It is the apoptosis process. In this study, we 
aimed to evaluate the effect of the most promising anti-inflammatory flavonoids until now, 
and two, less active, in the human neutrophils apoptosis and to study the mechanisms by 
which this effect was produced, and provide an insight on the structure/activity 
relationship. The delayed apoptosis of neutrophils has been related with numerous acute 
and chronic inflammatory diseases.(36-38) In fact, in the event of inflammatory processes, 
neutrophils over-produce a myriad of inflammatory mediators, as already described, which 
lead to the damage of the adjacent healthy tissues, propagating the inflammation. As so, 
this delayed apoptosis and clearance of neutrophils may contribute to solve the unwanted 
and exaggerated inflammation.(39) 
All the tested flavonoids induced neutrophil’s apoptosis. Luteolin 4c, flavonoids 3c and 2c, 
and chrysin 4a were the ones that led to a greater increase of apoptosis. Some studies 
have already defined the flavonoid’s ability to modulate neutrophils apoptosis, but did not 
establish a relationship to their structure.(40, 41) Based on the results obtained in present 
work, we may conclude that catechol group is important for the activity, but not 
determinant, as chrysin 4a has no substitution in B-ring and was equally active (figure 5).  
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Figure 5 - Studied flavonoids that presented the best pro-apoptotic effect. 
 
Furthermore it was studied which caspases pathways were involved in the pro-apoptotic 
effect. The studied flavonoids were effective pro-apoptotic molecules; this effect is 
potentially undertaken via caspases 3, 8 and 9, but no mitochondrial involvement could be 
observed, indicating a key role of the extrinsic pathway. The studies of caspases inhibition 
in inflammatory cells, namely in neutrophils, are scarce; and, as it is well described, the 
apoptosis modulation effect vary among cell types; this being one of the reasons why this 
kind of study is important for a better understanding of the mechanisms by which 
flavonoids act in each cell type.(42) p53 is a transcription factor directly related to 
apoptosis induction and its up-regulation triggers the extrinsic pathway of apoptosis.(43) 
However, under the studied experimental conditions no effect of the studied flavonoids 
was observed in p53 activation. 
 
Combining and integrating all the works developed under this thesis, it is clear that a 
pattern of action of these flavonoids was found. Overall, flavonoids 3’,4’- dihydroxyflavone, 
5,3’,4’-trihydroxyflavone, 7,3’,4’-trihydroxyflavone, and luteolin (figure 6) were undoubtedly 
good modulators of the pro-inflammatory mediators, which may represent excellent new 
alternatives for the resolution of inflammatory processes. 
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Figure 6 - Chemical structures of the most promising flavonoids found as modulators of 
the pro-inflammatory mediators. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3’,4’-Dihydroxyflavone 5,3’,4’-Trihydroxyflavone 
5,3’,4’-Trihydroxyflavone Luteolin 
IV. Discussion and Conclusions
149
 IV.2. Conclusions 
 
From the results obtained in the course of the performed studies it may be concluded that: 
 
 
 The structural features of flavonoids clear influence the modulation of all the pro-
inflammatory mediators; 
 
 All the tested flavonoids were able to modulate the human neutrophils’ oxidative 
burst; 
 
 The catechol moiety in B-ring was essential for a greater inhibition of ROS 
production; 
 
 The catechol moiety in B-ring was essential for a greater inhibition of LTB4 
production, independently of the substitution pattern in A-ring; 
 
 The type of inhibition of soybean LOX, as the flavonoids interaction with it, are not 
only dependent on the OH groups in B-ring, but also in A-ring; 
 
 The less substituted flavonoids were better inhibitors of PGE2 production, via COX-
1; 
 
 The catechol moiety in B-ring was essential for a greater inhibition of PGE2 
production, via COX-2; 
 
 The flavonoids that inhibited the PGE2 production, via COX-2, simultaneously 
inhibited the production of pro-inflammatory cytokines; 
 
 The selected flavonoids are pro-apoptotic molecules, and exert their effects via 
caspases, but no mitochondrial involvement could be observed, indicating a key role of 
the extrinsic pathway; 
 
 Flavonoids 3’,4’- dihydroxyflavone, 5,3’,4’-trihydroxyflavone, 7,3’,4’-
trihydroxyflavone, and luteolin, comprising the essential structural features referred, are 
undoubtedly promising new alternatives for the resolution of inflammatory processes. 
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